Generated by All in One SEO v4.9.8, this is an llms.txt file, used by LLMs to index the site. # Pediatric Endocrine Society Advancing Endocrine Health in Children and Adolescents ## Sitemaps - [XML Sitemap](https://pedsendo.org/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [June 2026 President's Letter](https://pedsendo.org/presidents-message/june-2026-presidents-letter-copy/) - Dear Colleagues, Welcome to my PES monthly President's Newsletters! I want to begin by expressing my heartfelt gratitude to Dr. Laurie Cohen for her outstanding leadership this past year. She is a role model for us all. I am deeply honored to step into this role and to work alongside our members in advancing PES's - [New Meds and Tech - Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes ](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-afrezza-rapid-acting-inhaled-insulin-approved-for-children-≥-6-years-old-with-diabetes/) - Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and edited by Dania Al-Hamad, MD and Neha Patel, DO Afrezza® (insulin human) inhalation powder is a drug and device combination product consisting of a rapid-acting Technosphere® insulin (TI) and an oral inhaler - [New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17) ](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-dt-committee-teplizumab-approval-expanded-to-stage-3-type-1-diabetes-ages-8-17/) - New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17) Prepared on behalf of PES Drugs and Therapeutics Committee by Neha Patel, DO. Teplizumab (Tzield™), a humanized anti–CD3 monoclonal antibody, is a disease-modifying therapy targeting the autoimmune process in type 1 diabetes (T1D). It was initially approved by the - [New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection ](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-dt-committee-imcivree-setmelanotide-injection/) - New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On March 19, 2026, the FDA approved and expanded indication for IMCIVREE® (setmelanotide), establishing it as the first and only FDA-approved therapy for patients aged 4 years and older with acquired hypothalamic obesity (aHO).1 The FDA approval was supported by data from the - [Drugs and Therapeutics Shortage Update: Estradiol Transdermal Patch ](https://pedsendo.org/drug-shortages/drugs-and-therapeutics-shortage-update-estradiol-transdermal-patch/) - Drugs and Therapeutics Shortage Update: Estradiol Transdermal Patch Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On 3/12/26, the American Society of Health-System Pharmacists (ASHP) reported shortages of estradiol transdermal patches from multiple manufacturers, including Amneal, Noven, Sandoz, and Zydus.1 Although specific products were not listed, media reports note limited availability of major brands such - [June Fellow Spotlight - Cassie Gessling, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/june-fellow-spotlight-cassie-gessling-md/) - Cassie Gessling, MD I am currently a second year (nearly third year!) fellow at Walter Reed National Military Medical Center. I graduated from the University of North Texas with a Biology degree and obtained my medical degree from Texas A&M. I completed residency training in pediatrics at Naval Medical Center Portsmouth, which was briefly interrupted by an operational medicine - [Historical Tidbit - Then and Now: This Month in Endocrine History ](https://pedsendo.org/historical-tidbits/historical-tidbit-then-and-now-this-month-in-endocrine-history/) - Historical Tidbit - Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO It is difficult to imagine a time when we did not know what compounds allowed the thyroid gland to exert its physiological effects on the body. Prior to 1914, all that was known was that “1) The thyroid contains some substance capable of producing marked physiologic effects, - [May 2026 President's Letter](https://pedsendo.org/presidents-message/may-2026-presidents-letter/) - Dear Colleagues, One month ago, we held another highly successful annual meeting. Attendance has continued to grow each year, with 1,334 participants this year. Many thanks to our co-chairs, Anshu Gupta and Marie‑Eve Robinson, and to the entire Program Committee for creating such an engaging and impactful experience, not to mention their rousing rendition of - [New Drugs and Therapeutics Update: Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D)  ](https://pedsendo.org/new-meds-and-tech/teplizumab-approval-expanded-to-children-1-year-with-stage-2-type-1-diabetes-t1d/) - Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D) Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and edited by Neha Patel, DO. Teplizumab is a humanized anti-CD3 monoclonal antibody that mitigates autoimmune beta-cell destruction by increasing regulatory T cells and inducing exhaustion of CD4+ and - [May Historical Tidbit- This Month in Endocrine History      ](https://pedsendo.org/historical-tidbits/may-this-month-in-endocrine-history/) - This Month in Endocrine History Submitted by Evan Graber, DO In May 1946, it had already been demonstrated that the thyroid gland utilized iodine more than any other organ in the body and that it’s function was regulated by the concentration of iodine present in the gland. Iodine was used as treatment for thyroid disease and radioactively tagged iodine could be used - [May Fellow Spotlight - Daniela Aguilar Abisad, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/may-fellow-spotlight-daniela-aguilar-abisad-md/) - Daniela Aguilar Abisad, MD I am a third year Pediatric Endocrinology Fellow at Stanford University. I was born and raised in the beautiful coastal town of Tampico, Mexico, where my Mexican-Lebanese heritage shaped my early perspectives on culture and community. I attended medical school at Tec de Monterrey and completed my pediatric residency at Nicklaus Children's Hospital - [In Memoriam - William Valentine Tamborlane Jr.: August 25, 1946 – May 12, 2026](https://pedsendo.org/in-memoriam/in-memoriam-william-valentine-tamborlane-jr-august-25-1946-may-12-2026/) - Obituary -William Valentine Tamborlane Jr. William V. (Bill) Tamborlane was born on August 25, 1946, in the Bronx, New York, to William and Eleanor Tamborlane. He attended Bergen Catholic High School in Oradell, New Jersey, and graduated Phi Beta Kappa in Chemistry from Georgetown University in 1968 and continued his education there through medical - [April 2026 President's Letter](https://pedsendo.org/presidents-message/april-2026-presidents-letter-copy/) - Dear Colleagues, This introduction to the President's Newsletter will be brief as we make the final preparations for the 2026 Annual Meeting. The Program Committee has organized a terrific conference featuring fascinating plenaries, symposia, and Meet the Professor and SPARK sessions. I especially look forward to seeing the work of the next generation of investigators. - [New Drugs and Therapeutics Update: JUXTAPID® (lomitapide) capsules ](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-juxtapid-lomitapide-capsules/) - New Drugs and Therapeutics Update: JUXTAPID® (lomitapide) capsules Prepared by Daniel Mak, MD On March 3rd, 2026, the FDA approved and expanded indication for JUXTAPID (lomitapide) capsules for pediatric use in children 2 years of age and older with homozygous familial hypercholesterolemia (HoFH).1 The FDA approval for pediatric use was based on the results of a Phase - [April Fellow Spotlight: Dr. Felicia Cooper ](https://pedsendo.org/member-spotlight/fellow-spotlight/april-fellow-spotlight-dr-felicia-cooper/) - Felicia Cooper, MD I am a third-year pediatric endocrinology fellow at Nemours Children’s Health in Orlando, Florida. I will be staying at my current institution as a pediatric endocrinologist starting July 2026. My medical training began shortly after high school—I completed a 7-year accelerated BS/MD pipeline program at Florida Atlantic University College of Medicine. I then - [April APP Spotlight: Jordin Frasch, DNP, APRN, CPNP-PC ](https://pedsendo.org/member-spotlight/app-spotlight/april-app-spotlight-jordin-frasch-dnp-aprn-cpnp-pc/) - Jordin Frasch, DNP, APRN, CPNP-PC Jordin Frasch, DNP, APRN, CPNP-PC is a Pediatric Nurse Practitioner at Cedars-Sinai Guerin Children’s in the Department of Pediatric Endocrinology in Los Angeles, California. Jordin completed her Doctor of Nursing Practice and Master of Science in Nursing at Duke University, where she trained as a Pediatric Nurse Practitioner in Primary - [April Historical Tidbit: Then and Now: This Month in Endocrine History  ](https://pedsendo.org/historical-tidbits/april-historical-tidbit-then-and-now-this-month-in-endocrine-history/) - Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1963, Arnold H. Kadish reported on the use of a “servomechanism for glucose monitoring and control,” the first closed-loop system. A patient with known diabetes had IV catheters placed for blood to infuse to an “Autoanalyzer” and to receive intervention. The patient had a glucose above 150 mg/dL, which - [March 2026 President's Letter](https://pedsendo.org/presidents-message/march-2026-presidents-letter/) - Dear Colleagues, "Beware the Ides of March" warned a soothsayer to Julius Caesar in William Shakespeare's Julius Caesar. The prophecy proved fatal when Caesar was assassinated in mid-March. While the specificity of that date was likely poetic license, the Ides of March has since become synonymous with foreboding. Historically, however, it was a day of reflection - [New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-sogroya-somapacitan-beco-injection/) - New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya® (somapacitan-beco) for three new pediatric indications. The therapy is now authorized for children aged 2.5 years and older with idiopathic short stature (ISS), small for gestational age (SGA) without - [Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update](https://pedsendo.org/new-meds-and-tech/depo-provera-and-increased-risk-of-meningioma-fda-label-update/) - Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and Drug Administration (FDA) approved an update to the U.S. Prescribing Information for Depo-Provera®, adding a warning about a potential increased risk of meningioma, a typically benign intracranial tumor. The - [Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics](https://pedsendo.org/new-meds-and-tech/navepegritide-yuviwel-for-children-with-achondroplasia-new-drugs-and-therapeutics/) - Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February 27th, 2026, the FDA approved Navepegritide (Yuviwel®), a C-natriuretic peptide (CNP) analog prodrug developed by Ascendis Pharmaceuticals using TransCon® CNP technology.1 The once‑weekly subcutaneous therapy is indicated to promote linear growth - [In Memoriam: Delbert A Fisher, MD (August 12, 1928 – March 4, 2026)](https://pedsendo.org/in-memoriam/in-memoriam-delbert-a-fisher-md-august-12-1928-march-4-2026/) - In Memoriam: Delbert A Fisher, MD (August 12, 1928 – March 4, 2026) Del Fisher, MD, one of the 38 founding members of our Society (formerly the Lawson Wilkins Pediatric Endocrine Society), passed away at age 97 years in March, 2026. Dr. Fisher was an icon in the field of endocrinology, the only individual to - [March Historical Tidbit - Then and Now: This Month in Endocrine History ](https://pedsendo.org/historical-tidbits/march-historical-tidbit-then-and-now-this-month-in-endocrine-history/) - March Historical Tidbit - Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In March 1922, Banting and Best published a preliminary report on the effect of subcutaneously administered pancreatic extract on a 14-year-old boy with diabetes. Previous attempts to treat diabetes with orally administered extracts had failed and the use of pancreatic extracts was almost abandoned. Banting and Best thought that the “internal secretion” - [March Fellow Spotlight - Sahaj Singh, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/march-fellow-spotlight-sahaj-singh-md/) - Sahaj Singh, MD I am Sahaj Singh, a second-year pediatric endocrinology fellow at Texas Children’s Hospital, Baylor College of Medicine. I am originally from India, where I began my medical education at the age of 18 at Kasturba Medical College, Manipal Academy of Higher Education, India, an Institution of Eminence and Deemed University. During my - [New Meds and Tech: DESMODA™ (desmopressin acetate) Oral Solution ](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-desmoda-desmopressin-acetate-oral-solution/) - New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution Prepared by Daniel Mak, MD DESMODA® (desmopressin acetate) Oral Solution On February 25th, 2026, the FDA approved DESMODA™ (desmopressin acetate) oral solution for the management of central diabetes insipidus (arginine vasopressin deficiency) as antidiuretic replacement therapy in both adult and pediatric patients of all ages.1 DESMODA™ - [February 2026 President's Letter](https://pedsendo.org/presidents-message/february-2026-presidents-letter/) - Dear Colleagues, This winter is bringing lots of flurries, both of actual snow (16" at my house this week on top of that remaining from the January storm) and of PES activities. Multiple education programs and webinars were delivered as part of the PES Education Committee Webinar Series and the PES SIG State of the Art Series, with many - [2026 Open Fellowship Positions](https://pedsendo.org/fellowship-posting/2026-open-fellowship-positions/) - National Institutes of Health Positions: 1 Description: ACGME-accredited pediatric endocrinology fellowship based at the National Institutes of Health Clinical Center, the largest clinical research hospital in the world. This unique fellowship combines exceptional clinical and research training in pediatric endocrinology over the course of 3 years. The fellowship is supported through close collaboration with nearby - [Drug alerts and recalls - Depo-Provera and Increased Risk of Meningioma: FDA-Label Update](https://pedsendo.org/drug-alerts/news-from-the-dt-committee-depo-provera-and-increased-risk-of-meningioma-fda-label-update/) - Depo-Provera and Increased Risk of Meningioma: FDA-Label Update. Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and Drug Administration (FDA) approved an update to the U.S. Prescribing Information for Depo‑Provera, adding a warning about a potential increased risk of meningioma, a typically benign intracranial tumor. The - [New Meds and Tech: Mounjaro (tirzepatide) approved in Pediatrics ](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-new-meds-and-tech-mounjaro-tirzepatide-approved-in-pediatrics/) - Mounjaro (tirzepatide) approved in Pediatrics Prepared on behalf of PES Drugs and Therapeutics Committee by, Evan Graber, DO, Emily Breidbart, MD, and Neha Patel, DO. Based on results from the SURPASS-PEDS trial1, the FDA has approved Mounjaro (tirzepatide) for use in children and adolescents aged 10 years and older with type 2 diabetes. The medication is indicated as an adjunct to - [February APP Spotlight - Karen L. Clark, MMSc, PA‑C](https://pedsendo.org/member-spotlight/app-spotlight/karen_clark/) - Karen L. Clark, MMSc, PA‑C Karen L. Clark, MMSc, PA‑C, is an Advanced Practice Provider with more than 20 years of experience in pediatric endocrinology at St. Jude Children’s Research Hospital. Since joining St. Jude in 2004, her clinical practice has centered on endocrine late effects in survivors of childhood cancer. She has contributed to - [February Fellow Spotlight - Rachael Mullin, DO, MS  ](https://pedsendo.org/member-spotlight/fellow-spotlight/february-fellow-spotlight-rachael-mullin-md/) - Rachael Mullin, DO, MS I am a third-year Pediatric Endocrinology fellow at Oregon Health & Science University (OHSU) in Portland, Oregon. Originally from Northern California, I earned my Bachelor of Science degree from the University of California, Los Angeles (UCLA), and went on to complete both my Master’s degree and medical training at Touro University California - [February Historical Tidbit: Then and Now: This Month in Endocrine History ](https://pedsendo.org/historical-tidbits/february-historical-tidbit-then-and-now-this-month-in-endocrine-history/) - February Historical Tidbit: Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In February 1985, Ullrich et al reported the amino acid sequence of the insulin receptor precursor. This allowed for elucidation of the function of the mature receptor as part of the tyrosine kinase family. Similarities between the insulin receptor and receptors of other tyrosine kinase-mediated growth factors were also reported. The - [January 2026 President's Letter](https://pedsendo.org/presidents-message/january-2026-presidents-letter-copy/) - Dear Colleagues: January marked the start of a new year and our winter Board of Directors meeting, where we also convened with our Mission Alliance Partners (MAP). Following a team‑building activity constructing bee hives for donation to the DC Beekeepers Alliance , a non‑profit dedicated to honey bee health and beekeeper education, we met with - [Historical Tidbit January - Then and Now: This Month in Endocrine History   ](https://pedsendo.org/historical-tidbits/historical-tidbit-january-then-and-now-this-month-in-endocrine-history/) - Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In January 1951, Lawson Wilkins et al published their case series demonstrating the successful treatment of congenital adrenal hyperplasia with cortisone. Seven females and 3 males were treated with cortisone and urinary levels of 17-ketosteroids, 11-oxysteroids (corticosteroids), and “estroids” were measured. 17-ketosteroids and estroids - [January Fellow Spotlight - Sydney Look, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/january-fellow-spotlight-sydney-look-md/) - Sydney Look, MD I am currently a second-year pediatric endocrinology fellow at the University of Utah. My inspiration to pursue pediatric endocrinology began soon after my diagnosis with type 1 diabetes (T1D) at age 16, when I attended a cycling camp for youth with T1D through the Florida Diabetes Camp. Meeting other adolescents with T1D helped me feel - [January APP Spotlight - John Weidinger ](https://pedsendo.org/member-spotlight/app-spotlight/january-app-spotlight-john-weidinger/) - John Weidinger John Weidinger graduated from Duquesne University’s Physician Assistant program in 1999. His first job as a PA was in an outpatient pediatrician’s office where he spent close to 6 years. In 2005, he started his journey at UPMC Children’s Hospital of Pittsburgh. He initially worked within the Weight Management and Wellness center (now embedded within - [Southern California Organization of Pediatric Endocrinology](https://pedsendo.org/regional-society/southern-california-organization-of-pediatric-endocrinology/) - Name of the Society: Southern California Organization of Pediatric Endocrinology States involved in the region: CA Website: https://www.scopendocrinology.org/ Want to learn more about this group or interested in joining? Contact us at info@pedsendo.org. - [December 2025 President's Letter](https://pedsendo.org/presidents-message/december-2025-presidents-letter/) - This month underscores the need for strong advocacy. The pediatric endocrinology match filled only 34% of programs and 49% of positions, reflecting a continued decline in applicants. A contributing factor includes lower reimbursement rates for pediatrics and pediatric endocrinology. Approximately half of U.S. children rely on Medicaid or the Children's Health Insurance Program (CHIP) for health coverage compared to - [Triangle Pediatric Endocrine Consortium (TPEC)](https://pedsendo.org/regional-society/triangle-pediatric-endocrine-consortium-tpec/) - Name of the Society: Triangle Pediatric Endocrine Consortium (TPEC) States involved in the region: NC Information: Twice yearly meetings with multiple institutions in the North Carolina triangle area and beyond. Want to learn more about this group or interested in joining? Contact us at info@pedsendo.org. - [Pestola](https://pedsendo.org/regional-society/pestola/) - Name of the Society: Pestola States involved in the region: TX, OK, LA, AK Website: https://www.pestola.org/ Want to learn more about this group or interested in joining? Contact us at info@pedsendo.org. - [Israel Society for Pediatric Endocrinology](https://pedsendo.org/regional-society/israel-society-for-pediatric-endocrinology/) - Name of the Society: Israel Society for Pediatric Endocrinology States involved in the region: Israel Website: https://www.ieps.org.il/ Want to learn more about this group or interested in joining? Contact us at info@pedsendo.org. - [Pediatric Endocrinologists of the Rocky Mountains (PERM)](https://pedsendo.org/regional-society/pediatric-endocrinologists-of-the-rocky-mountains-perm/) - Name of the Society: Pediatric Endocrinologists of the Rocky Mountains (PERM) States involved in the region: CO, UT, AZ, NM, WY, MT, ID, NV Information: PERM holds a regional meeting every 2 years and rotates the location. 2022 was held in CO, 2024 was held in UT, and 2026 will be held in NM. Want - [PEARL](https://pedsendo.org/regional-society/pearl/) - Name of the Society: PEARL States involved in the region: WA, OR, BC, AK Information: Annual meeting that rotates between Seattle, Portland and Vancouver. Members from Alaska, idaho, Alberta, and other adjacent states/provinces are more than welcome to attend. We have pediatric endocrinologist, pediatric endocrine nurses, and fellows attending. Industry-sponsored. Bruce Boston from Portland and - [Historical Tidbit - Oliver Wendell Holmes, Jr. (March 8, 1841 to March 6, 1935) American Jurist and Associate Justice of the Supreme Court of the United Stated  ](https://pedsendo.org/historical-tidbits/historical-tidbit-oliver-wendell-holmes-jr-march-8-1841-to-march-6-1935-american-jurist-and-associate-justice-of-the-supreme-court-of-the-united-stated/) - Oliver Wendell Holmes, Jr. (March 8, 1841 to March 6, 1935) American Jurist and Associate Justice of the Supreme Court of the United Stated Submitted by Alan D. Rogol, MD, Ph.D. Mr. Holmes was not a physician but lived during a major transition within medicine. In the mid-19th century, there was a real tension between the art and the new scientific discoveries in the practice of medicine. - [December Fellow Spotlight - Monica Garcia-Holguin ](https://pedsendo.org/member-spotlight/fellow-spotlight/december-fellow-spotlight-monica-garcia-holguin/) - Monica Garcia-Holguin My name is Monica Garcia-Holguin, and I am currently a second year Pediatric Endocrinology Fellow at the University of Texas Health Science Center at San Antonio. My path to medicine has been shaped by an international upbringing and a training journey across several cultures and health systems. I was born in Ecuador and spent my childhood - [In Memoriam - Dr. David T. Wyatt 1949 - December 6, 2025](https://pedsendo.org/in-memoriam/in-memoriam-dr-david-t-wyatt/) - David T Wyatt, MD, esteemed and beloved former section chief of Pediatric Endocrinology and Professor of Pediatrics, passed away on Saturday December 6, 2025, at the age of 76. He will be remembered for his sharp wit, his analytical and data driven approach to science and medicine, and his deep care for others and the - [July - Fellow Spotlight](https://pedsendo.org/member-spotlight/fellow-spotlight/july-fellow-spotlight/) - Kara Beliard, MD I am a 3rd-year Pediatric Endocrinology Fellow at the Kravis Children’s Hospital at Mount Sinai, NYC. My time is shared between patient care and basic science research. I am honored to be a part of the Diabetes Obesity and Metabolism Institute of Mount Sinai, where under the guidance of my mentor Dr. - [April 2021 President's Letter](https://pedsendo.org/presidents-message/april-2021-presidents-letter/) - Dear Colleagues, It has been my honor and privilege to serve as your President for the past year. This is my last letter to you as the President of the Pediatric Endocrine Society, and at the end of this month, Sharon Oberfield will take over as the new President. I look forward to working - [November 2025 President's Letter](https://pedsendo.org/presidents-message/november-2025-presidents-letter-2/) - At her 2011 Harvard University Class Day address, Amy Poehler said "You can't do it alone. As you navigate through the rest of your life, be open to collaboration. Other people and other people's ideas are often better than your own. Find a group of people who challenge and inspire you, spend a lot of - [Historical Tidbit - Vincent Du Vigneaud (May 18, 1901 to December 11, 1978) Nobel Laureate for peptide hormone synthesis ](https://pedsendo.org/historical-tidbits/historical-tidbit-vincent-du-vigneaud-may-18-1901-to-december-11-1978-nobel-laureate-for-peptide-hormone-synthesis/) - Historical Tidbit - Vincent Du Vigneaud (May 18, 1901 to December 11, 1978) Nobel Laureate for peptide hormone synthesis Alan D. Rogol, MD, Ph.D. Vincent Du Vigneaud earned his doctorate in chemistry at the Rochester School of Medicine in 1927 working on the biochemistry of sulfur containing compounds, specifically the sulfur of insulin. He became - [November Fellow Spotlight - Peggy Wu, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/november-fellow-spotlight-peggy-wu-md/) - Peggy Wu, MD Hello! I’m Peggy and I am a third year fellow at Lurie Children’s Hospital of Chicago. I am originally from Michigan and completed my undergraduate studies at the University of Michigan where I majored in Biochemistry and first became interested in medicine. I shadowed at C.S. Mott Children’s Hospital and fell in - [February 2025 President's Letter](https://pedsendo.org/presidents-message/february-2025-presidents-letter/) - Dear PES Members, Having just sent a couple messages earlier in the month, I will keep this note brief. As you know, registration for our Annual Meeting has opened. Please plan to join us in Maryland. In addition to other activities, the meeting will provide us an opportunity to congratulate this year’s PES Laurette Award - [March 2025 President's Letter](https://pedsendo.org/presidents-message/march-2025-presidents-letter/) - Dear PES Members, As a dual US and Canadian citizen, I admit that I find these times particularly sad and sincerely hope that in time we all find our way through the various wickets that are being put in front of us. It is important to note that PES is not a political organization; we - [April 2025 President's Letter](https://pedsendo.org/presidents-message/april-2025-presidents-letter/) - Dear PES Members, Although the times are turbulent, it is important to recognize that we at PES have a lot to celebrate. Several things come to mind immediately: -Our Annual meeting is just around the corner—May 15-18 at the National Harbor in Maryland. I look forward to seeing you there! -PES received many, many applications - [May 2025 President's Letter](https://pedsendo.org/presidents-message/may-2025-presidents-letter/) - Dear PES Members, Wow! Those of you who attended know that we just finished a remarkably successful Annual Meeting. Attendance set a new record—1223 compared to 1097 in Chicago and 938 in San Diego. Great content, a beautiful setting, and loads of networking and collegiality and dialogue. There was even a boisterous karaoke performance by - [June 2025 President's Letter](https://pedsendo.org/presidents-message/june-2025-presidents-letter/) - Dear PES members, It is an honor and privilege to start my term as PES President. I want to thank outgoing President Mark Palmert for his wisdom, leadership, friendship, and hard work, and I am truly grateful he will be by my side as Past President. I am also excited to be working with President - [July 2025 President's Letter](https://pedsendo.org/presidents-message/july-2025-presidents-letter/) - Dear PES Members, The month of July brought continued concerns regarding the practice of medicine and the conduct of scientific research. As I flew into the San Francisco airport a few weeks ago, I exited the plane into the Harvey Milk terminal, named after the first openly gay man to be elected to public office - [October 2025 President's Letter](https://pedsendo.org/presidents-message/october-2025-presidents-letter/) - Some days, I feel like the worst is happening and it’s hard to remain optimistic. However, I remember a poem that I loved from the Arrow Book of Silly Poems (one of my many purchases through the Scholastic Book Club when I was in grade school) that I loved as a child: “Twixt optimist and - [Protecting Standards of Care for Teplizumab Infusions in Type 1 Diabetes A unified statement from U.S. pediatric endocrinology leaders](https://pedsendo.org/public-policy/protecting-standards-of-care-for-teplizumab/) - This statement was authored by a group of U.S. pediatric endocrinology leaders with the greatest collective clinical and translational experience administering teplizumab and leading immunotherapy trials for type 1 diabetes. The authors represent diverse academic and clinical programs across the country and include investigators and clinicians most familiar with the implementation, safety monitoring, and real-world - [In Memoriam - Dr. Theodore "Ted" AvRuskin 1935 - September 14, 2025](https://pedsendo.org/in-memoriam/in-memoriam-theodore-avruskin/) - Dr. Theodore "Ted" AvRuskin 1935 - September 14, 2025 On September 14, 2025, Theodore “Ted” AvRuskin M.D. passed away at age 89 in Oregon from complications after surgery, while comforted by his devoted daughters. He is predeceased by his beloved wife of 58 years Marilyn, identical twin brother Stan, and sister Arlene. Survived by daughters - [In Memoriam - John Lindsey Kirkland, III June 24, 1942 - July 5, 2025](https://pedsendo.org/in-memoriam/in-memoriam-john-lindsey-kirkland-iii-june-24-1942-july-5-2025/) - John Lindsey Kirkland, III June 24, 1942 - July 5, 2025 Pittsboro, North Carolina - John Lindsey Kirkland, III, of Fearrington Village, Pittsboro, NC passed away peacefully on July 5, 2025 after his long illness with Alzheimer's Disease. He was 83 years old. John was born at Duke Hospital in Durham, NC. He graduated from - [October Fellow Spotlight - Leora Allen, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/october-fellow-spotlight-leora-allen-md/) - Leora Allen, MD I am a third-year fellow at MGH (Massachusetts General Hospital) in Boston. I am originally from Minnesota and completed my bachelor's degree at Washington University in St. Louis, where I majored in Psychology. I attended medical school at the American Medical Program at Tel Aviv University, completed my pediatrics residency at Stony - [Historical Tidbit - Robert McCarrison (March 16, 1878 to May 15, 1960) Iodine deficiency and Himalayan goiter  ](https://pedsendo.org/historical-tidbits/historical-tidbit-robert-mccarrison-march-16-1878-to-may-15-1960-iodine-deficiency-and-himalayan-goiter/) - Robert McCarrison (March 16, 1878 to May 15, 1960) Iodine deficiency and Himalayan goiter Submitted by Alan D. Rogol, MD, Ph.D Robert McCarrison was a physician from Northern Ireland who joined the Indian Medical Service just after graduation in 1901 and studied some infectious diseases before turning to the problem of endemic goiter in the Himalayan - [September 2025 President's Letter](https://pedsendo.org/presidents-message/september-2025-presidents-letter/) - Dear Colleagues, This month, we held the fall Board of Directors meeting. As the Board reviewed what the Committees and SIGs are doing, we were excited to see all the great work being done toward accomplishment of the PES strategic goals. When we looked at the “where are they now” surveys for past PES grant - [Historical Tidbit - Berta (December 1, 1906 to July 23, 1995) and Ernst (1905 to April 29, 1965) Scharrer   The beginnings of neurosecretion  ](https://pedsendo.org/historical-tidbits/historical-tidbit-berta-december-1-1906-to-july-23-1995-and-ernst-1905-to-april-29-1965-scharrer-the-beginnings-of-neurosecretion/) - Berta (December 1, 1906 to July 23, 1995) and Ernst (1905 to April 29, 1965) Scharrer -The beginnings of neurosecretion Submitted by Alan D. Rogol, MD, Ph.D. Berta and Ernst Scharrer attended the University of Munich and began a life-long exploration of an almost heretical concept of neurosecretion. Ernst noted that some neurons in the - [September APP Spotlight - Amanda G. Perkins, MSN, MPH, CPNP, CDCES ](https://pedsendo.org/member-spotlight/app-spotlight/september-app-spotlight-amanda-g-perkins-msn-mph-cpnp-cdces/) - Amanda G. Perkins, MSN, MPH, CPNP, CDCES Amanda is a Pediatric Nurse Practitioner and Certified Diabetes Care and Education Specialist practicing at Children’s National Hospital (CNH) in Washington, DC since 2019. She’s had diverse roles in the division, including inpatient and outpatient diabetes and endocrine care, clinical research, quality improvement, and precepting nurse practitioner students. - [September Fellow Spotlight - Jacob "Jake" N. Miller, DO, FAAP](https://pedsendo.org/member-spotlight/fellow-spotlight/september-fellow-spotlight-jacob-jake-n-miller-do-faap/) - Jacob "Jake" N. Miller, DO, FAAP (he/him/his) Hi! I’m Jake, a third-year fellow at Northwestern who has the privilege of learning from incredible endocrinologists at the Ann & Robert H. Lurie Children’s Hospital of Chicago. My path to pediatric endocrinology was rather long and winding. I began my studies in public health at the University - [August 2025 President's Letter](https://pedsendo.org/presidents-message/august-2025-presidents-letter/) - Dear PES Members, Earlier this month, I spent several days of my vacation hiking in Rocky Mountain National Park with my husband, as well as one day with some old friends. After driving up the scenic dirt-paved Old Fall River Road to the Alpine Visitor Center, we climbed the steps to 12,005 feet above sea - [Historical Tidbit - Aretaeus of Cappadocia (first and second centuries, CE) Apparent dual function of the testis ](https://pedsendo.org/historical-tidbits/historical-tidbit-aretaeus-of-cappadocia-first-and-second-centuries-ce-apparent-dual-function-of-the-testis/) - Aretaeus of Cappadocia (first and second centuries, CE) Apparent dual function of the testis Submitted by Alan D. Rogol, MD, Ph.D. Aretaeus of Cappadocia, the latter a former Roman province in eastern Turkey, recorded some observations that may have anticipated the two functions of the testis. Around 150 CE, when writing a chapter on gonorrhea, - [August APP Spotlight - Nichole Towns, MSN, CPNP](https://pedsendo.org/member-spotlight/app-spotlight/august-app-spotlight-nichole-towns-msn-cpnp/) - Nichole Towns, MSN, CPNP Nichole Towns, MSN, CPNP has served as a board-certified pediatric nurse practitioner on the Pediatric Endocrinology team at Levine Children’s Hospital-Concord since 2021. She earned her bachelor’s degree in nursing from Valparaiso University and her master’s degree in nursing from the University of North Carolina in Chapel Hill. She worked as - [August Fellow Spotlight - Bassem Shoucri, MD, PhD ](https://pedsendo.org/member-spotlight/fellow-spotlight/august-fellow-spotlight-bassem-shoucri-md-phd/) - Bassem Shoucri, MD, PhD I am a fourth-year endocrine fellow at UCLA, where I spend most of my time in a research lab. I grew up in Los Angeles and have done the majority of my training in Southern California. I studied bioengineering at UC San Diego before briefly moving to Washington, DC, to - [News from the D&T: KHINDIVI™ (hydrocortisone) Oral Solution](https://pedsendo.org/new-meds-and-tech/news-from-the-dt-khindivi-hydrocortisone-oral-solution/) - KHINDIVI™ (hydrocortisone) Oral Solution In May 2025, the FDA approved KHINDIVI™ (hydrocortisone) Oral Solution for the treatment of adrenal insufficiency (AI) in pediatric patients ages 5 years and older. It is indicated for the treatment of AI due to any underlying cause, including congenital adrenal hyperplasia (CAH). KHINDIVI™ is the only FDA-approved oral solution of - [New Drugs and Therapeutics Update-  Omnipod® 5 App now compatible with Dexcom G7](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-omnipod-5-app-now-compatible-with-dexcom-g7/) - Omnipod® 5 App now compatible with Dexcom G7 As of June 2025, the Omnipod® 5 App for iPhone is compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System and is available for download on the Apple App Store. Previously, the Omnipod® 5 App for iPhone was exclusively compatible with the Dexcom G6. This update allows insulin delivery - [July Fellow Spotlight - Jayde Hooven-Davis ](https://pedsendo.org/member-spotlight/fellow-spotlight/july-fellow-spotlight-jayde-hooven-davis/) - Jayde Hooven-Davis My name is Jayde Hooven-Davis and I am currently a rising third year pediatric endocrinology fellow/postdoctoral scholar at UPMC Children's Hospital of Pittsburgh. I am originally from Northampton, PA where my family continues to reside. I received my Bachelors of Science at The University of Scranton, earned my medical degree at Penn State - [July APP Spotlight - Jenny Sapolsky MSN, RN, FNP-BC, CDCES ](https://pedsendo.org/member-spotlight/app-spotlight/july-app-spotlight-jenny-sapolsky-msn-rn-fnp-bc-cdces/) - Jenny Sapolsky MSN, RN, FNP-BC, CDCES Hi! I’m Jenny Sapolsky, an enthusiastic Nurse Practitioner with over a decade of experience in diabetes education, currently working with the Endocrinology Team at Inova Children’s Hospital in Fairfax, Virginia. Born and raised in Northern Virginia, I feel deeply connected to the community I’m privileged to serve. I have - [Historical Tidbit - Robert M. Blizzard, MD (June 20, 1924 to July 22, 2018) ](https://pedsendo.org/historical-tidbits/historical-tidbit-robert-m-blizzard-md-june-20-1924-to-july-22-2018/) - Robert M. Blizzard, MD (June 20, 1924 to July 22, 2018) Submitted by Alan D. Rogol, MD, Ph.D. “Bob” was the consummate pediatric endocrinologist, melding the talents of a superb clinician with a deep understanding of the integrative aspects of physiology and imparting that wisdom to generations of pediatricians. He served as a medic in - [Historical Tidbit- Melvin Malcom Grumbach (December 21, 1925 to October 4, 2016) ](https://pedsendo.org/historical-tidbits/historical-tidbit-melvin-malcom-grumbach-december-21-1925-to-october-4-2016/) - Melvin Malcom Grumbach (December 21, 1925 to October 4, 2016) Submitted by Alan Rogol “Mel” was born in Brooklyn, NY and received most of his advanced education in New York including his medical education at Columbia. He was a fellow of Lawson Wilkins at Johns Hopkins and a life-long friend of Judson Van Wyk. One - [June APP Spotlight - Jamila Smith-Young, DNP, MPH, CPNP-AC ](https://pedsendo.org/member-spotlight/app-spotlight/june-app-spotlight-jamila-smith-young-dnp-mph-cpnp-ac/) - Jamila Smith-Young, DNP, MPH, CPNP-AC Dr. Jamila Smith-Young is a nurse practitioner with a certification in pediatric acute care. She is a native Memphian and has spent over 15 years in the healthcare field specializing in Endocrinology and Pulmonology. She currently practices as a Pediatric Endocrinology Nurse Practitioner for Le Bonheur Children’s Hospital focusing on - [In Memoriam - Songya Pang, MD: July 8, 1944 - June 10, 2025](https://pedsendo.org/in-memoriam/25801/) - Obituary - Songya Pang, MD To the Pediatric Endocrine Community: It is with great sadness that we acknowledge the sudden death of Dr. Songya Pang on June 10th, 2025, one month shy of her 81st birthday. Dr. Pang was a pioneer in her time - a leading female physician-scientist when there were few. Countless - [January 2025 President's Letter](https://pedsendo.org/presidents-message/january-2025-presidents-letter/) - Dear PES Members, At each year’s Annual Meeting there is a Presidential Address. Over the years, these talks have showcased incredible and productive careers; meaningful advances in knowledge; journeys taken to achieve those advances, including mentors, collaborators, trainees and influences; thoughts about the history of our field and our Society as well as thoughts about - [May Fellow Spotlight - Dalhila Solorzano Rubio , MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/may-fellow-spotlight-dalhila-solorzano-rubio-md/) - Dalhila Solorzano Rubio, MD I am currently a second-year pediatric endocrinology fellow at the University of Utah. My journey began in Colombia, where I obtained my medical degree and worked as a general physician for six years. I always felt a calling to work with children, ultimately guiding me to pursue pediatric residency training in - [Historical Tidbit - Maria Iandolo New, MD (December 11, 1928 to July 26, 2024)  ](https://pedsendo.org/historical-tidbits/historical-tidbit-maria-iandolo-new-md-december-11-1928-to-july-26-2024/) - Maria Iandolo New, MD (December 11, 1928 to July 26, 2024) Submitted by Alan D. Rogol, MD, Ph.D. Dr New was a pioneering pediatric endocrinologist and Pediatrics Chair at Cornell when few women attained those positions. She completed undergraduate work in chemistry at Cornell, medical school at Penn and trained in pediatrics and endocrinology at - [PES Statement Supporting Access to Gender Care](https://pedsendo.org/public-policy/pes-statement-supporting-access-to-gender-care/) - PES Statement Supporting Access to Gender Care The Pediatric Endocrine Society supports a patient and family/caregiver-centered approach to healthcare for all the conditions we treat. Our goal is provision of the best age-appropriate, evidence-based, and individualized care. To achieve that end, medical decisions should be based on the combination of the available detailed data and - [April Fellow Spotlight - Khushboo Golani, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/april-fellow-spotlight-khushboo-golani/) - Khushboo Golani, MD My name is Khushboo Golani, and I am currently a second-year fellow at Texas Children’s Hospital, Baylor College of Medicine in Houston, Texas. My medical journey began in India at DY Patil Deemed to be University, School of Medicine. Growing up in the age of social media, I was fascinated how the - [April APP Spotlight - Joseph Karpel, PA-C, MPH, BCADM ](https://pedsendo.org/member-spotlight/app-spotlight/april-app-spotlight-joseph-karpel-pa-c-mph-bcadm/) - Joseph Karpel, PA-C, MPH, BCADM I am a graduate of the Touro University California MPH/MSPAS Program. During my clinical year, I completed a three-month rotation with the Diabetes Research Education and Management (DREAM) Team, which sparked my passion for working with individuals living with diabetes. Following graduation, I began my career in adult general endocrinology - [Historical tidbit - Henry R. Harrower, MD (April 30, 1883-January 2, 1953) Organotherapist   ](https://pedsendo.org/historical-tidbits/historical-tidbit-henry-r-harrower-md-april-30-1883-january-2-1953-organotherapist/) - Henry R. Harrower, MD (April 30, 1883-January 2, 1953) Organotherapist submitted by Alan Rogol Henry Harrower, an entrepreneurial organotherapist, organized the founding of the Association for the Study of Internal Secretions in 1917, renamed the Endocrine Society. He edited Endocrinology for the first two volumes and was at the center of disagreements between the organotherapists - [New Drugs and Therapeutics Update: INVOKANA® (canagliflozin) ](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-invokana-canagliflozin/) - New Drugs and Therapeutics Update: INVOKANA® (canagliflozin) Prepared by Preneet Cheema Brar, MD, MS and Daniel Mak, MD. INVOKANA® (canagliflozin) In December 2024, the FDA approved INVOKANA® (canagliflozin) for the treatment of type 2 diabetes mellitus (T2DM) in pediatric patients ages 10 years and older. INVOKANA® is an oral sodium-glucose co-transporter 2 (SGLT2) inhibitor - [New Drugs and Therapeutics Update: VYKAT™ XR (diazoxide choline) ](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-vykat-xr-diazoxide-choline/) - New Drugs and Therapeutics Update: VYKAT™ XR (diazoxide choline) Prepared on behalf of PES Drugs and Therapeutics Committee by Dania Al-Hamad, MD, and Neha Patel, DO. On March 26, 2025, the U.S. Food and Drug Administration (FDA) approved VYKATTM XR (diazoxide choline extended-release) for the treatment of hyperphagia in patients 4 years and older with - [March Fellow Spotlight - Tristan Marvin Zapanta Uy](https://pedsendo.org/member-spotlight/fellow-spotlight/march-fellow-spotlight-tristan-marvin-zapanta-uy/) - Tristan Marvin Zapanta Uy I am Tristan Marvin Zapanta Uy (they/them), and I am currently a second-year clinical fellow in pediatric endocrinology at the Yale School of Medicine. It’s been such a winding road getting here. I graduated from a 7-year combined liberal arts and medicine program in the Philippines back in 2015, then I - [Historical Tidbit - Carlo Broschi (aka Farinelli, 1705-1782) and the Castrati](https://pedsendo.org/historical-tidbits/historical-tidbit-carlo-broschi-aka-farinelli-1705-1782-and-the-castrati/) - Carlo Broschi (aka Farinelli, 1705-1782) and the Castrati Submitted by Alan Rogol Castrations were performed on prepubertal boys to preserve the unbroken male voice through adulthood. The young castrate (musico) undertook intensive voice training under a music master. After multiple years the late teenager would have the chest of a man, but the vocal cords - [January APP Spotlight-Stephanie Tarlow](https://pedsendo.org/member-spotlight/app-spotlight/january-app-spotlight-stephanie-tarlow/) - Stephanie Tarlow is a physician assistant at Oregon Health & Science University in Portland, OR. She specializes in pediatric endocrinology. Her focus is treating children with diabetes. Stephanie has dreamed of working in pediatric endocrinology since she was diagnosed with Type 1 Diabetes at 12 years old. She draws on her personal and clinical experience - [Historical Tidbit - Angelo DiGeorge (April 15, 1921-October 11, 2009)](https://pedsendo.org/historical-tidbits/historical-tidbit-angelo-digeorge-april-15-1921-october-11-2009-2/) - Angelo DiGeorge (April 15, 1921-October 11, 2009) Submitted by Alan Rogol Angelo DiGeorge, a founding member of (Lawson Wilkins) Pediatric Endocrine Society), described a form of an autosomal dominant immunodeficiency condition (Birth Defects Orig Art Series IV 1968 116). His eponymous syndrome was first considered as isolated thymic deficiency but redefined as one of a - [February APP Spotlight - Sarah Sparks, MSN, CRNP, FNP-C](https://pedsendo.org/member-spotlight/app-spotlight/february-app-spotlight-sarah-sparks-msn-crnp-fnp-c/) - Sarah Sparks, MSN, CRNP, FNP-C Sarah Sparks is a board-certified nurse practitioner in the Division of Pediatric Endocrinology and Diabetes at Children’s of Alabama, where she has worked since 2018. With over 10 years of experience at Children’s of Alabama, she has developed expertise in diagnosing and managing both general pediatric endocrinopathies and pediatric diabetes, - [February Fellow Spotlight - Ryan Canter, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/february-fellow-spotlight-ryan-canter-md/) - Ryan Canter, MD I am a current second year combined adult/pediatric endocrinology fellow at the University of Utah. Originally from the Maryland suburbs of Washington, DC, I attended St. Mary's College of Maryland for college, and studied history, with a focus on the history of medicine. I was fascinated by the evolution of the physician-patient - [The Biological Reality of Sex and Intersex: A Response to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government”](https://pedsendo.org/public-policy/the-biological-reality-of-sex-and-intersex-a-response-to-the-executive-order-defending-women-from-gender-ideology-extremism-and-restoring-biological-truth-to-the-federal-government/) - The Biological Reality of Sex and Intersex: A Response to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government” What is the reason for this Statement? This Statement responds to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government,” - [In Memoriam – Frank S. French MD: February 7th, 2025](https://pedsendo.org/in-memoriam/in-memoriam-frank-s-french-md-february-7th-2025/) - I am writing today with the sad news that Dr. Frank S. French passed away on February 7th, 2025. Dr. French served as a faculty member and scientist at the University of North Carolina at Chapel Hill from the 1960s through the 2000s. He was one the founders of our division and one of the giants - [January Fellow Spotlight - Marinés Castillo Echevarría, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/january-fellow-spotlight-marines-castillo-echevarria/) - Marinés Castillo Echevarría, MD My name is Marinés Castillo Echevarría, an Endocrinology Fellow in my final year of training at the University of Alabama at Birmingham, Department of Pediatrics. I am originally from Puerto Rico where I earned a Bachelor of Science in Natural Sciences from the University of Puerto Rico, Cayey Campus. I obtained - [Historical Tidbit - Andrezej Viktor “Andrew” Schally, Ph.D. (November 30, 1926 to October 17, 2024)](https://pedsendo.org/historical-tidbits/historical-tidbit-andrezej-viktor-andrew-schally-ph-d-november-30-1926-to-october-17-2024-2/) - Andrezej Viktor “Andrew” Schally, Ph.D. (November 30, 1926 to October 17, 2024) Submitted by Alan Rogol Andrew Schally is a recently deceased Polish-American scientist who shared the 1977 Nobel Prize in physiology or medicine with Roger Guillemin and Rosalyn Yalow. He began his research career as a refugee technician and later earned a doctorate at - [January Fellow Spotlight - Katie Flass, PA-C](https://pedsendo.org/member-spotlight/fellow-spotlight/katie-flass-pa-c-january-fellow-spotlight/) - Katie Flass, PA-C Katie earned her undergraduate degree from Colorado State University in 2005 and a master’s in Physician Assistant Studies from the University of Colorado’s CHA/PA program in 2010. For the past six years, she has specialized in pediatric endocrinology and diabetes at Logan Health Pediatric Specialty Clinic in Kalispell, Montana, providing compassionate care - [2025 Open Fellowship Positions](https://pedsendo.org/fellowship-posting/2025-open-fellowship-positions/) - University of Florida Positions: 1 Description: The pediatric endocrine fellowship program at the University of Florida in Gainesville has an opening for a second fellow to join our group starting July 2025. We have full funding for a trainee who would be able to join 2 other fellows at our ACGME accredited program in sunny - [New Meds and tech - CRENESSITY (crinecerfont) capsules and oral solution](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-crenessity-crinecerfont-capsules-and-oral-solution/) - New Drugs and Therapeutics Update CRENESSITY (crinecerfont) capsules and oral solution On December 13, 2024, the FDA approved CRENESSITYTM (crinecerfont) as adjunctive treatment to glucocorticoid replacement to control androgen levels in adult and pediatric patients 4 years of age and older with classic congenital adrenal hyperplasia (CAH). In individuals with classic 21-hydroxylase deficiency (21-OHD) CAH, - [December 2024 President's Letter](https://pedsendo.org/presidents-message/december-2024-presidents-letter/) - Dear PES Members, As 2024 draws to a close, we have things to celebrate, things to look forward to, and things to ponder. In the celebration realm, many of us remember the wonderfully successful Annual Meeting we had in Chicago in May of 2024; I look forward to even better meeting in 2025 at the - [In Memoriam: Dr. Raphael David](https://pedsendo.org/in-memoriam/in-memorium-dr-raphael-david/) - Obituary for Dr. Raphael David (Ralph) January 17, 1926-January 17. 2021 It is with great sadness that we announce the passing of Dr. Raphael David on January 17, 2021. Dr. Raphael David was one of the founding members of the Pediatric Endocrine Society, formerly known as the Lawson Wilkins Pediatric Endocrine Society. Dr. Raphael David, - [In Memoriam: Dr. Tom Foley](https://pedsendo.org/in-memoriam/in-memorium-dr-tom-foley/) - Obituary for Dr. Tom Foley, MD We are writing to share the sad news that Dr. Tom Foley passed away Sunday in State College at the age of 83. Many of you had the honor of working with Dr. Foley during his tenure as an endocrinologist and Director of the Division of Pediatric Endocrinology at - [in Memoriam - Dr. Barbara Migeon](https://pedsendo.org/in-memoriam/in-memorium-dr-barbara-migeon/) - Dr. Barbara Migeon, a pioneer in genetic science, died of heart failure on Jan. 14 at age 91. She was born Barbara Ruben to Sara Gitin Ruben and Dr. William Ruben in Rochester, New York, on July 31, 1931, and became the sixth female professor at Hopkins. Dr. Migeon’s research focused on X-inactivation, the focus - [In Memoriam - Samir Najjar, MD](https://pedsendo.org/in-memoriam/in-memorium-samir-najjar-md/) - Celebrating the Life of Dr. Samir Najjar For those lucky enough to have met Dr. Samir Najjar, or better yet, having worked with him, I have no doubt that he sizzled the desire to pursue or further the field of pediatric endocrinology. He joined the American University of Beirut in 1960, and later relocated in - [In Memoriam: Edward O. Reiter M.D. 1943 – 2024](https://pedsendo.org/in-memoriam/in-memorium-edward-o-reiter-m-d-1943-2024/) - Edward Reiter Obituary (1943 - 2024) - Longmeadow, MA - The Republican A note from some of his fellows: Dr. Reiter's influence on the collective fellowship program cannot be overstated. His educating style, guidance, and leadership were mixed with a softness and kindness that cannot be re-created. He was genuinely concerned about our overall well-being, - [In Memoriam - Felix A. Conte, MD 1935-2024   ](https://pedsendo.org/in-memoriam/in-memorium-felix-a-conte-md-1935-2024/) - Felix (with the big smile) with Mel Grumbach at the Festschrift held for Mel and Selna Kaplan in conjunction with the VI Lawson Wilkins Pediatric Endocrine Society/ European Society for Pediatric Endocrinology Combined Meeting in Montreal, 2001. Felix A. Conte, MD 1935-2024 Dr. Felix Anthony Conte, a beloved, highly respected, and influential clinical pediatric endocrinologist, - [In Memoriam - Hans H. Bode, MD: September 24, 1932 - December 9, 2024](https://pedsendo.org/in-memoriam/in-memorium-hans-h-bode-md-september-24-1932-december-9-2024/) - Hans H. Bode, MD Professor Emeritus of Medicine It is with deep sadness that we announce the passing of Hans Henning Bode, who died peacefully in his sleep on December 9, 2024. He leaves his wife, travel companion, dance partner and culinary explorer of 60 years, Jane L. Bode, and four children, Stephanie Bode Ward - [Historical Tidbit: Angelo DiGeorge (April 15, 1921-October 11, 2009)](https://pedsendo.org/historical-tidbits/historical-tidbit-angelo-digeorge-april-15-1921-october-11-2009/) - Angelo DiGeorge (April 15, 1921-October 11, 2009) Submitted by Alan Rogol, MD Angelo DiGeorge, a founding member of (Lawson Wilkins) Pediatric Endocrine Society), described a form of an autosomal dominant immunodeficiency condition (Birth Defects Orig Art Series IV 1968 116). His eponymous syndrome was first considered as isolated thymic deficiency, but redefined as one of - [December Fellow Spotlight - Rachel Palting, DO](https://pedsendo.org/member-spotlight/fellow-spotlight/december-fellow-spotlight-rachel-palting-do/) - Rachel Palting, DO My name is Rachel Palting, and I am currently a 3rd year fellow at Oregon Health & Science University in Portland, Oregon. I grew up in Chesapeake, Virginia, and spent much of my life in different corners of the state. I majored in English, with a focus in creative writing and double-minored - [November 2024 President's Letter](https://pedsendo.org/presidents-message/november-2024-presidents-letter/) - Dear PES Members, From the end of November into the middle of December is a busy time for PES. I realize nobody really wants to read a long list of things, but there is a long list of exciting and important PES-related things happening. So, PLEASE read the list! And access the links below - [Historical Tidbit - Andrezej Viktor “Andrew” Schally, Ph.D. (November 30, 1926 to October 17, 2024)](https://pedsendo.org/historical-tidbits/historical-tidbit-andrezej-viktor-andrew-schally-ph-d-november-30-1926-to-october-17-2024/) - Andrezej Viktor “Andrew” Schally, Ph.D. (November 30, 1926 to October 17, 2024) Submitted by Alan Rogol, MD Andrezej Viktor “Andrew” Schally, Ph.D. (November 30, 1926 to October 17, 2024) Andrew Schally is a recently deceased Polish-American scientist who shared the 1977 Nobel Prize in physiology or medicine with Roger Guillemin and Rosalyn Yalow. He began - [November Fellow Spotlight -Andrew Kanouse, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/november-fellow-spotlight-andrew-kanouse-md/) - Andrew Kanouse, MD My name is Andrew Kanouse and I am currently a third-year fellow at Cohen Children’s Medical Center. Originally from the nearby Garden State, I studied human science and psychology at Georgetown University and ventured further south to attend medical school at Eastern Virginia Medical School. Having fallen in love with the children’s - [October 2024 President's Letter](https://pedsendo.org/presidents-message/october-2024-presidents-letter/) - Dear PES Members, While preparing the Strategic Plan, we heard from many members about activities they wanted PES to pursue that fit broadly under the umbrella of advocacy. Over the summer, we surveyed committee and SIG chairs and co-chairs to learn more about the advocacy activities being championed by their groups. Thanks to all who - [Historic Tidbit -  César Julien Jean Legallois (Feb 11, 1770 to Feb 10, 1814) and Internal Secretion](https://pedsendo.org/historical-tidbits/historic-tidbit-cesar-julien-jean-legallois-feb-11-1770-to-feb-10-1814-and-internal-secretion/) - César Julien Jean Legallois (Feb 11, 1770 to Feb 10, 1814) Submitted by Alan Rogol Legallois, an experimental physiologist and physician, anticipated the concept of internal secretion, originally stated as de Bordeu’s speculative hypothesis, in his Doctoral Thesis [1801]: Le sang est-il identique dans tous les vaisseaux qu’il parcourt? [Is the blood the same in - [October Fellow Spotlight - Chineze Ebo, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/october-fellow-spotlight-chineze-ebo-md/) - Chineze Ebo, MD My name is Chineze “Chi” Ebo, and I am a 3rd year Pediatric Endocrinology Fellow at Cincinnati Children’s Hospital Medical Center (CCHMC). I am from the Philadelphia area and attended Cornell University for college prior to attending medical school at Chicago Medical School at Rosalind Franklin University. I completed Pediatric Residency - [October APP Spotlight - Haley White Zarger](https://pedsendo.org/member-spotlight/app-spotlight/october-app-spotlight-haley-white-zarger/) - Haley White Zarger Haley has been a physician assistant in the Division of Endocrinology & Diabetes at UPMC Children’s Hospital of Pittsburgh (CHP) for the past 12 years. She treats patients with a variety of endocrine disorders but has a special interest in helping children with type 1 diabetes. She has been involved in QI - [September 2024 President's Letter](https://pedsendo.org/presidents-message/september-2024-presidents-letter/) - Dear PES Members, The Board of Directors had the opportunity to visit the Gaylord National Harbor Hotel this week in preparation for our Annual Meeting in May. The Gaylord, and the surrounding harbor, is a spectacular place to have a meeting! The hotel sits on the bank of the Potomac River and offers beautiful views - [Historical Tidbit - Louis Théophile Joseph Landouzy (1845-1917) and Opotherapy](https://pedsendo.org/historical-tidbits/historical-tidbit-louis-theophile-joseph-landouzy-1845-1917-and-opotherapy-2/) - Louis Théophile Joseph Landouzy (1845-1917) and Opotherapy Submitted by: Alan D. Rogol, MD, Ph.D In 1898 Landousy coined the expression opotherapy (from Greek opo(s), juice + treatment), when the substance administered is in the form of an extract to replace absent or insufficient hormone production with organic substances that serve the same purpose, but often - [September Fellow Spotlight - Claire Moore, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/september-fellow-spotlight-claire-moore-md/) - Claire Moore, MD My name is Claire Moore, and I am currently the third-year pediatric endocrinology fellow at Northwestern University/Ann and Robert H. Lurie Children’s Hospital in Chicago. I grew up in the Washington, D.C. area and graduated from Harvard College with a BA in History and Literature. Following college, I lived in New York - [September APP Spotlight - Michaela Kohler, MPAS, PA-C](https://pedsendo.org/member-spotlight/app-spotlight/september-app-spotlight-michaela-kohler-mpas-pa-c/) - Michaela Kohler, MPAS, PA-C Michaela is a Physician Assistant at Children’s Nebraska in Omaha, NE. She specializes in pediatric endocrinology and metabolic bone care. She earned her bachelor’s degree from Kansas State University and her master’s degree from Oklahoma City University. Michaela is deeply committed to supporting children and their families, especially those impacted by - [August 2024 President's Letter](https://pedsendo.org/presidents-message/august-2024-presidents-letter/) - Dear PES Members, I hope many of you had a chance to take a break from work and enjoy some summer activities over the past few months. And hopefully you had an opportunity to watch some of the Olympics too. There were so many memorable moments—Celine Dion at the Opening Ceremony; the incredible skill displayed - [New Meds and Tech from the PES Drugs and Therapeutics Committee: Twiist Insulin Pump](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-and-therapeutics-committee-twiist-insulin-pump/) - New Device Announcement. The twiist™ Automated Insulin Delivery (AID) system has received clearance from FDA 510(k), although the launch date is unclear. This insulin pump has been developed and produced by DEKA Research & Development Corporation in partnership with Sequel Med Tech. The device is intended for patients aged six years and above with type - [Historical Tidbit - Serge Voronoff (July 10, 1866 to September 3, 1951) and Monkey Testis Transplantation](https://pedsendo.org/historical-tidbits/historical-tidbit-serge-voronoff-july-10-1866-to-september-3-1951-and-monkey-testis-transplantation/) - Serge Voronoff (July 10, 1866 to September 3, 1951) and Monkey Testis Transplantation Alan D. Rogol, MD, Ph.D. Voronoff, a French surgeon of Russian ancestry and a great self-promoter, sought to rejuvenate aging men by the transplantation (implantation) of testes from younger “subjects”. Given the paucity of human material, he stated “that the glands of - [August Fellow Spotlight - Domenic Filingeri, DO MS](https://pedsendo.org/member-spotlight/fellow-spotlight/august-fellow-spotlight-domenic-filingeri-do-ms/) - Domenic Filingeri, DO MS I am a third-year pediatric endocrinology fellow at UPMC Children’s Hospital of Pittsburgh and am in my second year of T32-supported basic science research in diabetes. Originally from New Jersey in the USA, it’s always been incredible for me looking back at my journey through medicine and how it has taken - [August APP Spotlight - Talia Papiro, PharmD, BCPPS](https://pedsendo.org/member-spotlight/app-spotlight/august-app-spotlight-talia-papiro-pharmd-bcpps/) - Talia Papiro, PharmD, BCPPS Talia is a clinical pharmacy specialist in pediatric endocrinology at Yale New Haven Hospital. Talia earned her undergraduate and graduate degrees at the University of Connecticut. She completed post-graduate residency training at Johns Hopkins All Children’s Hospital (PGY-1) and Yale New Haven Children’s Hospital (PGY-2) and subsequently obtained board certification in - [In Memoriam: Maria Iandolo New, MD](https://pedsendo.org/in-memoriam/in-memoriam-maria-iandolo-new-md/) - With sorrow we announce the passing of Dr. Maria I. New on July 26, 2024. She was a pioneering figure in pediatric endocrinology and a past President of PES. Born and raised in New York City, she overcame family, economic and academic challenges to pursue her goal of becoming the first physician in her family. - [In Memoriam: Rev. Peter W. Gyves, SJ: August 25, 1951 - August 7, 2024](https://pedsendo.org/in-memoriam/in-memoriam-rev-peter-w-gyves-sj-august-25-1951-august-7-2024/) - Rev. Peter W. Gyves, SJ, was born on August 25, 1951, in Brooklyn, NY. He attended Xavier High School in New York City and graduated with a degree in Biology from Boston College. He went on to receive his Medical Degree from Georgetown University, a master’s in theology from Boston College, and a master’s in public - [In Memoriam: Roberto Lanes, MD. May 19, 1948 – July 28, 2024](https://pedsendo.org/in-memoriam/in-memoriam-roberto-lanes-md-may-19-1948-july-28-2024/) - Roberto Lanes M.D. Born in Caracas on May 19, 1948; Died in Toronto on July 28, 2024 Dr. Lanes, an internationally known pediatric endocrinologist who was originally from Caracas Venezuela died in Toronto last month from pancreatic cancer. Dr. Lanes completed his pediatric residency at Beth Israel Hospital in NYC and his fellowship at Johns - [New Meds and Tech from the PES Drugs and Therapeutics committee: Generic Victoza®](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-and-therapeutics-committee-generic-victoza/) - Generic Victoza® Teva pharmaceuticals launched a generic version of Victoza® (liraglutide injection 1.8mg ) The generic will cost $469.60 for a pack of two pens and $704.40 for a pack of three pens. According to GoodRx, Victoza typically costs around $560 for a two-pack and $850 for a three-pack, so this is about a 16% to - [Recall on a Small Subset of FreeStyle Libre 3 Sensors](https://pedsendo.org/drug-alerts/recall-on-a-small-subset-of-freestyle-libre-3-sensors/) - There has been a recall on a small subset of FreeStyle Libre 3 sensors in the U.S. Patients can go to the website http://www.freestyleconfirm.com to get information as to whether their sensors are affected and on how to get a free replacement. No other Libre products or countries are affected in this recall. https://abbott.mediaroom.com/2024-07-24-Abbott-Issues-Voluntary-Medical-Device-Correction-for-a-Small-Number-of-FreeStyle-Libre-R-3-Sensors-in-the-US - [July 2024 President's Letter](https://pedsendo.org/presidents-message/july-2024-presidents-letter/) - Dear PES Members, July starts with national celebrations. As a dual US and Canadian citizen, I get to celebrate both July 1st (Canada Day) and July 4th (Independence Day). Lots of fireworks! This summer those celebrations are happening alongside highly consequential national elections around the world, including in the UK, France, and, of course, the - [July Fellow Spotlight - Sarah Rosenheck, DO](https://pedsendo.org/member-spotlight/fellow-spotlight/july-fellow-spotlight-sarah-rosenheck-do/) - Sarah Rosenheck, DO My name is Sarah Rosenheck and I am a current third year pediatric endocrinology fellow at the Children’s Hospital at Montefiore. I received my medical degree at New York Institute of Technology College of Osteopathic Medicine and completed my pediatric residency at Goryeb Children’s Hospital in Morristown New Jersey. I was originally - [Historical Tidbit: Louis Théophile Joseph Landouzy (1845-1917) and Opotherapy](https://pedsendo.org/historical-tidbits/historical-tidbit-louis-theophile-joseph-landouzy-1845-1917-and-opotherapy/) - Historical Tidbit: Louis Théophile Joseph Landouzy (1845-1917) and Opotherapy Submitted by: Alan D. Rogol, MD, Ph.D In 1898 Landousy coined the expression opotherapy (from Greek opo(s), juice + treatment), when the substance administered is in the form of an extract to replace absent or insufficient hormone production with organic substances that serve the same purpose, - [June 2024 President's Letter](https://pedsendo.org/presidents-message/june-2024-presidents-letter/) - Dear PES membership, Thank you for the privilege of serving as PES President this year. I know it is cliché, but it is also true: it is an honor to be in this role. I also want to thank Tom Carpenter, who provides an exemplary model for me to try to follow. Tom is a - [In Memoriam: Carol Foster, MD. September 12, 1952 - June 22, 2024](https://pedsendo.org/in-memoriam/in-memoriam-carol-foster-md-september-12-1952-june-22-2024/) - We write to share the news that Carol Foster, MD, passed away this past weekend on June 22: Carol Marvel Foster, MD - Larkin Mortuary Obituaries Dr. Foster made significant contributions to Pediatric Endocrinology over her many years of service at the University of Utah Health and Primary Children’s Hospital. She held academic appointments as - [Historical Tidbit: Serge Veronoff (July 10, 1866 to September 3, 1951) and Monkey Testis Transplantation](https://pedsendo.org/historical-tidbits/historical-tidbit-serge-veronoff-july-10-1866-to-september-3-1951-and-monkey-testis-transplantation/) - Serge Veronoff (July 10, 1866 to September 3, 1951) and Monkey Testis Transplantation Submitted by Alan D. Rogol, MD, Ph.D. Voronoff, a French surgeon of Russian ancestry and a great self-promoter, sought to rejuvenate aging men by the transplantation (implantation) of testes from younger “subjects”. Given the paucity of human material, he stated “that the - [June Fellow Spotlight - Lauren Ray, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/june-fellow-spotlight-lauren-ray-md/) - Lauren Ray, MD I grew up on a horse farm in the small town of Versailles, KY. I went to Berry College for my undergraduate education and attended medical school at the University of Louisville School of Medicine. I then moved to Indianapolis for pediatric residency at Indiana University School of Medicine / Riley Hospital - [May 2024 President's Letter](https://pedsendo.org/presidents-message/may-2024-presidents-letter/) - Dear PES membership, I am reflecting on our successful and enthusiastic annual meeting a few weeks ago in this last installment of the President’s newsletter that I will pen. The excellent programming, exchange of information, and the overall spirit of the gathering portends well for the future of the society and the continued success of - [Historical Tidbit: Charles Henry Fagge (June 6, 1838 to 1883) and Endemic Cretinism](https://pedsendo.org/historical-tidbits/historical-tidbit-charles-henry-fagge-june-6-1838-to-1883-and-endemic-cretinism/) - Historical Tidbit: Charles Henry Fagge (June 6, 1838 to 1883) and Endemic Cretinism Submitted by Alan D. Rogol, MD, Ph.D. Fagge, an assistant physician at Guy’s Hospital in London described a 14-year-old boy with severe signs and symptoms of cretinism (as it was called) and a large bronchocoele (goiter). He had previously evaluated similar children, - [APP Spotlight - Lauren E. Culbreth, MPAS, PA-C, ACSM-EP ](https://pedsendo.org/member-spotlight/app-spotlight/app-spotlight-lauren-e-culbreth-mpas-pa-c-acsm-ep/) - Lauren E. Culbreth, MPAS, PA-C, ACSM-EP Lauren Culbreth is a Physician Assistant at Texas Children's Hospital in the Department of Pediatric Diabetes & Endocrinology in Houston, TX. Lauren completed her undergraduate and graduate training at the University of Florida. Her background and expertise in exercise physiology significantly influence her passion for utilizing physical activity as - [May Fellow Spotlight - Jordan Ross, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/fellow-spotlight-jordan-ross-md/) - Jordan Ross, MD After studying biochemistry at Samford University, I returned home to Memphis for medical school, Med/Peds residency, and Med/Peds endocrinology fellowship at the University of Tennessee Health Science Center. As part of my four-year fellowship, I rotate through pediatric and adult endocrinology clinics each week; this latter half of fellowship has a heavy - [April 2024 President's Letter](https://pedsendo.org/presidents-message/april-2024-presidents-letter/) - Dear PES membership, In my final month as your president, I wish to relate to you my sincere gratitude to all of you for allowing me to serve in this capacity over the past year. It has been a true privilege to represent PES in a leadership role, and to offer support and direction to - [April Fellow Spotlight - Shreshtha Banga, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/april-fellow-spotlight-shreshtha-banga-md/) - Shreshtha Banga, MD My journey began in India, where I grew up as the child of two Pediatricians, naturally gravitating towards Pediatrics myself. I pursued my dream by completing an MD in Pediatrics at Lady Hardinge Medical College in India, where I also met my husband. Together, we embarked on this journey, fuelled by our - [Historical Tidbit: Sir Victor Alexander Haden Horsley (1857 to 1916) and Myxoedema](https://pedsendo.org/historical-tidbits/historical-tidbit-sir-victor-alexander-haden-horsley-1857-to-1916-and-myxoedema/) - Historical Tidbit: Sir Victor Alexander Haden Horsley (1857 to 1916) and Myxoedema Submitted by Alan D. Rogol, MD, Ph.D. Horsley, a surgeon, professor and superintendent of the Brown Institution in London was interested in the thyroid and was a member of the Clinical Society to study myxoedema and cretinism in 1883. He produced experimental evidence - [March 2024 President's Letter](https://pedsendo.org/presidents-message/march-2024-presidents-letter/) - Spring has arrived and much is stirring at PES. Finishing touches of our Strategic Plan for the next 5 years is near completion, thanks to President-Elect Mark Palmert. Preparations for the meeting continue and current registration is comparable to where we were last year at this time. An active DISCOVERY program is planned, and other - [March Fellow Spotlight - Lexi Dias, DO](https://pedsendo.org/member-spotlight/fellow-spotlight/march-fellow-spotlight-lexi-dias-md/) - Lexi Dias, DO My name is Lexi Dias and I am a third year pediatric endocrine fellow at Yale. My training has taken me to many interesting places, but I am originally from Wilmington, North Carolina. Perhaps not dissimilar from others in our field, my journey into pediatric endocrinology started early in life. I was - [EVKEEZA©](https://pedsendo.org/new-meds-and-tech/evkeeza/) - In March 2023, the FDA extended the approval of Evinacumab (EVKEEZA©) to children 5-11 years with familial homozygous hypercholesteremia. Evinacumab had been previously approved for 12 and older (2021), as an add-on treatment in children and adolescents with familial homozygous hypercholesteremia. Evinacumab is a monoclonal antibody which blocks angioprotein-3 activity which targets hepatic and endothelial - [Historical Tidbit - Edward Schäfer (aka Sharpey-Schäfer) June 2, 1850 to March 29, 1935 and Endocrine Physiology](https://pedsendo.org/historical-tidbits/march-historical-tidbit-edward-schafer-aka-sharpey-schafer-june-2-1850-to-march-29-1935-and-endocrine-physiology/) - Edward Schäfer (aka Sharpey-Schäfer) June 2, 1850 to March 29, 1935 and Endocrine Physiology Submitted by Alan D. Rogol, MD, Ph.D. Edward Schäfer took on the name of his mentor, William Sharpey, the father of British physiology, just after the first World War. He was the pre-eminent British physiologist of his time and pioneered endocrine - [February 2024 President's Letter](https://pedsendo.org/presidents-message/february-2024-presidents-letter/) - The snow is falling, clinics are cancelled, staff is scrambling to call patients for reappointments, and coordinators are rebooking research participants due to the storm. . .but the snow is a spectacular sight, just fallen and deep. A break in the usual hectic pace offers that moment to reflect. We’re busy with Society issues, but - [Sogroya® (somapacitan-beco) injection 15mg Pen Supply Update](https://pedsendo.org/drug-shortages/sogroya-somapacitan-beco-injection-15mg-pen-supply-update/) - From: Novo Nordisk (mail@communications.novonordisk.com) Due to higher than anticipated demand, Novo Nordisk will be unable to provide the Sogroya 15 mg pen from Mid-February through May 2024. However, there is an ample supply of the 5mg and 10mg pens to address total overall Sogroya® demand and patient need moving forward. These other pen sizes are - [US FDA-approval of VAMOROLONE for Duchenne Muscular Dystrophy (DMD)*-a novel alternative steroid with unique properties](https://pedsendo.org/new-meds-and-tech/us-fda-approval-of-vamorolone-for-duchenne-muscular-dystrophy-dmd-a-novel-alternative-steroid-with-unique-properties/) - US FDA-approval of VAMOROLONE for Duchenne Muscular Dystrophy (DMD)*-a novel alternative steroid with unique properties. New Drugs and Therapeutics On October 26, 2023, the US Food and Drug Administration (FDA) approved AGAMREE (Vamorolone/VBP 15) 6 mg/kg/day for the treatment of Duchenne Muscular Dystrophy (DMD) for patients 2 years of age and older.1 [Catalyst Pharmaceuticals, - [February Fellow Spotlight - Imen Becetti, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/february-fellow-spotlight-imen-becetti-md/) - Imen Becetti, MD I am a third-year pediatric endocrinology fellow at Massachusetts General Hospital (MGH) in Boston, currently in my second year of clinical research. I received my medical degree from Weill Cornell Medicine-Qatar then completed my pediatric residency at Children’s Hospital of Richmond at Virginia Commonwealth University. I discovered my passion for endocrinology during - [Historical Tidbit: Téophile de Bordeu (1722-1776)](https://pedsendo.org/historical-tidbits/february-historical-tidbit-teophile-de-bordeu-1722-1776/) - Historical Tidbit: Téophile de Bordeu (1722-1776) Submitted by Alan Rogol, MD Incretory Activity and the Foundations of Endocrinology Théophile de Bordeu, a physician at the Court of Louis XV, brought forward a theory of incretory (internal secretory) activity. In 1776 in Analyse Médicinale du Sang (The Medical Analysis of the Blood) he hypothesized that all - [January 2024 President's Letter](https://pedsendo.org/presidents-message/january-2024-presidents-letter/) - Brrrrr, and greetings to all as we begin a New Year! The Board of Directors started 2024 with an in-person meeting and much discussion regarding critical societal programs and issues. Topping the list is the coming annual meeting in Chicago (May 2-5). The program is shaping up quite nicely -- a record number of abstracts - [In Memoriam: George E. Bacon. April 18, 1932 - December 27, 2023](https://pedsendo.org/in-memoriam/in-memoriam-george-e-bacon-april-18-1932-december-27-2023/) - George E. Bacon, 91, passed away peacefully Wednesday morning, December 27, in his sleep. Born on April 13, 1932, in New York City, he was the only child of Priscilla (Anderson) and Edgar S. Bacon, a dentist who served in World War II in the Pacific for two years. George was an Eagle Scout who - [LUPRON DEPOT-PED 45 mg for 6 months](https://pedsendo.org/new-meds-and-tech/lupron-depot-ped-45-mg-for-6-months/) - LUPRON DEPOT-PED 45 mg for 6 months Prepared and edited on behalf of the PES Drug & Therapeutics committee: Shilpa Mehta, MD, Amit Lahoti, MD, Aditi Khokar, MD, Anna Ryabets-Lienhard, DO, and Ryan Miller, MD LUPRON DEPOT-PED® (leuprolide acetate for depot suspension) 45 mg for 6-month intramuscular injection is a GnRH analog (GnRHa) approved as - [January Fellow Spotlight - Juwairriyyah Siddiqui, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/january-fellow-spotlight-juwairriyyah-siddiqui-md/) - I am Juwairriyyah Siddiqui, MD, a second-year Pediatric Endocrinology Fellow at Kravis Children’s Hospital at Mount Sinai. Growing up in a family of physicians fueled my passion for community service, inspiring me to pursue a career in medicine. My journey began at Deccan College of Medical Sciences in India where I attended medical school. My - [Historic Tidbit: Arnold Adolph Berthold (1803-1861) Testis Transplantation and the Regain of Male Sexual Characteristics and Behaviors](https://pedsendo.org/historical-tidbits/historic-tidbit-arnold-adolph-berthold-1803-1861-testis-transplantation-and-the-regain-of-male-sexual-characteristics-and-behaviors/) - Arnold Adolph Berthold (1803-1861) Testis Transplantation and the Regain of Male Sexual Characteristics and Behaviors Submitted by Alan Rogol In 1849 Berthold transplanted testes from roosters into the abdominal cavity of capons without vascular anastomoses or nerve connections. After 6 months he observed (in translation) that the grafted testes permitted “…these animals remained male in - [In Memoriam: Dr. Arlan Rosenbloom](https://pedsendo.org/in-memoriam/in-memoriam-dr-arlan-rosenbloom/) - This past weekend the Division of Endocrinology and the Department of Pediatrics lost their founding father and a giant in our field, Dr. Arlan Rosenbloom. Dr Rosenbloom came to the University of Florida as the founding pediatric endocrinologist in 1968, where he was promoted from assistant professor to associate professor in 1971, to full professor - [In Memoriam: Pierre Claude Sizonenko 1932 - 2023](https://pedsendo.org/in-memoriam/in-memoriam-pierre-claude-sizonenko-1932-2023/) - Professor Pierre Sizonenko died 13 February, 2023 at his home in Geneva, Switzerland, after a 15-year battle with multiple myeloma. Pierre was born and educated in Paris, followed by a research fellowship in Pediatric Endocrinology under Mel Grumbach and Selna Kaplan in 1967-1968. In 1969 he moved to Geneva, where along with his lifelong colleagues - [Statement on use of compounded semaglutide and other GLP-1 receptor agonists](https://pedsendo.org/drug-shortages/statement-on-use-of-compounded-semaglutide-and-other-glp-1-receptor-agonists/) - The use of glucagon-like-peptide-1 (GLP-1) receptor agonists for the treatment of obesity has increased significantly over the past year. Due to high demands and limited supply, patients and clinicians are turning to compounding pharmacies. Compounded medications are those that have been mixed or altered, typically to meet the specific needs of a patient. FDA initially - [In Memoriam: Joe D'Ercole, MD 1944 - 2023](https://pedsendo.org/in-memoriam/in-memoriam-joe-dercole-md-1944-2023/) - Augustine Joseph "Joe" D'Ercole, M.D., one of the giants of pediatric endocrinology, died on December 21, 2023 at home in Chapel Hill, NC. Joe graduated from the University of Notre Dame, B.A., in 1965 and Georgetown School of Medicine, M.D., in 1969. He completed Pediatric Residency in 1972 at Tufts New England Medical Center - [In Memoriam - Dr. Barry B. Bercu 1944-2023](https://pedsendo.org/in-memoriam/in-memoriam-dr-barry-b-bercu-1944-2023/) - Dr. Barry B. Bercu 1944-2023 Barry B. Bercu, M.D. died on Friday, November 24, 2023. Dr. Bercu, a pediatric endocrinologist long associated with the University of South Florida, was internationally recognized as a visionary pioneer for his breakthrough research and discoveries related to human growth hormone and the causes of, and treatments for, certain epidemic - [December 2023 President's Letter](https://pedsendo.org/presidents-message/december-2023-presidents-letter/) - Holiday greetings to all PES Members and Friends! As we close out another calendar year, one naturally considers 2023’s issues and events. The year will be most remembered for our first and highly successful independent in-person meeting, mixed with those beautiful views of San Diego’s harbor. Personally, I reflect on my deep dive into society - [November 2023 President's Letter](https://pedsendo.org/presidents-message/november-2023-presidents-letter/) - Dear PES members and friends, With the advancing fall, our recent elections led to an outstanding slate of new leaders for next year. Congratulations to Laurie Cohen, Andrew Dauber, and Paul Thornton (President Elect, Director, and Treasurer, respectively)! PES leadership has been busy with further refinement of our 5-year Strategic Plan under the direction of - [December Fellow Spotlight - Fulfilled Ighalo, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/december-fellow-spotlight-fulfilled-ighalo-md/) - Fulfilled Ighalo, MD I am currently in my second year of pediatric endocrinology fellowship at Baylor College of Medicine/Texas Children’s Hospital in Houston, Texas. I obtained my medical degree at St. George’s University School of Medicine. During my pediatric residency training at Tulane University my interest in endocrinology started after seeing my first patient with - [Historical Tidbit - Friedrich Wöhler (July 31, 1800 to September 3, 1882) and the Synthesis of Urea](https://pedsendo.org/historical-tidbits/historical-tidbit-friedrich-wohler-july-31-1800-to-september-3-1882-and-the-synthesis-of-urea/) - Friedrich Wöhler (July 31, 1800 to September 3, 1882) and the Synthesis of Urea Submitted by Alan Rogol, MD Friedrich Wöhler was a German chemist who worked in both the fields of inorganic and organic chemistry. For the former he had discovered a number of metals including Aluminum. To form organic compounds one required a - [Medication Shortage Alert – Pamidronate Disodium Injection](https://pedsendo.org/drug-shortages/medication-shortage-alert-pamidronate-disodium-injection/) - Medication Shortage Alert – Pamidronate Disodium Injection: Anna Ryabets-Lienhard, DO, Drugs and Therapeutics Committee Update 10/25/23: As of August-September, there has been a national shortage of pamidronate IV injection. The current reasons are due to Areva is no longer manufacturing the product, and Pfizer is experiencing ‘manufacturing delays’. Drug Shortage Detail: Pamidronate Disodium Injection (ashp.org); - [Levemir®, Discontinued](https://pedsendo.org/drug-alerts/levemir-discontinued/) - Novo Nordisk announced on 11/8/2023 that their long-acting insulin, Levemir®, will be phased out from United States markers completely discontinuing by December 2024. It cited manufacturing constraints, reduced patient access and available alternatives. Novo Nordisk to discontinue Levemir insulin in U.S. market | Reuters Reported timeline: Mid-January: expected supply disruptions of Levemir® FlexPen® April 1, 2024: - [November Fellow Spotlight-Jade Wyatt, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/november-fellow-spotlight-jade-wyatt-md/) - Jade Wyatt, MD I am currently a third-year pediatric endocrinology fellow at the University of North Carolina. I grew up in Texas, attended medical school at the University of Oklahoma, and subsequently completed my pediatric residency at the University of Utah. Early in fellowship, I developed a keen interest in caring for patients with thyroid - [Historic Tidbit: The Somatomedin and Dual Effector Theories of Growth Hormone Action](https://pedsendo.org/historical-tidbits/historic-tidbit-the-somatomedin-and-dual-effector-theories-of-growth-hormone-action/) - The Somatomedin and Dual Effector Theories of Growth Hormone Action Submitted by Alan D. Rogol, M.D., Ph.D. The somatomedin hypothesis stated that the uptake of sulfate in, for example rat costochondral, cartilage was due to a GH-dependent factor rather than GH itself. The key experiment noted that GH or serum from an hypophysectomized rat added - [October 2023 President's Letter](https://pedsendo.org/presidents-message/october-2023-presidents-letter/) - Dear PES members and friends, It has been an intense early fall, on several fronts. In early October we participated in the very successful international “Endo Bridge 2023” conference in Antalya, Turkey, despite the tension and instability related in the region. Our designated “on-the-spot” representative, Jennifer Law, reported that her experience was quite fruitful and - [New Meds and Tech from the PES Drugs & Therapeutics Committee - VOXZOGO-UPDATE](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-therapeutics-committee/) - Update to the Vosoritide (Voxzogo TM) indication in USA On October 20, 2023 US Food and Drug Administration (FDA) has extended approval of Voxzogo to children with Achondroplasia of all age groups with open epiphyses under accelerated approval program (VOXZOGO.COM). The results from an open-label, long-term phase 2 extension study were presented by BioMarin at - [New Drugs and Therapeutics Update – NGENLA](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-ngenla/) - New Drugs and Therapeutics Update – NGENLA By Dania Al-Hamad, MD, and Christine Yu, MD NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog, was approved by the FDA in June 2023 for treatment of growth failure in pediatric patients aged three years and older with growth hormone deficiency (GHD). Approval was based on an - [Historical Tidbit: Robert T. Morris (1857-1945) and Human Ovarian Transplantation](https://pedsendo.org/historical-tidbits/historical-tidbit-robert-t-morris-1857-1945-and-human-ovarian-transplantation/) - Historical Tidbit: Robert T. Morris (1857-1945) and Human Ovarian Transplantation Submitted by Alan D. Rogol, M.D., Ph.D. Robert Morris was an exceptional surgeon in New York City. He was among the first to successfully transplant ovarian tissue into the ovarian fundus of two young women in 1895 (NY Med J 1895; 62:436). One had spontaneous - [October Fellow Spotlight - Patricia Chu, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/october-fellow-spotlight-patricia-chu-md/) - Patricia Chu, MD I am a fourth-year Combined Adult and Pediatric Endocrinology Fellow at Penn Medicine/Children's Hospital of Philadelphia and am currently in the Master of Science in Clinical Epidemiology (MSCE) program at the University of Pennsylvania. I completed my bachelor's degree at the University of Chicago and then received my medical degree from Duke University School - [Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide)](https://pedsendo.org/new-meds-and-tech/jardiance-empagliflozin-and-synjardy-empagliflozin-and-metformin-hydrochlorothiazide/) - Brief Therapeutic Update from PES Drugs and Therapeutics Committee Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) were approved by the FDA for treatment of type 2 diabetes mellitus in children ≥ 10 years of age on June 20,2023.[1] The novel active ingredient in Jardiance® and - [Palovarotene (SohonosTM - Ipsen Pharmaceuticals Inc.)](https://pedsendo.org/new-meds-and-tech/palovarotene-sohonostm-ipsen-pharmaceuticals-inc/) - New Meds and Tech from PES Drugs and Therapeutics committee Palovarotene (SohonosTM - Ipsen Pharmaceuticals Inc.) By: Ambika Ashraf, MD and Anna Ryabets-Lienhard, DO Update: 9/10/2023 On August 17th, 2023, FDA approved Palovarotene (SohonosTM) for the treatment of fibrodysplasia ossificans progressiva (FOP) in girls ≥ 8 years old and in boys ≥ 10 - [September 2023 President's Letter](https://pedsendo.org/presidents-message/september-2023-presidents-letter/) - The deadline for applications is December 31, 2023, for 2024 awards for the applicant to be in North America in the spring of 2024. Call for Papers in Hormone Research in Paediatrics Global Challenges in Paediatric Endocrinology Hormone Research in Paediatrics, with an Impact Factor of 3.2 and a CiteScore of 5.6, is edited by - [Historical Tidbit: Paracelsus (1493-1541). A Man for All Seasons](https://pedsendo.org/historical-tidbits/historical-tidbit-paracelsus-1493-1541-a-man-for-all-seasons/) - Historical Tidbit: Paracelsus (1493-1541). A Man for All Seasons Submitted by Alan D. Rogol, M.D., Ph.D. Paracelsus, born Philippus Aureolus Theophrastue Bombastus von Hoenheim was a Swiss chemist and physician known to pharmacologists for the concept (translated) that all substances are poisons; there is none that is not a poison. The right dose differentiates a - [September Fellow Spotlight - Ana Menendez, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/september-fellow-spotlight-ana-menendez-md/) - Ana Menendez, MD My name is Ana Menendez and I am a third-year pediatric endocrinology fellow at the University of Connecticut, Connecticut Children’s Medical Center. I obtained my medical degree from Universidad, Dr. José Matías Delgado in El Salvador and completed pediatric residency at Flushing Hospital Medical Center in Queens, New York. During residency, I - [August 2023 President's Letter](https://pedsendo.org/presidents-message/august-2023-presidents-letter/) - Dear PES members and friends, Activity is ramping up -- ‘back-to-school’ advertisements are out, reminding us of the general rush to get down to business as the summer ends. With some (hopeful) cooling down of the weather, our activities often heat up with the onset of a new academic year. An upward trend in Covid - [Historical Tidbit: Jan Wolff (b. April 25, 1925) and Israel L. Chaikoff (b. July 2, 1902)—the Wolff-Chaikoff Effect](https://pedsendo.org/historical-tidbits/historical-tidbit-jan-wolff-b-april-25-1925-and-israel-l-chaikoff-b-july-2-1902-the-wolff-chaikoff-effect/) - Historical Tidbit: Jan Wolff (b. April 25, 1925) and Israel L. Chaikoff (b. July 2, 1902)—the Wolff-Chaikoff Effect Submitted by Alan D. Rogol, M.D., Ph.D. Wolff and Chaikoff discovered that excessive doses of iodine administered acutely to rabbits, transiently inhibited organification of iodine in the precursors of thyroxine. They noted specifically that excessive iodine exerts - [August Fellow Spotlight - Adriana Rodríguez González, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/august-fellow-spotlight-adriana-rodriguez-gonzalez-md/) - Adriana Rodríguez González, MD I am currently a 3rd year Pediatric Endocrinology Fellow at UPMC Children's Hospital in Pittsburgh, PA. I received my undergraduate degree at the University of Puerto Rico Rio Piedras Campus in Puerto Rico and completed my MD at the University of Puerto Rico Medical Science Campus. I relocated to Miami, FL where - [July 2023 President's Letter](https://pedsendo.org/presidents-message/july-2023-presidents-letter/) - Tom Carpenter, MD CALL FOR NOMINATIONS: The nominating committee is currently seeking nominations for positions on the Board of Directors. New this year, self-nomination is now permissible. If you are interested in board service, consider nominating yourself. Nominations are now being accepted for the following Board Positions: • President-Elect (3-year commitment: President-Elect, President, Past President) - [iLet® Bionic Pancreas](https://pedsendo.org/new-meds-and-tech/ilet-bionic-pancreas/) - Brief Therapeutic Update from PES Drugs and Therapeutics Committee iLet ® Bionic Pancreas On May 19, 2023, the U.S. Food and Drug Administration approved the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people 6 years of age and older with type 1 diabetes (1). These two devices are used - [Sogroya® (somapactian)](https://pedsendo.org/new-meds-and-tech/sogroya-somapactian/) - Brief Therapeutic Update from PES Drugs and Therapeutics Committee Sogroya® (somapactian) Once weekly Sogroya® (somapacitan-beco, Novo Nordisk) was approved by the United States Food and Drug Administration (FDA) for treatment in pediatric growth hormone deficiency (GHD), for children 2.5 years and older, in April 2023. It was previously approved by the FDA for adult GHD - [July Fellow Spotlight - Jessika Weber, DO](https://pedsendo.org/member-spotlight/fellow-spotlight/july-fellow-spotlight-jessika-weber-do/) - Jessika Weber, DO My name is Jessika, and I am a current 2nd year Pediatric Endocrinology Fellow at the University of Utah in Salt Lake City, UT. I received my undergraduate training in Montana at the University of Providence where I played collegiate volleyball as a setter and defensive specialist. I served as team captain - [The MiniMed™780G System](https://pedsendo.org/new-meds-and-tech/the-minimed780g-system/) - Brief Therapeutic Update from PES Drugs and Therapeutics Committee The MiniMed™780G System The MiniMed 780G System from Medtronic was approved by the US Food and Drug Administration on April 21, 2023 for use in patients seven years and older with type 1 diabetes.1 The FDA approval comes from the results of the US pivotal trial - [Historical Tidbit: Hakaru Hashimoto, M.D. (May 4, 1881 to January 9, 1934) and Hashimoto’s Disease](https://pedsendo.org/historical-tidbits/historical-tidbit-hakaru-hashimoto-m-d-may-4-1881-to-january-9-1934-and-hashimotos-disease/) - Historical Tidbit: Hakaru Hashimoto, M.D. (May 4, 1881 to January 9, 1934) and Hashimoto’s Disease Submitted by: Alan D. Rogol, MD, Ph.D. Hakaru Hashimoto was a Japanese doctor and medical scientist. The condition that now bears his name is an autoimmune disorder of the thyroid where the thyroid is infiltrated with mainly lymphocytes organized into - [June 2023 President's Letter](https://pedsendo.org/presidents-message/june-2023-presidents-letter/) - Dear PES members and friends, I am still relishing the very successful, first fully independent in-person meeting of the society in San Diego. The great success of this initial meeting emphasizes the vibrancy of our field, and our highly committed membership. I particularly wish to congratulate our outgoing president, Craig Alter. His dedication, vision and - [Solu-Cortef Shortage UPDATED](https://pedsendo.org/drug-shortages/solu-cortef-shortage/) - March 2023: Pfizer announced a supply disruption of Pfizer’s Solu-Cortef® (hydrocortisone sodium succinate for injection, USP) 100 mg/2 mL (50 mg/mL) ACT-O[1]VIAL™ Single Dose Vial presentations and provide guidance on how to access product reserved for patient specific emergency needs. Currently, all Solu-Cortef® (hydrocortisone sodium succinate for injection, USP) inventory is available from Pfizer through - [Wegovy supply shortage](https://pedsendo.org/drug-shortages/wegovy-supply-shortage/) - Novo Nordisk announced that due to significant demands, they are only able to supply limited quantities of 0.25 mg, 0.5 mg, and 1 mg dose strengths of Wegovy to wholesalers for distribution to retail pharmacies, this is acknowledged to have now causes a national shortage of medication. Novo Nordisk anticipates shortage to last through September - [June Fellow Spotlight - Naiomi Gunaratne-Breaux, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/june-fellow-spotlight-naiomi-gunaratne-breaux-md/) - Naiomi Gunaratne-Breaux, MD I am currently a rising 3rd year fellow in pediatric endocrinology at University of Chicago Medicine Comer Children’s Hospital in Chicago, IL. I received my undergraduate degree at the University of Miami and completed my MD at the University of Miami Miller School of Medicine. I was fortunate to return home to - [In Memoriam - Irene Solomon 1932-2022](https://pedsendo.org/in-memoriam/in-memoriam-irene-solomon-1932-2022/) - Irene Solomon 1932-2022 Irene Solomon (1932-2022) received her undergraduate degree from Radcliffe College and her medical degree from Harvard University (1958). She trained in pediatric endocrinology with Robert Blizzard and Orville Green in Ohio (1959-1962), then at Johns Hopkins (1963-1964). She completed pediatric residency and an additional year of fellowship at the University of California, - [Historical Tidbit - Allen O. Whipple, M.D. (Sept 2, 1881 to April 6, 1963) and Whipple’s Triad](https://pedsendo.org/historical-tidbits/historical-tidbit-allen-o-whipple-m-d-sept-2-1881-to-april-6-1963-and-whipples-triad/) - Allen O. Whipple, M.D. (Sept 2, 1881 to April 6, 1963) and Whipple’s Triad Submitted by Alan D. Rogol, M.D., Ph.D. Whipple’s triad is a collection of three clinical features indicating hyperinsulinism: autonomic or neuroglycopenic symptoms of hypoglycemia, e.g., shakiness or sweating; low plasma glucose concentration; and, resolution of these symptoms when plasma glucose levels - [Calcium Carbonate liquid, Calcitriol liquid and Calcitriol IV Shortages – Update](https://pedsendo.org/drug-shortages/calcium-carbonate-liquid-calcitriol-liquid-and-calcitriol-iv-shortages-update/) - Calcium Carbonate (1250mg salt/500mg elemental calcium/5mL) suspension - national shortage. The date of shortage resolution is unknown at this time. For patients on oral therapy, alternatives include: Calcium carbonate tablets (e.g., oyster shells) and alternative salt, such as calcium citrate Calcium carbonate custom compounding - Compounding pharmacies option – many compounding pharmacies are able to - [June APP Spotlight - Alex Nella](https://pedsendo.org/member-spotlight/app-spotlight/june-app-spotlight-alex-nella/) - Alex Nella, PA-C, RD, CDCES Alex Nella is a physician assistant working in pediatric endocrinology at UC Davis Health in Sacramento, California. As a relatively new PA, earning certification in 2021 after attending the PA program at the Betty Irene Moore School of Nursing at UC Davis, Alex draws knowledge from a 12-year career as - [May 2023 President's Letter](https://pedsendo.org/presidents-message/may-2023-presidents-letter/) - Craig A. Alter, MD NOW ACCEPTING NOMINATIONS FOR 2024 AWARDS & LECTURES Deadline: December 14, 2023 @ 5:00 PM ET Judson J. Van Wyk Prize The Del and Beverly Fisher Pediatric Endocrinology History Lectureship Young Investigator Award Clinician Award Educator Award Senior Researcher Award *Please note all nominations must be submitted through the online portal - [May Fellow Spotlight - Nikhita Chimatapu](https://pedsendo.org/member-spotlight/fellow-spotlight/june-fellow-spotlight-nikhita-chimatapu/) - Nikhita Chimatapu, MD I am a second-year fellow in pediatric endocrinology at the University of California, Mattel Children’s Hospital, Los Angeles. I obtained my medical degree from Mahatma Gandhi Mission’s Medical College in India and completed my pediatric residency at Icahn School of Medicine at Mount Sinai, Elmhurst Hospital in New York. My passion for - [Historical Tidbit: Dr. Saul Hertz (4/20/1905-7/28/1950) and radioactive iodine therapy](https://pedsendo.org/historical-tidbits/historical-tidbit-dr-saul-hertz-4-20-1905-7-28-1950-and-radioactive-iodine-therapy/) - Dr. Saul Hertz (4/20/1905-7/28/1950) and radioactive iodine therapy Submitted by Evan Graber, DO Based on studies that demonstrated that the thyroid takes up iodine, Hertz created radioactive isotopes of iodine and used them for thyroid diseases. He, along with Arthur Roberts, treated 48 hyperthyroid rabbits with I-128 and demonstrated increased thyroid uptake compared to normal - [Lilly to Divest BAQSIMI to Amphastar](https://pedsendo.org/news-announcements/lilly-to-divest-baqsimi-to-amphastar/) - Lilly focused on delivering the company's unprecedented pipeline of next-generation medicines to help patients Amphastar is the ideal company to continue Lilly's mission to help more people benefit from BAQSIMI INDIANAPOLIS and RANCHO CUCAMONGA, Calif., April 24, 2023 /PRNewswire/ -- In an effort to continue expanding the availability of BAQSIMI® to patients, Eli Lilly and Company (NYSE: LLY) and Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) have entered into - [April 2023 President's Letter](https://pedsendo.org/presidents-message/april-2023-presidents-letter/) - Hello to the Pediatric Endocrine Family. I am so excited to finally have our in-person meeting---only days away. I am thankful to the Program Committee under the leadership of Dr. Leena Nahata and Dr. Takara Stanley who organized a conference with such a variety of topics. I am thankful to both my fellow PES Board - [Historical Tidbit: Philip Edward Smith, Ph.D. (January 1, 1884-December 8, 1970)](https://pedsendo.org/historical-tidbits/historical-tidbit-philip-edward-smith-ph-d-january-1-1884-december-8-1970/) - Historical Tidbit: Philip Edward Smith, Ph.D. (January 1, 1884-December 8, 1970) Submitted by Alan D. Rogol, MD, Ph.D. Philip Smith developed methods to safely remove pituitary glands from many species. He is known for his work in tadpoles and the rat using a meticulous, reproducible, ventral parapharyngeal approach. He was able to separate functions due - [April APP Spotlight: Sarah Kelly DNP, APRN, NP-C](https://pedsendo.org/member-spotlight/app-spotlight/april-app-spotlight-sarah-kelly-dnp-aprn-np-c/) - Sarah Kelly DNP, APRN, NP-C Dr. Kelly is working her dream job! Living with type 1 diabetes since childhood, she always hoped to one day work with children with diabetes. Now, she works at Baylor College of Medicine’s Pediatric Diabetes and Endocrinology Division. Dr. Kelly splits her time between outpatient and inpatient diabetes care at - [Abbott Recall](https://pedsendo.org/drug-alerts/abbott-recall/) - FDA recall warning: April 6, 2023 Abbott pharmaceuticals has issued a warning impacting four million readers for glucose monitors after reports that devices were overheating and catching fire when patients used non-Abbott charging cords. For more details: https://secure-web.cisco.com/13NFGAMD4NEi09reegdwCyH1EYZisuiN8ZPbLr8IC6sc0l2n2u3ih7L1UI-UVkh-VQzA4I9jmREuciMrZFm5PQSoiAHTMDuIDL1gHiie74Eel7x6sgHSGOctKGOX8EbdzXPvF3X5zLGLwFsqTFYspID877c0kIASqp0EY3mgTRxwLkvN-oFfVLVqYc7b4Xn3QI-HViQtTBxVLCPfgYcYbjLiNp9muV91JT0frldfezMHqnDQkW7WpryDSP2ooSQpegDAYELc4EVJn1YXWjGSnqEyNKGYbOn3a836wOs3ImaoyLbx-VdckRYqJgJh1gNEoEonNRZvYci5s43bzkGV2T14ixDQxKpDtcJYzvj2Yh-3_5qQle5GgO1QajIDqI1UYJPCd7z0LmiXKXA2fyK-nf--Vd4CMnwgBDShQ6wZ4L9imZhLtrHmvLNJq3yVr5_p7/https%3A%2F%2Fwww.statnews.com%2F2023%2F04%2F06%2Fglucose-monitor-recall-freestyle-libre-abbott-fda%2F - [March 2023 President's Letter](https://pedsendo.org/presidents-message/march-2023-presidents-letter/) - Dear Friends, As we spring forward towards the PES Annual Meeting, many of us in Canada and the United States moved the clocks ahead. In the United States, only Arizona and Hawaii avoid changing the clocks as well as various areas in Canada. The rest of the world does not realize how this affects our - [Historical Tidbit: Philip Showalter Hench, MD (February 28, 1896-March 30, 1965)](https://pedsendo.org/historical-tidbits/historical-tidbit-philip-showalter-hench-md-february-28-1896-march-30-1965/) - Historical Tidbit: Philip Showalter Hench, MD (February 28, 1896-March 30, 1965) Submitted by Alan D. Rogol, MD, Ph.D Philip Hench administered cortisone to several patients with severe rheumatoid arthritis just after his colleague at the Mayo clinic, Edward Kendall had synthesized it (Mayo Clin Proc 1949; 24:181-197). Hench, along with Kendall, shared the Nobel Prize - [March Fellow Spotlight - Annie Gladding](https://pedsendo.org/member-spotlight/fellow-spotlight/march-fellow-spotlight-annie-gladding/) - Annie Gladding I am a first-year pediatric endocrinology fellow at Medical College of Wisconsin/Children's Hospital of Wisconsin. I received my business degree from the University of Maryland College Park but quickly realized that my passion was elsewhere - in medicine. I then landed in the Midwest for medical school at the Chicago College of Osteopathic - [March APP Spotlight - Kim Clash, CPNP](https://pedsendo.org/member-spotlight/app-spotlight/march-app-spotlight-kim-clash-cpnp/) - Kim Clash, CPNP Kim Clash is a Board-Certified Pediatric Nurse Practitioner working in Pediatric Endocrinology, focusing on gender-affirming care. She holds a master’s degree from the Johns Hopkins School of Nursing and has worked in Pediatric Endocrine care for over 20 years. Kim has experience in diabetes, general endocrine care, and gender care. She is - [New Meds and Tech from the PES Drugs and Therapeutics committee: Dexcom G7](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-and-therapeutics-committee-dexcom-g7/) - Dexcom G7 In December 2022, the Dexcom G7 continuous glucose monitor system was cleared by the FDA for use in people age 2 and older with all diabetes mellitus types. The G7 system is expected to be launched in the United States in early 2023. New features of the Dexcom G7 system include a - [New Drugs and Therapeutics Update: Wegovy®](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-wegovy/) - Wegovy® (semaglutide) once weekly injection is a glucagon-like peptide 1 receptor agonist (GLP1-RA) approved by the FDA in June, 2021 for weight management in adults. Wegovy was approved in December, 2022 for children aged 12 and up with a BMI at the 95th% or above. This approval directly preceded the release of the first comprehensive - [Brief updates from PES D&T Committee](https://pedsendo.org/new-meds-and-tech/brief-updates-from-pes-dt-committee/) - Difficulty filling prescriptions for diazoxide have been reported intermittently. Teva Pharmaceuticals reports that Proglycem® Oral Suspension 50 mg/mL 30 mL (NDC 00575-6200-30) is currently available. Providers may need to direct pharmacies to place an order with their wholesale supplier. Tidepool has received FDA approval for its interoperable automated insulin dosing app Tidepool Loop. The - [February 2023 President's Letter](https://pedsendo.org/presidents-message/february-2023-presidents-letter/) - Craig A. Alter, MD Growth Hormone Shortages Over the last few months, there has been world-wide shortages of growth hormone. I am sure that on a daily basis you are getting phone calls from families with concerns about running out of their GH supply. You and your staff are filling out forms (SMN) to get - [APP Spotlight: Kelly Friesner-Gephart, FNP](https://pedsendo.org/member-spotlight/app-spotlight/app-spotlight-kelly-friesner-gephart-fnp/) - Kelly Friesner-Gephart, FNP Kelly Friesner-Gephart is a nurse practitioner at Nationwide Children's Hospital with the Department of Endocrinology. She serves as the clinical coordinator and leader of the Diabetes/Insulin Inpatient Service Consult (DIISC) team. The DIISC team is a novel inpatient service aimed at reducing insulin-related adverse drug events (ADEs) and cares for all patients - [February Fellow Spotlight: Vickie Wu, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/february-fellow-spotlight-vickie-wu-md/) - Vickie Wu, MD I am a second year Pediatric Endocrinology Fellow at Kravis Children’s Hospital at Mount Sinai in New York City. I attended Harvard College in Cambridge, MA and Albany Medical College in Albany, NY. I completed my pediatric residency training at the Icahn School of Medicine at Mount Sinai. I loved my residency - [Drug Alerts/Recalls - TIROSINT®-SOL](https://pedsendo.org/drug-alerts/drug-alerts-recalls-tirosint-sol/) - IBSA Pharma Inc. has announced a voluntary recall of 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution due to concern for subpotency. Company testing revealed a slight decrease below 95% of the labeled amount of levothyroxine sodium for some lots. This recall does not apply to TIROSINT® (levothyroxine sodium) capsules. To date, IBSA has not - [Historical Tidbit: Theodor Kocher (25 August 1841 to 27 July 1917) and cachexia strumipriva](https://pedsendo.org/historical-tidbits/historical-tidbit-theodor-kocher-25-august-1841-to-27-july-1917-and-cachexia-strumipriva/) - Theodor Kocher (25 August 1841 to 27 July 1917) and cachexia strumipriva Submitted by Alan D. Rogol, MD, Ph.D Cachexia strumipriva, a condition having the signs and symptoms of severe hypothyroidism resulting from the complete loss of thyroid function was noted in a remarkable lecture by the Swiss surgeon Theodor Kocher to The German Society - [January 2023 President's Letter](https://pedsendo.org/presidents-message/january-2023-presidents-letter/) - Craig A. Alter, MD 2023 Annual Meeting Registration & Housing Opens February 1 Check here for up to the minute session content and meeting details! EDI Spotlight: February is Black History Month & American Heart Month Read More: Equity, Diversity and Inclusion Initiative - Pediatric Endocrine Society (pedsendo.org) An Invitation from the 11th Internatinal Meeting - [January Fellow Spotlight - Yesenia Sanchez-Kleinberg](https://pedsendo.org/member-spotlight/fellow-spotlight/january-fellow-spotlight-yesenia-sanchez-kleinberg/) - Yesenia Sanchez-Kleinberg I'm currently a second year pediatric endocrinology fellow at the Children's Hospital of Philadelphia. As a second year fellow, I'm pursuing the research track as a T32 trainee and I spend approximately 80% of my time doing research and 20% of my time doing clinical work. I love working with patients with Diabetes - [Historical Tidbit: Alfred F. Hess, MD (9 October 1875 to 5 December 1933) and the Prevention of Rickets](https://pedsendo.org/historical-tidbits/historical-tidbit-alfred-f-hess-md-9-october-1875-to-5-december-1933-and-the-prevention-of-rickets/) - Historical Tidbit: Alfred F. Hess, MD (9 October 1875 to 5 December 1933) and the Prevention of Rickets Submitted by Alan D. Rogol, MD, Ph.D Alfred Hess was a pediatrician at the Rockefeller Institute before going into private practice in New York. He determined the underlying factors for rickets, both in rats and children (Am - [December 2022 President's Letter](https://pedsendo.org/presidents-message/december-2022-presidents-letter/) - NEW DSD Guidelines The Department of Defense revised its regulations on medical qualification for military service, effective November 16th, 2022. The DSD-SIG and Board of PES supported efforts for revisions related to differences of sex development. Previously, many forms of DSD led to a blanket disqualification for service. This new standard disqualifies applicants with DSD - [New Drugs and Therapeutics Update TZIELDTM (teplizumab-mzwv)](https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-tzieldtm-teplizumab-mzwv/) - On November 17, 2022, the FDA announced the approval of TZIELDTM (teplizumab-mzwv), which is a CD-3 directed monoclonal antibody. This first-in-class therapy is intended to delay the onset of stage 3 type 1 diabetes (T1D) in individuals 8 years and older with stage 2 T1D. Stage 2 T1D is defined as at least two positive - [Historical Tidbit: James Bertram Collip (20 November 1892 to 19 June 1965) and Parathyroid Hormone](https://pedsendo.org/historical-tidbits/historical-tidbit-james-bertram-collip-20-november-1892-to-19-june-1965-and-parathyroid-hormone/) - Historical Tidbit: James Bertram Collip (20 November 1892 to 19 June 1965) and Parathyroid Hormone Submitted by Alan D. Rogol, MD, Ph.D “Bert” Collip was a Canadian biochemist who was an integral part of the team in Toronto that discovered insulin in 1922. He devised a purification method of alcohol precipitation that led to insulin - [December Fellow Spotlight - Einas Alkhatib, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/december-fellow-spotlight-einas-alkhatib-md/) - Einas Alkhatib, MD I am a second-year pediatric endocrinology fellow at Children’s National Hospital in Washington, D.C. After growing up in Minnesota, I attended St. Cloud State University in MN for undergrad, Oakland University William Beaumont School of Medicine (OUWB) in MI for med school, and Helen DeVos Children’s Hospital (HDVCH) in MI for residency. - [November 2022 President's Letter](https://pedsendo.org/presidents-message/november-2022-presidents-letter/) - December has numerous celebratory events frequently associated with gift giving. Let us recognize this diversity in the ways we celebrate for all encourage safe toys and gifts. Kwanzaa: Annual celebration of African American culture from December 26 to January 1 based on African harvest festival traditions from different parts of West and Southeast Africa. A seven - [Historical Tidbit: Dr. David Marine (20 September 1880 to 6 November 1976) and NaI as goiter prophylaxis](https://pedsendo.org/historical-tidbits/historical-tidbit-dr-david-marine-20-september-1880-to-6-november-1976-and-nai-as-goiter-prophylaxis/) - Historical Tidbit: Dr. David Marine (20 September 1880 to 6 November 1976) and NaI as goiter prophylaxis Submitted by Alan D. Rogol, MD, Ph.D David Marine, an American pathologist, re-started the virtually abandoned practice of adding iodine to the diet to prevent goiter. During 1916 to 1920 he administered 3 grains of NaI, taken daily - [Nathalie Josso, MD, PhD: 1934 - 2022](https://pedsendo.org/in-memoriam/nathalie-josso-md-phd-1934-2022/) - Nathalie Josso, MD, PhD Nathalie Josso, MD, PhD, was born in Paris in 1934. She obtained her MD degree from the University of Paris and did his internship in Paediatrics at Necker-Enfant Malades Hospital. Passionate about research, she was a disciple of Alfred Jost at Collège de France, with whom she learned about the existence - [FDA notice on sitagliptin contamination](https://pedsendo.org/drug-alerts/fda-notice-on-sitagliptin-contamination/) - FDA notice on sitagliptin contamination The Food and Drug Administration (FDA) recently reported the detection of a nitrosamine impurity (Nitroso-STG-19, known as NTTP) in samples of sitagliptin. NTTP belongs to the nitrosamine class of compounds, some of which are classified as probable or possible human carcinogens. Prior to the announcement, there were no data directly - [November Fellow Spotlight - Jody Grundman, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/november-fellow-spotlight-jody-grundman-md/) - Jody Grundman, MD I am currently a third-year pediatric endocrine fellow at Children’s National Hospital in Washington DC. I completed my Bachelor of Science degree at McGill University in Montreal Quebec Canada, my Masters of Public Health at Boston University, my medical degree at Ben Gurion University in Israel, and my pediatric residency at Albert - [October 2022 President's Letter](https://pedsendo.org/presidents-message/october-2022-presidents-letter/) - Craig A. Alter, MD IMPE Fellow's School Announcement The Global Fellows Program in Pediatric Endocrinology will be held March 1-4 in Buenos Aires, Argentina, just prior to the 2023 International Meeting of Pediatric Endocrinology (IMPE) in Buenos Aires, Argentina. The Global Fellows Program includes fellow participants and faculty from the sister Pediatric Endocrine Societies that participate - [October Fellow Spotlight - Julia Crowley, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/october-fellow-spotlight-julia-crowley-md/) - Julia Crowley, MD I am a third-year endocrinology fellow at the Children's Hospital of Philadelphia. I am doing primarily research currently with some clinical time. I also am the chief fellow for our fellowship program, and I spend time working with leadership on orientation, recruitment, scheduling, and fellow wellness. I am originally from Northern Virginia. - [October APP Spotlight: Erica Cordell, MSN, CRNP](https://pedsendo.org/member-spotlight/app-spotlight/october-app-spotlight-erica-cordell-msn-crnp/) - Erica Cordell, MSN, CRNP Erica Cordell is a nurse practitioner in the Division of Endocrinology and Diabetes at the University of Pittsburg Medical Center Children’s Hospital of Pittsburgh. She earned her Bachelor of Science in Nursing and Master of Science in Nursing from the University of Pittsburgh and has been with UPMC since 2004. As - [Historical Tidbit: Graves’ disease….or is it?](https://pedsendo.org/historical-tidbits/historical-tidbit-graves-disease-or-is-it/) - Historical Tidbit: Graves’ disease….or is it? Submitted by Evan Graber, DO In 1835 an Irish physician Sir Robert Graves first reported 4 women with “violent and long continued palpitations” and enlarged thyroid, giving rise to the eponymous condition now considered autoimmune hyperthyroidism. However, he was not the first to report the findings of what eventually - [George K. Degnon: August 2, 1940 - October 9, 2022](https://pedsendo.org/in-memoriam/george-k-degnon-august-2-1940-october-9-2022/) - It is with sadness that we share the news of the passing of the founder of Degnon Associates, George K. Degnon, CAE. In 1979, he and his wife, Marge, started their own association management company, Degnon Associates, Inc, where he spent several years lobbying for the health and well-being of children and public health. He served - [September 2022 President's Letter](https://pedsendo.org/presidents-message/septembe-2022-presidents-letter/) - Craig A. Alter, MD Calling for PES 2023 Annual Meeting Abstract Reviewers The Program Committee invites you to serve as an Abstract Reviewer for the 2023 Annual Meeting, to be held in San Diego, CA from May 5 - 8, 2023.By volunteering to review, you get a firsthand look at the abstracts submitted for the 2023 Annual Meeting and help - [Sept. Fellow Spotlight - Michelle Meder, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/september-fellow-spotlight-michelle-meder-md/) - Michelle Meder, MD I have recently started my third year of pediatric endocrinology fellowship at the University of Utah. I was raised in the St. Louis, Missouri area. I attended the University of Illinois for my undergraduate studies followed by completion of my medical degree at Chicago Medical School. As the mountains were calling, I - [Historical Tidbit: Early evidence of psychosocial effects on growth -Frederick II (13th century Emperor of the Holy Roman Empire and King of Italy and Germany)](https://pedsendo.org/historical-tidbits/historical-tidbit-early-evidence-of-psychosocial-effects-on-growth-frederick-ii-13th-century-emperor-of-the-holy-roman-empire-and-king-of-italy-and-germany/) - Historical Tidbit: Early evidence of psychosocial effects on growth -Frederick II (13th century Emperor of the Holy Roman Empire and King of Italy and Germany) Submitted by Alan D. Rogol, MD, Ph.D That psychosocial aspects may affect growth is at least as old as the 13th century when Frederick II (recorded by the monk Salimbene - [August 2022 President's Letter](https://pedsendo.org/presidents-message/august-2022-presidents-letter/) - Craig A. Alter, MD In Memoriam: Beverly Fisher It is with sadness that we share the news of the recent passing of Beverly Fisher. Beverly was the devoted wife of Dr. Delbert (Del) Fisher, a pioneer of pediatric endocrinology and former president of our Society. She was Del’s ‘right-hand’ for his countless accomplishments in pediatric - [New Meds and Tech from the PES Drugs & Therapeutics Committee - Qsymia®](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-therapeutics-committee-qsymia/) - New Meds and Tech from PES Drugs and Therapeutics committee In June 2022, the Food and Drug Administration (FDA) approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients ages 12 years and older with body mass index (BMI) at or above the 95th percentile for sex - [New Meds and Tech from the PES Drugs & Therapeutics Committee - FreeStyle Libre 3™](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-therapeutics-committee-freestyle-libre-3/) - New Meds and Tech from PES Drugs and Therapeutics committee The FreeStyle Libre 3 is the third generation of Abbot Laboratories’ continuous glucose monitoring system intended for day-to-day glucose monitoring in patients with diabetes mellitus. The Food and Drug Administration (FDA) approved the product for use by individuals 4 years and older with diabetes mellitus - [New Meds and Tech from the PES Drugs & Therapeutics Committee - Omnipod® 5](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-therapeutics-committee-omnipod-5/) - New Meds and Tech from PES Drugs and Therapeutics committee The Omnipod 5 (Insulet Inc) is a hybrid closed-loop system approved by the FDA on January 28, 2022 for use in children ≥ 6 years and adults with type 1 diabetes mellitus and subsequently approved in children as young as 2 years. Approval was based - [Historical Tidbit: A cautionary genetics tidbit](https://pedsendo.org/historical-tidbits/historical-tidbit-a-cautionary-genetics-tidbit/) - Historical Tidbit: A cautionary genetics tidbit Submitted by Walter L. Miller, MD Whole exome sequencing (WES) aims to determine the sequence of all protein-coding segments (‘exons’) in genomic DNA. As this ‘exome’ comprises only ~2% of the whole genome, it is easier and cheaper than sequencing the whole genome. WES is increasingly used to identify - [New Meds and Tech from the PES Drugs & Therapeutics Committee - GnRH agonists](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-therapeutics-committee-gnrh-agonists/) - New Meds and Tech from PES Drugs and Therapeutics committee PES Drug Alert - GnRH agonists On July 1, 2022 the Food and Drug Administration (FDA) announced that a warning about the risk of pseudotumor cerebri (idiopathic intracranial hypertension) will be added to the labeling for gonadotropin releasing hormone (GnRH) agonists which include Lupron Depot-Ped - [July 2022 President's Letter](https://pedsendo.org/presidents-message/july-2022-presidents-letter/) - Craig A. Alter, MD News from the EDI Action Team August 2022: Celebrating the Right to Vote On August 6, 1965, the Voting Rights Act (VRA) was signed into law. The VRA outlawed the discriminatory voting practices that had been adopted in many Southern states after the Civil war post-Reconstruction to deny Black Americans the - [History Tidbit: The adjustable micropipette](https://pedsendo.org/historical-tidbits/history-tidbit-the-adjustable-micropipette/) - History Tidbit: The adjustable micropipette Submitted by Walter Miller In our youth, many of us used glass pipettes to make buffers and other solutions. Following the introduction of the adjustable ‘Pipeteman’, such glass pipettes became museum pieces. As described by Martin Klingenberg (who was first to report P450 spectra), the modern piston-driven adjustable pipette with - [June 2022 President's Letter](https://pedsendo.org/presidents-message/june-2022-presidents-letter/) - Craig A. Alter, M.D. New Meds and Tech from PES Drugs and Therapeutics Committee: SKYTROFA® Anna Ryabets-Lienhard, DO, Christine Yu, MD, Emily Breidbart, MD In August 2021, FDA approved SKYTROFA®(lonapegsomatropin-tcgd), the first pediatric long-acting growth hormone (GH). Lonapegsomatropin-tcgd is a human growth hormone (GH) that utilizes TransCon® technology allowing once weekly subcutaneous administration of GH. SKYTROFA®is - [New Meds and Tech from the PES Drugs & Therapeutics Committee - Skytrofa](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-the-pes-drugs-and-therapeutics-committee-skytrofa/) - New Meds and Tech from PES Drugs and Therapeutics committee SKYTROFA® Anna Ryabets-Lienhard, DO, Christine Yu, MD, Emily Breidbart, MD In August 2021, FDA approved SKYTROFA® (lonapegsomatropin-tcgd), the first pediatric long-acting growth hormone (GH). Lonapegsomatropin-tcgd is a human growth hormone (GH) that utilizes TransCon® technology allowing once weekly subcutaneous administration of GH. SKYTROFA® is indicated - [June Public Policy Spotlight](https://pedsendo.org/public-policy/june-public-policy-spotlight/) - Public Policy Spotlight This spotlight will highlight recent articles both in lay and academic press that The PES Leadership believe would be of use to our constituents. Physicians as Political Pawns - The Texas Directive on Gender-Affirming Care and Other Moves https://pedsendo.org/wp-content/uploads/2022/06/Physicians-as-Political-Pawns-—-The-Texas-Directive-on-Gender-Affirming-Care-and-Other-Moves.pdf Battle over Gender Therapy https://www.nytimes.com/2022/06/15/magazine/gender-therapy.html?campaign_id=9&emc=edit_nn_20220615&instance_id=64091&nl=the-morning®i_id=104010269&segment_id=95173&te=1&user_id=f30adf7dee20f266408960cd96b26d8a - [Historical Tidbit: H. Franklin Bunn (7/7, 1935- )](https://pedsendo.org/historical-tidbits/historical-tidbit-h-franklin-bunn-july-7-1935/) - Historical Tidbit: H. Franklin Bunn (July 7, 1935- ) Submitted by Alan D. Rogol, MD, Ph.D Franklin Bunn, a hematologist noted (with Gabbay and Gallop) that the most abundant, fast-moving on electrophoresis, minor component of hemoglobin A, A1c previously described by Rahman (Clin Chim Acta 1968; 22:296) contained glucose (Science 1978; 200:21). It was attached - [June Fellow Spotlight - Janet Lucien, DO](https://pedsendo.org/member-spotlight/fellow-spotlight/june-fellow-spotlight-janet-lucien-do/) - What is your current position/how do you spend your time? I’m a third-year pediatric endocrinology fellow at the University of North Carolina in Chapel Hill. I’m in my last month of training and it’s amazing how fast the last three years have flown by! In addition to my clinical work, I’m also involved in an - [Spring 2022 President's Letter](https://pedsendo.org/presidents-message/spring-2022-presidents-letter/) - Dear Colleagues, It is my honor to serve as President of the Pediatric Endocrine Society, Before I present exciting news from our society, I would like to thank Dr. Sharon Oberfield, who worked tirelessly for the past year culminating with an amazing conference where there were 1081 attendees including 7% from other countries beyond North - [May Public Policy Spotlight](https://pedsendo.org/public-policy/may-public-policy-spotlight/) - New: Public Policy Spotlight We are providing the following articles/links on transgender care for members who want to be kept current or better understand the issues in Texas and Alabama when asked by colleagues, families, and patients. New Report Refutes Flawed Science of Texas and Alabama Transgender Legal Actions This article and its links will - [May Fellow Spotlight - Sabitha Sasidharan Pillai, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/may-fellow-spotlight-sabitha-sasidharan-pillai-md/) - Sabitha Sasidharan Pillai, MD I am a second-year pediatric endocrinology fellow at the Hasbro Children’s Hospital and Brown University in Providence, RI. My time is split between clinical work and research. During my pediatric residency in Kerala, India, I became interested in pediatric diabetes care and obesity. Later, when I joined as a faculty at Government Medical College, Calicut, my - [Dr. Juan Sotos -May 18 1927-May 7, 2022](https://pedsendo.org/in-memoriam/dr-juan-sotos-may-18-1927-may-7-2022/) - Dr. Juan Sotos -May 18 1927-May 7, 2022 It is with sadness that we share the news of the death May 7th of Dr. Juan Sotos. Dr. Sotos was truly a Renaissance man. He attended medical school in Valencia Spain where he also did a 1 year internship before coming to the United States where - [May APP Spotlight: Lauren Woodward, MSN, CPNP-AC, CDCES](https://pedsendo.org/member-spotlight/app-spotlight/may-app-spotlight-lauren-woodward-msn-cpnp-ac-cdces/) - Lauren Woodward, MSN, CPNP-AC, CDCES Lauren Woodward, MSN, CPNP-AC, CDCES has served as a board-certified pediatric nurse practitioner in the Department of Pediatric Endocrinology and Diabetes at Children’s of Alabama since 2011. Her areas of clinical interests include the management of pediatric patients with type I diabetes and metabolic bone disease. Lauren also maintains her Diabetes Care - [History Tidbit: Frederick Sanger (13 August 1913 to 19 November 2013) and the structure of insulin](https://pedsendo.org/historical-tidbits/history-tidbit-frederick-sanger-13-august-1913-to-19-november-2013-and-the-structure-of-insulin/) - History Tidbit: Frederick Sanger (13 August 1913 to 19 November 2013) and the structure of insulin Alan D. Rogol, MD, Ph.D Frederick Sanger obtained a doctorate in biochemistry in 1943 at Cambridge University. He continued to work there and deduced that insulin was a 2-chain heterodimer consisting of a 21-residue A chain linked to a - [PES Statement on Thyroid Monitoring in Infants and Young Children Receiving Iodine-Containing Contrast Media](https://pedsendo.org/news-announcements/pes-statement-on-thyroid-monitoring-in-infants-and-young-children-receiving-iodine-containing-contrast-media/) - On March 30th, 2022 the FDA released a Drug Safety Communication recommending monitoring of thyroid function in infants and children under 3 years of age within 3 weeks of receiving an injection of iodinated contrast media (ICM) for medical imaging. An FDA warning about the risk of iodine-induced hypothyroidism will be included in the prescribing - [April 2022 President's Letter](https://pedsendo.org/presidents-message/april-2022-presidents-letter/) - Dear Colleagues, This is my final President’s letter and in a few days we will be celebrating our 50th anniversary with a transformative annual meeting (April 28th-May 1st). Please see my personal invite to all of you below. Click Here to View It has been an extraordinary year. With some promise we are beginning to - [April APP Spotlight - Diana Perez, MPAS, PA-C](https://pedsendo.org/member-spotlight/app-spotlight/april-app-spotlight-diana-perez-mpas-pa-c/) - Diana Perez, MPAS, PA-C Diana Perez, MPAS, PA-C practices in the endocrine and diabetes division at Pediatric Multi-specialty clinic at Beacon’s Children’s Hospital in South Bend, Indiana. She received her Bachelor of Science in Biology from Goshen College in Goshen, Indiana. She then went on to receive her Master of Physician Assistant Studies from Chatham - [Historical Tidbit: Nicolae Paulsecu (Nicola Paulesco) (October 30, 1869-July 17, 1931)](https://pedsendo.org/historical-tidbits/historical-tidbit-nicolae-paulsecu-nicola-paulesco-october-30-1869-july-17-1931/) - Nicolae Paulsecu (Nicola Paulesco) (October 30, 1869-July 17, 1931) Submitted by Alan D. Rogol, MD, Ph.D Nicolae Paulescu, a Romanian physician/physiologist, studied and began his research career in Paris. He returned to Bucharest where he served as head of Physiology at the University. In 1916 he developed an aqueous pancreatic extract that when injected into - [Pediatric Subspecialty Loan Repayment Program](https://pedsendo.org/news-announcements/pediatric-subspecialty-loan-repayment-program/) - Great news regarding Pediatric Subspecialty Loan Repayment Program! One of the key recommendations of the PES Workforce Taskforce is to advocate for policies that lessen financial barriers to pediatric endocrinology to both improve recruitment and reduce the effect of debt on risk of burnout. On March 23rd we received notification from Matthew Mariani, Federal Advocacy - [March 2022 President's Letter](https://pedsendo.org/presidents-message/m-2022-presidents-letter/) - Dear Colleagues, Throughout history mid-March, and the arrival of the robust full moon has been known as the “Ides of March” and has been associated with ominous undertones. Specifically, in the year 44 B.C. the Ides of March marked the betrayal and assassination of Julius Caesar- which was documented in Shakespeare’s play by the same - [Drug Shortages](https://pedsendo.org/drug-shortages/drug-updates-lupron-depot-ped/) - Visit the following link for the latest reported drug shortages in pediatric endocrinology. ______________________________________________________________ Please note: This is a service to the membership, with periodic updates. Due to regional differences in supply chains, local availability may vary during periods of shortages. As always, it remains the responsibility of the practitioner to stay updated with respect - [March Fellow Spotlight - Camilia Kamoun, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/march-fellow-spotlight-camilia-kamoun-md/) - Camilia Kamoun, MD What is your current position/how do you spend your time? How did you get there? I am a 3rd year pediatric endocrinology fellow at the Children’s Hospital of Philadelphia. My time is split between research and clinical care, with most of my time working on research examining sex difference in growth hormone - [March APP Spotlight - Alexandra Armstrong](https://pedsendo.org/member-spotlight/app-spotlight/march-app-spotlight-alexandra-armstrong/) - Alexandra Armstrong Alexandra Armstrong is a board-certified pediatric nurse practitioner working at Children’s of Alabama since 2014. Alexandra has undergone specialized training in caring for children who have experienced adverse childhood events, and she has a specific interest in caring for high-risk patient populations. She has played an integral role is establishing a high-risk - [Historical Tidbit: Georg Ludwig Zülzer (George Ludwig Zuelzer) April 10, 1870-October 16, 1949](https://pedsendo.org/historical-tidbits/historical-tidbit-georg-ludwig-zulzer-george-ludwig-zuelzer-april-10-1870-october-16-1949/) - History Tidbit: Georg Ludwig Zülzer (George Ludwig Zuelzer) April 10, 1870-October 16, 1949 submitted by Alan D. Rogol, MD, Ph.D Georg Zülzer was a German physician who practiced medicine in Berlin until 1934. Experimentally he used calf pancreatic extract, Acomatol in dogs and humans (Zeitschr Exp Path Ther 1908; 5:307). A few patients improved in - [February 2022 President's Letter](https://pedsendo.org/presidents-message/february-2022-presidents-letter-2/) - February seems shorter than ever this year. This is due, in part, I believe to PES management and our committees working extraordinarily hard to ensure that our VIRTUAL 50th Anniversary Meeting will surpass all expectations. I personally thank all who have reached out to share their support of our decision. We are actually in the - [Response to Governor Greg Abbott’s Directive Regarding Management of Transgender Children and Adolescents](https://pedsendo.org/public-policy/response-to-governor-greg-abbotts-directive-regarding-management-of-transgender-children-and-adolescents/) - February 28, 2022 On behalf of the Pediatric Endocrine Society, the main academic and professional society of pediatric endocrinologists in North America with more than 1500 members, we write this letter to oppose the recent directive by Governor Greg Abbott ordering the Department of Family and Protective Services (DFPS) to investigate any reported instances - [February APP Spotlight - Lisa Truong](https://pedsendo.org/member-spotlight/app-spotlight/february-app-spotlight-lisa-truong/) - Lisa Truong Lisa Truong is a board-certified pediatric nurse practitioner specializing in congenital hyperinsulinism. She has worked at Cook Children’s Medical Center in Fort Worth, Texas for over 10 years. Lisa earned her bachelor’s degree in nursing from the University of Oklahoma in 2007 and her master’s degree in nursing from the University of Texas- - [February Fellow Spotlight - Hannah Jelley](https://pedsendo.org/member-spotlight/fellow-spotlight/february-fellow-spotlight-hannah-jelley/) - Hannah Jelley My name is Hannah Jelley and I am currently a second-year pediatric endocrinology fellow at the University of Utah/Primary Children’s Hospital in Salt Lake City, UT. I grew up in Tulsa, Oklahoma then journeyed down to New Orleans where I completed my undergraduate degree in public health at Tulane University. I returned - [Historic Tidbit: Marcel –Eugene-Émile Gley (January 18, 1857-October 24, 1930)](https://pedsendo.org/historical-tidbits/historic-tidbit-marcel-eugene-emile-gley-january-18-1857-october-24-1930/) - Historic Tidbit: Marcel –Eugene-Émile Gley (January 18, 1857-October 24, 1930) Alan D. Rogol, MD, Ph.D Eugene Gley studied medicine at Montpellier and Nancy receiving his doctorate in 1881 as an experimental physiologist. He was a prolific scientist in many areas of biology emphasizing “internal secretions”. His work was considered so outstanding that a Chair in - [January 2022 President's Letter](https://pedsendo.org/presidents-message/january-2022-presidents-letter/) - These past 2 weekends I spent time working on talks and reviews in our Upstate New York retreat. I was grateful that our generator worked, oil was in good supply and only deer tracks interrupted the serenity of the 6 inches of snow and the as low as minus 10-degree temperature outside. As I gazed - [New Meds and Tech from PES Drugs and Therapeutics Committee Evolocumab](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee-6/) - EVOLOCUMAB (REPATHA) Brenda Kohn MD, Dania Al-Hamad MD, Ambika P. Ashraf MD On September 24, 2021, Amgen announced that the FDA approved evolocumab (Repatha) as an adjunct treatment to diet and other LDL cholesterol (LDL-C)-lowering medications for patients aged 10 years and older with heterozygous Familial Hypercholesterolemia (HeFH). The approval followed results of the HAUSER-RCT Phase 3b study evaluating - [Historical Tidbit: Paul Langerhans (July 25, 1847-July, 20, 1888)](https://pedsendo.org/historical-tidbits/historical-tidbit-paul-langerhans-july-25-1847-july-20-1888/) - Historical Tidbit : Paul Langerhans (July 25, 1847-July, 20, 1888) Alan D. Rogol MD, Ph.D Paul Langerhans was a German pathologist who studied medicine in Jena and Berlin. While still a medical student he discovered 9 different cells within the pancreatic islets including those that secrete insulin-small, irregularly shaped polygonal cells without granules forming small - [January PES Fellow Spotlight: Samuel Cortez, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/january-pes-fellow-spotlight-samuel-cortez-md/) - PES Fellow Spotlight: Samuel Cortez, MD I have been committed to working with underserved and marginalized populations throughout my residency at the University of Kansas and medical school in El Salvador. Currently I am a Clinical Endocrinology and Diabetes Fellow at Washington University in St. Louis. I am also a Postdoctoral Clinical Research Fellow through - [January APP Spotlight: Camille S. Wheeler, MSN, FNP-C, CPN, RN](https://pedsendo.org/member-spotlight/app-spotlight/january-app-spotlight-camille-s-wheeler-msn-fnp-c-cpn-rn/) - Camille S. Wheeler, MSN, FNP-C, CPN, RN Camille S. Wheeler, MSN, FNP-C, CPN, RN earned her bachelor’s degree in Nursing from Mississippi University for Women in 2001 and her Master’s of Nursing studies from University of Memphis Loewenberg College of Nursing in December 2018. She started her career at North MS Medical Center caring - [Drug Alerts and Recalls](https://pedsendo.org/drug-alerts/drug-alerts-and-recalls/) - Visit the following link for the latest reported drug alerts or recalls in pediatric endocrinology. Please note: this is a service to the membership, with periodic updates. Drug recalls may not impact all manufacturers or all lots (if available, information will be provided or referenced). As always, it remains the responsibility of the practitioner to - [John Scott Parks - October 14, 1939 – December 23, 2021](https://pedsendo.org/in-memoriam/parks-john-scott-parks-october-14-1939-december-23-2021/) - John Scott Parks October 14, 1939 – December 23, 2021 It is with great sadness that we announce the passing of John Scott Parks MD, PhD. Parks was an innovative researcher in the genetics and molecular mechanism of growth, a gifted teacher who was a world-renowned lecturer, a kind and gentle pediatrician and a treasured - [December 2021 President's Letter](https://pedsendo.org/presidents-message/december-2021-presidents-letter/) - As we approach the coming New Year it is hard not to hope that in 2022 all of us will see an improvement in our day to day lives. Indeed, this has been an unusual and difficult to comprehend year for many of us! Nonetheless, we strive for a return to a modified normal and attainment - [New Ready-to-Use Glucagon Preparation: Zegalogue](https://pedsendo.org/new-meds-and-tech/new-ready-to-use-glucagon-preparation-zegalogue/) - Prepared on behalf of the PES Drugs and Therapeutics Committee by Kristal Matlock, MD, Dania Al-Hamad, MD, Vandana Raman, MD and Amit Lahoti, MD FDA approval for Zegalogue (dasiglucagon) marks the third FDA-approved, ready-to-use, stable glucagon preparation since 2019 that does not require reconstitution. Zegalogue 0.6 mg/0.6 mL autoinjector or pre-filled syringe was approved in - [Gajanthan Muthuvel, MD - December Fellow Spotlight](https://pedsendo.org/member-spotlight/fellow-spotlight/gajanthan-muthuvel-md-december-fellow-spotlight/) - Gajanthan Muthuvel, MD What is your current position/how do you spend your time? I am a third year Pediatric Endocrinology fellow at Cincinnati Children’s Hospital. I’m originally from Oshkosh, WI and completed medical school at the University of Wisconsin of Medicine and Public Health in Madison, WI, followed by Pediatric Residency at Mayo Clinic in - [ Israel S. Kleiner (April 8, 1885-June 15, 1966) - December Historical Tidbit](https://pedsendo.org/historical-tidbits/israel-s-kleiner-april-8-1885-june-15-1966-december-historical-tidbit/) - Israel S. Kleiner (April 8, 1885-June 15, 1966) Submitted by Alan D. Rogol, MD, Ph.D Israel Kleiner, a native of New Haven CT, completed his undergraduate and Ph.D (physiologic chemistry, 1909) at Yale University. His research career began at Rockefeller Institute, but he moved to NY Medical College becoming Dean in 1921. He was among - [Diana Mysliwiec, PA-C - December APP Spotlight](https://pedsendo.org/member-spotlight/app-spotlight/diana-mysliwiec-pa-c-december-app-spotlight/) - Diana Mysliwiec, PA-C, earned her bachelor’s degree in Biobehavioral Health from the Pennsylvania State University in 2007 and her Master of Physician Assistant Studies from Chatham University in 2009. Her first job as a PA was with Small Bowel and Multivisceral Transplant patients at UPMC Montefiore Hospital. In January 2011, she found her true passion - [November 2021 President's Letter](https://pedsendo.org/presidents-message/november-2021-presidents-letter/) - Dear Friends and PES Family, I added family to the salutation because Thanksgiving is traditionally a time for family gatherings. We can only hope that with Covid-19 vaccinations recently approved for our 5 to 11 year old children that there indeed will be more ability and comfort spending this holiday with our families. Thanksgiving is - [Samuel Rahbar, MD (May 12, 1929-November 10, 2012) - November Historical Tidbit](https://pedsendo.org/historical-tidbits/samuel-rahbar-md-may-12-1929-november-10-2012-november-historical-tidbit/) - Samuel Rahbar, MD (May 12, 1929-November 10, 2012) Alan D. Rogol MD, Ph.D Samuel Rahman was an Iranian trained physician/scientist who noted a fast moving hemoglobin component on electrophoresis in subjects with diabetes (Clin Chim Acta 1968; 22:296). As a visiting scientist at the Albert Einstein College of Medicine in 1968-1969, he worked in the - [PES APP Spotlight](https://pedsendo.org/member-spotlight/app-spotlight/pes-app-spotlight-3/) - Maureen Dever MSN, CRNP, CDCES, PCPNP-BC has been a Pediatric Nurse Practitioner in Pediatric Endocrinology and Diabetes since 2000. She graduated with her MSN, CRNP-Pediatrics from Drexel University in Philadelphia, PA, and her RN, BSN in Nursing from Temple University in Philadelphia, PA. Maureen is also Board Certified as a Diabetes Care and Education Specialist. Maureen - [October 2021 President's Letter](https://pedsendo.org/presidents-message/october-2021-presidents-letter/) - Dear Friends and colleagues, This is my 6th President’s letter and I hardly feel that half of my term as president is over. So much more to do- and actually, so little time! I thought I would take this opportunity to advise you of some of the activities that go on behind the scenes to - [Eugene L. Opie (July 5, 1873-March 12, 1971) - October Historical Tidbit](https://pedsendo.org/historical-tidbits/eugene-l-opie-july-5-1873-march-12-1971-october-historical-tidbit/) - Eugene L. Opie (July 5, 1873-March 12, 1971) Alan D. Rogol, MD, PH.D Eugene Opie graduated from Johns Hopkins University and was in the Medical School’s first graduating class (1897). He worked with William Welch in the Department of Pathology, especially on pancreatic anatomy. As a medical student he noted morphological alterations in the islets - [Megan Pruett, MSN, CPNP - October APP Spotlight](https://pedsendo.org/member-spotlight/app-spotlight/megan-pruett-msn-cpnp-october-app-spotlight/) - Megan Pruett, MSN, CPNP Megan Pruett, MSN, CPNP has been an endocrine nurse practitioner for over 15 years at Children’s Healthcare of Atlanta in both the diabetes clinics and the Aflac Cancer and Blood Disorders Center. She is an experienced diabetes clinician and cares for oncology and hematology patients with endocrine disease, and cancer survivors - [Meghan Craven, MD - October Fellow Spotlight](https://pedsendo.org/member-spotlight/fellow-spotlight/meghan-craven-md-october-fellow-spotlight/) - Meghan Craven, MD What is your current position/how do you spend your time? I am currently a third-year fellow at Children’s Hospital of Philadelphia and also completing my Master of Public Health at the University of Pennsylvania. As a senior fellow, I spend the majority of my time doing clinical research, but I have - [35th Anniversary of PES](https://pedsendo.org/oral-history/35th-anniversary-of-pes/) - In April 1972, three planning meetings were held for the purpose of discussing the organization of a "North American Society for Pediatric Endocrinology." The name "Lawson Wilkins Pediatric Endocrine Society" was chosen and the first set of temporary officers was selected. In May, 1972, a Constitution and Bylaws were adopted, officers were formally approved, and - [September 2021 President's Letter](https://pedsendo.org/presidents-message/september-2021-presidents-letter/) - Dear PES members, As I review the listings and notices below regarding upcoming activities, I am amazed at how active we were this summer and will be this fall due to the energy and vitality of our community. September, the start of autumn, has been a month that noted the 20-year anniversary of 9/11/2001. I - [Historical Tidbit - Frederick M. Allen, MD (16 March 1879 to 11 January 1964) Dietary Treatment for Diabetes Mellitus before Insulin](https://pedsendo.org/historical-tidbits/historical-tidbit-frederick-m-allen-md-16-march-1879-to-11-january-1964-dietary-treatment-for-diabetes-mellitus-before-insulin/) - History Tidbit: Frederick M. Allen, MD (16 March 1879 to 11 January 1964) Dietary Treatment for Diabetes Mellitus before Insulin. Submitted by Alan D. Rogol, MD, Ph.D Before the discovery of insulin in 1922 T1DM was often a rapidly fatal condition. Allen realized that it was a global disorder of metabolism rather than just a - [PES APP Spotlight](https://pedsendo.org/member-spotlight/app-spotlight/pes-app-spotlight-2/) - Stephanie Woerner, MSN, FNP-C, CDCES has been an endocrine nurse practitioner for 14 years at Indiana University/Riley Hospital for Children. She participates in both general pediatric endocrine clinics as well as diabetes clinics. She also serves as an investigator and sub-investigator in numerous Type 1 Diabetes research studies. The Type 1 research team focuses on - [September Fellow Spotlight - Sruthi Menon, MD, PGY-6](https://pedsendo.org/member-spotlight/fellow-spotlight/september-fellow-spotlight-sruthi-menon-md-pgy-6/) - Sruthi Menon, MD, PGY-6 Clinical Fellow, Diabetes & Endocrinology, Texas Children's Hospital/ Baylor College of Medicine I am a 3rd year fellow in pediatric endocrinology at Baylor College of Medicine/Texas Children’s Hospital. I grew up in India and completed medical school at Madras Medical College, Chennai before moving to the United States for the rest of my medical - [August 2021 President's Letter](https://pedsendo.org/presidents-message/august-2021-presidents-letter/) - Dear Colleagues, August traditionally is a time for reflection and the true start of the new academic year. In August, which also is a time many take vacations, we often make plans for personal renewal and try to take a few days away at least from email, texting and i- Phones. This year, unfortunately, many - [New Meds and Tech from PES Drugs and Therapeutics Committee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-dt-committee/) - Brief Therapeutic Update from PES Drugs and Therapeutics Committee (THYQUIDITYTM) THYQUIDITYTM is a liquid levothyroxine preparation that is FDA approved for (i) treatment of congenital or acquired forms of primary, secondary and tertiary hypothyroidism, and (ii) pituitary thyrotropin suppression as an adjunct therapy in thyrotropin-dependent well-differentiated thyroid cancer (1). Safety and efficacy data for THYQUIDITYTM - [PES APP Spotlight](https://pedsendo.org/member-spotlight/app-spotlight/pes-app-spotlight/) - Leslie Pitts, MSN, CPNP-AC, CDCES, AP-PEN has been an endocrine nurse practitioner for 11 years at Children’s of Alabama in Birmingham, Alabama. She has a background as a diabetes and insulin pump educator prior to her career as a nurse practitioner, and she has personal experience living with Type 1 Diabetes. She is a - [Historical Tidbit - Elliott Proctor Joslin (6 June 1869 to 28 January 1962) The treatment of those with T1DM, pre- and post- the Discovery of Insulin](https://pedsendo.org/historical-tidbits/historical-tidbit-elliott-proctor-joslin-6-june-1869-to-28-january-1962-the-treatment-of-those-with-t1dm-pre-and-post-the-discovery-of-insulin/) - History Tidbit: Elliott Proctor Joslin (6 June 1869 to 28 January 1962) The treatment of those with T1DM, pre- and post- the Discovery of Insulin Submitted by Alan D. Rogol, MD, Ph.D. Elliott Joslin graduated from Harvard Medical School as the valedictorian in 1895. After post-graduate training he practiced medicine in the Back Bay area - [July 2021 President's Letter](https://pedsendo.org/presidents-message/july-2021-presidents-letter/) - Dear Colleagues. As I write our July letter it is hard for me to believe that 3 months have passed since I started the presidency. Our nation is still combatting the pandemic - yes, it is a war. We have seen some “light at the end of the tunnel” with the number of cases declining - [Historical Tidbit - Oskar Minkowski (January 13, 1858-July 18, 1931) and the discovery of the pancreatic origin of diabetes, 1889](https://pedsendo.org/historical-tidbits/historical-tidbit-oskar-minkowski-january-13-1858-july-18-1931-and-the-discovery-of-the-pancreatic-origin-of-diabetes-1889/) - Oskar Minkowski (January 13, 1858-July 18, 1931) and the discovery of the pancreatic origin of diabetes, 1889 submitted by Alan D. Rogol, MD, Ph.D Serendipity may lead to discoveries of major significance. Minkowski with Joseph von Mering were discussing whether free fatty acids were essential for fat absorption. Minkowski proposed total pancreatectomy in a - [July Fellow spotlight - Justin Dey, MD](https://pedsendo.org/member-spotlight/fellow-spotlight/july-fellow-spotlight-justin-dey-md/) - Justin Dey, MD, I am a 1st year fellow (brand new!) in Peds Endo at Medical College of Wisconsin/Children’s Wisconsin. I grew up in Arizona, did my undergrad and medical school at Saint Louis University in Missouri, and just finished my Pediatric Residency here at MCW in Wisconsin. I have always been interested in teaching - [June 2021 President's Letter](https://pedsendo.org/presidents-message/june-2021-presidents-letter/) - Dear All, We are hopefully beginning with the start of summer to work through the challenges of reopening post Covid-19. As we ramp up our academic/clinical schedules, we move forward with optimism seasoned with caution as well as look toward new models of health care delivery to our patients. The summer for us at PES - [Congratulations PESLA Graduate - Dr. Minu George](https://pedsendo.org/member-spotlight/congratulations-pesla-graduate-dr-minu-george/) - Congratulations to Dr. Minu George, our most recent graduate from our PES Leadership advantage program! PES Leadership Advantage provides physician leaders with the core skills key to becoming impactful voices at the leadership table. PES Leadership Advantage enhances three overarching areas of high performance: Leadership Fundamentals, Leading & Influencing Others, and Navigating & Guiding Your Enterprise. - [June Fellow Spotlight - Dr. Jia Zhu ](https://pedsendo.org/member-spotlight/fellow-spotlight/june-fellow-spotlight-dr-jia-zhu/) - Dr. Jia Zhu I am currently a third-year clinical fellow at Boston Children's Hospital, and I am excited to join the faculty as an attending physician as of July 1, 2021! My journey started at MIT where I discovered biology and genetics and wanted to apply science to medicine. In medical school at Harvard, I had the - [Historical tidbit - Moses Barron, MD (November 8, 1883-December 22, 1974)](https://pedsendo.org/historical-tidbits/historical-tidbit-moses-barron-md-november-8-1883-december-22-1974/) - Moses Barron, MD (November 8, 1883-December 22, 1974) submitted by Alan D. Rogol, MD, Ph.D Moses Barron MD, a Russian immigrant, graduated from the University of Minnesota in 1911 became an instructor in Pathology at the medical school. After WW I he returned to the University and wrote a landmark paper “The relation of the - [May 2021 President's Letter](https://pedsendo.org/presidents-message/may-2021-presidents-letter/) - By the time you read my first Presidential letter it will be almost a month since our first PES standalone meeting, April 28- May 3, 2021. I would like to thank, in particular, Madhu Misra, MD our immediate past President, Erica Eugster, Md- past President, Selma Witchel MD and Ambika Ashraf- MBBS, DCH, MD co-chairs - [May Fellow Spotlight - Anna Chin, MD, MPH](https://pedsendo.org/member-spotlight/fellow-spotlight/fellow-spotlight-anna-chin-md-mph/) - Anna Chin, MD, MPH I am currently a third-year pediatric endocrinology fellow at Brown University/Hasbro Children's Hospital. I graduated from University of Massachusetts Medical School and also completed a combined residency in internal medicine and pediatrics at UMass. Before attending medical school, I obtained my MPH at Dartmouth Medical School and spent a gap year working - [Historical tidbit - Andrea Prader, MD (December 23, 1919-June 3, 2001)](https://pedsendo.org/historical-tidbits/historical-tidbit-andrea-prader-md-december-23-1919-june-3-2001/) - Andrea Prader, MD (December 23, 1919-June 3, 2001) submitted by Alan D. Rogol, MD, Ph.D Andrea Prader was a Swiss pediatrician who came to the United States in the 1950’s where he became interested in endocrinology especially from contact with Dr. Lawson Wilkins. He returned to Zurich to become Professor and Chair of the Pediatrics. - [The Pediatric Endocrine Society Opposes Bills that Harm Transgender Youth](https://pedsendo.org/news-announcements/the-pediatric-endocrine-society-opposes-bills-that-harm-transgender-youth-2/) - POSITION STATEMENT APRIL 2021 The Pediatric Endocrine Society Opposes Bills that Harm Transgender Youth Bills that threaten the health of transgender and gender diverse (TGD) youth have been introduced in multiple state legislatures across the United States. These bills undermine medical recommendations and seek to criminalize health care professionals who provide gender-affirming care such - [Historical Tidbit - Donald S. Fredrickson, MD (August 8, 1924-June 7, 2002)](https://pedsendo.org/historical-tidbits/donald-s-fredrickson-md-august-8-1924-june-7-2002/) - Donald S. Fredrickson, MD (August 8, 1924-June 7, 2002) by Alan D. Rogol, MD, Ph.D Dr. Fredrickson received his MD in 1949 from Michigan and did post graduate work at the Peter Bent Brigham and MGH in Boston. He joined the NIH in 1953 as a clinical associate and stayed on in the Laboratory of - [The Pediatric Endocrine Society Opposes Bills that Harm Transgender Youth](https://pedsendo.org/news-announcements/the-pediatric-endocrine-society-opposes-bills-that-harm-transgender-youth/) - Bills that threaten the health of transgender and gender diverse (TGD) youth have been introduced in multiple state legislatures across the United States. These bills undermine medical recommendations and seek to criminalize health care professionals who provide gender-affirming care such as puberty suppressing medications and gender-affirming hormone therapy. Read full position statement here. - [March 2021 President's Letter](https://pedsendo.org/presidents-message/march-2021-presidents-letter/) - Dear Colleagues, Spring is here, and with its advent, there is an expectation of positivity, new happenings, and good things to come. Here in Boston, temperatures are creeping up to 50s and 60s and the first daffodils are now in bloom. Elsewhere in the country, trees are bursting forth their young spring mantle and gorgeous - [PES Leadership Advantage INSPIRE Module Registration is OPEN!](https://pedsendo.org/news-announcements/pes-leadership-advantage-inspire-module-registration-is-open/) - PES Leadership Advantage INSPIRE Module Registration is OPEN! PES Leadership Advantage provides physician leaders with the core skills key to becoming impactful voices at the leadership table. PES Leadership Advantage enhances three overarching areas of high performance: Leadership Fundamentals, Leading & Influencing Others, and Navigating & Guiding Your Enterprise. Four separate modules: Influence, Engage, Inspire and Envision comprise the program. INSPIRE Module coming - [Historical Tidbit - Dorothy Mary Crowfoot Hodgkin](https://pedsendo.org/historical-tidbits/historical-tidbit-dorothy-mary-crowfoot-hodgkin/) - Dorothy Mary Crowfoot Hodgkin (May 12, 1910-July 29, 1994) Alan D. Rogol MD, Ph.D Dorothy Hodgkin was a Noble Prize (Chemistry) winning British scientist who used a mass of x-ray spectra, extensive calculations and astute analysis to determine complex molecular crystal structures. Her long foray into the structure of proteins began before she published her - [Historical Tidbit - Eleanor Colle (MacLean)](https://pedsendo.org/historical-tidbits/historical-tidbit-eleanor-colle-maclean/) - Eleanor Colle (MacLean) (January 27 1926-June 2, 2015) Alan D. Rogol, MD, Ph.D Fondly known as “EC”, Dr. Colle was born in Minneapolis, MN, and completed undergraduate and medical (1950) studies at the University of Minnesota. Working with Robert Ulstrom she published a landmark paper on ketotic hypoglycemia (J Pediatr 1964; 64:632) and a series - [March Fellow Spotlight - Puja Singh, MD ](https://pedsendo.org/member-spotlight/fellow-spotlight/puja-singh-md-fellow-spotlight/) - Puja Singh, MD I am a first year pediatric endocrinology fellow at UT Southwestern in Dallas, TX. I grew up in northern Illinois. I completed my undergraduate degree at University of Kentucky, Lexington, and received my MD from University of Cincinnati College of Medicine. My pediatrics residency was at Medical College of Wisconsin/Children’s Wisconsin - [February 2021 President's Letter](https://pedsendo.org/presidents-message/february-2021-presidents-letter/) - Dear Colleagues, I trust you are all now vaccinated and doing well. The Program Committee, Board and Management have exciting tidings for you, namely the opening of registration for the 2021 Annual Meeting. If you missed the notification on Friday, February 19th, please see the link below to register. For those who deferred conference registration - [New Meds and Tech from PES Drugs and Therapeutics Committee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee-5/) - New Meds and Tech from PES Drugs and Therapeutics Committee The MimiMedTM 770G System Prepared by: Molly Regelmann, MD and Anna Ryabets-Lienhard, DO Uptodate as of: 2/4/2021 On August 31, 2020, the FDA approved the MiniMedTM 770G System from Medtronic for patients with type 1 diabetes mellitus ages 2 – 6 years. This is the - [PES Leadership Advantage Module and dates announced!](https://pedsendo.org/news-announcements/pes-leadership-advantage-module-and-dates-announced/) - Early Bird Registration opens early March. Hold the dates now. DATES AND TIMES: Segment 1 Friday, May 21st, 2:00-4:30 ET Segment 2 Friday, June 4th, 2:00-4:30 ET Segment 3 Friday June 11th, 2:00-4:30 ET - [2021 Annual Meeting Registration IS OPEN!!](https://pedsendo.org/news-announcements/2021-annual-meeting-registration-is-open/) - REGISTRATION IS OPEN!! We are so pleased to announce that the Registration Portal is now open for you to join us for the 2021 PES Virtual Annual Meeting on April 30 – May 3, 2021! To register for the conference, please click HERE Please note: If you deferred your conference registration from the 2020 Annual Meeting, - [February Fellow Spotlight: Ryan Dyess](https://pedsendo.org/member-spotlight/fellow-spotlight/february-fellow-spotlight-ryan-dyess/) - My name is Ryan Dyess and I am a Pediatric Endocrinology Fellow, PGY-5 at the University of Louisville School of Medicine. Professionally, I spend time exploring all areas of medicine: clinically, learning/teaching, and performing research (clinical) as a part of my Fellowship training. Personally, I enjoy exercise in most all forms, particularly golf, but with - [Alfred Jost, Ph.D (1916-1991) and Sexual Ambiguity](https://pedsendo.org/historical-tidbits/alfred-jost-ph-d-1916-1991-and-sexual-ambiguity/) - Alfred Jost, Ph.D (1916-1991) and Sexual Ambiguity Submitted by Alan D. Rogol, MD, Ph.D Alfred Jost was a French fetal endocrinologist who examined mammals (rabbits) rather than the usual avian models for sexual development. Major findings were that castration of the male fetus before sexual differentiation led to female phenotype with persistent Müllerian structures and - [January 2021 President's Letter](https://pedsendo.org/presidents-message/january-2021-presidents-letter/) - Dear Colleagues, My best wishes to all for a very Happy New Year. We are now at the end of a tumultuous month, and I hope we can settle in to a period of relative calm while our leaders strive to bring this terrible pandemic under control. This month saw the passing of two giants - [New Meds and Tech from PES Drugs and Therapeutics committee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee-4/) - Approval of generic glucagon for management of hypoglycemia Prepared by: Kristal Matlock, Preneet Cheema Brar, Molly Regelmann UpToDate as of: 1/20/2021 On December 28, 2020, the U.S. Food and Drug Administration (FDA) announced approval of the first generic Glucagon for Injection Emergency Kit, 1 mg/vial. Indications include treatment of severe hypoglycemia and as a diagnostic aid - [New Meds and Tech from PES Drugs and Therapeutics committee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee-3/) - Setmelanotide Prepared by: Anshu Gupta, MD, MS and Brenda Kohn, MD Up-to-date as of December 14, 2020 On November 27, 2020, setmelanotide (IMCIVREE™; Rhythm Pharmaceuticals, Inc.), a melanocortin-4 (MC4) receptor agonist, received U.S. Food & Drug Administration (FDA) approval for the treatment of three rare monogenic types of obesity: proopiomelanocortin (POMC ) deficiency, proprotein convertase - [New Meds and Tech from PES Drugs and Therapeutics committee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee-2/) - Saxenda (Liraglutide) Approved for Adolescent Obesity Prepared by: Laura Page, MD and Shilpa Mehta, MD Up to date as of December 10, 2020 On December 4, 2020, the FDA approved the GLP-1 agonist Saxenda® (Liraglutide) for the treatment of obesity in adolescents (12-17 years) in conjunction with lifestyle changes. Use is limited to adolescents with - [January History Tidbit](https://pedsendo.org/historical-tidbits/january-history-tidbit/) - McCune-Albright syndrome (D.J. McCune, MD (1902-1976), Fuller Albright MD (1900-1969) Submitted by: Alan D. Rogol, MD, Ph.D In 1936 McCune described a patient with disseminated osteitis fibrosa, skin pigmentation, precocious puberty and hyperthyroidism (Am J Dis Child 1936; 52:743). The next year Albright noted 5 patients with similar findings (precocious puberty), but with marked variability - [December 2020 President's Letter](https://pedsendo.org/presidents-message/december-2020-presidents-letter/) - Dear Colleagues, First of all, my sincere congratulations to our Van Wyk award winner, Dr. Dorothy Becker. The Awards and Honors Committee and the Board of Directors are delighted that Dr. Becker’s many contributions to pediatric endocrinology are being recognized by this most prestigious award, and we look forward to felicitating her at the 2021 - [December Fellow Spotlight: Dr. Abby Walch](https://pedsendo.org/member-spotlight/fellow-spotlight/december-fellow-spotlight-dr-abby-walch/) - I am currently a 2nd year fellow in the UCSF pediatric endocrinology program. Most of my time currently is spent doing research, clinical work, and taking classes in the Advanced Training in Clinical Research Certificate Program. My interests are in the clinical care, clinical research, and advocacy for transgender and gender diverse patients. I am originally - [Jean H. Dussault, MD](https://pedsendo.org/historical-tidbits/jean-h-dussault-md/) - Jean H. Dussault, MD Working with our 10th president, Del Fisher, JH Dussault adapted a method for the determination of thyroxine by RIA to blood spots used for newborn PKU genetic screening (Guthrie cards). In Quebec he used this technique to launch an automated screening program using the samples for the Network for Genetic Medicine - [November 2020 President's Letter](https://pedsendo.org/presidents-message/november-2020-presidents-letter/) - Dear Colleagues, The PES elections are now over. Congratulations to Craig Alter and Tandy Aye for being elected to the positions of President Elect and Director of the PES. The election slate included stellar candidates, and any of the candidates would have been terrific in these roles. You can rest assured that the transition of - [Practice Management Committee Pearls](https://pedsendo.org/practice-managemet-pearls/practice-management-pearls/) - The Practice Management Committee is tasked with the responsibility of providing strategies, tools and information needed to facilitate the office management and practice of pediatric endocrinology. To this end, we hope to provide periodic “pearls” as pertains to billing and/or office management, recognizing that each institution, state and region likely has subtle differences (we encourage - [PES Workforce Action Team perspectives paper on sustaining the pediatric endocrine workforce](https://pedsendo.org/public-policy/pes-workforce-action-team-perspectives-paper-on-sustaining-the-pediatric-endocrine-workforce/) - The PES Workforce Action Team (WAT), led by Dr. David Allen, was set up in 2019 and has been working to raise awareness of the challenges we face with our shrinking workforce relative to the number of pediatric endocrine referrals, and on strategies to increase the pipeline for pediatric endocrinology. Here is a perspectives paper - [History Tidbit - November 2020](https://pedsendo.org/historical-tidbits/history-tidbit-november-2020/) - Fuller Albright, MD (1900-1969), Albright’s hereditary osteodystrophy Albright described a syndrome in children characterized by short stature, short neck, obesity, subcutaneous calcifications, shortened metacarpals with hypocalcemia and hyperphosphatemia (Endocrinology 1942; 30:922-32). He hypothesized that it was due to resistance to PTH, since exogenous PTH did not cause phosphaturia. Later pseudohypoparathyroidism type 1a was found due - [New Meds and Tech from PES Drugs and Therapeutics committee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee/) - Hydrocortisone Granules (Alkindi Sprinkle) Prepared by: Takara Stanley, Seth Marks and Kyriakie Sarafoglou Up to date as of: November 4, 2020 On September 29, 2020, the United States Food and Drug Administration approved hydrocortisone granules for pediatric use in the United States, under the brand name, “Alkindi Sprinkle”. Hydrocortisone granules have regulatory approval in Europe - [October 2020 President's Letter](https://pedsendo.org/presidents-message/october-2020-presidents-letter/) - Dear Colleagues, As a reminder, the President’s monthly message is now posted all month long on our new and improved website. This format should make it simpler for you to locate, read and keep up to date with the latest society and specialty news all month long! The 2020 presidential elections are now around the - [October Fellow Spotlight: Dr. Alison Coren](https://pedsendo.org/member-spotlight/fellow-spotlight/october-fellow-spotlight-dr-alison-coren/) - I completed medical school at Northwestern University, then pursued residency and pediatric endocrine fellowship training at the Medical College of Wisconsin (MCW). I completed fellowship in June 2020. I am currently an assistant professor at the Medical College of Wisconsin. I primarily divide my time between clinical duties and various clinical research projects. I - [Historical Tidbit - October 2020](https://pedsendo.org/historical-tidbits/historical-tidbit-october-2020/) - Franz Josef Kallmann (1897-1965) and Kallmann syndrome Dr. Kallmann, a psychiatrist interested in the genetics of psychiatric diseases described men with congenital hypogonadotropic hypogonadism and anosmia [Am J Ment Defic. 1944; 48: 203–236], denoted Kallmann syndrome. The pathophysiology is impaired development of the olfactory system and disrupted embryonic migration of GnRH neurons to the hypothalamus. - [New Meds and Tech from PES Drugs and Therapeutics Committee (Liraglutide)](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-from-pes-drugs-and-therapeutics-committee-liraglutide/) - Prepared by: Vandana Raman, Shilpa Mehta, and Amit Lahoti. Last Updated on: 8/11/20 Liraglutide is a long-acting analog of human glucagon-like peptide (GLP)-1. It was approved by the FDA in June 2019 for the treatment of type 2 diabetes in children and adolescents aged 10-17 years if glycemic targets are not met with metformin (with - [September 2020 President's Message](https://pedsendo.org/presidents-message/september-2020-presidents-message/) - Dear Colleagues, With the first month of the academic year behind us, and the frenzy of September quietening down, it is time of take stock of a most unusual summer and the months ahead. The passing of Ruth Bader Ginsburg was gut-wrenching for all kinds of reasons. And now it is time for each of - [Historical Tidbit - September 2020](https://pedsendo.org/historical-tidbits/historical-tidbit-september-2020/) - Ernst Knobil, Ph.D (1926-2000) Ernst Knobil was a pioneer in several aspects of endocrinology. He and his colleagues determined the species specificity of primate growth hormones. By the beginning of the 1960s it was known that non-primate-derived GH molecules (intact or following mild enzyme hydrolysis) were without effect in rhesus monkeys and man, but that - [September PedsEndo Discovery Spotlight: Mikayla Gallenberger, MD](https://pedsendo.org/member-spotlight/student-spotlight/september-pedsendo-discovery-spotlight-mikayla-gallenberger-md/) - Mikayla Gallenberger, MD Incoming PGY-1, University of Utah Pediatrics Graduated Medical School from the University of Wisconsin School of Medicine and Public Health in May 2020 What is your most memorable experience in medical school so far? One of the most memorable experiences in medical school was when I had the - [September Fellow Spotlight: Dr. Janaki Vakharia](https://pedsendo.org/member-spotlight/fellow-spotlight/september-fellow-spotlight-dr-janaki-vakharia/) - I am an endocrinology fellow at Massachusetts General Hospital. I am pursuing a combined adult and pediatric fellowship and last year completed my adult clinical year. Now, I am in my second year of fellowship completing my pediatric clinical year and I also see patients in the adult endocrinology clinic one half day a week. - [JUST ANNOUNCED FOR OCTOBER - Special Virtual Offering of PES Leadership Advantage – Engage Module](https://pedsendo.org/news-announcements/just-announced-for-october-special-virtual-offering-of-pes-leadership-advantage-engage-module/) - Fri 16 October 16, 2020 / 2:00 pm - 4:30 pm PES Leadership Advantage FALL MODULE OFFERING Since our virtual, live delivery of the INFLUENCE module in May was a great success, we are moving forward with a virtual live delivery of the ENGAGE module this fall (previously called Module 2). We are making the - [PES Statement Promoting Access to Healthcare for All Children](https://pedsendo.org/public-policy/pes-statement-promoting-access-to-healthcare-for-all-children/) - On January 18, 2018, the Trump administration announced it would be creating a "Division of Conscience and Religious Freedom" at the Department of Health and Human Services. This new office will defend doctors, nurses, and other healthcare workers who discriminate against patients based on their reproductive history and gender identity. Below is PES's statement promoting - [New Meds and Tech: FDA Alert for Medical Providers Regarding Necrolytic Migratory Erythema (NME) with Chronic Glucagon Use](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-fda-alert-for-medical-providers-regarding-necrolytic-migratory-erythema-nme-with-chronic-glucagon-use/) - 5.5 Necrolytic Migratory Erythema Necrolytic migratory erythema (NME), a skin rash commonly associated with glucagonomas (glucagon-producing tumors) and characterized by scaly, pruritic erythematous plaques, bullae, and erosions, has been reported postmarketing following continuous glucagon infusion. NME lesions may affect the face, groin, perineum and legs or be more widespread. In the reported cases NME resolved with - [New Meds and Tech: Tirosint-SOL](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-tirosint-sol/) - Levothyroxine sodium oral solution (Tirosint-SOL) has now been approved by the FDA and is available for use in the US. Please click on the link below for details regarding the product and its dosing. This is for informational purposes only, and is not meant to be an endorsement of the product by PES. - [New Meds and Tech: Vitamin D Preparations and Safety Issues](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-vitamin-d-preparations-and-safety-issues/) - Vitamin D is a fat soluble vitamin that is essential for maintaining bone health and also has other potential health benefits. While some of these other health benefits are not yet well defined, vitamin D is important for achieving and maintain optimal bone density, prevention of rickets and osteomalacia. Because of this, vitamin D is - [New Meds and Tech: Glucagon Preparations](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-glucagon-preparations/) - The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly) and a stable liquid form without need for reconstitution (Gvoke, Xeris Pharmaceuticals). These innovative formulations provide the reliability of a ready-to-use glucagon preparation that can be administered quickly and - [New Meds and Tech: Increlex](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-increlex/) - In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy, changes have been made to the Prescribing Information (PI) and Patient Package Insert (PPI) of Increlex ® (Mecasermin, recombinant human insulin-like growth factor-1) manufactured by Ipsen pharmaceuticals. - [New Meds and Tech: Newer Insulin Preparation - Faster Insulin Aspart (Fiasp)](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-newer-insulin-preparation-faster-insulin-aspart-fiasp/) - Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before meals, Fiasp may be dosed immediately before meals and up to 20 minutes after starting a meal, providing added flexibility for more accurate dosing in children who may be variable in - [New Meds and Tech: New Cortisol Assays, New Threshold for Adrenal Insufficiency](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-new-cortisol-assays-new-threshold-for-adrenal-insufficiency/) - [New Meds and Tech: Tandem® Diabetes Care Control-IQ Technology](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-tandem-diabetes-care-control-iq-technology/) - In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery and deliver automated correction boluses using Dexcom G6 continuous glucose monitoring (CGM) values. It is currently approved for patient ages 14 years and older. - [New Meds and Tech: Riomet ER™](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-riomet-er/) - Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in the US at the end of February, 2020. Riomet ER™ is dosed once daily and is currently the only FDA-approved liquid formulation of extended-release metformin. This may be an - [COVID-19 Resources](https://pedsendo.org/news-announcements/covid-19-resources/) - These resources have been identified by members as being useful during these difficult times. They are provided as a reference only. Timely information about COVID-19 that is curated specifically for endocrinologists is available at “Clinical Endocrinology News” International Society for Pediatric and Adolescent Diabetes (ISPAD): COVID-19 in children with diabetes: Keep Calm and Mind your - [New Meds and Tech: Freestyle Libre 2](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-freestyle-libre-2/) - Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system. It was approved by the FDA in June 2020, was previously approved in Europe, but is still awaiting approval in Canada. FDA approval includes use in children, age 4 - [New Meds and Tech: Semglee](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-semglee/) - Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc. and Biocon Ltd., was approved by the FDA on June 11, 2020. Semglee™ joins the original insulin glargine (Lantusâ) and another biosimilar product (Basaglarâ) on the US market, allowing - [July PedsENDO Discovery Spotlight: Meredith Hanrahan](https://pedsendo.org/member-spotlight/july-pedsendo-discovery-spotlight-meredith-hanrahan/) - Name: Meredith Hanrahan Year: 3rd Year Medical Student (Class of 2022) Program: M.D. Program School: Geisinger Commonwealth School of Medicine What is your most memorable experience in medical school so far? I would have to say the most memorable experience for me in medical school so far has been organizing the Geisinger - [July PedsENDO Discovery Spotlight: Amanda Barks](https://pedsendo.org/member-spotlight/july-pedsendo-discovery-spotlight-amanda-barks/) - Name: Amanda Barks Year: G5/MS3 (Defending thesis and returning to clinic summer 2020) Program: MD/PhD School: University of Minnesota Medical School What is your most memorable experience in medical school so far? My most memorable experience in medical school so far is when I saw a patient for follow-up in - [July Fellow Spotlight: Iman Al-Gadi, MD](https://pedsendo.org/member-spotlight/july-fellow-spotlight-iman-al-gadi-md/) - My name is Iman, and I just started the third year of my pediatric endocrinology fellowship at Baylor College of Medicine/Texas Children’s Hospital. I consider myself a global citizen, as I grew up in two countries on different continents: Saudi Arabia and the United States (California, Illinois, and Texas). I had two loving, highly educated - [New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)](https://pedsendo.org/new-meds-and-tech/new-meds-and-tech-burosumab-twza-crysvita-ultragenyx-pharmaceuticals/) - Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast growth factor 23 (FGF-23). It was approved by FDA for children ≥ 1 year and adults for the treatment of X-linked hypophosphatemia (XLH) in April 2018 and expanded to - [Announcing the PES 2021 Virtual Annual Meeting](https://pedsendo.org/news-announcements/announcing-the-pes-2021-virtual-annual-meeting/) - PES Going Virtual for 2021 We are pleased to announce the dates for the PES 2021 VIRTUAL Annual Meeting! April 30th- May 3rd, 2021 We are excited to think innovatively of what our first virtual standalone meeting will look like, and how best to provide our attendees with an exciting and stellar meeting with robust - [Robert Blizzard Interviews 2012](https://pedsendo.org/oral-history/robert-blizzard-interviews-2012/) - In 2012, Dr. Robert Blizzard graciously agreed to sit with Dr. Mark Parker and record interviews for the History Committee of the Pediatric Endocrine Society. These include career stories, personal anecdotes, as well as reminiscences of friends and colleagues. Career Choice Dr. Blizzard discusses his early career - Audio is complete; video missing first part - [The Legacy of Lawson Wilkins](https://pedsendo.org/oral-history/the-legacy-of-lawson-wilkins/) - A keynote presentation by Claude J. Migeon, MD, given at the 2ND Annual LWPES/PAS Fellows Workshop in Vancouver, Canada, 2010 Watch the Video - [Pediatric Endocrinology: Our Short but Remarkable History](https://pedsendo.org/oral-history/pediatric-endocrinology-our-short-but-remarkable-history/) - 2003 Southern Pediatric Endocrine Society Annual Meeting November 7-9, 2003 Charlotte, North Carolina 2003 Meeting Syllabus Video Log Video Part 1 Video Part 2 Video Part 3 Video Part 4 Video Part 5 Video Part 6 Video Part 7 Video Part 8 - [PES Historical Tidbits 2018](https://pedsendo.org/historical-tidbits/pes-historical-tidbits-2018/) - PES Trivia, at Your Fingertips These tidbits were originally published in our 2018 President's newsletters. May 2018 – submitted by Walter Miller Treating CAH with cortisone Lawson Wilkins had ameliorated salt loss in CAH with deoxycorticosterone, but his treatments with ACTH, testosterone and several androgen analogues failed. Wilkins’ preliminary report described suppressing one patient’s urinary - [PES Historical Tidbits 2014](https://pedsendo.org/historical-tidbits/pes-historical-tidbits-2014/) - PES Trivia, at Your Fingertips These tidbits were originally published in our 2014 President's newsletters. November 2014 - submitted by Del Fisher John Eager Howard, Lawson Wilkins, and Walter Fleischmann reported early attempts to stimulate growth in adolescent "pituitary dwarfs" via daily oral or parenteral administration of 25 mg of methyltestosterone for "over one - [PES Historical Tidbits 2015](https://pedsendo.org/historical-tidbits/pes-historical-tidbits-2015/) - PES Trivia, at Your Fingertips These tidbits were originally published in our 2015 President's newsletters. December 2015 - submitted by History Committee 2015 is the 100th anniversary of the discovery of the lowly bacteriophage, the semi-living viral entities that infect bacteria (FW Twort, Lancet 186:1241-1243, 1915). Phage studies yielded the principles of genetic recombination, DNA - [PES Historical Tidbits 2016](https://pedsendo.org/historical-tidbits/pes-historical-tidbits-2016/) - PES Trivia, at Your Fingertips These tidbits were originally published in our 2016 President's newsletters. December 2016 – submitted by Walter Miller Bioassays for lactogenic and somatogenic activities were described in the 1930’s, but it took another 40 years to show that GH and Prl are distinct hormones. Frantz and Kleinberg showed that primate GH’s - [PES Historical Tidbits 2017](https://pedsendo.org/historical-tidbits/pes-historical-tidbits-2017/) - PES Trivia, at Your Fingertips These tidbits were originally published in our 2017 President's newsletters. December 2017 - submitted by Walter Miller DNA Sequencing The development of rapid, accurate DNA sequencing did for genetics what invention of the microscope did for cell biology. Maxam & Gilbert (PNAS 74:560-564,1977) and Sanger (PNAS 74:5463-5467,1977) devised the first - [100th Anniversary of the Birth of Lawson Wilkins](https://pedsendo.org/oral-history/100th-anniversary-of-the-birth-of-lawson-wilkins/) - The 100th Anniversary Symposium honoring the birth of Lawson Wilkins was held in May 1994 in San Francisco. The speakers were the first 5 presidents of the Society and they provided the historical perspective, the influence of Lawson Wilkins, and the current state of knowledge that has arisen from the earlier studies that were undertaken - [Transgender Letter to Governor of South Dakota](https://pedsendo.org/public-policy/transgender-letter-to-governor-of-south-dakota/) - The PES Board of Directors wishes to publicly thank Steve Rosenthal for his recent and timely leadership on crafting, and sending a letter to the South Dakota governor encouraging the veto of a bill. The bill required students at state public schools to use restrooms and other facilities based on their "chromosomes and anatomy" at - [Stephen Rosenthal on "CBS This Morning"](https://pedsendo.org/public-policy/stephen-rosenthal-on-cbs-this-morning/) - In case you missed today's "CBS This Morning", our very own Stephen Rosenthal was interviewed for his expertise on transgender youth. He was honored to be able to say a few words regarding this inspiring child and family. Congratulations again, Dr. Rosenthal! - [Congressman Ed Whitfield Receives Lifetime Achievement in Diabetes Award](https://pedsendo.org/public-policy/congressman-ed-whitfield-receives-lifetime-achievement-in-diabetes-award/) - Henry Rodriguez, Chair of the Public Policy Council and the Council's liaison to the Diabetes Advocacy Alliance (DAA), had the honor of presenting Congressman Ed Whitfield with the Lifetime Achievement in Diabetes award on March 1st, at a DAA reception to honor Congressman Whitfield and to welcome the new leadership of the Congressional Diabetes Caucus. - [Coalition Letter Endorsing the Ensuring Children's Access to Specialty Care Act](https://pedsendo.org/public-policy/coalition-letter-endorsing-the-ensuring-childrens-access-to-specialty-care-act/) - Click here to view the final coalition letter signed by 70 medical, public health, and patient organizations endorsing the Ensuring Children's Access to Specialty Care Act (H.R. 1859/S. 2782). - [PES Sends Letter to DOE in Support of Transgender Students](https://pedsendo.org/public-policy/pes-sends-letter-to-doe-in-support-of-transgender-students/) - On June 9, the PES SIG on Transgender Health sent a letter in support of the U.S. Department of Education guidance on the rights of transgender students, to the governors of the 12 states that have refused to follow them (AL, AZ, GA, LA, ME, MS, OK, TN, TX, UT, WI, WV). States that do - [PES Signs Letter in Opposition to the 2017 NDAA](https://pedsendo.org/public-policy/pes-signs-letter-in-opposition-to-the-2017-ndaa/) - The most recent version of the 2017 National Defense Authorization Act (NDAA) (S.2943) has the potential to eliminate certain health care providers from the Military Health System. This includes Pediatricians, OB-Gyns and other essential providers of health care to infants, children and families of members of our Armed Forces. In addition, the bill provides for - [PES Joins Coalition to Support Reauthorizing PSLRP](https://pedsendo.org/public-policy/pes-joins-coalition-to-support-reauthorizing-pslrp/) - The House and Senate have been negotiating a large, bipartisan mental health package over much of the past year. The most recent draft of this package in the House (H.R. 2646) includes Section 722, which reauthorizes the pediatric subspecialty loan repayment program (PSLRP). The PSLRP was a discretionary program originally authorized in the Affordable Care - [PES Signs Amicus Brief](https://pedsendo.org/public-policy/pes-signs-amicus-brief/) - We are pleased to note that with unanimous approval of our Board of Directors, PES (in addition to other professional societies and academic centers in the U.S.) signed on to an amicus brief filed on November 29, 2016, in the United States District Court for the Western District of Pennsylvania in support of the right - [Kaiser Health News Report on GnRH](https://pedsendo.org/public-policy/kaiser-health-news-report-on-gnrh/) - Media Release: Updated Information About Safety Events after Gonadotropin Releasing Hormone Agonist Therapy. 3/21/17 Dear Colleagues, On 2/2/17, Kaiser Health News published an article raising concerns about potential long-term side effects of leuprolide acetate for depot suspension in women previously treated with this medication. In the article, it was reported that the FDA issued the - [Sample Letter Advocating for the SDP](https://pedsendo.org/public-policy/sample-letter-advocating-for-the-sdp/) - The Special Diabetes Program (SDP) supports research to prevent, treat, and cure type 1 diabetes and its complications and type 2 diabetes treatment and prevention strategies for American Indian and Alaska Native populations. The SDP expired on October 1 and Congress is currently reviewing legislation to reauthorize the program. At issue is how to pay ## Pages - [Home](https://pedsendo.org/) - Advance and promote the endocrine health of children, adolescents and young adults and support the professionals that work on their behalf Learn More Clinical Resources See a variety of tools and resources. Learn More Patient Education Learn more about pediatric endocrine health. Learn More What is a Pediatric Endocrinologist? Discover information about the field and - [Camps](https://pedsendo.org/patient-resources/camps/) - PES is pleased to share the following information on various upcoming camps! Please note that PES was not involved in the development of any camp or camp website, and a listing here does not imply endorsement by PES, but rather a resource for patients and families. If you know of other camps that you would - [Patient Resources Request Form](https://pedsendo.org/patient-resources-request-form/) - If you were unable to find the resource you were looking for in our library, please complete this form and share your request. Our Education Resources Committee will review your submission and do their best to provide resources that meet your needs. - [PES SIG State of the Art Series](https://pedsendo.org/pes-sig-state-of-the-art-series/) - Our webinar series titled "State of the Art" hosted by PES SIGs is underway. Each Special Interest Group (SIG) has been allocated a specific instructive webinar within their specialized subject. You can find the schedule for each month and access recordings of past webinars below. Upcoming SIG State of the Art Webinars Thursday, August 27, - [Patient Education](https://pedsendo.org/patient-resources/patient-education/) - A Patient Education Subcommittee comprising members from the PES Education Council and the American Academy of Pediatrics Section on Endocrinology have been working together since 2010 to develop a series of patient education fact sheets covering topics such as growth, thyroid, puberty, diabetes, adrenal, PMOS, and vitamin D. All patient education sheets were updated in - [Future Meetings](https://pedsendo.org/education-events/future-meetings/) - Future Annual Meetings Day Hour Minute Second Call for Session Ideas 2028 Annual MeetingApril 27-30, 2028Pittsburgh, PA 2029 Annual MeetingMay 10-14, 2029San Diego, CA2030 Annual MeetingMay 2-5, 2030Denver, CO - [2026 Annual Meeting Session Recordings & Presentations](https://pedsendo.org/2026-annual-meeting-session-recordings-presentations/) - Thank you for attending the 2026 PES Annual Meeting in San Francisco, CA! Below are links to the audio recordings and presentation slides for sessions where presenters granted permission to record and share their content. Thursday, April 30, 2026 Opening Plenary: Welcome & Lawson Wilkins Lecture; Speakers: Laurie Cohen, MD, Marie-Ève Robinson, MD, CM, MSc, FRCPC, - [PES Research Surveys](https://pedsendo.org/clinical-resources/and-the-survey-says/) - Thank you to all PES survey responders! The PES Research Affairs Committee receives and reviews surveys three times per year. This allows PES members to provide expert input on educational and practice improvement initiatives and to support research projects of members and members-in-training. Throughout the year, we'd like to highlight the survey results and publications. - [Health Systems Disparity Initiative](https://pedsendo.org/education-events/health-systems-disparity-initiative/) - Co-Chairs: Ilene Fennoy, MD and Ambika Ashraf, MD Mission Statement: Our mission is to affirm the ideology of the PES as a scientific community that fosters inclusion, acceptance, and support for every person independent of race, ethnicity, gender, sexual orientation, or religion. Towards this end, our focus is to: Recognize implicit and explicit bias in - [Mid-Career Investigator Award Application](https://pedsendo.org/mid-career-investigator-award-application/) - [Outstanding Mentor Award Application](https://pedsendo.org/outstanding-mentor-award-application/) - [Van Wyk Prize Application](https://pedsendo.org/van-wyk-prize-application/) - [New Investigator Application](https://pedsendo.org/new-investigator-application/) - [Educator Award Application](https://pedsendo.org/educator-award-application-2/) - [Clinician Award Application](https://pedsendo.org/clinician-award-application-2/) - [2027 Blizzard Lectureship Application](https://pedsendo.org/2027-blizzard-lectureship-application/) - [Kaplowitz Lecture Award Application](https://pedsendo.org/kaplowitz-lecture-award-application/) - [Leadership](https://pedsendo.org/about-pes/leadership/) - Board of Directors PES Staff - [2026 Rising Star Grant Application](https://pedsendo.org/2026-rising-star-grant-application/) - [PES Education Committee Webinar Series](https://pedsendo.org/pes-education-committee-webinar-series/) - The PES Webinar Series covers hot topics/controversies in pediatric endocrinology and are presented by stalwarts in the field. These talks cover perspectives and discussions that are unlikely to be found in standard textbooks. The webinars are only offered to PES members and pediatric endocrinology trainees. The webinars will be held quarterly. Upcoming Webinars Date: Monday, July - [2023 Annual Meeting Exhibitors and Sponsors](https://pedsendo.org/2023-virtual-annual-meeting-exhibitors-and-sponsors-copy/) - Thank you to our 2023 Annual Meeting Sponsors for your Generous Support Thank you to the 2023 PES Annual Meeting Exhibitors - [PES 2026 Mission Alliance Partners Spotlight](https://pedsendo.org/about-pes/2025-mission-alliance-partners/) - Welcome to the PES Mission Alliance Partner (MAP) Spotlight! This platform was designed for our Mission Alliance Partners to virtually share with the PES membership: Information about their company Product showcase/theaters (to include newly approved products, a new angle to or new summative information about existing products) Educational sessions (e.g. a symposium style session - [PES Annual Meeting](https://pedsendo.org/education-events/pes-2026-annual-meeting/) - Thank You for Joining Us at the PES 2026 Annual Meeting Our 2026 Annual Meeting brought together leading experts, clinicians, researchers, and trainees from across the field of pediatric endocrinology for an engaging and impactful experience. We are grateful to everyone who attended, presented, and contributed to the success of this year's meeting. Thank you - [Pfizer, Inc](https://pedsendo.org/pfizer/) - Address: Pfizer Inc, 66 Hudson Blvd East, New York, NY 10001 Phone: Customer Service and Product Inquiries: 1-800-879-3477 Monday through Friday 9:00 a.m. to 7:00 p.m. EST Website: https://www.pfizer.com/ Brief summary of content: At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We - [Soleno Therapeutics](https://pedsendo.org/soleno-therapeutics/) - About Us: Soleno Therapeutics, Inc. (Soleno) is dedicated to the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead product, VYKAT™ XR (diazoxide choline) extended-release tablets, is a once-daily oral treatment for hyperphagia in individuals aged 4 and older with Prader-Willi syndrome (PWS). For more information, please visit www.vykatXRhcp.com. - [Mission Alliance Partners](https://pedsendo.org/about-pes/mission-alliance-partners-copy/) - 2026 Mission Alliance Partners -- Thank you! Thank you to the 2026 Mission Alliance Partners for your expression of commitment to further development of the field of Pediatric Endocrinology by your year-long support of PES, and our continued efforts to Advance and promote the endocrine health of children, adolescents and young adults and support the - [ETON Pharmaceuticals](https://pedsendo.org/eton-pharmaceuticals/) - About Us: Eton Pharmaceuticals is a rare disease focused pharmaceutical company built on the belief that many rare conditions have been historically underserved and overlooked by large pharmaceutical companies. These are often small patient populations with complex needs that don't fit traditional models. From the beginning, Eton set out to reimagine rare disease care - - [Tolmar](https://pedsendo.org/tolmar/) - About Us: Fensolvi® (leuprolide acetate) for injectable suspension, is a GnRH agonist treatment for children with Central Precocious Puberty (CPP). Fensolvi is a 6-month, subcutaneous injection, enabled by a unique in-situ polymeric gel extended delivery system. To learn more visit www.Fensolvi.com Fensolvi® is manufactured by Tolmar, a specialty pharmaceutical company with an established commercial presence - [Lilly](https://pedsendo.org/lilly/) - About Us: Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries - [Bridgebio QED](https://pedsendo.org/bridgebio/) - About Us: BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke - [Zealand Pharma](https://pedsendo.org/zealand-pharma/) - About Us: Zealand Pharma is a biotechnology company focused on advancing medicines for obesity and metabolic health, including rare diseases like congenital hyperinsulinism. With more than 25 years of peptide R&D expertise and a proprietary data platform leveraging advanced data driven and AI/ML approaches, we aim to lead a new era in metabolic health. More - [BioMarin](https://pedsendo.org/biomarin/) - About Us: BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery - [Keenova](https://pedsendo.org/keenova/) - About Us: At Keenova, we believe that no one should be alone in their pursuit of better health. This purpose drives us as we pair quality therapeutics with human support-showing up in big moments and small to help patients find comfort and confidence. We bring deep expertise and resolve to every therapeutic area we serve, - [Kyowa Kirin](https://pedsendo.org/kyowa-kirin/) - About Us: At Kyowa Kirin, patients are at the center of everything we do. We are a global specialty pharmaceutical company dedicated to discovering and advancing innovative medicines for rare and hard-to-treat diseases where the need remains greatest. Based in Japan with worldwide operations, Kyowa Kirin works across the continuum-from drug discovery to commercialization-guided by - [Labcorp](https://pedsendo.org/labcorp/) - About Us: Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Learn more about us at www.labcorp.com/treatment-areas/endocrinology Address: - [Egetis Therapeutics](https://pedsendo.org/egetis-therapeutics/) - About Us: Egetis Therapeutics is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment. The Company's lead drug candidate Emcitate® (tiratricol) is developed for the treatment of patients with monocarboxylate transporter 8 (MCT8) deficiency, a - [Neurocrine Biosciences](https://pedsendo.org/neurocrine-biosciences/) - About Us: Neurocrine was founded in 1992 by Wylie Vale, Ph.D., of the Salk Institute for Biological Studies, where he contributed to Nobel Prize-winning work in endocrinology, and award-winning Stanford University neurologist Lawrence Steinman, Ph.D. Since then, we have been developing treatments for rare and under-addressed diseases, sometimes in collaboration with other pharmaceutical companies. Our - [Ascendis Pharma, Inc.](https://pedsendo.org/ascendis-pharma/) - About Us: Ascendis Pharma is a global biopharmaceutical company focused on advancing treatments for rare conditions to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical - [Novo Nordisk, Inc.](https://pedsendo.org/novo-nordisk/) - About Us: Novo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, - [Special Interest Groups](https://pedsendo.org/clinical-resources/sigs/) - Pediatric Endocrine Society members have various backgrounds and specialized interests. Within the Society, smaller groups of investigators interested in specific aspects of Pediatric Endocrinology tend to form, and the Society can serve as a platform for the formation of such Special Interest Groups (SIGs). SIGs provide a forum for interested members to collaborate and facilitate - [Contact](https://pedsendo.org/about-pes/contact/) - We look forward to hearing from you. Send us a message using the form on this page, or connect with us via the contact info below. Connect With Us - [Committees](https://pedsendo.org/about-pes/committees/) - About Our Committees The Pediatric Endocrine Society (PES) is dedicated to advancing the endocrine health and well-being of children and adolescents. Our committees play a pivotal role in fulfilling this mission by focusing on various aspects of pediatric endocrinology. These committees are composed of experts and professionals who work collaboratively to foster research, education, and - [Mentoring Program](https://pedsendo.org/education-events/fellows-residents-students/mentoring-program/) - The Research Affairs Council is soliciting mentors and mentees to register for the next wave of the Mentoring Initiative. The Mentoring Initiative has a strong track record of success since the 2018-2019 cohort with 39 mentees. Building on overwhelmingly positive participant feedback and continued success, the RAC is preparing the next round of mentor–mentee matches - [2026 PES Annual Meeting Poster Presenters Resource Page](https://pedsendo.org/education-events/pes-2026-annual-meeting-poster-presenters-recource-page/) - Conference Program (Subject to change) View Conference Brochure Hotel Reservations Reserve your hotel room at the San Francisco Marriott Marquis as soon as possible, as the PES room block is expected to fill quickly. The block closes on April 6, or sooner if all rooms are booked. Book Your Hotel Room Register for - [PedsENDO365](https://pedsendo.org/pedsendo365/) - PedsENDO365 Fellow Initiative PedsENDO365 provides pediatric endocrine fellows an opportunity to enhance clinical concepts, skills in clinical decision making, career development, quality improvement, and leadership. These sessions will foster building of a learning community for fellows in an environment of innovation, collaboration, and discovery with guidance from expert faculty facilitators. The sessions are being held via Zoom and limited - [Society History](https://pedsendo.org/about-pes/society-history/) - History of Pediatric Endocrinology In the article below, Dr. Delbert A. Fisher provides a colorful description of the history of pediatric endocrinology and the central role played by Dr. Lawson Wilkins and other major leaders in the early development of this specialty in North America. Read more about it in: A Short History of Pediatric - [2026 Annual Meeting Exhibitors and Sponsors](https://pedsendo.org/2026-annual-meeting-exhibitors-and-sponsors/) - Thank you to our 2026 Annual Meeting Sponsors for your Generous Support Thank you to the 2026 PES Annual Meeting Exhibitors - [Industry Sponsored Symposia](https://pedsendo.org/industry-sponsored-symposia/) - Industry Sponsored Symposium: Exploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health Wednesday, February 11, 2026 at 10:30 am - 11:30 am ET Description: Congenital hyperinsulinemia (CHI) is a complex and serious disorder that most often appears in newborns and young infants as prolonged, often severe, hypoglycemia. When diagnosis or treatment is - [Find a Pediatric Endocrinologist](https://pedsendo.org/patient-resources/find-a-pediatric-endocrinologist/) - Looking for a pediatric endocrinologist? See the Membership Directory Please be advised, this is a list of current PES members. Being in this Membership Directory is voluntary and means the listed providers are board certified and have paid Society dues but is not an endorsement or recommendation. Verify your insurance coverage directly with the provider. - [Online Community](https://pedsendo.org/clinical-resources/online-community/) - A Brand-New PES Community Platform We’re excited to announce the launch of our new and improved PES Community Platform. This modern, user-friendly system will make it easier than ever to collaborate, communicate, and stay connected with your colleagues. Each SIG, Committee, and other leadership groups will have its own dedicated community with tools to share - [SEED](https://pedsendo.org/seed/) - Student Endocrinology Exposure Development (SEED) Program SEED is a novel interactive session series being hosted by the Pediatric Endocrine Society that aims to enhance clinical learning for medical students and increase their exposure to pediatric endocrinology. Upcoming Webinars Date: Tuesday, June 2, 2026, 12:00 PM EST Title: Turner syndrome/Klinefelter syndrome Brief Description: This interactive lecture - [PedsENDO Discovery Program](https://pedsendo.org/education-events/fellows-residents-students/pedsendo-discovery-program/) - Congratulations to the 2026 Cohort! PES Medical Student/Resident Education Subcommittee PES Discovery Program Committee Doris Fadoju (Subcommittee Chair) Nandini Vijayakanthi (Subcommittee Co-Chair) PedsENDO Discovery Program The PedsENDO Discovery Program launched in 2019 as part of a multi-pronged approach to address workforce shortage in pediatric endocrinology. Medical students, first and second year residents​ interest​ed in - [PES Membership](https://pedsendo.org/about-pes/pes-membership/) - Benefits for All Members Regular Members Fellow / In-Training Members Associate Members Advanced Practice Provider Members Read below for information on membership criteria and the application process. Please note that applications may take up to three months for review and processing. Dues cover the current calendar year. Benefits for All Members Access the PES "Members - [Specific Aims Initiative](https://pedsendo.org/specific-aims-initiative/) - [Clinical Studies](https://pedsendo.org/patient-resources/clinical-studies/) - [Online Education](https://pedsendo.org/education-events/online-education/) - Virtual Education Programs and Webinars PES wishes to thank our Platinum and Gold Mission Alliance Partners; BioMarin, Neurocine Biosciences, Sanofi, Soleno Therapeutics, Eton Pharmaceuticals, Novo Nordisk, Pfizer, and Tolmar for support of our digital education materials and webinars PES takes pride in providing diverse online educational opportunities for our members. Our offerings include the - [Professional Links](https://pedsendo.org/professional-links/) - The Pediatric Endocrine Society is closely cooperating with numerous organizations, foundations and societies providing scientific information. There are extensive pediatric endocrine materials for patients and family available. Here are the links to some "sister" societies, journals, foundations and other resources: African Society for Pediatric and Adolescent Endocrinology Arab Society for Paediatric Endocrinology and Diabetes Asia - [Insurance Appeal Letter Templates](https://pedsendo.org/clinical-resources/insurance-appeal-letter-templates/) - The templates below were prepared by the Drug & Therapeutics and Practice Management Committees to assist in appeals. They are formatted for EPIC but can be adapted to any EMR. The letters are current as of August 28, 2019 - please note that updated references may be available after that time. We hope that these - [2026 PES Annual Meeting Oral Presenters Resource Page](https://pedsendo.org/education-events/pes-2026-annual-meeting-oral-resources/) - Conference Program (Subject to change) View Conference Brochure Hotel Reservations Reserve your hotel room at the San Francisco Marriott Marquis as soon as possible, as the PES room block is expected to fill quickly. The block closes on April 6, or sooner if all rooms are booked. Book Your Hotel Room Register for - [PES Industry Sponsored Symposia Series](https://pedsendo.org/pes-industry-sponsored-symposia-series/) - Please note: These are self-contained Industry sponsored symposia. The content and opinions presented in these symposia solely represent those of the Sponsoring Organization and do not reflect the views of PES. The PES education committee is not engaged in the creation of session content. If Continuing Medical Education (CME) credits are being provided for these - [2026 PES Annual Meeting Speaker Resource Page](https://pedsendo.org/education-events/pes-2026-annual-meeting-speaker-resources/) - Conference Program (Subject to change) View Conference Brochure Hotel Reservations The host hotel is the San Francisco Marriott Marquis. If you completed the form requesting that PES reserve your hotel room, your reservation has been secured. Once the room block closes on April 6, the hotel will send confirmation emails directly to all - [Spring Fellows Retreat](https://pedsendo.org/education-events/fellows-residents-students/spring-fellows-retreat/) - "Being able to meet and learn from other fellows and faculty over across the country" - Fellow Participant, 2025 "Interacting with fellows from other institutions. It was nice there was not multiple fellows from the same institution so it forced people to make new acquaintances." - Fellow Participant, 2025 "I really enjoyed the faculty panel! - [2026 Travel Grant](https://pedsendo.org/2026-travel-grant/) - [Exhibit & Sponsorship Opportunities](https://pedsendo.org/about-pes/exhibit-opportunities/) - Increase your visibility with your target audience by exhibiting at the PES Annual Meeting. One hall + one set of meeting dates = attendees from many related organizations in one place at the same time...a good equation. Space for 2026 is sold out! - [Job Board](https://pedsendo.org/careers/job-board/) - [Join PES](https://pedsendo.org/about-pes/join/) - PES has over 1600 members representing the multiple disciplines of Pediatric Endocrinology. Benefits available to all PES members include: Access to educational materials, job board, toolkits, practice guidelines, and other great resources Subscription to our society Journal, Hormone Research in Paediatrics Networking opportunities with Pediatric Endocrinologists from around the world via the PES Connected - [2026 MAP Spotlight Information](https://pedsendo.org/2026-map-spotlight-information/) - [PES Annual Meeting](https://pedsendo.org/education-events/pes-2025-annual-meeting/) - Abstract Submissions Now Open! The Pediatric Endocrine Society invites you to contribute your latest research to our 2026 Annual Meeting in San Francisco, CA (April 30 - May 3, 2026). Share your science through oral or poster presentations in this premier gathering of pediatric endocrinology professionals. Submission deadline: Friday, December 5, 2025, at 11:59 PM - [Mentor Match Program](https://pedsendo.org/mentor-match-program/) - When PES members are asked what most inspired them or helped them succeed in their careers, the most common response is: “I had a fantastic mentor.” Fostering meaningful mentor–mentee relationships is a priority for PES. The PES Mentoring Initiative is led by the Research Affairs Council and designed to support professional growth through intentional, structured - [Regional Societies](https://pedsendo.org/about-pes/regional-societies/) - About The Regional Societies Pediatric Endocrine Society (PES) is dedicated to advancing the endocrine health and well-being of children and adolescents through collaboration, shared learning, and community building. In addition to our internal Committees and Special Interest Groups, PES values strong relationships with regional pediatric endocrinology groups and sister societies that support education, research, and - [Clinical Resource Library](https://pedsendo.org/clinical-resources/clinical-resource-library/) - Search by Title Clinical Topic Resource Type Society Topic Audience Date Range Submit a Clinical Resource Have a resource to add to the library? Submit your resource for consideration below. Submit a Resource - [2026 PedsENDO Discovery Program Application](https://pedsendo.org/2026-pedsendo-discovery-program-application/) - Visit the PedsENDO Discovery Program Page - [Awards, Grants & Lectureships](https://pedsendo.org/awards-grants-lectureships/) - Awards Laureate Awards Abstract Awards Awards chosen from submitted Annual Meeting abstracts. Lectureships At our annual meeting, various supported/endowed awards are offered for lifetime achievement, quality improvement, and historical contributions to the field of pediatric endocrinology. Nominations are now open! Click the Lectureships below for more information and to nominate: Grants The - [Communication request from](https://pedsendo.org/communication-request-from/) - [2026 Fima Lifshitz Research Grant](https://pedsendo.org/2026-fima-lifshitz-research-grant/) - [Education & Events](https://pedsendo.org/education-events/) - PES is committed to improving care through teaching, discovery and dissemination of knowledge and providing educational opportunities for professional growth and practice development at all stages of your career development. Upcoming Events See All Events PES Annual Meeting The 2026 PES Annual Meeting will be held in San Francisco, California from April 30th to - [Industry Sponsored Symposia](https://pedsendo.org/23455-2/) - 2026 PES Industry Sponsored Virtual Symposia Policies and Guidelines Virtual sessions can be scheduled at a date and time that is mutually convenient for both PES and company. The cost for holding a virtual symposium is $20,000 USD. Sessions can be offered live or pre-recorded and will be available after the session to PES members - [2026 Annual Meeting Call for Reviewers](https://pedsendo.org/2026-annual-meeting-call-for-reviewers/) - The Program Committee invites you to volunteer as an Abstract Reviewer for the 2026 Annual Meeting, taking place April 30 - May 3 in San Francisco, California. As a reviewer, you'll play a vital role in shaping the scientific content of the meeting by evaluating submitted abstracts. We're expanding our reviewer community to include a - [2026 Research Fellowship Grant](https://pedsendo.org/2026-research-fellowship-grant/) - [2026 Junior Faculty Grant 2nd Year](https://pedsendo.org/2026-junior-faculty-grant-2nd-year/) - [2026 Junior Faculty Research Grant](https://pedsendo.org/2026-junior-faculty-research-grant/) - [Become a Mission Alliance Partner](https://pedsendo.org/about-pes/become-a-mission-alliance-partner/) - Ask not what you can do for us or what we can do for you, but what we can do together to support our members and the patients for whom we provide care! If you are in the field of endocrinology and diabetes, and want to demonstrate your commitment to: Education Training and workforce development - [2026 HSD Research Grant](https://pedsendo.org/2026-hsd-research-grant/) - [International Scholars Program Awards Application](https://pedsendo.org/international-scholars-program-awrds-application-2/) - [News & Publications](https://pedsendo.org/news-publications/) - PES News & Announcements See the latest news and updates from PES. See More News Newsletter Archive Find newsletters from the past several years, including President's Messages. See Our Newsletters Journal Hormone Research in Paediatrics is the official Journal of the Pediatric Endocrine Society. See Our Journal - [Alexion](https://pedsendo.org/about-pes/alexion-2/) - About Us: At Alexion, AstraZeneca Rare Disease, our mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do. Our pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement - [PES 2025 Mission Alliance Partner Spotlight](https://pedsendo.org/pes-mission-alliance-partner-spotlight-copy/) - Welcome to the PES Mission Alliance Partner (MAP) Spotlight! This platform was designed for our Mission Alliance Partners to virtually share with the PES membership: Information about their company Product showcase/theaters (to include newly approved products, a new angle to or new summative information about existing products) Educational sessions (e.g. a symposium style session about - [Sanofi](https://pedsendo.org/sanofi/) - About Us: Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine - [Chiesi Global Rare Diseases](https://pedsendo.org/chiesi/) - About Us: We work closely with individuals impacted by rare disease, caregivers, healthcare professionals, and academic and industry partners to help ensure our products deliver value to people living with rare diseases. We apply a deliberate and careful approach to the production and commercialization of all our unique products and services. From research to production, - [Board Review Course](https://pedsendo.org/education-events/board-review-course/) - PES offers a live Board Review Course every two years by the Pediatric Endocrine Society to provide targeted preparation for the Pediatric Endocrinology Boards and the Pediatric Endocrinology Recertification Exam. It is also an intensive review of Pediatric Endocrinology for Pediatricians and Adult Endocrinologists. It provides a targeted preparation for the Pediatric Endocrinology Boards and - [Ethics in Pediatric Endocrinology MOC](https://pedsendo.org/careers/certification/ethics-in-pediatric-endocrinology-moc-2/) - Ethics in Pediatric Endocrinology: Curriculum for Fellows and Faculty MOC/CME Activity This activity contains a series of 8 modules (each followed by approximately 5-10 questions) that focus on ethical issues frequently encountered in Pediatric Endocrinology. Based on the topics covered in the case modules from Ethics in Pediatric Endocrinology: Curriculum for Fellows and Faculty, this activity addresses the identification of the ethical - [Maintenance of Certification (MOC)](https://pedsendo.org/careers/certification/maintenance-of-certification-moc/) - Click here for a list of QI projects related to pediatric endocrinology that have been approved by the ABP for MOC Part 4 credit. Additional details about these projects can be found on the ABP website. Getting ABP MOC Part 4 Approval The American Board of Pediatrics (ABP) provides an online application form for individuals - [PES Obesity SIG MOC/CME Activity](https://pedsendo.org/careers/pes-obesity-sig-moc-cme-activity/) - This activity contains approximately 60 items that focus on a stepwise approach to the diagnosis and management of pediatric obesity and its comorbidities including a review of evidenced-based clinical practice therapeutic guidelines. Learning Objectives Upon completion of this activity, participants will be able to: Describe the epidemiology of childhood obesity and influences of environmental and - [Precocious Puberty Self-Assessment MOC/CME](https://pedsendo.org/careers/certification/precocious-puberty-self-assessment-moc-cme/) - Precocious Puberty Self-Assessment Recognition of abnormal pubertal development is essential for diagnosis and effective treatment of the underlying pathology, prevention of long-term consequences and a return to normal physical development. Puberty is a universal experience with profound implications for adolescents' physical and emotional functioning as well as long-term sexual and reproductive health. This online activity - [ESPE E-Learning Web Portal](https://pedsendo.org/education-events/fellows-residents-students/espe-e-learning-web-portal/) - The ESPE e-learning webportal gives you entrance to an interactive learning environment for up to date paediatric endocrinology. This unique web portal provides medical students, residents, fellows, specialists, consultants and teachers around the world, access to an online network to meet each other, gain, share, contribute and develop knowledge in an accessible and flexible way. - [Journal](https://pedsendo.org/news-publications/journal/) - The mission of Hormone Research in Paediatrics is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini reviews, clinical guidelines, and papers on novel insights from clinical practice. Periodic editorials from outstanding paediatric endocrinologists address the main published - [Join a SIG](https://pedsendo.org/join-a-sig/) - [PES 2024 Mission Alliance Partner Spotlight](https://pedsendo.org/pes-mission-alliance-partner-spotlight/) - Welcome to the PES Mission Alliance Partner (MAP) Spotlight! This platform was designed for our Mission Alliance Partners to virtually share with the PES membership: Information about their company Product showcase/theaters (to include newly approved products, a new angle to or new summative information about existing products) Educational sessions (e.g. a symposium style session about - [2025 Board Review Course Pre-Recorded Presentations](https://pedsendo.org/2025-board-review-course-pre-recorded-presentations/) - We are excited to welcome you to the in-person PES Board Review Course, which will be held at the AC Hotel National Harbor Washington, DC, May 12th - 15th. There are 6 presentations that have been pre-recorded for your viewing prior to the in-person class. The presentations, along with PDF slides, handouts and cram sheets - [Strategic Plan](https://pedsendo.org/about-pes/strategic-plan/) - Strategic Plan 2023-2027 Mission To promote and advance the endocrine well-being of children, adolescents and young adults and to support the professionals who work on their behalf. Vision To be the professional home and voice of pediatric endocrinology in North America. Goals Grow the Pediatric Endocrinology Workforce to Meet Demands Maintain a Robust Infrastructure that - [PES Membership Application File Upload](https://pedsendo.org/pes-membership-application-file-upload/) - Required Documents for Membership Applications Regular - Letter of recommendation - CV Associate - Letter from program director or Regular member describing the individual's interest and involvement in Pediatric Endocrinology Fellow - Institution, Program Director's Name and Email Address Advanced Practice Provider - CV - [PES Cooking Recipe Archive](https://pedsendo.org/pes-cooking-recipe-archive/) - Gallo Pinto - Nicaraguan Rice & Beans Expand A delicious and versatile rice and bean dish that can be eaten for breakfast, lunch, or dinner. 1 package (14-16 oz) small dried red beans, such as Central American red beans (not kidney beans). 3 cups cooked beans needed for recipe 2 1/2 cups red bean cooking - [PES 2025 BRC Speaker Information](https://pedsendo.org/pes-2025-brc-speaker-information/) - [2025 MAP Spotlight Information](https://pedsendo.org/2025-map-spotlight-information/) - [New Fellows Sign Up](https://pedsendo.org/new-fellows-sign-up/) - [Quality Improvement Toolkit](https://pedsendo.org/quality-improvement-toolkit/) - [Open Fellowship Positions](https://pedsendo.org/open-fellowship-positions/) - [Junior Faculty Grant, 2nd Year](https://pedsendo.org/junior-faculty-grant-2nd-year/) - [Policies and Bylaws](https://pedsendo.org/about-pes/policies-and-bylaws/) - PES Bylaws Read the Current Bylaws - [2025 Election Vote](https://pedsendo.org/2025-election-vote/) - [2025 Election](https://pedsendo.org/2025-election/) - The PES Nominating Committee is pleased to present you with an exceptional slate of candidates for this year's election for President-Elect and Director. The terms are as follows: President-Elect (3-year commitment: 1-year as President-Elect, 1-year as President, 1-year as Past President) Director (3-year term) All elected Officers will assume office at the time of the - [EDI Research Grant Application](https://pedsendo.org/edi-research-grant-application/) - [PES Research Fellowship Grant Application (to include PES Human Growth Foundation Research Fellowship Grant)](https://pedsendo.org/pes-research-fellowship-grant-application/) - [PES Junior Faculty Research Grant Application (to include the Fima Lifshitz Junior Faculty Clinical Research Grant)](https://pedsendo.org/pes-junior-faculty-research-grant-application/) - [PES Rising Star Grant Application (to include the The Raphael David, MD Rising Star Grant)](https://pedsendo.org/pes-rising-star-grant-application/) - [2025 Annual Meeting Call for Reviewers](https://pedsendo.org/2025-annual-meeting-call-for-reviewers/) - The Program Committee invites you to volunteer as an Abstract Reviewer for the 2025 Annual Meeting, taking place in National Harbor, MD, from May 15-18. As a reviewer, you will play a key role in shaping the scientific program by reviewing abstracts submitted for the meeting. We are committed to growing our pool of reviewers - [2024 ByLaws Vote](https://pedsendo.org/2024-bylaws-vote/) - SUMMARY OF THE PROPOSED KEY MODIFICATIONS 2024 Article I. Name and Registered Office The change is recommended in order to remove unnecessary details. Article III. Membership Section 4. Suspension, Reinstatement and Termination. We don't actually suspend members, so this section is unnecessary. Membership is cancelled if there is a failure to pay dues by February - [Fellows, Residents, and Students](https://pedsendo.org/education-events/fellows-residents-students/) - Considering a Career in Pediatric Endocrinology? For more information about Pediatric Endocrinology, please visit the Council of Pediatric Subspecialties website or download the helpful PDF below, created by the PES Subcommittee for Residents and Medical Students Education. Sign Up for the PES Listserv Download PDF Pediatric Endocrinology Programs Explore the links below for - [Submit a Fellowship Position](https://pedsendo.org/education-events/fellows-residents-students/submit-a-fellowship-position/) - Please fill out the form below. The information collected will only be used for contacting you regarding this fellowship posting. - [Fellows, Residents, and Students Listserv Sign-Up](https://pedsendo.org/fellows-residents-and-students-listserv-sign-up/) - [Junior Faculty Grant 2nd Year Application](https://pedsendo.org/junior-faculty-grant-2nd-year-application/) - [Outstanding Mentor of the Year Award Application](https://pedsendo.org/outstanding-mentor-of-the-year-award-application/) - [PES Human Growth Foundation Research Fellowship Grant](https://pedsendo.org/pes-human-growth-foundation-research-fellowship-grant/) - [Fima Lifshitz Junior Faculty Clinical Research Grant Application](https://pedsendo.org/fima-lifshitz-junior-faculty-clinical-research-grant-application/) - [Travel Grant Application](https://pedsendo.org/travel-grant-application/) - [International Scholars Program Application](https://pedsendo.org/international-scholars-program-application/) - [Kaplowitz Lectureship Application](https://pedsendo.org/kaplowitz-lectureship-application/) - [EDI Research Award Application](https://pedsendo.org/edi-research-award-application/) - [Senior Investigator Award Application](https://pedsendo.org/2025-senior-investigator-award-application/) - [The Del and Beverly Fisher Pediatric Endocrinology History Lectureship Application](https://pedsendo.org/the-del-and-beverly-fisher-pediatric-endocrinology-history-lectureship-application/) - [Robert M. Blizzard, MD, Lectureship Application](https://pedsendo.org/robert-m-blizzard-md-lectureship-application/) - [The Raphael David, MD Rising Star Grant Application](https://pedsendo.org/the-raphael-david-md-rising-star-grant-application/) - [New Investigator Award Application](https://pedsendo.org/new-investigator-award-application/) - [Judson J. Van Wyk Prize Application](https://pedsendo.org/judson-j-van-wyk-prize-application/) - [Educator Award Application](https://pedsendo.org/educator-award-application/) - [Clinician Award Application](https://pedsendo.org/clinician-award-application/) - [Join a Committee](https://pedsendo.org/join-a-committee/) - [PES Committees](https://pedsendo.org/about-pes/pes-committees/) - Awards and Honors Committee Drugs & Therapeutics Committee Education Committee EDI Committee History Committee International Relations Committee Membership Committee MOC and QI Committee NIH Committee Nominating Committee Practice Management Committee Program Committee Public Policy Committee Publications Committee Research Affairs Committee Training Committee Website Committee Awards & Honors Committee The Awards and Honors Committee comprises two - [Clinical Study Submission](https://pedsendo.org/clinical-study-submission/) - [Patient Education Videos](https://pedsendo.org/patient-education-videos/) - Educational video for new families with an infant with DSD We are excited to offer a new translation for our educational video about an infant undergoing evaluation for DSD, which is now available in both English and Spanish. These 8-minute videos provide a detailed introduction to the concepts related to DSD in the context of - [Omnitrope](https://pedsendo.org/omnitrope/) - About Us: Sandoz is a global leader in off-patent medicines, based on our strong scientific heritage. Our purpose is to pioneer access for patients. We focus on driving access to make a difference for patients, working always with patients in mind. Address: 100 College Rd West Princeton, NJ 08540 United States Phone: (609) 627-8500 Email: - [Endo Pharmaceuticals](https://pedsendo.org/endo-pharmaceuticals/) - About Us: Endo Pharmaceuticals (OTC: ENDPQ) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments - [Survey Request](https://pedsendo.org/survey-request/) - Survey Guidelines and Tips - [Sandoz](https://pedsendo.org/about-pes/sandoz/) - About Us: Sandoz is the leading global provider of off-patent medicines. These generic and biosimilar medicines are more affordable than reference medicines. With a comprehensive portfolio of around 1,500 products covering most major therapeutic areas and available in over 100 countries, we make a real difference for patients and healthcare systems worldwide. Address: 100 College - [Lumos Pharma](https://pedsendo.org/lumos-pharma/) - About Us: Lumos Pharma is a clinical-stage biopharmaceutical company committed to identifying, developing, and commercializing life-changing therapies for patients and families living with rare diseases. The Company's clinical development program currently focuses on rare diseases associated with growth hormone deficiencies; the first indication targeted is Moderate Pediatric Growth Hormone Deficiency (PGHD). LUM-201 (ibutamoren) is an - [2024 Annual Meeting Exhibitors and Sponsors](https://pedsendo.org/2024-annual-meeting-exhibitors-and-sponsors/) - Thank you to our 2024 Annual Meeting Sponsors for your Generous Support Thank you to the 2024 PES Annual Meeting Exhibitors - [PES Cooking Initiative](https://pedsendo.org/pes-cooking-initiative/) - On behalf of The EDI Committee of The Pediatric Endocrine Society, we are very pleased to inform the PES membership of a new initiative: The "PES Cooking Initiative". Each day is a new opportunity for us to eat healthily. We are creating a PES Cultural Cookbook, a collection of culturally diverse recipes. Please share your - [Mailing List and Advertising](https://pedsendo.org/about-pes/mailing-list-and-advertising/) - Mailing Order Form Launching a new product? Interested in the latest trends? Reaching over 1600 Pediatric Endocrinologists with your mailing could not be easier! Click here for pricing and mailing label order form Advertising Are you looking for a cost-efficient medium to showcase your product, service, or organization? With advertisements in the Hormone Research in - [2024 MAP Spotlight Form](https://pedsendo.org/2024-map-spotlight-form/) - [Regional Meeting Grant Application](https://pedsendo.org/awards-grants-lectureships/regional-meeting-grant-application/) - [2024 Election](https://pedsendo.org/2024-election/) - The PES Nominating Committee is pleased to present you with an exceptional slate of candidates for this year's election for President-Elect, Treasurer, and Director. The terms are as follows: President-Elect (3-year commitment: 1-year as President-Elect, 1-year as President, 1-year as Past President) Treasurer (4-year term) Director (3-year term) All elected Officers will assume office at - [2024 Election Vote](https://pedsendo.org/2024-election-vote/) - [PES 2024 International Scholar Award Application](https://pedsendo.org/pes-2023-international-scholar-award-application/) - Deadline to submit is December 31, 2023 - [Herself in Every Moment: A Peer Conversation on the Importance of Individualized Treatment for Children with CPP](https://pedsendo.org/herself-in-every-moment-a-peer-conversation-on-the-importance-of-individualized-treatment-for-children-with-cpp/) - Please join our discussion on central precocious puberty (CPP) and the importance of an individualized treatment approach to address each patient’s unique needs. This presentation features a patient case and relevant data from two newly published studies and focuses on the need for timely and ongoing treatment. Speakers: Karen O. Klein, MD​ Pediatric Endocrinologist​ Rady - [Video Vignettes/Interviews](https://pedsendo.org/video-vignettes-interviews/) - We proudly completed a major oral history project that was led by Erinn Rhodes! Many senior members were asked a series of questions about their journey into and through a career in pediatric endocrinology. It has been exciting to preview some of the statements and hear what the PES has meant to senior members and - [PES 50th Anniversary](https://pedsendo.org/education-events/pes-50th-anniversary/) - PES is 50 years old! We were excited to celebrate our golden anniversary with all of our members formally as part of the 2022 Virtual Annual Meeting, and are happy share some of the exciting projects that took place to commemorate this special milestone of our society with you here! Video vignettes/interviews: We proudly completed - [Clinical Trial Submission](https://pedsendo.org/clinical-trial-submission/) - [Pediatric Endocrine Program Directors](https://pedsendo.org/careers/pediatric-endocrine-program-directors/) - Pediatric Endocrine Program Directors are a subgroup of our membership who are responsible for supervising all aspects of the fellowship training programs in endocrinology in their respective institutions in accordance with program requirements for graduate medical education as set forth by the Accreditation Council for Graduate Medical Education (ACGME). There are one to two assigned - [PES TRENDS SIG: State of the Art Webinar](https://pedsendo.org/pes-sig-state-of-the-art-series/pes-trends-sig-state-of-the-art-webinar/) - [Survey Results Form](https://pedsendo.org/survey-results-form/) - [Rhythm Pharmaceuticals](https://pedsendo.org/rhythm-pharmaceuticals/) - About Us: Rhythm Pharmaceuticals is a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases by rapidly advancing care and precision medicines addressing the root cause. To learn more, please visit https://www.rhythmmedicalgateway.com/index.html. Rhythm has commercialized IMCIVREE - [Adolescent Female with Suspected Polycystic Ovarian Syndrome (PCOS)](https://pedsendo.org/adolescent-female-with-suspected-polycystic-ovarian-syndrome-pcos/) - Suggestive history and physical findings: Expand Symptoms/Signs: Signs of Hyperandrogenism: Irregular menstrual periods, hirsutism, acne, frontal and temporal balding, hoarseness of voice, clitoromegaly in severe cases Excessive weight gain common Family history: History of PCOS, infertility, irregular menstrual periods, hirsutism may be present in mother, sisters, other female 1st degree relatives. For more information, please - [PES 2023 Mission Alliance Partner Spotlight](https://pedsendo.org/pes-2023-mission-alliance-partner-spotlight/) - [About PES](https://pedsendo.org/about-pes/) - PES has over 1600 members representing the multiple disciplines of Pediatric Endocrinology. The members are dedicated to research and treatment of children with endocrine disorders; reproductive, bone, thyroid, diabetes, obesity, growth, pituitary and adrenal. The Society works to promote the continuing education of its membership. Get in Touch with Our Team PES Membership General member - [Organizations Promoting Pediatric Endocrine Care](https://pedsendo.org/patient-resources/organizations-promoting-pediatric-endocrine-care/) - INTERNATIONAL CONSORTIUM OF PEDIATRIC ENDOCRINOLOGY (ICPE) Member Societies: African Society for Pediatric and Adolescent Endocrinology (ASPAE) Arab Society for Paediatric Endocrinology and Diabetes (ASPED) Asia Pacific Pediatric Endocrine Society(APPES) Australia and New Zealand Society for Paediatric Endocrinology and Diabetes (ANZSPED) Chinese Society of Pediatric Endocrinology and Metabolism (CSPEM) European Society for Pediatric Endocrinology (ESPE) Global Pediatric Endocrinology and Diabetes - [2021 Obesity SIG MOC/CME Activity](https://pedsendo.org/2021-obesity-sig-moc-cme-activity/) - [National Institutes of Health (NIH) Lecture Series](https://pedsendo.org/clinical-resources/nih-draft/) - The NIH Lecture Series was established to educate our members on ongoing opportunities for research-related venues for pediatric endocrinologists. 2022 WEBINARS Our next information seminars from the PES/NIH liaison committee are listed below. The topics to be covered aim to demystify the NIH operations and encourage our new generation of pediatric endocrinologists to seek extramural - [PES Leadership Advantage (PESLA)](https://pedsendo.org/pes-leadership-advantage-pesla/) - After a six-year successful run, the PES Leadership Advantage Program has now concluded. Over 60 PES members have participated in one or more of the in person or virtual workshops since its 2016 inception. The PES Leadership Advantage Program has provided physician leaders with the core skills key to becoming impactful voices at the leadership - [50th Anniversary Interviews](https://pedsendo.org/50th-anniversary-interviews/) - President's Fireside Chat Allen, David Alter, Craig August, Gilbert Becker, Dorothy Bercu, Barry Carpenter, Tom Chernausek, Steven Copeland Kenneth D'Ercole, Joseph Elders, Joycelyn Eugster, Erica Geffner, Mitch Haymond, Morey Kaplowitz, Paul LaFranchi, Steve Laron, Zvi Lee, Mary Lee, Peter Levitsky, Lynne Majzoub, Joseph Malozowski, Saul Miller, Walter Misra, Madhu Oberfield, Sharon Pescovitz, Ora Plotnick, Leslie - [Donate](https://pedsendo.org/about-pes/donate/) - Generous contributions like yours are making the advancement of the Pediatric Endocrine Society mission possible. This support remains vital as we work to implement the member-driven goals and objectives set forth in our strategic plan. Your donation makes it possible to continue to provide our members with the necessary tools and resources to better serve - [PES Obesity Self-Assessment Activity 2022](https://pedsendo.org/pes-obesity-self-assessment-activity-2022/) - [Provention Bio](https://pedsendo.org/proventionbio/) - About Us: Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company leveraging a transformational drug development strategy focused on the prevention or interception of immune-mediated disease. Provention's diversified portfolio includes teplizumab, a pre-commercial-stage candidate that has been shown to delay the onset of insulin-dependent type 1 diabetes (T1D) in at-risk patients during the presymptomatic phase - [PES - 50 Year Anniversary Timeline](https://pedsendo.org/pes-50-year-anniversary-timeline/) - [2022 Virtual Annual Meeting Exhibitors and Sponsors](https://pedsendo.org/education-events/pes-annual-meeting/2022-virtual-annual-meeting-exhibitors-and-sponsors/) - Thank you to our 2022 Annual Meeting Sponsors for your Generous Support Thank you to the 2022 PES Annual Meeting Exhibitors - [Cancer Survivorship](https://pedsendo.org/education-events/pes-50th-anniversary/cancer-survivorship/) - [Azurity Pharmaceuticals](https://pedsendo.org/azurity-pharmaceuticals/) - About Us: Triptodur® (triptorelin) for extended-release injectable suspension is an FDA approved medication distributed in the US by Azurity Pharmaceuticals, Inc. Azurity is a privately held, specialty pharmaceutical company that focuses on developing innovative products that meet the needs of patients with underserved conditions. For more information regarding Triptodur® (triptorelin) for extended release injectable suspension, - [Endocrine Sciences](https://pedsendo.org/endocrine-sciences/) - About Us: Labcorp's Esoterix laboratory (formerly Endocrine Sciences) is a research-quality reference laboratory specializing in highly specific and sensitive endocrine testing services. By maintaining our singular focus, we provide a unique service oriented to the distinct requirements of the practice of endocrinology. We are an industry leader in developing new, clinically relevant assays and establishing defined - [2022 Election](https://pedsendo.org/2022-election/) - The PES Nominating Committee is pleased to present you with an exceptional slate of candidates for this year's election for President-Elect, one At-Large Director, and Secretary. The terms are as follows: President-Elect (3-year commitment: 1-year as President-Elect, 1-year as President, 1-year as Past President) Secretary (4-year term) Director (3-year term) All elected Officers will assume - [Adolescent With Suspected Hirsutism Test](https://pedsendo.org/adolescent-with-suspected-hirsutism-test/) - Differential diagnosis of Hirsutism: Physiologic hyperandrogenism of puberty Idiopathic hyperandrogenism PCOS Less commonly: Congenital Adrenal Hyperplasia (CAH): late onset CAH, mild CAH, non classic/virilizing CAH Androgen secreting tumors of the adrenal glands or ovaries Hypothyroidism Cushing’s disease Severe hyperprolactinemia Hypertrichosis Exposure to androgenic drugs Additional Information: Hirsutism affects 5–10% of reproductive-aged females Diagnosis of - [GHD Knowledge Center](https://pedsendo.org/clinical-resources/ghd-resource-center/) - Welcome to the GHD knowledge center! This initiative aims to educate on the diagnosis, causes and consequences of GHD. There are three workstreams, each led by an expert in the field, consisting of a webcast, an infographic and an interactive quiz. We hope you enjoy this educational series. Pediatric Growth Hormone Deficiency (GHD)Medical Education Series - [Past PES Education Committee Webinars](https://pedsendo.org/education-events/online-education/past-pes-education-committee-webinars/) - July 19, 2021: Ravinder J. Singh - Cortisol Assays and the Controversy Continues Webinar recording April 19, 2021: Joseph A. Majzoub - Disorders of Water Metabolism Webinar recording January 25, 2021: Ambika Ashraf - Pediatric Dyslipidemia Webinar recording October 19, 2020: Laura Bachrach - Pediatric Densitometry – Promise and Pitfalls in Clinical Practice Webinar recording - [Fellowship Position Listings](https://pedsendo.org/fellowship-position-listings/) - Search by Title - [2021 Meeting Videos](https://pedsendo.org/2021-meeting-videos/) - Missing Presentation Sun 2:45- 3:45 - Oral Abstracts Basic (missing 1, Greely ) Friday LWPES Lecture Final Version Symposium: Congenital hypothyroidism: recent insights into causes, diagnosis, and treatment Year in Review MTP: The ABCs of CDA - an overview of Career Development Awards Meet The Professor Cushing Disease: Case Based Discussion Meet The - [2021 Virtual Annual Meeting Exhibitors and Sponsors](https://pedsendo.org/education-events/pes-annual-meeting/2021-virtual-annual-meeting-exhibitors-and-sponsors/) - PES wishes to thank our generous sponsors and exhibitors for their support of our 2021 virtual annual meeting and exhibits. Thank you to our Sponsors for your generous support! Thank you to the 2021 PES annual meeting exhibitors! - [2020 Annual Meeting Online Education](https://pedsendo.org/2020-annual-meeting-online-education/) - Pre-recorded virtual sessions from 2020 meeting Special Interest Group Session Recordings - [PES SIG State of the Art Series Schedule](https://pedsendo.org/pes-sig-state-of-the-art-series-schedule/) - SIG Date/time Notes September 2020 Obesity September 18, 2020 4pm-5pm September is National Childhood Obesity Month. October, 2020 Ethics October 29, 2020, 2020 4-5pm EST Global Ethics Day will take place on 21 October 2020. November, 2020 Diabetes UPDATE: December 3, 2020 6pm – 7pm • November is Diabetes Awareness Month December, 2020 PCOS - [PES News & Announcements](https://pedsendo.org/news-publications/pes-news-announcements/) - More Articles - [Abbvie](https://pedsendo.org/about-pes/abbvie/) - About Us: AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services - [Fellowship Position Submission](https://pedsendo.org/fellowship-position-submission/) - [Student Resources](https://pedsendo.org/clinical-resources/student-resources/) - [Clinical Resource Submission](https://pedsendo.org/clinical-resources/clinical-resource-library/clinical-resource-submission/) - [Clinical Scholar Awards Second Year Submission](https://pedsendo.org/awards-grants-lectureships/https-apps-pedsendo-org-awards-clinical-second-year/) - If you are applying for CSA 2nd-year funding, please fill out all information below. This information will be competitively reviewed with all other applications (1st year and 2nd year CSA applications). - [Ipsen](https://pedsendo.org/ipsen/) - About Us: About Ipsen in North America Ipsen (Euronext: IPN; ADR: IPSEY) is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes innovative medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Diseases. At Ipsen, we focus our resources, investments and energy on discovering, developing and commercializing - [Public Policy and Advocacy](https://pedsendo.org/about-pes/public-policy-and-advocacy/) - [Patient Resources](https://pedsendo.org/patient-resources/) - What is a Pediatric Endocrinologist? Learn more about the field of pediatric endocrinology. Start Here Patient Education A Patient Education Subcommittee comprising members from the PES Education Council and the American Academy of Pediatrics Section on Endocrinology have developed a series of patient education fact sheets covering topics such as growth, thyroid, puberty, diabetes, adrenal, - [MAP Spotlight Raffle](https://pedsendo.org/map-spotlight-raffle/) - [Privacy Policy](https://pedsendo.org/privacy-policy/) - The Pediatric Endocrine Society (PES) is committed to protecting your privacy and developing technology that gives you the most powerful and safe online experience. This Privacy Policy governs data collection and usage by PES and applies to its website, other platforms used to facilitate management of the services provided to you (e.g., conference registration sites); - [Test](https://pedsendo.org/test/) - Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat - [Clinical Update and Case Discussion Course](https://pedsendo.org/education-events/fellows-residents-students/clinical-update-and-case-discussion-course/) - Looking for the most up to date information on the care of transgender youth? Want to know more about fertility in survivors of childhood cancer? PES partnered with our colleagues in the Canadian Pediatric Endocrine Group to bring you the 2018 Clinical Update and Case Discussion Course. The day included key sessions on clinical areas - [Clinical Resources](https://pedsendo.org/clinical-resources/) - Clinical Resource Library Our clinical resources library has been created to provide you with tools to serve your patients and to make sure you have the most relevant information you need to advance the practice. Visit Our Resource Library GHD Resource Center The Growth Hormone Deficiency (GHD) Resource Center aims to educate on the diagnosis, - [Accessibility Statement](https://pedsendo.org/accessibility-statement/) - This website has been built with the accessibility of all people in mind. It is periodically checked against best practices and standards as defined by Section 508 of the U.S. Rehabilitation Act and the Web Content Accessibility Guidelines, WCAG 2.1, of the World Wide Web Consortium Web Accessibility Initiative. This includes: Skip links, landmarks, and - [Practical Clinical Tools](https://pedsendo.org/education-events/fellows-residents-students/practical-clinical-tools/) - Patient Education For a list of patient education fact sheets, visit the Patient Education page. Transition Toolkit for Patients and Professionals This toolkit helps patients gain a greater awareness of their health history and health needs as they transition into adult self-management. View the Toolkit Additional External Resources Genetics, Including Klinefelter Syndrome and Turner - [Careers](https://pedsendo.org/careers/) - The field of pediatric endocrinology offers various career opportunities and, in some cases, multiple ones for the same individual, including: Job Board See the latest employment opportunities for PES members. Visit the Job Board Pediatric Endocrine Program Directors Learn about this subgroup of PES membership. Learn More Certification Read more about the ABP's criteria for - [Past Annual Meetings](https://pedsendo.org/education-events/pes-annual-meeting/past-annual-meetings/) - 2017 Washington, DC September 14 - September 17 2016 Baltimore, MD April 28 - May 2 2015 San Diego, CA April 24 - April 28 2014 Vancouver, BC, Canada May 2 - May 6 2013 Washington, DC May 3 - May 6 2012 Boston, MA April 26 - April 27 2011 Denver, CO April 29 - [Certification](https://pedsendo.org/careers/certification/) - Eligibility criteria for initial board certification in pediatric endocrinology, as set forth by the American Board of Pediatrics (ABP), include completion of three years of training in a full-time, broad-based fellowship program accredited by the Accreditation Council for Graduate Medical Education (ACGME) in the United States or by the Royal College of Physicians and Surgeons - [Transition Toolkit](https://pedsendo.org/patient-resources/transition-toolkit/) - Transition Toolkit for Professionals and Patients This Transition Toolkit will help patients gain a greater awareness of their health history and health needs and prepare them to accept their adult responsibility of self-management. In addition, it streamlines the transfer of relevant health information to patients' adult healthcare providers. This Toolkit will also help educate patients, - [Events Calendar](https://pedsendo.org/news-publications/events-calendar/) - [What is a Pediatric Endocrinologist?](https://pedsendo.org/patient-resources/what-is-a-pediatric-endocrinologist/) - Pediatric endocrinologists are physicians who have special training and expertise in the care of children and adolescents with hormone disorders. Hormones are chemical signals secreted by various glands that travel to target tissues through the bloodstream. Although most pediatric endocrinologists see patients in the setting of an academic medical center or private practice, others work - [Conflict of Interest Statement](https://pedsendo.org/about-pes/conflict-of-interest-statement/) - Purpose: The PES considers collaborative relationships with industry to be valuable to the mission of the Society, and is committed to manage these relationships responsibly and ethically. The PES is also pledged to leadership of the Society and its activities that is objective and unencumbered by conflicts of interest (COI). To manage potential COI in - [Submit a Clinical Study](https://pedsendo.org/patient-resources/clinical-studies/submit-a-clinical-study/) - Submit a clinical study. Submissions will be reviewed before posting to the site. Please ensure we can reach you at the contact information you provide. - [Programs](https://pedsendo.org/programs/) - [Regions](https://pedsendo.org/regions/) - [Sitemap](https://pedsendo.org/sitemap/) ## Downloads - [2023 Annual Meeting Conference Brochure V4](https://pedsendo.org/download/2023-annual-meeting-conference-brochure-v4/) - [Board Review Course Brochure](https://pedsendo.org/download/board-review-course-brochure/) - [Board Review Course Brochure](https://pedsendo.org/download/board-review-course-brochure-2/) - 2023 Board Review Course Brochure - [PES 2023 Annual Meeting Schedule at a Glance Final](https://pedsendo.org/download/pes-2023-annual-meeting-schedule-at-a-glance-final/) - [PES 2023 Annual Meeting Schedule at a Glance](https://pedsendo.org/download/pes-2023-annual-meeting-schedule-at-a-glance/) - 2023 Annual Meeting Schedule at a Glance as of 9.15.2022 - [New Meds and Tech VOXZOGO](https://pedsendo.org/download/new-meds-and-tech-voxzogo/) - VOXZOGO - [New Meds and Tech Skytrofa](https://pedsendo.org/download/new-meds-and-tech-skytrofa/) - Skytrofa - [2022 Prospectus](https://pedsendo.org/download/2022-prospectus/) - PES 2022 Virtual Exibit Sponsor Prospectus Final - [PES 2022 Virtual Exhibit Sponsor Prospectus](https://pedsendo.org/download/pes-2022-virtual-exhibit-sponsor-prospectus/) - PES 2022 Virtual Exhibit Sponsor Prospectus - [Evolocumab](https://pedsendo.org/download/evolocumab/) - [New Ready-to-Use Glucagon Preparation: Zegalogue](https://pedsendo.org/download/new-ready-to-use-glucagon-preparation-zegalogue/) - [Lipid LT4](https://pedsendo.org/download/lipid-lt4/) - [new med tech file](https://pedsendo.org/download/new-med-tech-file/) - [Medtech Dt Glucagon](https://pedsendo.org/download/medtech-dt-glucagon/) - [Setmelanotide](https://pedsendo.org/download/setmelanotide/) - [New Meds and Tech-PES DT- Saxenda- long version for web1](https://pedsendo.org/download/new-meds-and-tech-pes-dt-saxenda-long-version-for-web1/) - [New Meds and Tech-PES DT- (Alkindi)- long version-FINAL](https://pedsendo.org/download/new-meds-and-tech-pes-dt-alkindi-long-version-final/) - [Liraglutide PES long version-final](https://pedsendo.org/download/liraglutide-pes-long-version-final/) - [Burosumab Twza (Crysvita-Ultragenix Pharmaceuticals)](https://pedsendo.org/download/burosumab-twza-crysvita-ultragenix-pharmaceuticals/) - [Tirosint-SOL](https://pedsendo.org/download/tirosint-sol/) - [Vitamin D Preparations and Safety Issues Full PDF](https://pedsendo.org/download/vitamin-d-preparations-and-safety-issues-full-pdf/) - [Glucagon Preparations Full PDF](https://pedsendo.org/download/glucagon-preparations-full-pdf/) - [Increlex Full PDF](https://pedsendo.org/download/increlex-full-pdf/) - [Newer Insulin Preparation: Faster insulin Aspart (Fiasp) Full PDF](https://pedsendo.org/download/newer-insulin-preparation-faster-insulin-aspart-fiasp-full-pdf/) - [New Cortisol Assays, New Threshold for Adrenal Insufficiency Full PDF](https://pedsendo.org/download/new-cortisol-assays-new-threshold-for-adrenal-insufficiency-full-pdf/) - [Limitations in Supply of Hydrocortisone Tablets Update Full PDF](https://pedsendo.org/download/limitations-in-supply-of-hydrocortisone-tablets-update-full-pdf/) - [Tandem Diabetes Care Control-IQ Technology Full PDF](https://pedsendo.org/download/tandem-diabetes-care-control-iq-technology-full-pdf/) - [Riomet ER Full PDF](https://pedsendo.org/download/riomet-er-full-pdf/) - [Freestyle Libre 2 Full PDF](https://pedsendo.org/download/freestyle-libre-2-full-pdf/) - [Semglee Full PDF](https://pedsendo.org/download/semglee-full-pdf/) ## Venues - [The Worthington Renaissance Fort Worth Hotel](https://pedsendo.org/venue/the-worthington-renaissance-fort-worth-hotel/) - [Buenos Aires, Argentina](https://pedsendo.org/venue/buenos-aires-argentina/) - [Example Venue](https://pedsendo.org/venue/example-venue/) ## Organizers - [Eton Pharmaceuticals](https://pedsendo.org/organizer/eton-pharmaceuticals-2/) - [Yoko Co](https://pedsendo.org/organizer/yoko-co/) - [Eton Pharmaceuticals](https://pedsendo.org/organizer/eton-pharmaceuticals/) ## Events - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2026-07-28/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2026-08-25/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2026-09-22/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2026-10-27/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2026-11-24/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2026-12-22/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2027-01-26/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2027-02-23/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2027-03-23/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2027-04-27/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2027-05-25/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES PMOS SIG Monthly Meeting](https://pedsendo.org/event/pes-pmos-sig-monthly-meeting/2027-06-22/) - Monthly meetings occur on the 4th Tuesday of the month at 12pm ET. If you’re interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [Didactic: "Being an Ally that ACTS"](https://pedsendo.org/event/didactic-being-an-ally-that-acts/) - The PES Health Systems & Disparities Committee invites all PES members to participate in an interactive training program focused on allyship and effective advocacy in healthcare. Through a combination of didactic learning and case-based small-group discussions, participants will gain practical tools to recognize and address bias, support colleagues and trainees, and foster a culture of - [Facilitator Training Webinar](https://pedsendo.org/event/facilitator-training-webinar/) - The PES Health Systems & Disparities Committee invites all PES members to participate in an interactive training program focused on allyship and effective advocacy in healthcare-3-part webinar. Through a combination of didactic learning and case-based small-group discussions, participants will gain practical tools to recognize and address bias, support colleagues and trainees, and foster a culture - [Case Practicum Workshop](https://pedsendo.org/event/case-practicum-workshop/) - The PES Health Systems & Disparities Committee invites all PES members to participate in an interactive training program focused on allyship and effective advocacy in healthcare. Through a combination of didactic learning and case-based small-group discussions, participants will gain practical tools to recognize and address bias, support colleagues and trainees, and foster a culture of - [State of the Art - TREND SIG: Long-Acting Growth Hormone in Cancer Survivors: Risks, Benefits, and Clinical Practice](https://pedsendo.org/event/state-of-the-art-trend-sig-long-acting-growth/) - Session Type: SIG: State of the Art: TREND SIG Session Title: Long-Acting Growth Hormone in Cancer Survivors: Risks, Benefits, and Clinical Practice Brief Description Long-acting growth hormone (LAGH) offers new possibilities for improving treatment experience and adherence in growth hormone deficiency, but its role in childhood cancer survivors remains uncertain. In this interactive debate, two - [Shaping the Future of Care in Achondroplasia and Related Conditions](https://pedsendo.org/event/shaping-the-future-of-care-in-achondroplasia-and-related-conditions/) - It is an exciting time in the management of achondroplasia and related conditions, and the IAF is delighted to introduce a conference focused on sharing experience and practical guidance to enhance care for affected individuals. The programme equips attendees with the knowledge, skills, and professional connections needed to optimise outcomes for those they support. The - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-06-24/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Quarterly Education Webinar: Collateral Damage: Radiation’s Effect on Endocrine Organs](https://pedsendo.org/event/quarterly-education-webinar-collateral-damage-radiations-effect-on-endocrine-organs/) - Date: Monday, July 20, 2026 / 4:00 pm – 5:00 pm ET Title: Collateral Damage: Radiation’s Effect on Endocrine Organs Description: This talk will cover the impact of radiation on endocrine function. Learning objectives: Explain the risk for hormonal dysfunction by radiation dose and target area. Describe the unique effects of radiation on growth and pubertal - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2027-02-15/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2027-03-15/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-06-15/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-07-20/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-08-17/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-09-21/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-10-19/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-11-16/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-12-21/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2027-01-18/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2027-04-19/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [Diabetes Type 2 SIG Meeting](https://pedsendo.org/event/diabetes-type-2-sig-meeting/2027-05-17/) - For more information on the Diabetes Type 2 SIG, click here. To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-04-23/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-05-28/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2025-10-23/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2025-11-27/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2025-12-25/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-01-22/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-02-26/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-03-26/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2025-08-28/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2025-09-25/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2025-07-25/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-10-14/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-11-11/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-12-09/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2028-01-13/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2028-02-10/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2028-03-09/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2028-04-13/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2028-05-11/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-06-10/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-07-08/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-08-12/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-09-09/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-12-10/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-01-14/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-02-11/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-03-11/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-04-08/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2027-05-13/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-05-14/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-06-11/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-07-09/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-08-13/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-09-10/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-10-08/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-11-12/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-01-08/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-02-12/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-03-12/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2026-04-09/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Lipid SIG Meeting](https://pedsendo.org/event/pes-lipid-sig-meeting/2026-03-05/) - For more information on the Lipid SIG, click here. To join a SIG, click here. - [PES Lipid SIG Meeting](https://pedsendo.org/event/pes-lipid-sig-meeting/2026-04-30/) - For more information on the Lipid SIG, click here. To join a SIG, click here. - [PES Lipid SIG Meeting](https://pedsendo.org/event/pes-lipid-sig-meeting/2025-09-04/) - For more information on the Lipid SIG, click here. To join a SIG, click here. - [PES Lipid SIG Meeting](https://pedsendo.org/event/pes-lipid-sig-meeting/2025-12-04/) - For more information on the Lipid SIG, click here. To join a SIG, click here. - [PES APP SIG Meeting](https://pedsendo.org/event/pes-app-sig-meeting-2/2025-11-03/) - For more information on the APP SIG, click here. To join a SIG, click here. - [PES APP SIG Meeting](https://pedsendo.org/event/pes-app-sig-meeting-2/2026-02-09/) - For more information on the APP SIG, click here. To join a SIG, click here. - [PES APP SIG Meeting](https://pedsendo.org/event/pes-app-sig-meeting-2/2026-04-30/) - For more information on the APP SIG, click here. To join a SIG, click here. - [PES APP SIG Meeting](https://pedsendo.org/event/pes-app-sig-meeting-2/2026-08-10/) - For more information on the APP SIG, click here. To join a SIG, click here. - [PES Podcast Club: Genetic Data From Over 20,000 U.S. Children Misused for 'Race Science'](https://pedsendo.org/event/pes-podcast-club-genetic-data-from-over-20000-u-s-children-misused-for-race-science/) - Revised PES_Podcast_Club_Flyer Tuesday, June 9, 2026 at 6:15 PM Eastern This Session's Topic: "Genetic Data From Over 20,000 U.S. Children Misused for 'Race Science'" New York Times audio article · January 24, 2026 · ~20 min listen nytimes.com/2026/01/24/us/children-genetics-race-science.html Please join the PES Health Systems & Disparities Committee for a virtual Podcast Club on Tuesday, June - [PES Ethics SIG Webinar: Ethics Case-Based Discussion - Spring Edition](https://pedsendo.org/event/pes-ethics-sig-webinar-ethics-case-based-discussion-spring-edition/) - Tuesday, April 14, 2026, 5:30-6:30pET - State of the Art: Ethics SIG Session Title: Ethics Case-Based Discussion - Spring Edition Brief Description: Join the PES Ethics SIG for a discussion of clinical cases that raise ethical questions. PES members are invited to submit cases with ethical dilemmas to present for discussion for this webinar. Cases should - [PES Hypoglycemia SIG Webinar: Diagnosis and Management of Ketotic Hypoglycemia](https://pedsendo.org/event/pes-hypoglycemia-sig-webinar-diagnosis-and-management-of-ketotic-hypoglycemia/) - Wednesday, April 15, 2026, 5-6pET - State of the Art: Hypoglycemia SIG Session Title: Diagnosis and Management of Ketotic Hypoglycemia Brief Description: This seminar will review how patients normally respond to fasting and how ketones are produced. It will help clinicians distinguish normal (physiologic) ketotic hypoglycemia from disease-related causes. The session will cover when and how - [PES TREND SIG & PedsEndo 365 Webinar: Evaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders](https://pedsendo.org/event/pes-trend-sig-pedsendo-365-webinar-evaluation-and-management-of-dsd/) - Tuesday, March 24, 2026, 3-5pET - State of the Art: TREND SIG & PedsEndo 365 Session Title: Evaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders Brief Description: In collaboration with the Tumor Related Endocrine and Neuroendocrine Disorders (“TREND”) SIG, the PedsEndo365 aims to improve increased awareness of late effects observed in childhood cancer - [PES Hypoglycemia SIG Meeting](https://pedsendo.org/event/pes-hypoglycemia-sig-meeting/) - Mission Statement Hypoglycemia disorders are rare, but their consequences in children can be severe and have a lasting impact. The PES Hypoglycemia Disorders Special Interest Group (SIG) aims to improve the diagnosis and management of infants and children with hypoglycemia disorders through education, clinical care standardization, research and advocacy. To Learn more about the - [PES Thyroid SIG Webinar, Pediatric Thyroid US Series - Session 1 - Normal Thyroid US](https://pedsendo.org/event/pes-thyroid-sig-webinar-pediatric-thyroid-us-series-1-normal-thyroid-us/) - Thursday, February 26, 2026, 5-6pET - State of the Art: Thyroid SIG Session Title: Pediatric Thyroid US Series - Session 1 - Normal Thyroid US Brief Description: This is a 3 part series on the Pediatric Thyroid US. This first session is focused on Normal Thyroid US. Learning Objectives Identify features of normal thyroid anatomy - [Industry Sponsored Symposium: Real-World Patient and Clinical Perspectives: Preparing Your Pediatric Patients for Successful Care Transitions in Classic Congenital Adrenal Hyperplasia](https://pedsendo.org/event/industry-sponsored-symposium-real-world-patient-and-clinical-perspectives-preparing-your-pediatric-patients-for-successful-care-transitions-in-classic-congenital-adrenal-hyperplasia/) - Industry Sponsored Symposium: Real-World Patient and Clinical Perspectives: Preparing Your Pediatric Patients for Successful Care Transitions in Classic Congenital Adrenal Hyperplasia Wednesday, March 11, 2026 at 3:00 – 4:00pm ET Sponsored by Neurocrine BioSciences Description: Featuring insights from a patient, caregiver, and an expert healthcare provider and researcher, this presentation highlights the clinical and practical - [PES Thyroid SIG Webinar, Pediatric Thyroid US Series: 2. Abnormal Thyroid US.](https://pedsendo.org/event/pes-thyroid-sig-webinar-pediatric-thyroid-us-series-2-abnormal-thyroid-us/) - Thursday, June 4, 2026, 5-6pET - State of the Art: Thyroid SIG Session Title: Pediatric Thyroid US Series 2: Abnormal Thyroid US. Brief Description: This is a 3 part series on the Pediatric Thyroid US. This second session is focused on Abnormal Thyroid US Learning Objectives Identify features of thyroid diseases, benign thyroid nodules, and cancer. - [Understanding the impact of bias and stigma on children affected by obesity](https://pedsendo.org/event/understanding-the-impact-of-bias-and-stigma-on-children-affected-by-obesity/) - Tuesday, February 3, 2026, 12-1pET - State of the Art: Obesity SIG & HSD Committee Session Title: Understanding the impact of bias and stigma on children affected by obesity Brief Description: Bias and stigma have been shown to be common experiences of individuals affected by obesity. Understanding the impact of bias and stigma on children. - [2026 Annual Meeting](https://pedsendo.org/event/2026-annual-meeting/) - April 30- May 3, 2026 San Francisco, CA - [PES State of the Art Webinar; Incorporating patient advocates into the DSD/Intersex Multidisciplinary Clinics](https://pedsendo.org/event/pes-state-of-the-art-webinar-incorporating-patient-advocates-into-the-dsd-intersex-multidisciplinary-clinics/) - Wednesday, March 11, 2026, 7-8pET - State of the Art: DSD SIG Session Title: Incorporating patient advocates into the DSD/Intersex Multidisciplinary Clinics Brief Description: This session will focus on the incorporation of patient advocates into the Intersex/DSD multidisciplinary clinics. The session will be open to members of PES and members of the Society of Pediatric Psychology. - [PES Ethics SIG: Beyond the Algorithm: Ethical AI in Pediatric Endocrinology](https://pedsendo.org/event/pes-ethics-sig-beyond-the-algorithm-ethical-ai-in-pediatric-endocrinology/) - Wednesday, February 11, 2026, 4-5pET - State of the Art: Ethics SIG Session Title: Beyond the Algorithm: Ethical AI in Pediatric Endocrinology Brief Description: Artificial intelligence is rapidly transforming how we practice medicine—from clinical decision support and documentation to patient communication and diagnostic reasoning. As pediatric endocrinologists, we face unique opportunities and challenges as these tools - [PES Turner Syndrome SIG Webinar: Prenatal Counseling for Turner Syndrome](https://pedsendo.org/event/pes-turner-syndrome-sig-webinar-prenatal-counseling-for-turner-syndrome/) - Thursday, February 5, 2026, 6-7pET - State of the Art: Turner Syndrome SIG Session Title: Prenatal Counseling for Turner Syndrome Brief Description: Speaker will discuss prenatal genetic counseling strategies and spectrum in Turner syndrome. Case based discussion. Learning Objectives Understand the landscape and principles of genetic counseling for prenatal diagnoses of Turner syndrome Application of these - [Industry Sponsored Symposium: Exploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health](https://pedsendo.org/event/industry-sponsored-symposium-exploring-innovative-pathways-for-congenital-hyperinsulinism-treatment-pioneering-pathways-to-better-health/) - Industry Sponsored Symposium: Exploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health Wednesday, February 11, 2026 at 10:30 am - 11:30 am ET Description: Congenital hyperinsulinemia (CHI) is a complex and serious disorder that most often appears in newborns and young infants as prolonged, often severe, hypoglycemia. When diagnosis or treatment is - [PES Endo365 Webinar: Career Pathways for Pediatric Endocrine Fellows](https://pedsendo.org/event/pes-endo365-webinar-career-pathways-for-pediatric-endocrine-fellows/) - Tuesday, January 20, 2026, 3-5p ET Session Title: Career Pathways for Pediatric Endocrine Fellows Brief Description: This activity addresses the following key concepts: 1. Common viable career paths after fellowship training. 2. Importance of identifying what paths match values, skills, and interests 3. Role of networking in identifying mentors and job prospects. Learning Objectives: 1. - [PES DSD SIG Webinar: Gonadal Management in DSD](https://pedsendo.org/event/pes-dsd-sig-webinar-management-of-the-risky-gonad-in-individuals-with-dsd/) - Wednesday, February 18, 2026, 1-2pET - State of the Art: DSD SIG Session Title: Gonadal Management in DSD Brief Description: Individuals with various forms of differences of sex development (DSD) may be at increased risk of developing gonadal germ cell cancer. This risk depends on several factors including the presence of the gonadoblastoma region on - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting-2/2028-06-08/) - Meets on the Second Thursday of the month at 5pET. If you're interested in joining a SIG or want to learn more, click here. SIG participation are for PES Members only. To join this SIG and get the meeting invite, click here. - [PES Turner Syndrome SIG: Book Club](https://pedsendo.org/event/pes-turner-syndrome-sig-book-club/) - TS Journal Club When: Jan 20th, 2026 @ 7PM Eastern Where: Zoom Topic: TBA - [PES Thyroid SIG Webinar, Graves’ Disease Series, 3: Challenging Cases in Graves’ Disease](https://pedsendo.org/event/pes-thyroid-sig-webinar-graves-disease-series-3-challenging-cases-in-graves-disease/) - Thursday, February 25, 2027, 5-6pET - State of the Art: Thyroid SIG Session Title: Graves' Disease Series, 3: Challenging Cases in Graves’ Disease Brief Description: This is a 3 part series on Graves' Disease. This third session is focused on Challenging Cases in Graves’ Disease Learning Objectives Patient considering definitive treatment and how to decide which - [PES Thyroid SIG Webinar, Graves’ Disease Series, 2: Treatment, complications, prognosis, emerging therapies for Graves’ Disease.](https://pedsendo.org/event/pes-thyroid-sig-webinar-graves-disease-series-2-treatment-complications-prognosis-emerging-therapies-for-graves-disease/) - Thursday, December 10, 2026, 5-6pET - State of the Art: Thyroid SIG Session Title: Graves' Disease Series, 2: Treatment, complications, prognosis, emerging therapies for Graves’ Disease. Brief Description: This is a 3 part series on Graves' Disease. This second session is focused on treatment, complications, prognosis, and emerging therapies for Graves’ Disease. Learning Objectives Present current - [PES Thyroid SIG Webinar, Graves' Disease Series, 1: Diagnosis and differential diagnosis in Hyperthyroidism](https://pedsendo.org/event/pes-thyroid-sig-webinar-graves-disease-series-1-diagnosis-and-differential-diagnosis-in-hyperthyroidism/) - Thursday, October 22, 2026, 5-6pET - State of the Art: Thyroid SIG Session Title: Graves' Disease Series, 1: Diagnosis and differential diagnosis in Hyperthyroidism. Brief Description: This is a 3 part series on Graves' Disease. This first session is focused on Epidemiology, pathophysiology, and clinical presentation of Graves’ Disease. Diagnosis and differential diagnosis in Hyperthyroidism. Learning - [PES Thyroid SIG Webinar, Pediatric Thyroid US Series: 3. Case Based Learning](https://pedsendo.org/event/pes-thyroid-sig-webinar-pediatric-thyroid-us-series-3-case-based-learning/) - Thursday, August 27, 2026, 5-6pET - State of the Art: Thyroid SIG Session Title: Pediatric Thyroid US Series 3: Case Based Learning Brief Description: This is a 3 part series on the Pediatric Thyroid US. This third session is focused on Case Based Learning. Apply the 2026 updated ATA pediatric thyroid nodule and DTC guidelines into - [PES Bone&Mineral Webinar: New, Disruptive Precision Therapies for Achondroplasia: Changing the Rules of the Game](https://pedsendo.org/event/pes-bonemineral-webinar-new-disruptive-precision-therapies-for-achondroplasia-changing-the-rules-of-the-game/) - Monday, February 9, 2026, 4-5pET - State of the Art: Bone and Mineral SIG Session Title: New, Disruptive Precision Therapies for Achondroplasia: Changing the Rules of the Game Brief Description: This presentation will discuss newly approved and emerging pharmacotherapies for the treatment of achondropDISABLEDlasia. Special attention will be given to potential benefits of these treatments on - [Industry Sponsored Symposium: Advancement in the Delivery of Hydrocortisone](https://pedsendo.org/event/advancement-in-the-delivery-of-hydrocortisone/) - When: Tuesday, November 11 at 6:30 PM CT Description: A discussion that focuses on the necessity of accurate dosing in children with adrenal insufficiency. Learning objectives: Review pediatric adrenal insufficiency (AI), including its management, treatment approaches, and monitoring recommendations Gain an understanding on the history of treatment and explore the role of Alkindi Sprinkle® and - [PES Hypoglycemia SIG Webinar: Demystifying the Fasting Test](https://pedsendo.org/event/26449/) - Tuesday, January 27, 2026, 5-6pET - State of the Art: Hypoglycemia SIG Session Title: Demystifying the Fasting Test Brief Description: The diagnostic evaluation of an infant or child that presents with hypoglycemia is a critical step for establishing the specific diagnosis and treatment. This evaluation relies on obtaining a “critical sample” during a spontaneous episode - [PES Webinar: Pediatric Hypertriglyceridemia: Case-Based Algorithms](https://pedsendo.org/event/pes-webinar-pediatric-hypertriglyceridemia-case-based-algorithms/) - Thursday, January 8, 2026, 7-8pET - State of the Art: Lipid SIG Session Title: Pediatric Hypertriglyceridemia: Case-Based Algorithms Brief Description: Pediatric hypertriglyceridemia is a clinically significant and increasingly recognized condition with implications for both acute and long-term health. Pediatric endocrinologists play a key role in identifying, stratifying, and managing this lipid disorder, which may range - [PES SEED Webinar: Turner syndrome/Klinefelter syndrome](https://pedsendo.org/event/pes-seed-webinar-turner-syndrome-klinefelter-syndrome/) - Date: Tuesday, June 2, 2026, 12:00 PM EST Title: Turner syndrome/Klinefelter syndrome Brief Description: This interactive lecture explores two key sex chromosome aneuploidies — Turner syndrome (45,X) and Klinefelter syndrome (47,XXY). Students will learn about the genetic and chromosomal basis of each condition, their characteristic physical and reproductive features, underlying pathophysiology, diagnostic methods (including karyotyping - [PES SEED Webinar: Evaluation and Management of Common Endocrine Emergencies](https://pedsendo.org/event/26421/) - Date: Tuesday, March 3, 2026, 12:00 PM EST Title: Evaluation and Management of Common Endocrine Emergencies Brief Description: SEED talk re endocrine emergencies Learning objectives: 1. Review emergent medical conditions of endocrine origin 2. Discuss the evaluation for endocrine emergencies, including which clinical presentations raise concern for an endocrine emergency 3. Describe management of endocrine - [PES SEED Webinar: Calcium Pathophysiology/Management](https://pedsendo.org/event/pes-seed-webinar-calcium-pathophysiology-management/) - Date: Wednesday, February 11, 2026, 12:00 PM EST Title: Calcium Pathophysiology/Management Brief Description: SEED lecture for medical students re calcium, speaker Monica Grover from Stanford Learning objectives: 1. Describe common conditions that can impact calcium and phosphorus physiology 2. Review the impacts of parathyroid hormone and vitamin D on calcium physiology 3. Discuss management strategies - [PES SEED Webinar: Congenital Adrenal Hyperplasia](https://pedsendo.org/event/pes-seed-webinar-congenital-adrenal-hyperplasia/) - Date: Thursday, December 4, 2025, 12:00 PM EST Title: Congenital Adrenal Hyperplasia Brief Description: SEED lecture for medical students regarding CAH. Learning objectives: 1. Discuss the adrenal steroidogenesis pathway, and how enzymatic defects could lead to CAH 2. Review clinical manifestations of CAH 3. Discuss management of CAH, and how it may differ dependent on - [Clinical Endocrinology 2026 Course](https://pedsendo.org/event/an-invitation-from-the-harvard-medical-school-massachusetts-general-hospital-clinical-endocrinology-2026-course/) - The objective of this course is to provide an update for endocrinologists and to allow internists and other health care providers to be comfortable with clinical problems in endocrinology. A faculty of 49 speakers, primarily Harvard Medical School faculty and several select outside experts, chosen for their recognized educational and communication skills, present the most - [Industry Sponsored Symposium: Increlex (mecasermin) For the Treatment of Severe Primary IGF-1 Deficiency (SPIGFD)](https://pedsendo.org/event/industry-sponsored-symposium-increlex-mecasermin-for-the-treatment-of-severe-primary-igf-1-deficiency-spigfd/) - When: Wednesday, November 5, at 6:30 CT Description: An overview of severe primary IGF-1 deficiency and its treatment option. Learning Objectives: Review the role of growth hormone and IGF-1 in growth and understand the pathophysiology and differential diagnosis of primary and severe primary IGF-1 deficiency (SPIGFD). Explore the clinical profile of Increlex® for SPIGFD, including - [Industry Sponsored Symposium: Navigating CAH: An Interactive Case Study Approach for Pediatric Specialists](https://pedsendo.org/event/industry-sponsored-symposium-navigating-cah-an-interactive-case-study-approach-for-pediatric-specialists/) - September 10, 2025 | 12:00 – 1:00 PM ET Sponsored by: Medscape Education. Supported by an independent educational grant from Neurocrine Biosciences, Inc. PROGRAM DESCRIPTION Congenital adrenal hyperplasia (CAH) presents complex, lifelong challenges that impact patients' quality of life—from growth suppression in children to long-term metabolic and psychological effects. This symposium offers clinicians a unique opportunity to - [Primary Ovarian Insufficiency in Pediatric Cancer Survivors ](https://pedsendo.org/event/primary-ovarian-insufficiency-in-pediatric-cancer-survivors/) - Wednesday, October 29, 2025 5:00 PM EST Session Type SIG: State of the Art: TREND SIG Session Title Primary Ovarian Insufficiency in Pediatric Cancer Survivors Brief Description Ovarian dysfunction is a frequent late - effect in pediatric cancer survivors- however it is important to understand how ovarian secretory function and reproductive function are affected differetnly. - [Turner Syndrome Research Night Out](https://pedsendo.org/event/turner-syndrome-research-night-out/) - Join us for upcoming Turner Syndrome Research Night Out What’s happening? Hear from recent peds endo fellow grads about their experiences in Turner syndrome research. Meet seasoned TS research mentors who will share insider tips and highlight TS resources that are perfect for student, resident, or fellow projects. If you’re a med student, resident, or fellow curious about TS research - [Second Annual GPED Meeting](https://pedsendo.org/event/second-annual-gped-meeting/2025-12-06/) - Greetings from Global Pediatric Endocrinology and Diabetes! We are delighted to share an important update for the Second Annual GPED Meeting, taking place virtually on 29–30 November and 6–7 December 2025. The full scientific program and speaker lineup are now available! This year’s meeting brings together a distinguished group of experts, clinicians, and researchers from - [Second Annual GPED Meeting](https://pedsendo.org/event/second-annual-gped-meeting/2025-11-29/) - Greetings from Global Pediatric Endocrinology and Diabetes! We are delighted to share an important update for the Second Annual GPED Meeting, taking place virtually on 29–30 November and 6–7 December 2025. The full scientific program and speaker lineup are now available! This year’s meeting brings together a distinguished group of experts, clinicians, and researchers from - [Industry Sponsored Symposium: Managing Achondroplasia Together: Physician and Caregiver Perspectives](https://pedsendo.org/event/industry-sponsored-symposium-managing-achondroplasia-together-physician-and-caregiver-perspectives/) - Industry Sponsored Symposium: Managing Achondroplasia Together: Physician and Caregiver Perspectives Sponsored by BioMarin Pharmaceutical Inc. October 7th 7:00-8:00 pm ET Learn about the underlying cause of inhibited bone growth in achondroplasia and explore management options with a clinical expert. Hear from a caregiver as they share their experiences and perspectives navigating achondroplasia. Speaker - [PES Obesity SIG Meeting](https://pedsendo.org/event/pes-obesity-sig-meeting/) - For more information on the Obesity SIG, click here. To join a SIG, click here. - [Industry Sponsored Symposium: A New Treatment Era for Congenital Adrenal Hyperplasia: Androgen Management and Glucocorticoid Dose Reduction in Clinical Practice](https://pedsendo.org/event/industry-sponsored-symposium-a-new-treatment-era-for-congenital-adrenal-hyperplasia-androgen-management-and-glucocorticoid-dose-reduction-in-clinical-practice/) - Industry Sponsored Symposium: A New Treatment Era for Congenital Adrenal Hyperplasia: Androgen Management and Glucocorticoid Dose Reduction in Clinical Practice October 1, 2025 I 12:00 – 1:00 PM MT (2pET) Sponsored by: Neurocrine Biosciences PROGRAM DESCRIPTION This interactive, case-based presentation will provide an in-depth look at clinical data for a newly approved, non-glucocorticoid treatment for classic congenital adrenal - [Quarterly Education Committee Webinar: Dyslipidemia in Diabetes and Beyond](https://pedsendo.org/event/quarterly-education-committee-webinar-update-on-use-of-technology-for-management-of-diabetes/) - Date: Monday, October 20, 2025 / 4:00 pm – 5:00 pm EST Title: Dyslipidemia in Diabetes and Beyond Learning objectives: Analyze the pathophysiology between dyslipidemia and diabetes Assess current evidence-based guidelines and management strategies for managing dyslipidemia in pediatric diabetes and other high risk pediatric populations Develop tailored interventions for those who do not respond to - [PES Leader Orientation](https://pedsendo.org/event/pes-leader-orientation/) - For New and Returning SIG and Committee Leaders! Reach out to info@pedsendo.org for more information or the zoom link. The session will be recorded and made available to leaders following. - [Ethics and DSD Journal Club: What's in a name?](https://pedsendo.org/event/ethics-and-dsd-journal-club-whats-in-a-name/) - Brief Description You are invited to join an interactive discussion of a recent commentary published in Nature Reviews Urology titled "Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD" (https://doi.org/10.1038/s41585-025-01035-5). Part of the discussion will include an opportunity to hear from and dialogue with some of the authors. Learning Objectives Understand the - [STOA: Ethics SIG, Beyond the Protocol: Case-Based Exploration of Ethical Challenges in Pediatric Research](https://pedsendo.org/event/stoa-ethics-sig-beyond-the-protocol-case-based-exploration-of-ethical-challenges-in-pediatric-research/) - Brief Description Call for Research Ethics Cases! The PES Ethics SIG is seeking real-world cases to be discussed at our upcoming webinar on ethical challenges in pediatric research, especially if in relation to pediatric endocrinology. Minimal preparation is needed — share your case and join a thoughtful, case-based conversation. All PES members, especially fellows, - [Quarterly Education Webinar: Hereditary Endocrine Tumor Syndromes: Easy as ABC and 123!](https://pedsendo.org/event/quarterly-education-webinar-hereditary-endocrine-tumor-syndromes-easy-as-abc-and-123/) - Date: Monday, October 19, 2026 / 4:00 pm – 5:00 pm EST Title: Hereditary Endocrine Tumor Syndromes: Easy as ABC and 123! Description: Hereditary Endocrine Tumor Syndromes: Easy as ABC and 123! Learning objectives: Discuss the major hereditary endocrine tumor syndromes Identify clinical clues to an early diagnosis Describe management of the child with a hereditary endocrine tumor - [Quarterly Education Webinar: Thyroid cancer in children and adolescents](https://pedsendo.org/event/quarterly-education-webinar-thyroid-cancer-in-children-and-adolescents/) - Date: Monday, March 16, 2026 / 4:00 pm – 5:00 pm EST Title: Thyroid cancer in children and adolescents Description: This session will review thyroid cancer in children and adolescents. Learning objectives: Discuss the epidemiology and genetics of thyroid cancer in children Discuss diagnosis of thyroid cancer in children Explain current approaches to thyroid cancer treatment in children - [PES Public Policy Committee Meeting](https://pedsendo.org/event/pes-public-policy-committee-meeting/2025-09-05/) - For more information on the Public Policy Committee, click here. To join a committee, click here. - [PES Public Policy Committee Meeting](https://pedsendo.org/event/pes-public-policy-committee-meeting/2025-11-12/) - For more information on the Public Policy Committee, click here. To join a committee, click here. - [PES Turner Syndrome SIG](https://pedsendo.org/event/pes-turner-syndrome-sig/) - For more information on the TS SIG, click here. To join a SIG, click here. - [PES Podcast Club: The Immortal Life of Henrietta Lacks](https://pedsendo.org/event/pes-podcast-club/) - Podcast Club: The Immortal Life of Henrietta Lacks Tuesday, October 14, 2025, 8:00pm Eastern time We’re excited to announce that we will be discussing The Immortal Life of Henrietta Lacks and its related podcast. The Immortal Life of Henrietta Lacks Join us for robust discussion: https://zoom.us/meeting/register/fyPzlN_JSh-h1ydgUzTuaw The Immortal Life of Henrietta Lacks How one woman, - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-06-25/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-07-23/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-08-27/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-09-24/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-10-22/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-11-26/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2026-12-24/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2027-01-28/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2027-02-25/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2027-03-25/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2027-04-22/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Thyroid SIG](https://pedsendo.org/event/pes-thyroid-sig/2027-05-27/) - For more information: Thyroid Disease SIG - Pediatric Endocrine Society To join the SIG, please click here. - [PES Bone & Mineral SIG: Current and emerging treatments for hypoparathyroidism](https://pedsendo.org/event/pes-bone-mineral-sig-current-and-emerging-treatments-for-hypoparathyroidism/) - Thursday, July 17, 2025 Session Type SIG: State of the Art: Bone & Mineral SIG Session Title Current and emerging treatments for hypoparathyroidism Brief Description Hypoparathyroidism remains a challenging condition to manage in children. Unlike many endocrine hormone deficiencies, hormone replacement has never been approved for use in children with parathyroid hormone deficiency. The current - [State of the Art: Lipid SIG - Sitosterolemia](https://pedsendo.org/event/state-of-the-art-lipid-sig-rare-cholesterol-disorders/) - Thursday, April 3, 2025 - State of the Art: Lipid SIG Session Title: Sitosterolemia Brief Description: The SIG will identify a speaker with special expertise in pediatric lipid disorder. The speaker will discuss rare cholesterol disorders seen in pediatric patients and share diagnostic as well as management challenges associated with such disorders. Learning Objectives: 1. - [PES PedsENDO365: Career Pathways of Pediatric Endocrine Fellows](https://pedsendo.org/event/pes-pedsendo365-career-pathways-of-pediatric-endocrine-fellows/) - Monday, February, 10, 2025 03:00 pm – 5:00 pm EST Session Type: PedsENDO365 Session Title: Career Pathways of Pediatric Endocrine Fellows Brief Description: This activity addresses the following key concepts: 1. Common viable career paths after fellowship training. 2. Importance of identifying what paths match values, skills, and interests 3. Role of networking in identifying - [PES Ethics SIG: Ethics Case-Based Discussion](https://pedsendo.org/event/pes-ethics-sig-ethics-case-based-discussion/) - Wednesday, February 12, 2025 Session Type SIG: State of the Art: Ethics SIG Session Title Ethics Case-Based Discussion Brief Description Join the PES Ethics SIG for a discussion of clinical cases that raise ethical questions. PES members are invited to submit cases with ethical dilemmas to present for discussion for this webinar. Cases should be - [Industry Sponsored Symposium: From Referral to Resolution: Untangling the Diagnosis and Treatment of Lipodystrophy](https://pedsendo.org/event/industry-sponsored-symposium-from-referral-to-resolution-untangling-the-diagnosis-and-treatment-of-lipodystrophy/) - Industry Sponsored Symposium: From Referral to Resolution: Untangling the Diagnosis and Treatment of Lipodystrophy Wednesday, January 29th, 2025 | 6:00–6:20 pm ET Sponsored by Chiesi PROGRAM DESCRIPTION The educational webinar will be a brief case presentation by Dr. Nivedita Patni of a pediatric patient with Acquired Generalized Lipodystrophy. Dr. Patni will discuss the patient presentation, - [PES SEED Webinar: A Day in the Life of A Pediatric Endocrinologist](https://pedsendo.org/event/pes-seed-webinar-a-day-in-the-life-of-a-pediatric-endocrinologist/) - Thursday, January 16, 2025 12:00 pm – 1:00 pm EST Session Title: A Day in the Life of A Pediatric Endocrinologist Brief Description: A series of cases that a pediatric endocrinologist would see in a typical clinic day Learning objectives: Identify Common Pediatric Endocrine Disorders: Students will be able to recognize and describe the presentation, - [Quarterly Education Committee Webinar: Evaluation of new presentations of POI, including use of biomarkers, and genetic landscape](https://pedsendo.org/event/quarterly-education-committee-webinar-evaluation-of-new-presentations-of-poi-including-use-of-biomarkers-and-genetic-landscape/) - Date: Monday, January 27, 2025 / 4:00 pm – 5:00 pm EST Title: Evaluation of new presentations of POI, including use of biomarkers, and genetic landscape Description: An in-depth look at primary ovarian insufficiency Learning objectives: To categorize the genetics of age at menopause and primary ovarian insufficiency (POI) To list phenotypes associated with POI To understand the - [PES State of the Art Webinar: Fair Game? Sex and Gender Categorization in Elite Sports](https://pedsendo.org/event/pes-state-of-the-art-webinar-fair-game-sex-and-gender-categorization-in-elite-sports/) - PES State of the Art Webinar: DSD SIG, Ethics SIG & Society of Pediatric Psychology DSD SIG Session Title: Fair Game? Sex and Gender Categorization in Elite Sports Brief Description: The debate over the participation of athletes with sex and gender variations has become heated, often politicized, but rarely relying on science. This session will offer - [State of the Art Webinar hosted by the PCOS SIG](https://pedsendo.org/event/state-of-the-art-webinar-hosted-by-the-pcos-sig/) - Wednesday, December 18, 2024, 7:00 PM EST Session Title: Emerging therapies in Adolescent PCOS Brief Description Dr. Cree will discuss recent findings related to metabolic dysfunction in adolescent Polycystic Ovarian Syndrome and evidence regarding use of novel therapies, including GLP-1 agonists, for this condition. Learning Objectives Review current guidelines for diagnosis of PCOS in adolescents - [PES TREND SIG: Who? What? When?  Current approaches to nuclear imaging  and radiotherapeutics for Pediatric Neuroendocrine Tumors](https://pedsendo.org/event/pes-trend-sig-functional-imaging-of-pediatric-neuroendocrine-neoplasms-who-what-when/) - Tuesday, January 28, 2025 12:00 PM EST Session Title Who? What? When? Current approaches to nuclear imaging and radiotherapeutics for Pediatric Neuroendocrine Tumors Brief Description This session will focus on use of radioisotopes for imaging and treatment of neuroendocrine neoplasms. Learning Objectives To describe common diagnostic uses for radioisotopes in evaluation of suspected/confirmed pediatric neuroendocrine - [PES SEED Webinar, Differences of Sex Development: Overview for the future Pediatric Endocrinologist](https://pedsendo.org/event/differences-of-sex-development-overview-for-the-future-pediatric-endocrinologist/) - SEED is a novel interactive session series being hosted by the Pediatric Endocrine Society that aims to enhance clinical learning for medical students and increase their exposure to pediatric endocrinology. Title: Differences of Sex Development: Overview for the future Pediatric Endocrinologist Brief Description: This talk, geared for medical students, will explore the biological diversity within - [PES Turner Syndrome SIG: Navigating Fertility Dilemmas in Turner Syndrome](https://pedsendo.org/event/pes-turner-syndrome-sig-navigating-fertility-dilemmas-in-turner-syndrome/) - Wednesday, February 5, 2025 Session Title Navigating Fertility Dilemmas in Turner Syndrome Brief Description Dr. van der Velden will discuss the current landscape for fertility preservation in individuals with Turner Syndrome, current challenges and future directions. She will share expertise in this area gained from leading Turner Fertility trials and leadership during the creation of - [Quarterly Education Committee Webinar: Navigating the world of ever-changing treatments for youth-onset type 2 diabetes](https://pedsendo.org/event/quarterly-education-committee-webinar-navigating-the-world-of-ever-changing-treatments-for-youth-onset-type-2-diabetes/) - Date: Monday, March 17, 2025 / 4:00 pm – 5:00 pm EST Title: Navigating the world of ever-changing treatments for youth-onset type 2 diabetes Description: Presentation of different treatment options for youth with Type 2 diabetes Learning objectives: Describe unique aspects of the pathophysiology of type 2 diabetes and how they affect treatment. Understand the mechanism for the - [PES Obesity SIG Webinar: Body composition and energy expenditure changes with newer anti-obesity therapies](https://pedsendo.org/event/pes-obesity-sig-webinar-body-composition-and-energy-expenditure-changes-with-newer-anti-obesity-therapies/) - Tuesday, April 29, 2025 Session Type SIG: State of the Art: Obesity SIG Session Title Body composition and energy expenditure changes with newer anti-obesity therapies Brief Description To review the pathophysiology of obesity including body composition, energy expenditure, and discuss the newer anti-obesity therapies. Learning Objectives Understand obesity and obesity phenotypes Discuss current data on - [Quarterly Education Committee Webinar: Updates in the treatment of hypoparathyroidism](https://pedsendo.org/event/quarterly-education-committee-webinar-updates-in-the-treatment-of-hypoparathyroidism/) - Date: Monday, January 26, 2026 / 4:00 pm – 5:00 pm EST Title: Updates in the treatment of hypoparathyroidism Description: Discussion on Hypoparathyroidism diagnosis and treatment Learning objectives: Understand the role of parathyroid hormone and the calcium-sensing receptor in mineral metabolism and how derangements can lead to hypocalcemia Understand the use of conventional therapy for the treatment of - [Quarterly Education Committee Webinar: Updated Clinical Practice Guidelines for Turner Syndrome](https://pedsendo.org/event/quarterly-education-committee-webinar-updated-clinical-practice-guidelines-for-turner-syndrome/) - Date: Monday, July 21, 2025 / 4:00 pm – 5:00 pm EST Title: Updated Clinical Practice Guidelines for Turner Syndrome Description: A presentation on the new guidelines presented for Turner syndrome Learning objectives: Review the advances in the diagnostics and genetics of Turner syndrome Hormone replacement therapy in Turner syndrome: what is new? Role of the pediatric endocrine - [PES APP SIG meeting](https://pedsendo.org/event/pes-app-sig-meeting/2024-09-09/) - The PES APP SIG is focused on the unique education and practice needs of pediatric endocrine APPs, thereby aligning with the PES strategic plan goals of supporting the pediatric endocrine workforce, increasing interprofessional membership and involvement, providing high-quality clinical education, and advocating for the needs of patients, their families and our members. If you're - [PES APP SIG meeting](https://pedsendo.org/event/pes-app-sig-meeting/2025-01-13/) - The PES APP SIG is focused on the unique education and practice needs of pediatric endocrine APPs, thereby aligning with the PES strategic plan goals of supporting the pediatric endocrine workforce, increasing interprofessional membership and involvement, providing high-quality clinical education, and advocating for the needs of patients, their families and our members. If you're - [PES APP SIG meeting](https://pedsendo.org/event/pes-app-sig-meeting/2025-08-04/) - The PES APP SIG is focused on the unique education and practice needs of pediatric endocrine APPs, thereby aligning with the PES strategic plan goals of supporting the pediatric endocrine workforce, increasing interprofessional membership and involvement, providing high-quality clinical education, and advocating for the needs of patients, their families and our members. If you're - [PES SEED Webinar: Approach to Diagnosis and Treatment of Youth Onset Diabetes](https://pedsendo.org/event/pes-seed-webinar-approach-to-diagnosis-and-treatment-of-youth-onset-diabetes/) - Friday, March 28, 2025 3:00 pm – 4:00 pm EST Session Type: SEED Session Title: Approach to Diagnosis and Treatment of Youth Onset Diabetes Brief Description: This lecture will review the various types of diabetes in youth. The pathophysiology, diagnostic criteria and treatment of for T1D and T2D will be reviewed in detail. Complications rates - [PedsENDO365: Bridging the gap in health disparities in Pediatric Endocrinology](https://pedsendo.org/event/pedsendo365-bridging-the-gap-in-health-disparities-in-pediatric-endocrinology/) - Wednesday, November 20, 2024, 3:00 – 5:00 pm EST Session Type: PedsENDO365 Session Title: Bridging the gap in health disparities in Pediatric Endocrinology Brief Description: This session is aimed at helping pediatric endocrine trainees understand the health disparities that affect endocrine care, learn effective ways to communicate across cultural barriers, establish trust and develop an - [Industry Sponsored Symposium: Diagnostic Journey of a Patient with Suspected Skeletal Dysplasia](https://pedsendo.org/event/industry-sponsored-symposium-diagnostic-journey-of-a-patient-with-suspected-skeletal-dysplasia/) - Industry Sponsored Symposium: Diagnostic Journey of a Patient with Suspected Skeletal Dysplasia Wednesday, November 13th, 2024 | 6:00–7:00 pm ET Sponsored by BioMarin PROGRAM DESCRIPTION Learn about the multifaceted diagnostic journey of a patient with suspected skeletal dysplasia. 45-minute presentation | 15-minute audience Q&A We hope you will join us for a conversation featuring: - [AAP FLEXPEDS: Supporting the Careers of Women Pediatric Physician Scientists – What the NIH has to offer!](https://pedsendo.org/event/aap-flexpeds-supporting-the-careers-of-women-pediatric-physician-scientists-what-the-nih-has-to-offer/) - AAP FLEXPEDS (Female Leadership and Excellence in Pediatric Subspecialities) presents: Supporting the Careers of Women Pediatric Physician Scientists – What the NIH has to offer! November 6th at 4-5:30 pm ET – Women and allies are welcome to attend! Learning Objectives: By the end of the webinar, participants will be able to: 1. Understand how - [Industry Sponsored Symposium: A DEEPER LOOK INTO ACHONDROPLASIA](https://pedsendo.org/event/industry-sponsored-symposium-a-deeper-look-into-achondroplasia/) - Wednesday, October 30, 2024 6:00 - 7:00 PM Eastern Sponsored by: BioMarin PROGRAM DESCRIPTION Join us for an educational webinar covering essential facets of achondroplasia: its root cause, how the condition affects the body, and impacts families, and ways to recognize and manage its complications. This is a great opportunity to gain learnings that will empower - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-07-22/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-08-26/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-09-23/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-10-28/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-11-25/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-12-23/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-01-27/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-02-24/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-03-24/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-04-28/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-05-26/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-06-23/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-07-28/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-08-25/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-09-22/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-10-27/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-11-24/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-12-22/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2027-01-26/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2027-02-23/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2027-03-23/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2027-04-27/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [Diabetes SIG Meeting](https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2027-05-25/) - The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org. - [PES Website Committee](https://pedsendo.org/event/pes-website-committee/) - The Website Committee is charged to review website function and utilization, to coordinate with SIGs and other committees regarding sharing of content and updates to appear on the website, and to optimize use of multiple social media platforms for societal communication. If you're interested in joining the Website Committee, click here. If you need the - [Quarterly Education Committee Webinar: Monogenic Diabetes: Recent Consensus Guidelines for MODY and Neonatal Diabetes](https://pedsendo.org/event/quarterly-education-committee-webinar-monogenic-diabetes-recent-consensus-guidelines-for-mody-and-neonatal-diabetes/) - Monday, October 7, 2024 04:00 pm – 5:00 pm EST Session Type: Quarterly Education Committee Webinar Session Title: Monogenic Diabetes: Recent Consensus Guidelines for MODY and Neonatal Diabetes Brief Description: A review monogenic diabetes and update Learning objectives: To become familiar with the most common subtypes of monogenic diabetes: MODY and neonatal diabetes. 2. To - [PES Quarterly Education Committee: Monogenic Diabetes: Recent Consensus Guidelines for MODY and Neonatal Diabetes](https://pedsendo.org/event/pes-quarterly-education-committee-monogenic-diabetes-recent-consensus-guidelines-for-mody-and-neonatal-diabetes/) - Monday, October 7, 2024 04:00 pm – 5:00 pm EST Session Type: Quarterly Education Committee Webinar Session Title: Monogenic Diabetes: Recent Consensus Guidelines for MODY and Neonatal Diabetes Brief Description: A review monogenic diabetes and update Learning objectives: To become familiar with the most common subtypes of monogenic diabetes: MODY and neonatal diabetes. 2. To - [PES UPSTANDER case scenarios small group breakout session](https://pedsendo.org/event/pes-upstander-case-scenarios-small-group-breakout-session/) - Upstander training is built upon the framework of IQEE (Interrupt. Question. Educate. Echo), adopted with permission from the Learning for Justice project by the Southern Poverty Law Center. The skills acquired may be used from the witness or victim perspective; however, the main focus is on building strength for others to Speak Up so that - [PES UPSTANDER didactic presentation](https://pedsendo.org/event/pes-upstander-didactic-presentation/) - Upstander training is built upon the framework of IQEE (Interrupt. Question. Educate. Echo), adopted with permission from the Learning for Justice project by the Southern Poverty Law Center. The skills acquired may be used from the witness or victim perspective; however, the main focus is on building strength for others to Speak Up so that - [PES UPSTANDER Facilitator Training](https://pedsendo.org/event/pes-upstander-facilitator-training/) - Please note: This is a 3-part series. Facilitators should register for all three sessions. General attendees need to register for sessions 2 and 3 Upstander training is built upon the framework of IQEE (Interrupt. Question. Educate. Echo), adopted with permission from the Learning for Justice project by the Southern Poverty Law Center. The skills acquired may - [PES Quarterly Education Committee Webinar](https://pedsendo.org/event/pes-quarterly-education-committee-webinar/) - Session Title: Challenges in the diagnosis and treatment of short stature attributed to GH deficiency Brief Description: Discussion regarding the diagnosis and treatment of growth hormone deficiency. Learning objectives: Explain why Growth hormone stimulation testing is of diagnostic value in a subset of children Explain why GST+ clinical history reveals a diagnostic continuum Explain why - [PEARL Conference 2024](https://pedsendo.org/event/pearl-conference-2024/) - September 13–14, 2024 Harbour Centre, SFU Vancouver Campus 555 West Hastings Street Vancouver, BC V6B 4N6 The 2024 PEARL (Pediatric Endocrinology Association for Research and Leaning) Meeting will be hosted by the University of British Columbia's Division of Pediatric Endocrinology. This meeting will feature two half‐days (Friday afternoon, Saturday morning) of guest presenters and keynote speakers - [Industry Sponsored Symposium: Evolving Treatment Paradigms for Growth Hormone Deficiency: Integrating Novel Therapies](https://pedsendo.org/event/industry-sponsored-symposium-evolving-treatment-paradigms-for-growth-hormone-deficiency-integrating-novel-therapies/) - Industry Sponsored Symposium: Evolving Treatment Paradigms for Growth Hormone Deficiency: Integrating Novel Therapies Tuesday, July 30, 2024 7:00 PM - 8:00 PM Eastern Provided by Haymarket Medical Education Supported by an educational grant from Novo Nordisk Inc. PROGRAM DESCRIPTION Join Drs. Craig Alter, Sara A. DiVall, and Bradley Miller for an engaging discussion of optimal strategies - [State of the Art Webinar hosted by: Ethics SIG](https://pedsendo.org/event/state-of-the-art-webinar-hosted-by-ethics-sig/) - Session Title: Medically Possible, Not Medically Necessary: Case-Based Discussion of Ethical Questions in Pediatric Endocrinology Brief Description PES members are invited to submit de-identified pediatric endocrinology cases that raise ethical questions. Minimal preparation is required. If your case is selected, you would be invited to present the case and the PES Ethics SIG will facilitate - [PES Podcast Club, hosted by EDI Committee](https://pedsendo.org/event/pes-podcast-club-hosted-by-edi-committee/) - Podcast Club: July 23rd at 7:30 PM EST Featuring "Remembering and Unremembering, from Kigali to Nashville" from NPR’s Code Switch, also available on Apple Podcasts. Remembering and unremembering, from Kigali to Nashville : Code Switch : NPR Register Here - [Industry Sponsored Symposium: DETECT— Advances in the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician](https://pedsendo.org/event/industry-sponsored-symposium-detect-advances-in-the-delayed-onset-of-type-1-diabetes-strategies-to-improve-awareness-and-care-for-the-practicing-clinician/) - July 24th, 2024, from 3:00 PM ET – 4:15 PM ET Session Description: This virtual symposium will have 2 highly regarded faculty speakers. The program design allows for a high level of interactivity with case-based discussion and Q&A as well as breaks in the faculty presentations where the learners utilize Whiteboard and 2D Ultra 4K - [PES SEED Webinar: Pediatric Thyroid Disease](https://pedsendo.org/event/pes-seed-webinar-pediatric-thyroid-disease/) - Thursday, June 13, 2024 1:00 PM EST Brief Description This lecture will cover a range of topics, including the anatomy and function of the thyroid gland in children, common thyroid disorders seen in pediatric patients, diagnostic methods such as blood tests and imaging studies, and treatment options including medication, surgery, and radioactive iodine therapy. We - [Competency-Based Medical Education and Entrustable Professional Activities in Pediatric Endocrinology](https://pedsendo.org/event/abp-talk/) - Friday, April 5, 2024 01:00 pm – 2:00 pm EST Session Title: ABP Talk Brief Description: Competency-Based Medical Education and Entrustable Professional Activities in Pediatric Endocrinology Learning Objectives: 1. Define competency-based medical education (CBME) and Entrustable Professional Activities (EPAs) 2. Discuss the role of CBME and EPAs in improving education and assessment to advance child - [Genetics of Turner syndrome: Beyond the classic 45, X](https://pedsendo.org/event/genetics-of-turner-syndrome-beyond-the-classic-45-x/) - Wednesday, April 3, 2024, 5:00 PM EST Session Type SIG: State of the Art: Turner syndrome SIG Session Title Genetics of Turner syndrome: Beyond the classic 45, X Brief Description The webinar will provide a brief overview of the current genetic landscape of Turner syndrome with a focus on the clinical utility of different genetic - [Lipid SIG Webinar: Kids and Cholesterol: Challenges from Screening to Treatment](https://pedsendo.org/event/lipid-sig-webinar-kids-and-cholesterol-challenges-from-screening-to-treatment/) - Thursday, March 28, 2024, 7:00 PM EST Session Type SIG: State of the Art: Lipid SIG Session Title Kids and Cholesterol: Challenges from Screening to Treatment. Brief Description Our speaker will give a PES webinar regarding challenges in pediatric lipid management. Learning Objectives To identify the clinical challenges in lipid management in pediatrics To review - [PES Annual Meeting](https://pedsendo.org/event/pes-annual-meeting/) - The Pediatric Endocrine Society's Annual Meeting brings together our diverse international community of over 1,000 clinicians, researchers, and trainees to share the excitement of new ideas, establish new friendships, and learn the latest insights covering the wide scope of our diverse field. We invite you to be part of this in 2024! - [PES EDI Webinar: Disparities in Diabetes Technology: An Evidence-based Roadmap to Equity](https://pedsendo.org/event/pes-edi-webinar-disparities-in-diabetes-technology-an-evidence-based-roadmap-to-equity/) - Wednesday, March 27, 2024, 12:00 PM EST Session Type SIG: State of the Art: EDI Session Title Disparities in Diabetes Technology: An Evidence-based Roadmap to Equity Brief Description In this webinar, we will discuss multi-factorial drivers of disparities in pediatric type 1 diabetes with specific focus on the role of diabetes technology utilization. We will - [State of the Art - Transgender Health SIG and Ethics SIG](https://pedsendo.org/event/state-of-the-art-transgender-health-sig-and-ethics-sig/) - Title: Neurodiversity in Gender Dysphoria Description: Neurodiverse young people are more likely than neurotypical people to be gender diverse and gender diverse individuals are more likely to be neurodiverse than cisgender people. This presentation will review the current research in these intersecting areas and provide some tips for best clinical practices. Learning Objectives Learn about autism - [State of the Art; TREND SIG: Update on management of prolactinomas](https://pedsendo.org/event/state-of-the-art-trend-sig-update-on-management-of-prolactinomas/) - Session Type SIG: State of the Art: TREND SIG Session Title Update on management of prolactinomas Brief Description The Consensus statement on Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement was published in 2023 in Nature Reviews Endocrinology. We would like to review the new guidelines with a focus on - [PedsENDO365 Webinar: Pediatric Bone Disorders](https://pedsendo.org/event/pedsendo365-webinar-pediatric-bone-disorders/) - Session Title Pediatric Bone Disorders Brief Description The goal of this session is to increase fellow’s understanding of pathophysiology, diagnostic tools, and therapeutic options of various pediatric bone disorders, including primary bone disorders such as rickets and osteogenesis imperfecta and secondary causes of osteoporosis. Learning Objectives Understand pathophysiology and different subtypes of rickets Review the - [Quarterly Education Webinar: State of Immunotherapy in Type 1 Diabetes](https://pedsendo.org/event/quarterly-education-webinar-state-of-immunotherapy-in-type-1-diabetes/) - Session Title: State of Immunotherapy in Type 1 Diabetes Brief Description: This talk will discuss immunotherapy and its utility in Type 1 diabetes. Learning objectives: Identify mechanisms of immunotherapy action and their role in type 1 diabetes and pre-type 1 diabetes. List practical hurdles to T1D prevention and beta cell preservation. Discuss the role - [SEED Webinar, Pediatric Obesity: Current Management](https://pedsendo.org/event/seed-webinar-pediatric-obesity-current-management/) - Title Pediatric Obesity: Current Management Brief Description Obesity is a serious health issue affecting the pediatric population. It is a complex chronic disease that carries a significant risk of comorbidities. The prevalence of pediatric obesity has increased exponentially in recent years with prevalence increasing with age, particularly in children from lower socioeconomic status. Lifestyle and - [Postponed: EDI Podcast Club](https://pedsendo.org/event/23535/) - The EDI Task Force invites all to join our Podcast Club on Tuesday, February 13 at 8:00 PM Eastern on the CODE SWITCH podcast 'Remembering and unremembering, from Kigali to Nashville' by Leah Donnella, Veralyn Williams, Courtney Stein, Jess Kung, Gene Demby Listen to the podcast beforehand, then join us for a discussion! Listen on Apple Listen on Spottfy Listen on Google For centuries, the idea of - [Quarterly Education Webinar: Islet auto-transplantation in children](https://pedsendo.org/event/quarterly-education-webinar-islet-auto-transplantation-in-children/) - Monday, January 29, 2024 /4:00 pm – 5:00 pm EST Brief Description: This talk will discuss islet cell auto-transplantation in children. Learning objectives: Understand the rationale for total pancreatectomy with islet auto-transplantation Understand the procedure of a total pancreatectomy with islet auto-transplantation Be familiar with islet function outcomes after islet auto-transplantation Speaker: Melena Bellin, - [PedsENDO365 - Career Pathways for Pediatric Endocrine Fellows](https://pedsendo.org/event/pedsendo365-career-pathways-for-pediatric-endocrine-fellows-2/) - Brief Description This activity addresses the following key concepts: 1. Common viable career paths after fellowship training. 2. Importance of identifying what paths match values, skills, and interests 3. Role of networking in identifying mentors and job prospects. Learning Objectives Describe the career pathways available after endocrine fellowship Identify what career pathway/s match your skills, - [SEED: Hypoglycemia](https://pedsendo.org/event/seed-hypoglycemia/) - Brief Description This talk will present an overview of the differential diagnosis of hypoglycemia, digging deeper into hyperinsulinism, the most common cause of persistent HI in infants and children. Learning Objectives review the differential diagnosis of hypoglycemia review initial evaluation to determine cause of hypoglycemia review the diagnosis and management of hyperinsulinism Speaker Dr. Winnie - [SIG State of the Art Webinar: Bone SIG](https://pedsendo.org/event/sig-state-of-the-art-webinar-bone-sig/) - December 15: State of the Art - Bone Title: Bone Stress Injuries and Stress Fractures in Adolescents and Young Adults: Natural History, Evaluation and Management Strategies Description: Review of risk factors and metabolic workup to consider in adolescents and young adults with bone stress injuries, as well as management strategies. Learning Objectives To have a better - [SIG State of the Art Webinar: Diabetes](https://pedsendo.org/event/sig-state-of-the-art-webinar-diabetes/) - November 13: State of the Art - Diabetes Title: Tips for Setting up a Multidisciplinary Clinic for Youth-onset Type 2 Diabetes Speakers: Megan Kelsey, MD, Children's Hospital Colorado, University of Colorado School of Medicine, Department of Pediatrics, Helen Seagle, RD, Children's Hospital Colorado, Lauren Gulley, PhD, Children's Hospital Colorado, University of Colorado School of Medicine, Department of Pediatrics, Claudia Retamal-Munoz, RN, - [New Advances in the Diagnosis and Management of Congenital Hyperinsulinism](https://pedsendo.org/event/new-advances-in-the-diagnosis-and-management-of-congenital-hyperinsulinism/) - Description: A comprehensive review of diagnosis and management of congenital hyperinsulinism with emphasis on newly published international guidelines Learning objectives: Describe the clinical manifestations, genetics, and natural history of congenital hyperinsulinism Review recent advances in the medical and surgical management of hyperinsulinism Review long-term outcomes and follow up of children with hyperinsulinism Speaker: Diva D. - [SEED Program: Rickets? Acquired vs inherited?](https://pedsendo.org/event/seed-program-rickets-acquired-vs-inherited/) - Speaker: Nadia Merchant, MD, Assistant Professor of Pediatrics Pediatric Endocrinologist and Geneticist Description: Rickets can vary from being asymptomatic to irritability, growth retardation, and sudden death. Nutritional-acquired rickets is the most common cause of rickets worldwide that we still see in the US. Let’s learn about preventing nutritional rickets! This presentation will review causes of - [PedsENDO365: SMART goals for a Happy Professional Journey](https://pedsendo.org/event/pedsendo365-smart-goals-for-a-happy-professional-journey/) - SMART goals for a Happy Professional Journey Description: SMART goals for a Happy Professional Journey is a career development session that provides Pediatric Endocrine Fellows with tools and skills for SMART goal setting. This can be used by fellows to develop individualized learning plans with mentoring from their program faculty or program director. Objectives: By end - [State of the Art - Differences of Sex Development ](https://pedsendo.org/event/state-of-the-art-differences-of-sex-development/) - October 19: State of the Art - Differences of Sex Development Title: Partial Androgen Insensitivity Syndrome (PAIS) – Commonly Suspected and Rarely Encountered Speaker: Professor S. Faisal Ahmed, MBChB, MD, MA, FRCPCH, Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Sick Children Description: PAIS is a very rare condition, and each pediatric endocrinologist will probably not see more - [SIG State of the Art Webinar: Obesity](https://pedsendo.org/event/sig-state-of-the-art-webinar-obesity/) - September 13: State of the Art - Obesity Title: Treating (Understanding) Complicated Obesity Speaker: Gitanjali Srivastava, MD, FACP, FAAP, ABOM, Vanderbilt University School of Medicine Description: Join us to review novel therapeutics and treatment options for pediatric obesity and associated complications. - [Industry Sponsored Symposia – Early Identification and Effective Management of Hypercholesterolemia in Children](https://pedsendo.org/event/industry-sponsored-symposia-early-identification-and-effective-management-of-hypercholesterolemia-in-children/) - Title: Early Identification and Effective Management of Hypercholesterolemia in Children Date: Thursday, September 28 from 7:00 – 8:00 pm Eastern Session Description: This interactive virtual symposium, sponsored by Regeneron Medical Affairs, with Don P. Wilson, MD, a renowned pediatric lipidologist, will focus on diagnosing lipid disorders (including familial hypercholesterolemia) and managing treatment goals in children. Speaker: Don P. - [Industry Sponsored Symposia - Achondroplasia a Multidisciplinary Conversation on Comprehensive Care](https://pedsendo.org/event/industry-sponsored-symposia-achondroplasia-a-multidisciplinary-conversation-on-comprehensive-care/) - Title: Achondroplasia a Multidisciplinary Conversation on Comprehensive Care Date: Thursday, September 14 from 6:00 – 7:00pm EST Summary of Session: Achondroplasia (Ach), the most common skeletal dysplasia with disproportionate short stature, is characterized by a number of medical, functional, and psychosocial challenges across the lifespan of an individual. Up until recently, the treatment of the developmental complications - [Technology for Type 1 Diabetes in 2023 - New Options and Emerging Devices](https://pedsendo.org/event/quarterly-webinar/) - Speaker: Gregory P. Forlenza, MD Associate Professor Barbara Davis Center University of Colorado Anschutz Medical Campus Description: With multiple new FDA approved T1D technology options in 2023, the therapeutic landscape has become more diverse for patients and providers. We will discuss peer reviewed literature on current commercial options, educate on device tuning, and outline the - [PedsENDO365](https://pedsendo.org/event/pedsendo365-2/) - Quality Improvement for Endocrinology Fellows June 2, 2023 / 3:00-5:00 PM ET Objectives: Apply Plan-Do-Study Act Quality Improvement (QI) methodology using a real-world example. Understand utility of QI tools including: process map, pareto chart, fishbone diagram, control/run chart Describe how to find access to additional training / toolkits and review how QI projects can fulfill - [SEED Program: Transgender Care](https://pedsendo.org/event/seed-program-transgender/) - Description: An overview of the role pediatric endocrinologist in the care of transgender youth with a focus on gender affirming endocrine care (puberty suppression and hormone therapy). Learning Objectives: Understand the concept of gender dysphoria and it's relation to mental health in transgender youth Know what are the Standards of Care Recommendations on Gender Affirming - [Transgender SIG: State of the Art Webinar](https://pedsendo.org/event/transgender-sig-state-of-the-art-webinar/) - Description: This webinar will provide an update on the state-of-art of options for fertility preservation in transgender and gender diverse youth assigned male at birth. Learning Objectives: Describe how often transgender female adolescents seek to freeze sperm Discuss different fertility preservation methods for sperm collection in transgender adolescents and the relative pros and cons for - [Lipid SIG: State of the Art Webinar](https://pedsendo.org/event/lipid-sig-state-of-the-art-webinar/) - Description: Within the past several years, there have been major therapeutic advances and new clinical trial data on the treatment of hypertriglyceridemia and its relationship to cardiovascular disease (CVD). New medications that either function within the liver to prevent protein production using anti-sense technologies and monoclonal antibodies that target proteins that block triglyceride clearance are - [Turner Syndrome SIG: State of the Art Webinar](https://pedsendo.org/event/turner-syndrome-sig-sota-webinar/) - Title: Patient Education in Turner Syndrome: Challenges and Opportunities Speakers: Kristina Suorsa-Johnson, PhD, Ashley W. Wong, CGC Brief summary: This webinar will discuss disclosure of Turner Syndrome to parents and their children with a focus on how to approach challenging situations. These may include delayed sharing of the diagnosis from parents to their offspring or concerns about - [PedsENDO365: Primary Adrenal Disorders](https://pedsendo.org/event/pedsendo365/) - Primary Adrenal disorders: A case based discussion Description: The PES invites all pediatric endocrine fellows for a clinical case-based discussion on 'primary adrenal disorders' as part of PedsEndo365 initiative for Pediatric Endocrine Fellows on March 17th 2023, 3-5pm ET via Zoom. The session is being hosted by the PES fellow education subcommittee in collaboration with - [Adrenal SIG: State of the Art Webinar](https://pedsendo.org/event/adrenal-sig-state-of-the-art-webinar/) - CAH Management and Emerging Therapies Speaker: Maria G. Vogiatzi, MD Description: Describe current CAH management with glucocorticoid +/ mineralocorticoid replacement and how they may affect outcomes, such as obesity, cardiometabolic risk factors and quality of life. Describe new and emerging therapies, such as modifying release hydrocortisone, hydrocortisone microsprinkles, trials with CRH antagonists, continuous sc hydrocortisone - [SEED Program: Congenital Hypothyroidism](https://pedsendo.org/event/seed-program-congenital-hypothyroidism/) - Student Endocrinology Exposure Development (SEED) Program SEED is a novel interactive session series being hosted by the Pediatric Endocrine Society that aims to enhance clinical learning for medical students and increase their exposure to pediatric endocrinology. ---------------------------- Speaker: Doris Fadoju, MD, Assistant Professor, Pediatric Endocrinology, Emory University School of Medicine, Children’s Healthcare of Atlanta Brief Description: Discuss thyroid hormone - [PedsENDO365: Career Pathways for Pediatric Endocrine Fellows](https://pedsendo.org/event/pedsendo365-career-pathways-for-pediatric-endocrine-fellows/) - Career Pathways for Pediatric Endocrine Fellows By end of this activity, participants will be able to: Describe the career pathways available after endocrine fellowship Identify what career pathway/s match your skills, values and interests. Evaluate two possible career paths and next steps needed via networking with professionals at various stages of career in that track (clinician-scientist (basic/clinical), clinician-educator, - [EDI: Movie Club](https://pedsendo.org/event/edi-movie-club/) - Movie choice - Crip Camp, available on Netflix Please save the date (1/10/23, 8 pm) and invite your friends to this movie club discussion! *Please note, this is not a movie night, so please watch the movie in advance, but please feel free to bring popcorn or wine to the discussion! - [PedsENDO365 Fellow Initiative Webinar](https://pedsendo.org/event/pedsendo365-fellow-initiative-webinar/) - SMART Goals for a Happy Professional Journey - Career Development Part 1 - [SEED Webinar: Approach to Short Stature](https://pedsendo.org/event/seed-webinar-approach-to-short-stature/) - [Quarterly Education Webinar: Hypophosphatemic Rickets and FGF-23](https://pedsendo.org/event/quarterly-education-webinar-hypophosphatemic-rickets-and-fgf-23/) - Hypophosphatemic Rickets and FGF-23 presented by Dr. Erik Imel - [Obesity SIG State of the Art: Pharmacotherapy in Pediatric Obesity](https://pedsendo.org/event/obesity-sig-state-of-the-art-pharmacotherapy-in-pediatric-obesity/) - Pharmacotherapy in Pediatric Obesity presented by Sonali Malhotra, MD - [Student Endocrinology Exposure Development (SEED) Webinar](https://pedsendo.org/event/student-endocrinology-exposure-development-seed-webinar-2/) - A Case of Pediatric Gigantism Presented by Cathrine Constantacos, MD, FAAP, Assistant Professor, Pediatric Endocrinology, Wake Forest University, School of Medicine, Medical Director, Brenner Children’s Pediatric Multispecialty Clinics, Chair, Pediatric Endocrine Society Website and Social Media Committee SEED is a novel interactive session series that aims to enhance clinical learning for medical students and increase their - [DSD SIG: State of the Art Webinar](https://pedsendo.org/event/dsd-sig-state-of-the-art-webinar/) - Steroidogenic Factor 1 (NR5A1/SF1) and its Broad Phenotype of DSDs presented by Dr. Christa Flueck, Head of Endocrinology, Diabetes and Metabolism Unit of the University Hospital of Bern Pediatrics Division and Principal Investigator at the Department for BioMedical Research (DBMR) - [New Steroids, New Treatments, and New Approaches to Congenital Adrenal Hyperplasia Webinar](https://pedsendo.org/event/new-steroids-new-treatments-and-new-approaches-to-congenital-adrenal-hyperplasia-webinar/) - Quarterly Webinar presented by Dr. Richard Auchus View Recording - [2023 Annual Meeting](https://pedsendo.org/event/2023-annual-meeting/) - [11th International Meeting of Pediatric Endocrinology](https://pedsendo.org/event/11th-international-meeting-of-pediatric-endocrinology/) - [Student Endocrinology Exposure Development (SEED) Webinar: Turner Syndrome](https://pedsendo.org/event/student-endocrinology-exposure-development-seed-webinar-turner-syndrome/) - Turner Syndrome SEED presented by Carolina Di Blasi, MD, Associate Professor, Seattle Children’s Hospital Giovanna Beauchamp, MD, Assistant Professor, Children's of Alabama During this SEED session, we will review normal and abnormal growth and the differential of short stature as an intro to understand and learn about Turner Syndrome. Learning Objectives: Understand normal phases of - [EDI Book Club: The Spirit Catches You and You Fall Down](https://pedsendo.org/event/edi-book-club-the-spirit-catches-you-and-you-fall-down/) - The Spirit Catches You and You Fall Down explores the clash between a small county hospital in California and a refugee family from Laos over the care of Lia Lee, a Hmong child diagnosed with severe epilepsy. Lia's parents and her doctors both wanted what was best for Lia, but the lack of understanding between - [2022 Virtual Annual Meeting](https://pedsendo.org/event/2022-virtual-annual-meeting/) - We hope you will join us at the upcoming virtual Annual Meeting. Our goal for the 2022 Annual Meeting is to provide a unique opportunity to engage with colleagues and make new connections from around the world! - [State of the Art: Transgender Health](https://pedsendo.org/event/state-of-the-art-transgender-health/) - Models of Care for Transgender Youth: Has the Pendulum Swung Too Far Towards Access at the Expense of Quality? Presented by Robert Garofalo, MD, MPH, Co-director of the Lurie Children’s Gender Development Team, Division Chief, Adolescent Medicine, Lurie Children’s Hospital Dr. Garofalo is the co-director of the Lurie Children’s Gender Development Team and professor of - [Pediatric Endocrinology Flipped Classroom: “EndoFlip”](https://pedsendo.org/event/pediatric-endocrinology-flipped-classroom-endoflip/) - Pediatric Endocrinology Flipped Classroom: “EndoFlip” consisting of asynchronous audio-visual learning materials that are accessible “on-demand” to support knowledge acquisition as well as case guides to support an interactive classroom experience focused on knowledge application. The first Program - Lipid Metabolism – is now available on MedEd On The Go and will serve as this session of - [PES EDI Book Club](https://pedsendo.org/event/pes-edi-book-club/) - Interior Chinatown is a 2020 novel by Charles Yu. It is his second novel and was published by Pantheon Books on January 28, 2020. It won the 2020 National Book Award for Fiction. - [SIG State of the Art: Prenatal Diagnosis for Turner Syndrome: An Update](https://pedsendo.org/event/sig-state-of-the-art-prenatal-diagnosis-for-turner-syndrome-an-update/) - Prenatal Diagnosis for Turner Syndrome: An Update Turner syndrome is increasingly diagnosed during pregnancy as a result of the ability of cell- free DNA testing of maternal plasm to detect mosaic sex chromosome abnormalities. An understanding of the advantages and potential pitfalls of this available technology allows the pediatric endocrinologist to play a key role - [Student Endocrinology Exposure Development (SEED) Webinar: 14-Year-Old Boy Presenting with Pubertal Delay](https://pedsendo.org/event/student-endocrinology-exposure-development-seed-webinar/) - During this presentation, Dr. Shanker will go over the questions to be asked during history taking process, including presenting complaint, past medical history, relevant physical examination, that will help to go over the various differential diagnosis. The later part of the presentation will discuss about the further evaluation and management of the Klinefelter syndrome. - [Satellite Symposium: The Latest Advancements in Achondroplasia](https://pedsendo.org/event/satellite-symposium-the-latest-advancements-in-achondroplasia/) - This virtual symposium, sponsored by BioMarin Pharmaceutical Inc., will address the latest advancements in achondroplasia, the most common form of disproportionate short stature, or dwarfism. In a panel discussion, experts will review the underlying cause of achondroplasia, share key information and news that you and your practice should know, and discuss pediatric endocrinology's evolving role in the care of children with this condition. - [State of the Art: Bone and Mineral SIG](https://pedsendo.org/event/state-of-the-art-bone-and-mineral-sig/) - Title: New Insights into Skeletal Fragility in Type 1 Diabetes Description: Type 1 diabetes is one of the most common chronic diseases of childhood. Previous research has demonstrated that children with type 1 diabetes suffer from low bone mineral density. This talk will shed light on new knowledge in regards to the bone health of - [Cost-effective Care in Pediatric Endocrinology: When testing Usually Can be Avoided](https://pedsendo.org/event/cost-effective-care-in-pediatric-endocrinology-when-testing-usually-can-be-avoided/) - Cost-effective Care in Pediatric Endocrinology: When testing Usually Can be Avoided presented by Paul Kaplowitz, MD, Professor Emeritus of Pediatrics at Children's National Hospital Monday, January 24, 2022 from 4:00 - 5:00 PM ET - [NIH Lecture Series – Role of the Program Director & NIH and Peer Review of Grant Applications](https://pedsendo.org/event/nih-lecture-series-role-of-the-program-director-nih-and-peer-review-of-grant-applications/) - Session 2: March 22, 2022 from 7:00 PM-8:00 PM ET “The Role of the Program Director” presented by Barbara Linder, MD, PhD, Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK “The NIH and Peer Review of Grant Applications” presented by John Connaughton, PhD, Branch Chief, Grants Review, NIDDK - [NIH Lecture Series - NIH 101 & Training and Career Development Overview](https://pedsendo.org/event/nih-lecture-series-nih-101-training-and-career-development-overview/) - Session 1: January 25, 2022 from 7:00 PM-8:00 PM ET “NIH 101” presented by Saul Malozowski, MD, PhD, MBA, Senior Advisor for Endocrine Physiology in Division Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK “Training and Career Development Overview” presented by Lisa Spain, PhD, Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK - [State of the Art: Diabetes SIG](https://pedsendo.org/event/state-of-the-art-diabetes-sig/) - Join us for 'Striving for the Optimal Pediatric Diabetes Care in the US: Is it Sustainable' webinar! - [State of the Art: PCOS SIG](https://pedsendo.org/event/state-of-the-art-pcos-sig/) - Join us for this webinar presented by the Polycystic ovary syndrome (PCOS) SIG! - [PedsENDO365](https://pedsendo.org/event/20142/) - Pediatric Endocrine Fellows, join us for a two-part career development series! PART 1: SMART Learning Goals for a Happy Professional Journey - [Student Endocrinology Exposure Development (SEED) Program](https://pedsendo.org/event/20146/) - SEED is a novel interactive session series that aims to enhance clinical learning for medical students and increase their exposure to pediatric endocrinology. Join us for Why Does My 4 Year Old Have Pubic Hair session - [SIG Webinar: DSD](https://pedsendo.org/event/sig-webinar-dsd/) - DSD: A Historical and Personal Odyssey Presented by: Professor Ieuan Hughes, FMedSci FRCP FRCPCH FLSWFMedSci FRCPC Emeritus Professor of Paediatrics University of Cambridge, Cambridge, United Kingdom - [The 14th International Conference on Advanced Technologies & Treatments for Diabetes](https://pedsendo.org/event/the-14th-international-conference-on-advanced-technologies-treatments-for-diabetes/) - June 2-5, 2021 The 14th International Conference on Advanced Technologies & Treatments for Diabetes Virtual Conference attd.kenes.com ATTD 2021 brings together diabetes healthcare professionals, researchers, scientists, industry, and corporate professionals from around the world. Join the community and hear about the latest advancements in science and technology, meet the leaders and establish useful connections. Register - [PES Leadership Advantage](https://pedsendo.org/event/pes-leadership-advantage/2020-10-16/) - FALL MODULE OFFERING Since our virtual, live delivery of the INFLUENCE module in May was a great success, we are moving forward with a virtual live delivery of the ENGAGE module this fall (previously called Module 2). We are making the modules virtually accessible while maintaining the enjoyment of large group interaction and smaller chat sessions in virtual breakout - [SIG Webinar: Diabetes](https://pedsendo.org/event/pes-state-of-the-art-webinar-diabetes-sig/) - November is Diabetes Awareness Month. In recognition, our SIG state of the Series will be hosted by the PES Diabetes SIG: - [International Meeting of Pediatric Endocrinology 2021](https://pedsendo.org/event/international-meeting-of-paediatric-endocrinology-2021/) - [NEUROENDOCRINOLOGY VIRTUAL CONFERENCE](https://pedsendo.org/event/neuroendocrinology-conference/) - This is a Clinical Symposium on Disorders of the Neuroendocrine System. The Virtual Conference will take place on 11/13/2020, Friday. Brochure - [The Overcoming Obesity 2020 Virtual Conference](https://pedsendo.org/event/the-overcoming-obesity-2020-virtual-conference/) - Save the date! The Overcoming Obesity 2020 Virtual conference will be held between October 7-11 | 30 CME/CE | Learn More. Registration options include a one-day pass for the Pediatric Endocrine Track on Friday (October 9th), which is co-sponsored by the Pediatric Endocrine Society. - [SIG Webinar: Lipid](https://pedsendo.org/event/sig-webinar-lipid/) - Details TBD - [SIG Webinar: Transgender Health](https://pedsendo.org/event/sig-webinar-transgender-health/) - Details TBD International Transgender Day of Visibility is an annual event occurring on March 31 dedicated to celebrating transgender people and raising awareness of discrimination faced by transgender people worldwide, as well as a celebration of their contributions to society. - [SIG Webinar: Turner Syndrome](https://pedsendo.org/event/sig-webinar-turner-syndrome/) - Details TBD Turner Syndrome Awareness Month - [SIG Webinar: Bone and Mineral](https://pedsendo.org/event/sig-webinar-bone-and-mineral/) - Details TBD - [SIG Webinar: PCOS](https://pedsendo.org/event/sig-webinar-pcos/) - Details TBD - [SIG Webinar: Ethics](https://pedsendo.org/event/sig-webinar-ethics/) - Details TBD Global Ethics Day will take place on 21 October 2020. - [SIG Webinar: Obesity](https://pedsendo.org/event/sig-webinar-obesity/) - Details TBD September is National Childhood Obesity Month - [PES Division Chiefs Meeting](https://pedsendo.org/event/pes-division-chiefs-meeting/) - The purpose of the meeting will be improved advocacy for pediatric endocrinology, as well as networking opportunities. Newer Division Chiefs will be able to meet more seasoned leaders, and to discuss topics such as "How to lobby your administration for increased support?", "How should budgets be structured for a Pediatric Endocrine Division?", or "What are the benchmarks for RVUs and numbers of clinics per week at different institutions?" ## People - [Laurie Cohen, MD](https://pedsendo.org/person/laurie-cohen-md/) - [Tandy Aye, MD](https://pedsendo.org/person/tandy-aye-md/) - [Takara Stanley, MD](https://pedsendo.org/person/takara-stanley-md/) - [Philip Zeitler, MD, PhD](https://pedsendo.org/person/philip-zeitler/) - [Paul Thornton, MB, BCh, MRCPI](https://pedsendo.org/person/paul-thornton-mb-bch-mrcpi/) - [Andrew Dauber, MD, MMSC](https://pedsendo.org/person/andrew-dauber-md-mmsc/) - [Radhika Muzumdar, MD](https://pedsendo.org/person/radhika-muzumdar-md/) - [Lisa Swartz Topor, MD, MMSc](https://pedsendo.org/person/lisa-swartz-topor/) - [Erica Eugster, MD](https://pedsendo.org/person/erica-eugster/) - [Mark Palmert, MD, PhD](https://pedsendo.org/person/mark-palmert-md/) - [Jessica Widing](https://pedsendo.org/person/jessica-widing/) - [Sonja Hix](https://pedsendo.org/person/sonja-hix/) - [Ryan Gorham](https://pedsendo.org/person/ryan-gorham/) - [Maureen Thompson](https://pedsendo.org/person/maureen-thompson/) - [Amanda Joslin](https://pedsendo.org/person/amanda-joslin/) - [Bailey Czajkowski](https://pedsendo.org/person/bailey-czajkowski/) ## Awards - [Outstanding PES Mentor Award](https://pedsendo.org/award/outstanding-pes-mentor-award/) - This annual award acknowledges extraordinary skill, dedication, and years of service as a Mentor to PES junior faculty and trainees. This award honors Mentors who have excelled at fostering the early careers of our junior faculty and trainees. Nominees must be PES members in good standing and working in North America. Please collect the following materials - [New Investigator Award](https://pedsendo.org/award/young-investigator-award/) - This award is granted to a physician-scientist within the first ten years of completing their clinical pediatric endocrinology fellowship, and whose innovative and cutting-edge clinical, basic or translational research is aimed to significantly advance the field of pediatric endocrinology. Such individuals will either be a 4th - 5th Year Fellow, or have the rank of - [Mid-Career Investigator Award](https://pedsendo.org/award/midcareer-investigator-award/) - This award is granted to a min-level career investigator (10-25 years post fellowship) whose innovative and cutting-edge clinical, basic or translational research has significantly advanced the field of pediatric endocrinology and earned the nominee international recognition in the field. Nominees should be PES members in good standing and working in North America. Evidence of eligibility - [Judson J. Van Wyk Prize](https://pedsendo.org/award/judson-j-van-wyk-prize/) - The Judson J. Van Wyk Prize is the Society’s most prestigious award in recognition of outstanding career achievement by a member in the field of pediatric endocrinology. This award, established in honor of Judson J. Van Wyk, MD, stands in tribute to an outstanding leader whose career is marked by scientific excellence, leadership, and dedication - [ Clinician Award](https://pedsendo.org/award/clinician-award/) - This award is granted to a PES member in good standing and working in North America, at least 10 years in practice, who is widely acknowledged by her or his peers as possessing exemplary clinical acumen, knowledge and expertise. Suggested metrics include (but are not limited to) co-authorship of published Practice Guidelines and clinical Position - [Educator Award](https://pedsendo.org/award/educator-award/) - This award is granted to a PES member in good standing and working in North America, at least 10 years in practice, who is renowned among colleagues and trainees alike for being an extraordinarily gifted and dedicated teacher and mentor. Evidence of eligibility may include, but is not limited to; institutional teaching awards, quantity and - [Robert M. Blizzard, MD Lectureship](https://pedsendo.org/award/robert-m-blizzard-md-lectureship/) - The Robert M. Blizzard, MD, lectureship was established to honor the contributions and career of Dr. Blizzard to the Pediatric Endocrine Society (PES), the pediatric endocrine community at large, and especially to the children of the world with disorders of the endocrine system. The Lecturer, who need not be a member of the PES and/or - [Paul Kaplowitz, MD, Endowed Lectureship](https://pedsendo.org/award/paul-kaplowitz-md-endowed-lectureship/) - Dr. Paul Kaplowitz, in collaboration with the American Academy of Pediatrics and the Pediatric Endocrine Society, has established the Paul Kaplowitz, MD, Endowed Lectureship for contributions to cost-effective care and quality improvement in pediatric endocrinology. Dr. Kaplowitz has long been interested in finding ways to reduce unnecessary testing and treatment, particularly in the areas of - [PES Rising Star Grant](https://pedsendo.org/award/rising-star-grant/) - Research Grant Program for Fellows: The purpose of this small grant is to support and encourage research efforts of fellows. The maximum amount of funding available for each of these grants is $2500 for one year. The PES plans to fund approximately 5 grants per year. One of these grants, the named RSG; The Raphael - [The Raphael David, MD Rising Star Grant](https://pedsendo.org/award/the-raphael-david-md-rising-star-grant/) - Research Grant Program for Fellows The purpose of this small grant is to support and encourage research efforts of fellows. The maximum amount of funding available for each of these grants is $2500 for one year. The Raphael David, MD Rising Star Grant, will be given preferentially to an application related to the developmental biology - [PES Junior Faculty Research Grants](https://pedsendo.org/award/clinical-scholar-awards/) - Purpose: To promote early career research development of academic pediatric endocrinologists. Description and Qualifications of the Candidate: Fellows in their third year of endocrine training or early-stage faculty members who are PES members in good standing are eligible to apply for the Junior Faculty Grant, formerly the Clinical Scholar Award (CSA). Applicants must provide institutional - [The Del and Beverly Fisher Pediatric Endocrinology History Lectureship](https://pedsendo.org/award/the-del-and-beverly-fisher-pediatric-endocrinology-history-lectureship/) - This Lectureship was established through a generous donation by the Fishers in 2014 to generate ongoing interest in the history of Pediatric Endocrinology. The proposed lecture should cover some aspect of relevant history, e.g., pioneers, specific diseases, therapies, practice, basic science, understanding of disease mechanisms, diagnostic methods, etc. There are no membership restrictions for lecturers. - [PES Human Growth Foundation Research Fellowship Grant](https://pedsendo.org/award/human-growth-foundation-award/) - Purpose: To support the final year of research training in a pediatric endocrinology fellowship for highly qualified individuals preparing for a career in academic pediatric endocrinology. Both clinical and basic research projects are eligible for support. Description and Qualifications of the Candidate: Applicants must provide institutional documentation of fellowship status at the time of the - [Addressing Health Disparities Research Grant](https://pedsendo.org/award/edi-specific-research-award/) - Purpose: To support the development of research and education related to disparities in care/outcomes and the cause of those disparities with the goal of enhancing understanding of the needs of our patients, their families, and caregivers, and to improve the delivery of equitable and inclusive care to a diverse population. Qualifications of Candidate: Fellows in - [Fima Lifshitz Junior Faculty Clinical Research Grant](https://pedsendo.org/award/fima-lifshitz-junior-faculty-clinical-research-grant/) - Purpose: To promote early career research development of academic pediatric endocrinologists. Description and Qualifications of the Candidate: Fellows in their third year of endocrine training or early-stage faculty members who are PES members in good standing are eligible to apply for the Junior Faculty Grant, formerly the Clinical Scholar Award (CSA). Applicants must provide institutional - [PES Research Fellowship Grants](https://pedsendo.org/award/research-fellowship-awards/) - Purpose: To support the final year of research training in a pediatric endocrinology fellowship for highly qualified individuals preparing for a career in academic pediatric endocrinology. Both clinical and basic research projects are eligible for support. Description and Qualifications of the Candidate: Applicants must provide institutional documentation of fellowship status at the time of the - [PES Travel Grants](https://pedsendo.org/award/pes-travel-awards/) - The 2026 Travel Grants have been announced. Congratulations to the 60+ selected! PES is pleased to offer Fellows presenting at the PES Annual Meeting the opportunity to win Travel Grants. Eligible applicants fall under the following categories: Applicants are eligible if they are a fellow in April 2026 and if they are PES member at - [International Scholars Program](https://pedsendo.org/award/international-scholars-program/) - Do you know a young pediatrician or pediatric endocrinologist in a resource limited country who would like to gain experience or specific skills in your clinic or lab? Are you interested in hosting such a person at your institution? The PES is now accepting applications for the PES International Scholar Award. PES will award two - [Regional Grant](https://pedsendo.org/award/regional-grant/) - Up to $2,000 per meeting is available to support as many as four Pediatric Endocrinology Regional Meetings each year. These grants are designed to strengthen collaboration among institutions, foster regional engagement, and provide opportunities for Fellows to participate. Funds may be used to offset costs for an invited speaker and will be distributed after the - [Paul Kaplowitz Abstract Award](https://pedsendo.org/award/paul-kaplowitz-abstract-award/) - The Paul Kaplowitz abstract award will recognize the best abstract by a junior faculty, resident or medical student for a study designed to decrease the use of unnecessary tests, procedures and/or treatments in pediatric endocrinology that result in cost-effective care. Abstracts may also consider studies to discuss co-management and how primary care and pediatric endocrinology - [Human Growth Foundation Award](https://pedsendo.org/award/human-growth-foundation-award-2/) - The Human Growth Foundation Award was established in 2007 to encourage Fellows training in pediatric endocrinology to pursue clinical and bench investigations that may lead to a better understanding of human growth. A $1,000 prize is awarded annually to the best growth-related abstract submitted by a Fellow to the PES annual meeting. PES is grateful - [AAP and PES Leona Cuttler Award](https://pedsendo.org/award/aap-and-pes-leona-cuttler-award/) - In memory of Leona Cuttler and her extensive career as an advocate for children with endocrine disorders, this award will be given to acknowledge the best abstract by a pediatric endocrine fellow, resident, or medical student on a topic that has a focus on Quality Improvement (QI) in Pediatric Endocrinology. Abstracts will be graded based - [Lawson Wilkins, MD Lectureship](https://pedsendo.org/award/lawson-wilkins-md-lectureship/) - We will accept nominations for this award in 2026. This lectureship was established to honor Lawson Wilkins, MD, the primary individual responsible for the establishment and recognition of the discipline of pediatric endocrinology. The Lawson Wilkins Pediatric Endocrine Society was founded in 1972 by a group of Dr. Wilkins' trainees; in 2010 the name of - [External Grants](https://pedsendo.org/award/external-grants/) - Click on the below links for details about award amounts, duration, eligibility criteria, and application processes and deadlines. Some grants require institutional nomination. Information may not be completely up to date. Please email the PES office at info@pedsendo.org with any errors, corrections, updates, or additions. This list is provided for informational purposes only and does not ## Job Listings - [Pediatric Endocronologist](https://pedsendo.org/job-listing/assistant-professor/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-16/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-15/) - [Pediatric Endocrinology](https://pedsendo.org/job-listing/pediatric-endocrinology-2/) - [Pediatric Endocrinology](https://pedsendo.org/job-listing/pediatric-endocrinology/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-14/) - [Physician, Pediatric Endocrinology](https://pedsendo.org/job-listing/physician-pediatric-endocrinology/) - [Assistant /Associate Professor](https://pedsendo.org/job-listing/assistant-associate-professor/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-13/) - [Assistant or Associate Professor](https://pedsendo.org/job-listing/assistant-or-associate-professor/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-12/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-11/) - [Section Chief, Pediatric Endocrinology](https://pedsendo.org/job-listing/section-chief-pediatric-endocrinology-2/) - [Chief of Pediatric Endocrinology](https://pedsendo.org/job-listing/chief-of-pediatric-endocrinology/) - [Pediatric Endocrinologist - Topeka, KS](https://pedsendo.org/job-listing/pediatric-endocrinologist-topeka-ks/) - [Academic Scholar - Assistant, Associate, or Full Professor](https://pedsendo.org/job-listing/academic-scholar-assistant-associate-or-full-professor/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-10/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-9/) - [Assistant Professor - Pediatric Endocrinology](https://pedsendo.org/job-listing/assistant-professor-pediatric-endocrinology-2/) - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-8/) - [Children's Hospital of Michigan - Pediatric Endocrinologist](https://pedsendo.org/job-listing/childrens-hospital-of-michigan-pediatric-endocrinologist/) - [Ascension St. Vincent (Indianapolis) - Pediatric Endocrinologist](https://pedsendo.org/job-listing/ascension-st-vincent-indianapolis-pediatric-endocrinologist/) - [Fellowship Position - University of Chicago](https://pedsendo.org/job-listing/fellowship-position-university-chicago/) - This program has an open fellowship position to start in the summer of 2020. Please contact the program directly for information and instructions on how to apply for the position. Number of positions for 2020: 2 - [Fellowship Position - Memorial Sloan Kettering Cancer Center](https://pedsendo.org/job-listing/fellowship-position-memorial-sloan-kettering-cancer-center/) - This program has an open fellowship position to start in the summer of 2020. Please contact the program directly for information and instructions on how to apply for the position. Number of positions for 2020: 2 - [Fellowship Position - McMaster University](https://pedsendo.org/job-listing/fellowship-position-mcmaster-university/) - This program has an open fellowship position to start in the summer of 2020. Please contact the program directly for information and instructions on how to apply for the position. Number of positions for 2020: 1 - [Fellowship Position - Hospital for Sick Children/University of Toronto](https://pedsendo.org/job-listing/fellowship-position-hospital-for-sick-children-university-of-toronto/) - This program has an open fellowship position to start in the summer of 2020. Please contact the program directly for information and instructions on how to apply for the position. Number of positions for 2020: 1 - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-7/) - Ochsner LSU Health System – Shreveport and Louisiana State University Health Science Center- Shreveport is seeking a BC/BE Pediatric Endocrinologist to join the Department of Pediatrics. We are seeking a full-time physician at the Assistant or the Associate Professor level. Applicants must qualify for a Louisiana license. This position is for inpatient and outpatient pediatric endocrine/diabetes care, as - [Assistant Professor, Associate Professor or Professor](https://pedsendo.org/job-listing/assistant-professor-associate-professor-or-professor/) - The Department of Pediatrics, Division of Endocrinology, in the College of Medicine at the University of Kentucky is seeking candidates for an Assistant Professor, Associate Professor, or Professor to provide quality subspecialty care. MD, DO or degree equivalent and board eligibility/board certification in Pediatric Endocrinology are required. The Pediatric Endocrinology Division is currently staffed with - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-6/) - If you deliver a dose of compassion to every patient you see, you may be an ideal addition to the Legacy community. You’ll provide medical and surgical services within an assigned clinic, forging relationships with staff, and delivering expert care to patients. Every aspect of your work will reflect the Legacy mission of making life - [Pediatric Endocrinologist with RWJBarnabas Health](https://pedsendo.org/job-listing/pediatric-endocrinologist-with-rwjbarnabas-health/) - RWJBarnabas Health is seeking to add a fourth full-time Pediatric Endocrinologist to our team. This position is primarily clinical, based at the Children's Hospital of New Jersey at Newark Beth Israel Medical Center in Newark, NJ, with additional site responsibilities in Livingston, NJ affiliated with Saint Barnabas Medical Center. The scope of the practice is - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-5/) - Driscoll Children’s Hospital is seeking a BC/BE Pediatric Endocrinologist to join a well-established program. Join Dr. Ana Paez, Program Medical Director, Dr. Anca Tomsa, Dr. Rajan Senguttuvan and Jennifer Olivarez, FNP-C, and a support staff consisting of one Dietician CDE, one Social Worker, three RNs, four endocrinology RNs, and one nurse coordinator. This is an - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-4/) - The Department of Pediatrics at Southern Illinois University School of Medicine is recruiting an additional pediatric endocrinologist at the Assistant Professor level. The successful applicant has the opportunity to design and implement the program according to his/her interest and career goals. Opportunities exist to participate in resident and medical student education and receive an advanced - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-3/) - UF Health – The Power of Together! At UF Health, together, we strive to create unstoppable momentum toward the goal of improving individual and community health through discovery, clinical and translational science and technology, exceptional education and patient-centered, innovative, high-quality health care. At the heart of our mission is to provide high-quality clinical care and to promise every patient - [Pediatric Endocrinology Fellowship Training](https://pedsendo.org/job-listing/pediatric-endocrinology-fellowship-training/) - Fellowship Opportunity in Pediatric Endocrinology We have an unexpected vacancy for a second-year pediatric endocrinology position but are amenable to other possibilities such as a "superfellow," graduate wanting to get some additional training or first-year fellow. The fellowship in Pediatric Endocrinology at Cohen Children’s Medical Center is a long-standing and fully accredited three-year program approved - [Pediatric Endocrinology Attending](https://pedsendo.org/job-listing/pediatric-endocrinology-attending/) - The Herman and Walter Samuelson Children's Hospital at Sinai Hospital of Baltimore is seeking a Pediatric Endocrinologist to join its Division of Pediatric Endocrinology. The individual selected will provide patient care, teaching, and consultative services as a Pediatric Endocrinologist. Option for academic appointment. Requirements: Must hold an MD/DO degree Equivalent Board certified or eligible in - [Assistant Professor of Clinical Pediatrics (Endocrinology) - LAC+USC](https://pedsendo.org/job-listing/assistant-professor-of-clinical-pediatrics-endocrinology-lacusc/) - The Keck School of Medicine of USC's Department of Pediatrics at LAC+USC Medical Center is seeking a full-time, board-certified/board eligible pediatric endocrinologist to join our faculty as an Assistant Professor of Clinical Pediatrics. The Division of Pediatric Endocrinology at LAC+USC Medical Center serves a diverse, underserved population of patients at a state-of-the-art public hospital and - [Pediatric Endocrinology Nurse Practitioner - Large Group](https://pedsendo.org/job-listing/pediatric-endocrinology-nurse-practitioner-large-group/) - Lutheran Children’s Hospital in Fort Wayne, Indiana seeks to recruit a BC Pediatric Nurse Practitioner to join an established pediatric endocrinology practice. Our current endocrinology team consists of 1 board-certified pediatric endocrinologist, 2 certified diabetes educators, a pediatric dietitian, a pediatric social worker, and 2 pediatric endocrine nurses. Heavily supported by pediatric intensivists, pediatric hospitalists, - [Assistant Professor - Pediatric Endocrinology](https://pedsendo.org/job-listing/assistant-professor-pediatric-endocrinology/) - Position Description Contributes to the university’s mission through teaching, research, and service, some variation by academic unit. Required Qualifications Academic degree as defined by the academic unit and as appropriate for the position held. Demonstrated record of effectiveness as a teacher, a record of peer-reviewed publication and/or peer-reviewed creative activity which has contributed to the - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist/) - The Department of Pediatrics at the University of Rochester is seeking a board-certified/board-eligible Pediatric Endocrinologist to join the Division of Pediatric Endocrinology. The candidate would join four other pediatric endocrinologists and three NPs who provide inpatient services for the Golisano Children’s Hospital and outpatient services for a catchment area of approximately one million persons. This - [Academic Scholar - Assistant, Associate, or Full Professor](https://pedsendo.org/job-listing/academic_scholar/) - The Department of Pediatrics, University at Buffalo (UB), Jacobs School of Medicine and Biomedical Sciences and Oishei Children’s Hospital of Buffalo are recruiting a full-time faculty physician in the Division of Endocrinology/Diabetes. The ideal candidate must hold a medical degree and be board certified in both pediatrics and pediatric endocrinology. The candidate will provide clinical care for - [Division Chief - Pediatric Endocrinology](https://pedsendo.org/job-listing/division-chief-pediatric-endocrinology/) - The Endocrinology Division of Nemours Children's Specialty Care, Pensacola is seeking to hire a Division Chief. Physician candidates must be board-certified or eligible in Pediatric Endocrinology and be eligible for unrestricted Florida medical license. Our physicians practice within our clinic and at our 530-bed partner hospital. Our physicians have 100% pediatric practice. Full-time Physician Assistant, - [Peds Endocrinology](https://pedsendo.org/job-listing/peds-endocrinology/) - The division of pediatric endocrinology at East Tennessee State University is expanding to add a third pediatric endocrinologist to an enthusiastic team supported by advanced practitioners, diabetes educators, pediatric endocrine nurses and dietician. Since opening in 2015, the clinic has thrived by investing in the community to provide excellent clinical care, teach the next generation of - [Section Chief, Pediatric Endocrinology](https://pedsendo.org/job-listing/section-chief-pediatric-endocrinology/) - Children’s Hospital at Dartmouth-Hitchcock (CHaD) and The Geisel School of Medicine at Dartmouth seek a Section Chief of Pediatric Endocrinology. Candidates should be board certified with outstanding clinical pediatric endocrinology skills and demonstrated excellence in teaching and scholarly activities. Opportunities to continue or pursue research interests are available. Academic appointment at The Geisel School of - [Chief for the Division of Endocrinology and Diabetes](https://pedsendo.org/job-listing/chief-for-the-division-of-endocrinology-and-diabetes/) - The Department of Pediatrics in the Duke University School of Medicine is seeking a physician at the Associate Professor or Professor level to serve as Chief for the Division of Endocrinology. Proven leadership and excellence in clinical care, education, research, and administrative experience are required. Candidates must have a Doctorate of Medicine (or equivalent) and - [Pediatric Endocrinologist](https://pedsendo.org/job-listing/pediatric-endocrinologist-2/) - Northern Light Eastern Maine Medical Center seeks a second BC/BE pediatric endocrinologist to join our hospital-employed, outpatient practice. Our newly renovated facility, just a short drive from our main hospital campus, houses pediatric primary care, and many pediatric specialty services. Our pediatric endocrinologists are supported by a full-time PA who supports management of patients with ## Clinical Studies - [A Phase 2 Randomized, Human Growth Hormone-controlled, multicenter Basket study of Vosoritide in Children with Turner Syndrome, Short Stature Homeobox-containing Gene Deficiency, and Noonan Syndrome with and inadequate response to Human Growth Hormone.](https://pedsendo.org/clinical-study/a-phase-2-randomized-human-growth-hormone-controlled-multicenter-basket-study-of-vosoritide-in-children-with-turner-syndrome-short-stature-homeobox-containing-gene-deficiency-and-noonan-syndrome-w/) - [Vosoritide for Selected Genetic Causes of Short Stature](https://pedsendo.org/clinical-study/vosoritide-for-selected-genetic-causes-of-short-stature/) - Inclusion/Exclusion Criteria INCLUSION CRITERIA Parent(s) or guardian(s) are willing and able to provide written, signed informed consent after the nature of the study has been explained and prior to performance of any research-related procedure. Also, subjects under the age of 18 are willing and able to provide assent (if required) after the nature of the ## Clinical Resources - [Infant with a Variation in Sex Characteristics (Ambiguous Genitalia)](https://pedsendo.org/clinical-resource/infant-with-a-variation-in-sex-characteristics-ambiguous-genitalia/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand History: • Poor feeding • Lethargy • Family history of SIDS • Family history - [Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline](https://pedsendo.org/clinical-resource/central-precocious-puberty-an-endocrine-society-clinical-practice-guideline/) - Abstract Background Central precocious puberty (CPP), which is traditionally defined as the development of secondary sexual characteristics before age 8 years in girls and age 9 years in boys, results from the premature activation of the hypothalamic–pituitary–gonadal (HPG) axis. CPP can be associated with short adult stature, adverse psychosocial outcomes, and increased cardiometabolic and cancer - [Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age](https://pedsendo.org/clinical-resource/thyroid-monitoring-after-intravascular-iodinated-contrast-media-in-infants-and-children-through-3-years-of-age/) - This is a multi-society joint statement summarizing the evidence and consensus recommendations regarding thyroid function monitoring after administration of intravascular iodinated contrast in young children. - [Long-Acting Growth Hormone Table](https://pedsendo.org/clinical-resource/lagh-table/) - [What is Hypothalamic Obesity?](https://pedsendo.org/clinical-resource/what-is-hypothalamic-obesity/) - What is Hypothalamic Obesity? Hypothalamic obesity (HO) is a rare health problem that happens when part of the brain called the hypothalamus gets injured or does not work the right way. Hypothalamic Obesity Spanish Translation - [International Consensus Guidelines on the Implementation and Monitoring of Vosoritide Therapy in Individuals with Achondroplasia](https://pedsendo.org/clinical-resource/international-consensus-guidelines-on-the-implementation-and-monitoring-of-vosoritide-therapy-in-individuals-with-achondroplasia/) - Since the approval of vosoritide in 2021, a need was created for a treatment guideline for support clinicians. An international collaborative of leading experts and patient advocates was formed to develop a consensus statement to provide recommendations across the treatment pathway, from starting treatment with vosoritide through ongoing monitoring and evaluation, to stopping vosoritide and - [Type 2 diabetes in youth](https://pedsendo.org/clinical-resource/type-2-diabetes-in-youth/) - Handout on type 2 diabetes in youth for medical students or residents, created by the PES resident/medical student education subcommittee - [Type 1 diabetes in youth](https://pedsendo.org/clinical-resource/type-1-diabetes-in-youth/) - Handout on type 1 diabetes in youth for medical students or residents, created by the PES resident/medical student education subcommittee - [Type 2 diabetes in youth: Rationale for use of off-label antidiabetic agents](https://pedsendo.org/clinical-resource/type-2-diabetes-in-youth-rationale-for-use-of-off-label-antidiabetic-agents/) - This is a perspective that very briefly summarizes the evidence at that time of publication for treatment of youth-onset type 2 diabetes, as well as some of the challenges that are faced in getting up-to-date treatment studies in this population. The authors use this information, as well as what is known from adult studies, to - [Lipid SIG Algorithms](https://pedsendo.org/clinical-resource/lipid-sig-algorithms/) - Lipid management algorithms were developed by SIG members as a resource for use in clinical care and trainee education. Relevant guidelines were applied in the development of decision trees for lipid management in patients with diabetes, elevated LDL, or elevated triglycerides. The algorithms were reviewed by the Lipid SIG group members and further modified after - [Triaging and initial treatment in the patient with suspected type 2 diabetes](https://pedsendo.org/clinical-resource/triaging-and-initial-treatment-in-the-patient-with-suspected-type-2-diabetes/) - [PES Lipid SIG Diabetes and Lipids Algorithm](https://pedsendo.org/clinical-resource/pes-lipid-sig-diabetes-and-lipids-algorithm/) - [X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline](https://pedsendo.org/clinical-resource/x-linked-hypophosphatemia-management-in-children-an-international-working-group-clinical-practice-guideline/) - X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline This important resource provides healthcare practitioners with expert recommendations that will help guide the diagnosis, monitoring, and treatment of X-linked Hypophosphatemia in a pediatric population. People who have or care for someone with XLH may also find this information valuable for the purpose - [Persistent Growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health related quality of life](https://pedsendo.org/clinical-resource/persistent-growth-promoting-effects-of-vosoritide-in-children-with-achondroplasia-are-accompanied-by-improvements-in-physical-and-social-aspects-of-health-related-quality-of-life/) - Publication of impact on health-related quality of life from 3 year data with vosoritide. These data suggest that after 3 years of treatment, vosoritide demonstrates a positive effect on physical and social functioning among children with achondroplasia, particularly in children with a more pronounced change in height z-score. - [Anti Obesity Medication Guideline](https://pedsendo.org/clinical-resource/anti-obesity-medication-guideline/) - The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original protocol developed by Claudia Fox, MD, of University of Minnesota’s Center for Pediatric Obesity Medicine. It listed each medication’s indication, contraindication, use cautions and the Patient Handout, etc. - [Triaging and initial treatment in the patient with suspected type 2 diabetes](https://pedsendo.org/clinical-resource/triaging-and-initial-treatment-in-the-patient-with-suspected-type-2-diabetes-2/) - These treatment pathways were developed by the type 2 diabetes subgroup of the PES Diabetes SIG, using evidence base when available in combination with expert clinical experience. They consist of 3 parts: 1. An algorithm to help triage patients with clinical features of type 2 diabetes when the type of diabetes has not yet been - [International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia](https://pedsendo.org/clinical-resource/international-consensus-statement-on-the-diagnosis-multidisciplinary-management-and-lifelong-care-of-individuals-with-achondroplasia/) - Achondroplasia is the most common skeletal dysplasia and is characterized by a variety of medical, functional and psychosocial challenges across the lifespan. There is variability in the clinical care pathways and protocols by clinicians who manage these patients. This publication is a consensus of 55 international experts statements and recommendations that aim to capture the - [What is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?](https://pedsendo.org/clinical-resource/what-is-the-role-for-pediatric-endocrinologists-in-the-management-of-skeletal-dysplasias/) - Despite the recognized expertise of pediatric endocrinologists, children with skeletal dysplasias have not been consistently managed by these physicians. Growth-altering treatments have broadened the role of the pediatric endocrinologist to manage and sometimes become primary coordinators for genetic disorders such as Turner syndrome and Prader-Willi syndrome. It is illustrated how recent advances in understanding the - [Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study- a multicenter retrospective cohort study of achondroplasia in the US](https://pedsendo.org/clinical-resource/growth-in-achondroplasia-including-stature-weight-weight-for-height-and-head-circumference-from-clarity-achondroplasia-natural-history-study-a-multicenter-retrospective-cohort-study-of-achondropla/) - Achondroplasia growth charts included in this article. Achondroplasia is the most common genetic skeletal disorder causing disproportionate short stature/dwarfism. Common additionalfeatures include spinal stenosis, midface retrusion, macrocephaly and a generalized spondylometaphyseal dysplasia whichmanifest as spinal cord compression, sleep disordered breathing, delayed motor skill acquisition and genu varus withmusculoskeletal pain. To better understand the interactions and - [Child with Suspected Delayed Puberty](https://pedsendo.org/clinical-resource/child-with-suspected-delayed-puberty/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Boys: No testicular enlargement (≥4ml or 2.5 cm in long diameter) by age 14 - [Infant with Suspected Congenital Hypothyroidism](https://pedsendo.org/clinical-resource/infant-with-suspected-congenital-hypothyroidism/) - Primary Care provider guidelines for referral. - [Child With Suspected Type 2 Diabetes](https://pedsendo.org/clinical-resource/child-with-suspected-type-2-diabetes-2/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms: Polyuria, nocturia, enuresis, increased thirst, Fatigue, Increased appetite, unexpected and unplanned weight loss - [Child With Suspected Type 1 Diabetes](https://pedsendo.org/clinical-resource/child-with-suspected-type-1-diabetes-2/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms: Polyuria, nocturia, enuresis, increased thirst, increased appetite, weight loss, fatigue. *Vomiting, Rapid/deep breathing, - [Child with Suspected Turner Syndrome](https://pedsendo.org/clinical-resource/child-with-suspected-turner-syndrome/) - Primary Care provider guidelines for referral. - [Child with Suspected Short Stature](https://pedsendo.org/clinical-resource/child-with-suspected-short-stature/) - Primary Care provider guidelines for referral. - [Child with Suspected Rickets](https://pedsendo.org/clinical-resource/child-with-suspected-rickets/) - Primary Care provider guidelines for referral. - [Child with Suspected Klinefelter Syndrome](https://pedsendo.org/clinical-resource/child-with-suspected-klinefelter-syndrome/) - Primary Care provider guidelines for referral. - [Infant with Suspected Hyperthyroidism](https://pedsendo.org/clinical-resource/infant-with-suspected-hyperthyroidism/) - Primary Care provider guidelines for referral. - [Child With Suspected Hypoglycemia](https://pedsendo.org/clinical-resource/infant-with-suspected-hypoglycemia/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/signs: Jitteriness, tremor, cyanosis, seizures, apnea, tachypnea, weak or high pitched cry, limp, lethargy, - [Child with Suspected Hypocalcemia](https://pedsendo.org/clinical-resource/child-with-suspected-hypocalcemia/) - Primary Care provider guidelines for referral. - [Child With Suspected Hyperthyroidism](https://pedsendo.org/clinical-resource/child-with-suspected-hyperthyroidism-2/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms: Anxiety, restlessness, mood swings, panic attacks, behavioral problems, deterioration in school performance, inability - [Child with Suspected Hyperglycemia](https://pedsendo.org/clinical-resource/child-with-suspected-hyperglycemia/) - Primary Care provider guidelines for referral. - [Adolescent Female With Suspected Hirsutism](https://pedsendo.org/clinical-resource/adolescent-with-suspected-hirsutism/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/signs: • Excessive terminal hair growth in locations typically seen in adult males (face, - [Child With Suspected Acquired Hypothyroidism](https://pedsendo.org/clinical-resource/child-with-suspected-acquired-hypothyroidism-2/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Constipation, fatigue, sluggishness, cold sensitivity/ intolerance, heavy or irregular menses, pale or dry skin, - [Child With Suspected Gynecomastia](https://pedsendo.org/clinical-resource/child-with-suspected-gynecomastia/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/signs: • Palpable subareolar breast tissue in male • Breast tissue may be asymmetric, - [Child With Suspected Excessive Cortisol Production](https://pedsendo.org/clinical-resource/child-with-suspected-excessive-cortisol-production/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/Signs: • Progressive weight gain (mostly truncal) with slowing of linear growth • "Moon - [Child With Abnormal Newborn Screen for Congenital Hypothyroidism](https://pedsendo.org/clinical-resource/child-with-abnormal-newborn-screen-for-congenital-hypothyroidism/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Often, no signs or symptoms, but may see: • Wide fontanelle • Lethargy • - [Child with Suspected Sexual Precocity](https://pedsendo.org/clinical-resource/child-with-suspected-sexual-precocity/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Females before 8 yrs of age: Estrogenic: Breast development, vaginal discharge/bleeding Androgenic: Pubic hair, - [Child with suspected Obesity and Metabolic Syndrome](https://pedsendo.org/clinical-resource/child-with-suspected-obesity-and-metabolic-syndrome/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/Signs: Overweight (BMI > 85 %ile for age and sex) or obese (BMI > - [Child with suspected Diabetes Insipidus](https://pedsendo.org/clinical-resource/child-with-suspected-diabetes-insipidus/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/signs: Polyuria, polydipsia, weight loss Pathological polyuria or polydipsia is defined as exceeding 2L/m2/day. - [Child with Early Pubic Hair/Mature Body Odor](https://pedsendo.org/clinical-resource/child-with-early-pubic-hair-body-odor/) - Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an endocrine condition, and when to refer to Pediatric Endocrinology. Suggestive history and physical findings: Expand Symptoms/signs: Before age 8 yrs (female) or 9 yrs (male): Pubic hair (coarse, curly) - [Child with Suspected Adrenal Insufficiency](https://pedsendo.org/clinical-resource/child-with-suspected-adrenal-insufficiency/) - Primary Care provider guidelines for referral. - [Adolescent Female with Suspected PCOS](https://pedsendo.org/clinical-resource/adolescent-female-with-suspected-pcos/) - Primary Care provider guidelines for referral. - [Department of Defense Medical Standards for Military Service](https://pedsendo.org/clinical-resource/department-of-defense-medical-standards-for-military-service/) - The Department of Defense revised its regulations on medical qualification for military service, effective November 16th, 2022. The DSD-SIG and Board of PES supported efforts for revisions related to differences of sex development. Previously, many forms of DSD led to a blanket disqualification for service. This new standard disqualifies applicants with DSD if the DSD - [PES Statement on Thyroid Monitoring in Infants and Young Children Receiving Iodine-Containing Contrast Media](https://pedsendo.org/clinical-resource/pes-statement-on-thyroid-monitoring-in-infants-and-young-children-receiving-iodine-containing-contrast-media/) - [Adrenal Disorders](https://pedsendo.org/clinical-resource/adrenal-disorders/) - Handout on adrenal disorders for medical students or residents, created by the PES resident/medical student education subcommittee - [Hypercalcemia](https://pedsendo.org/clinical-resource/hypercalcemia/) - Handout on hypercalcemia for medical students or residents, created by the PES resident/medical student education subcommittee - [Hypocalcemia](https://pedsendo.org/clinical-resource/hypocalcemia/) - Handout on hypocalcemia for medical students or residents, created by the PES resident/medical student education subcommittee - [Pediatric Hypoglycemia](https://pedsendo.org/clinical-resource/pediatric-hypoglycemia/) - Handout on hypoglycemia for medical students or residents, created by the PES resident/medical student education subcommittee - [hypopituitarism](https://pedsendo.org/clinical-resource/hypopituitarism/) - Handout on hypopituitarism in pediatrics for medical students or residents, created by the PES resident/medical student education subcommittee - [Puberty](https://pedsendo.org/clinical-resource/puberty/) - Handout on puberty for medical students or residents, created by the PES resident/medical student education subcommittee - [Short Stature](https://pedsendo.org/clinical-resource/short-stature/) - Handout on short stature for medical students or residents, created by the PES resident/medical student education subcommittee - [Thyroid disorders](https://pedsendo.org/clinical-resource/thyroid-disorders/) - Handout on thyroid disorders for medical students or residents, created by the PES resident/medical student education subcommittee - [Vitamin D and Rickets](https://pedsendo.org/clinical-resource/vitamin-d-and-rickets/) - Handout on vitamin D and rickets for medical students or residents, created by the PES resident/medical student education subcommittee - [State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)](https://pedsendo.org/clinical-resource/state-of-the-art-review-emerging-therapies-the-use-of-insulin-sensitizers-in-the-treatment-of-adolescents-with-polycystic-ovary-syndrome-pcos/) - [The Role of Recombinant Human Insulin-Like Growth Factor-I in Treating Children with Short Stature](https://pedsendo.org/clinical-resource/the-role-of-recombinant-human-insulin-like-growth-factor-i-in-treating-children-with-short-stature/) - [Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations](https://pedsendo.org/clinical-resource/vitamin-d-deficiency-in-children-and-its-management-review-of-current-knowledge-and-recommendations/) - [Position Statement on Genital Surgery in Individuals with Differences of Sex Development (DSD)/Intersex Traits](https://pedsendo.org/clinical-resource/position-statement-on-genital-surgery-in-individuals-with-differences-of-sex-development-dsd-intersex-traits/) - [2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer (Thyroid 2016)](https://pedsendo.org/clinical-resource/2015-american-thyroid-association-management-guidelines-for-adult-patients-with-thyroid-nodules-and-differentiated-thyroid-cancer-thyroid-2016/) - [An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of PCOS in Adolescence (HRP 2017)](https://pedsendo.org/clinical-resource/an-international-consortium-update-pathophysiology-diagnosis-and-treatment-of-pcos-in-adolescence-hrp-2017/) - An International Consortium Update on the Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence, - [Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline](https://pedsendo.org/clinical-resource/pediatric-obesity-assessment-treatment-and-prevention-an-endocrine-society-clinical-practice-guideline/) - [Improving Long-Term Outcomes of Youth with Lipid Abnormalities - Expanding the Role of Pediatric Endocrinologists](https://pedsendo.org/clinical-resource/improving-long-term-outcomes-of-youth-with-lipid-abnormalities-expanding-the-role-of-pediatric-endocrinologists/) - [Review of Prader-Willi Syndrome: The Endocrine Approach (Transl Pediatr. 2017)](https://pedsendo.org/clinical-resource/review-of-prader-willi-syndrome-the-endocrine-approach-transl-pediatr-2017/) - A review of the current literature pertaining to the endocrine concerns of Prader Willi Syndrome and current recommendations for screening and management of these conditions. - [Diabetes and Metabolic Syndrome in Survivors of Childhood Cancer (Horm Res Paediatr. 2019)](https://pedsendo.org/clinical-resource/diabetes-and-metabolic-syndrome-in-survivors-of-childhood-cancer-horm-res-paediatr-2019/) - [Increasing Minority Participation in Clinical Research](https://pedsendo.org/clinical-resource/increasing-minority-participation-in-clinical-research/) - [Proposed Endocrine Funding Priorities for the NICHD Strategic Plan: Expert Opinion from the Pediatric Endocrine Society](https://pedsendo.org/clinical-resource/proposed-endocrine-funding-priorities-for-the-nichd-strategic-plan-expert-opinion-from-the-pediatric-endocrine-society/) - [UCSF Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People](https://pedsendo.org/clinical-resource/ucsf-guidelines-for-the-primary-and-gender-affirming-care-of-transgender-and-gender-nonbinary-people/) - [WPATH Standards of Care Version 7](https://pedsendo.org/clinical-resource/wpath-standards-of-care-version-7/) - [PES Statement Promoting Safety of Transgender Youth (PES Statement 2017)](https://pedsendo.org/clinical-resource/pes-statement-promoting-safety-of-transgender-youth-pes-statement-2017/) - [Statement on Gender-Affirmative Approach to Care from the Pediatric Endocrine Society Special Interest Group on Transgender Health (Curr Opin, Peds 2017)](https://pedsendo.org/clinical-resource/statement-on-gender-affirmative-approach-to-care-from-the-pediatric-endocrine-society-special-interest-group-on-transgender-health-curr-opin-peds-2017/) - [Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline (JCEM 2017)](https://pedsendo.org/clinical-resource/endocrine-treatment-of-gender-dysphoric-gender-incongruent-persons-an-endocrine-society-clinical-practice-guideline-jcem-2017/) - [PES 2019 Transgender Statement](https://pedsendo.org/clinical-resource/pes-2019-transgender-statement/) - [Update of Newborn Screening and Therapy for Congenital Hypothyroidism (Pediatrics 2006)](https://pedsendo.org/clinical-resource/update-of-newborn-screening-and-therapy-for-congenital-hypothyroidism-pediatrics-2006/) - [Screening, Diagnosis and Management of Congenital Hypothyroidism: ESPE Consensus Guidelines (Arch Dis Child Educ Pract Ed. 2015)](https://pedsendo.org/clinical-resource/screening-diagnosis-and-management-of-congenital-hypothyroidism-espe-consensus-guidelines-arch-dis-child-educ-pract-ed-2015/) - [Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma (J Endo Soc 2018)](https://pedsendo.org/clinical-resource/update-on-multiple-endocrine-neoplasia-type-2-focus-on-medullary-thyroid-carcinoma-j-endo-soc-2018/) - [Revised ATA Guidelines for the Management of Medullary Thyroid Carcinoma (Thyroid 2015)](https://pedsendo.org/clinical-resource/revised-ata-guidelines-for-the-management-of-medullary-thyroid-carcinoma-thyroid-2015/) - [Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer (Thyroid 2015)](https://pedsendo.org/clinical-resource/management-guidelines-for-children-with-thyroid-nodules-and-differentiated-thyroid-cancer-thyroid-2015/) - [TANNER: Clinical Longitudinal Standards for Height and Height Velocity for North American Children](https://pedsendo.org/clinical-resource/tanner-clinical-longitudinal-standards-for-height-and-height-velocity-for-north-american-children/) - [TANNER: Clinical Longitudinal Standards for Height, Weight, Height Velocity, Weight Velocity, and Stages of Puberty](https://pedsendo.org/clinical-resource/tanner-clinical-longitudinal-standards-for-height-weight-height-velocity-weight-velocity-and-stages-of-puberty/) - [Thelarche, Pubarche, and Menarche Attainment in Children with Normal and Elevated Body Mass Index (Pediatrics)](https://pedsendo.org/clinical-resource/thelarche-pubarche-and-menarche-attainment-in-children-with-normal-and-elevated-body-mass-index-pediatrics/) - [Secondary Sexual Characteristics and Menses in Young Girls Seen in Office Practice: A Study from the Pediatric Research in Office Settings Network (Pediatrics 1997)](https://pedsendo.org/clinical-resource/secondary-sexual-characteristics-and-menses-in-young-girls-seen-in-office-practice-a-study-from-the-pediatric-research-in-office-settings-network-pediatrics-1997/) - A Study From the Pediatric Research in Office Settings Network describing Secondary Sexual Characteristics and Menses in Young Girls. - [Consensus on Use of Gonadotropin-Releasing Hormone Analogs in Children (Pediatrics 2009)](https://pedsendo.org/clinical-resource/consensus-on-use-of-gonadotropin-releasing-hormone-analogs-in-children-pediatrics-2009/) - An International Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children. - [Revised D&T Statement on GnRHa and Prolonged QT 2017](https://pedsendo.org/clinical-resource/revised-dt-statement-on-gnrha-and-prolonged-qt-2017/) - PES Drugs and Therapeutics Committee presents a statement on the Risk of Prolonged QT Interval with Gonadotropin Releasing Hormone Agonists. - [Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity](https://pedsendo.org/clinical-resource/clinical-considerations-regarding-the-use-of-obesity-pharmacotherapy-in-adolescents-with-obesity/) - [Treatment of Adolescent Obesity in 2020](https://pedsendo.org/clinical-resource/treatment-of-adolescent-obesity-in-2020/) - A brief synopsis of available treatments for pediatric obesity. - [Childhood Obesity (JCEM 2005)](https://pedsendo.org/clinical-resource/childhood-obesity-jcem-2005/) - A consensus statement on the widespread public health crisis in childhood obesity. - [ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018](https://pedsendo.org/clinical-resource/asmbs-pediatric-metabolic-and-bariatric-surgery-guidelines-2018/) - [Prevention and Treatment of Pediatric Obesity: ENDO Practice Guidelines (JCEM 2008)](https://pedsendo.org/clinical-resource/prevention-and-treatment-of-pediatric-obesity-endo-practice-guidelines-jcem-2008/) - An Endocrine Society Clinical Practice Guideline about Prevention and Treatment of Pediatric Obesity, based on expert opinion. - [Clinical Practice Guidelines for MEN1 (JCEM 2012)](https://pedsendo.org/clinical-resource/clinical-practice-guidelines-for-men1-jcem-2012/) - 10 experts provide Clinical Practice Guidelines for diagnosis and management of Multiple Endocrine Neoplasia Type 1 (MEN1). - [Pheochromocytoma in Children with MEN Type 2B (JCEM 2019)](https://pedsendo.org/clinical-resource/pheochromocytoma-in-children-with-men-type-2b-jcem-2019/) - A retrospective chart review describing Pheochromocytoma in Children and Adolescents With Multiple Endocrine Neoplasia Type 2B. - [NIH National Heart, Lung and Blood Institute: Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents](https://pedsendo.org/clinical-resource/nih-national-heart-lung-and-blood-institute-expert-panel-on-integrated-guidelines-for-cardiovascular-health-and-risk-reduction-in-children-and-adolescents/) - [2018 Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice](https://pedsendo.org/clinical-resource/2018-guideline-on-the-management-of-blood-cholesterol-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice/) - [Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents](https://pedsendo.org/clinical-resource/expert-panel-on-integrated-guidelines-for-cardiovascular-health-and-risk-reduction-in-children-and-adolescents/) - A summary report of the NHLBI Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, directed towards all primary care providers. - [Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents (Circul 2007)](https://pedsendo.org/clinical-resource/drug-therapy-of-high-risk-lipid-abnormalities-in-children-and-adolescents-circul-2007/) - A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents. - [Re-Evaluating "Transitional Neonatal Hypoglycemia": Mechanism and Implications for Management (J Peds 2015)](https://pedsendo.org/clinical-resource/re-evaluating-transitional-neonatal-hypoglycemia-mechanism-and-implications-for-management-j-peds-2015/) - A commentary on “Transitional Neonatal Hypoglycemia”: Mechanism and Implications for Management. - [Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children (J Peds 2015)](https://pedsendo.org/clinical-resource/evaluation-and-management-of-persistent-hypoglycemia-in-neonates-infants-and-children-j-peds-2015/) - The Famous "Neonatal Hypoglycemia Guideline": Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. - [Historic Value: Standards from Birth to Maturity for Height, Weight, Height Velocity, and Weight Velocity: British Children (Part II) 1965](https://pedsendo.org/clinical-resource/historic-value-standards-from-birth-to-maturity-for-height-weight-height-velocity-and-weight-velocity-british-children-part-ii-1965/) - The origin of growth charts: part 2. - [Historic Value: Standards from Birth to Maturity for Height, Weight, Height Velocity, and Weight Velocity: British Children (Part 1) 1965](https://pedsendo.org/clinical-resource/historic-value-standards-from-birth-to-maturity-for-height-weight-height-velocity-and-weight-velocity-british-children-1965/) - The origin of growth charts: part 1. - [Historic Value: Treatment of Short Stature in Children and Adolescents with Human Pituitary Growth Hormone](https://pedsendo.org/clinical-resource/historic-value-treatment-of-short-stature-in-children-and-adolescents-with-human-pituitary-growth-hormone/) - The first paper from 1964 describing treatment of 35 children with short stature with human growth hormone. - [Growth Hormone (GH) Treatment to Final Height in Children with Idiopathic Short Stature: Evidence for a Dose Effect (The Journal of Pediatrics)](https://pedsendo.org/clinical-resource/growth-hormone-gh-treatment-to-final-height-in-children-with-idiopathic-short-stature-evidence-for-a-dose-effect-the-journal-of-pediatrics/) - An open-label randomized study analyzing the effect of two doses of growth hormone (GH) on final height and height velocity during the first 2 years of treatment of children with idiopathic short stature. - [Effect of Growth Hormone Treatment on Adult Height in Peripubertal Children with Idiopathic Short Stature: A Randomized, Doubleblind, Placebo-Controlled Trial (The Journal of Clinical Endocrinology and Metabolism)](https://pedsendo.org/clinical-resource/effect-of-growth-hormone-treatment-on-adult-height-in-peripubertal-children-with-idiopathic-short-stature-a-randomized-doubleblind-placebo-controlled-trial-the-journal-of-clinical-endocrinology-an/) - A Systematic Review and Meta-Analyses Describing the Effect of Growth Hormone Treatment on Adult Height of Children with Idiopathic Short Stature - [Use of Aromatase Inhibitors in Children and Adolescents with Disorders of Growth and Adolescent Development (Pediatrics 2008)](https://pedsendo.org/clinical-resource/use-of-aromatase-inhibitors-in-children-and-adolescents-with-disorders-of-growth-and-adolescent-development-pediatrics-2008/) - A review of published data regarding the use of aromatase inhibitors in pediatrics. - [Growth Hormone Treatment and Neoplasia - Coincidence or Consequence? (JCEM 2007)](https://pedsendo.org/clinical-resource/growth-hormone-treatment-and-neoplasia-coincidence-or-consequence-jcem-2007/) - The LWPES Writing Committee presents a special editorial on whether there is an association of growth hormone treatment and neoplasia. - [Changes in Recombinant Human Growth Hormone Prescribing Information (PES D & T Committee 2008)](https://pedsendo.org/clinical-resource/changes-in-recombinant-human-growth-hormone-prescribing-information-pes-d-t-committee-2008/) - Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of rhGH. - [GH Deficiency, Idiopathic Short Stature, and IGF-I Deficiency Treatment Guidelines (HRP 2016)](https://pedsendo.org/clinical-resource/gh-deficiency-idiopathic-short-stature-and-igf-i-deficiency-treatment-guidelines-hrp-2016/) - PES Drugs and Therapeutics and Ethics committees present guidelines for Growth Hormone and Insulin-like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. - [Cost-Conscious Growth-Promoting Treatment: When Discretion Is the Better Part of Value (HRP 2018)](https://pedsendo.org/clinical-resource/cost-conscious-growth-promoting-treatment-when-discretion-is-the-better-part-of-value-hrp-2018/) - A mini-review on cost-conscious growth-promoting treatment. - [Diagnosis and Management of Silver-Russell Syndrome: 1st International Consensus Statement (Nat. Rev. Endocrinology 2017)](https://pedsendo.org/clinical-resource/diagnosis-and-management-of-silver-russell-syndrome-1st-international-consensus-statement-nat-rev-endocrinology-2017/) - The first international consensus statement on diagnosis and management of Silver–Russell syndrome presented by 41 task force members from 16 countries. - [Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome: Proceedings from the 2016 Cincinnati International TS Meeting (Eur J Endocrinol. 2017)](https://pedsendo.org/clinical-resource/clinical-practice-guidelines-for-the-care-of-girls-and-women-with-turner-syndrome-proceedings-from-the-2016-cincinnati-international-ts-meeting-eur-j-endocrinol-2017/) - This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: Diagnostic and genetic issues Growth and development - [Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children With Prader-Willi Syndrome (JCEM 2018)](https://pedsendo.org/clinical-resource/improved-mental-and-motor-development-during-3-years-of-gh-treatment-in-very-young-children-with-prader-willi-syndrome-jcem-2018/) - A prospective cohort study showing Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children With Prader-Willi Syndrome. - [Partnering with Parents to Disclose Klinefelter Syndrome to Their Child (Acta Paed 2016)](https://pedsendo.org/clinical-resource/partnering-with-parents-to-disclose-klinefelter-syndrome-to-their-child-acta-paed-2016/) - Recommendations for healthcare providers on how to partner with the patient family in appropriate disclosure of diagnosis of Klinefelter syndrome to their child. - [Endocrine Aspects of Klinefelter Syndrome (Curr Opin End Diabetes Obes. 2019 Feb)](https://pedsendo.org/clinical-resource/endocrine-aspects-of-klinefelter-syndrome-curr-opin-end-diabetes-obes-2019-feb/) - A detailed review of endocrine aspects of Klinefelter Syndrome. - [Hypothalamic Obesity: Prologue and Promise (HRP 2019)](https://pedsendo.org/clinical-resource/hypothalamic-obesity-prologue-and-promise-hrp-2019/) - Etiology as well as past/current treatment approaches in the categories of hyperinsulinism, surgical approaches, and targeting energy expenditure/anorectic drugs. - [Skeletal Morbidity in Children and Adolescents During and Following Cancer Therapy (HRP 2019)](https://pedsendo.org/clinical-resource/skeletal-morbidity-in-children-and-adolescents-during-and-following-cancer-therapy-hrp-2019/) - [Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up (HRP 2019)](https://pedsendo.org/clinical-resource/hypogonadism-in-children-with-a-previous-history-of-cancer-endocrine-management-and-follow-up-hrp-2019/) - [Male Reproductive Health after Childhood, Adolescent, and Young Adult Cancers: A Report From the Children's Oncology Group (J Clin Oncol. 2012)](https://pedsendo.org/clinical-resource/male-reproductive-health-after-childhood-adolescent-and-young-adult-cancers-a-report-from-the-childrens-oncology-group-j-clin-oncol-2012/) - [Female Reproductive Health After Childhood, Adolescent, and Young Adult Cancers: Guidelines for the Assessment and Management of Female Reproductive Complications (J Clin Oncol. 2013)](https://pedsendo.org/clinical-resource/female-reproductive-health-after-childhood-adolescent-and-young-adult-cancers-guidelines-for-the-assessment-and-management-of-female-reproductive-complications-j-clin-oncol-2013/) - [Balancing the Benefits and Harms of Thyroid Cancer Surveillance in Survivors of Childhood, Adolescent and Young Adult Cancer: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium (Cancer Treat Rev. 2018)](https://pedsendo.org/clinical-resource/balancing-the-benefits-and-harms-of-thyroid-cancer-surveillance-in-survivors-of-childhood-adolescent-and-young-adult-cancer-recommendations-from-the-international-late-effects-of-childhood-cancer-gu/) - [Thyroid Sequelae of Pediatric Cancer Therapy](https://pedsendo.org/clinical-resource/thyroid-sequelae-of-pediatric-cancer-therapy/) - [Central Precocious Puberty Following the Diagnosis and Treatment of Paediatric Cancer and Central Nervous System Tumours: Presentation and Long-Term Outcomes (Clin Endocrinol (Oxf). 2016)](https://pedsendo.org/clinical-resource/central-precocious-puberty-following-the-diagnosis-and-treatment-of-paediatric-cancer-and-central-nervous-system-tumours-presentation-and-long-term-outcomes-clin-endocrinol-oxf-2016/) - [Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy - A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee (J Clin Endocrinol Metab. 2015)](https://pedsendo.org/clinical-resource/risk-of-neoplasia-in-pediatric-patients-receiving-growth-hormone-therapy-a-report-from-the-pediatric-endocrine-society-drug-and-therapeutics-committee-j-clin-endocrinol-metab-2015/) - [Neuroendocrine Morbidity After Pediatric Optic Gliomas: A Longitudinal Analysis of 166 Children Over 30 Years (JCEM 2015)](https://pedsendo.org/clinical-resource/neuroendocrine-morbidity-after-pediatric-optic-gliomas-a-longitudinal-analysis-of-166-children-over-30-years-jcem-2015/) - [Endocrine Outcomes for Children with Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy with Stem-Cell Rescue on the SJMB-96 Trial (J Clin Oncol. 2008)](https://pedsendo.org/clinical-resource/endocrine-outcomes-for-children-with-embryonal-brain-tumors-after-risk-adapted-craniospinal-and-conformal-primary-site-irradiation-and-high-dose-chemotherapy-with-stem-cell-rescue-on-the-sjmb-96-trial/) - [Craniopharyngioma (Endocr Rev. 2014)](https://pedsendo.org/clinical-resource/craniopharyngioma-endocr-rev-2014/) - [Endocrine Disorders Among Long-Term Survivors of Childhood Head and Neck Rhabdomyosarcoma](https://pedsendo.org/clinical-resource/endocrine-disorders-among-long-term-survivors-of-childhood-head-and-neck-rhabdomyosarcoma/) - [Endocrine Complications and Components of the Metabolic Syndrome in Survivors of Childhood Malignant Non-Brain Solid Tumors (HRP 2014)](https://pedsendo.org/clinical-resource/endocrine-complications-and-components-of-the-metabolic-syndrome-in-survivors-of-childhood-malignant-non-brain-solid-tumors-hrp-2014/) - [Late Effects in Children Treated with Intensive Multimodal Therapy for High-Risk Neuroblastoma: High Incidence of Endocrine and Growth Problems (BMT 2014)](https://pedsendo.org/clinical-resource/late-effects-in-children-treated-with-intensive-multimodal-therapy-for-high-risk-neuroblastoma-high-incidence-of-endocrine-and-growth-problems-bmt-2014/) - [National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report](https://pedsendo.org/clinical-resource/national-institutes-of-health-hematopoietic-cell-transplantation-late-effects-initiative-the-cardiovascular-disease-and-associated-risk-factors-working-group-report/) - [NCI, NHLBI/PBMTC First International Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges-Thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive Risks](https://pedsendo.org/clinical-resource/nci-nhlbi-pbmtc-first-international-conference-on-late-effects-after-pediatric-hematopoietic-cell-transplantation-endocrine-challenges-thyroid-dysfunction-growth-impairment-bone-health-reproduc/) - [Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation](https://pedsendo.org/clinical-resource/endocrine-disorders-in-childhood-cancer-survivors-treated-with-haemopoietic-stem-cell-transplantation/) - [Endocrine Late-Effects of Childhood Cancer and its Treatments](https://pedsendo.org/clinical-resource/endocrine-late-effects-of-childhood-cancer-and-its-treatments/) - [Childhood Cancer Treatments and Associated Endocrine Late Effects: A Concise Guide for the Pediatric Endocrinologist (HRP 2019)](https://pedsendo.org/clinical-resource/childhood-cancer-treatments-and-associated-endocrine-late-effects-a-concise-guide-for-the-pediatric-endocrinologist-hrp-2019/) - [Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review](https://pedsendo.org/clinical-resource/long-term-endocrine-and-metabolic-consequences-of-cancer-treatment-a-systematic-review/) - [Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline](https://pedsendo.org/clinical-resource/hypothalamic-pituitary-and-growth-disorders-in-survivors-of-childhood-cancer-an-endocrine-society-clinical-practice-guideline/) - Short Stature/Impaired Linear Growth GHD Central Precocious Puberty Hypogonadotropic Hypogonadism Central Hypothyroidism ACTH deficiency - [Late Effects of Treatments for Childhood Cancer (NIH-National Cancer Institute)](https://pedsendo.org/clinical-resource/late-effects-of-treatments-for-childhood-cancer-nih-national-cancer-institute/) - Endocrine Late-Effects of Treatment for Childhood Cancer - [Long-Term Follow Up Guidelines for Survivors of Cancer (Children Oncology Group 2018)](https://pedsendo.org/clinical-resource/long-term-follow-up-guidelines-for-survivors-of-cancer-children-oncology-group-2018/) - The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers - [Clinical Management of Menstruation in Adolescent Females With Developmental Delay (Endocrinologist 2004)](https://pedsendo.org/clinical-resource/clinical-management-of-menstruation-in-adolescent-females-with-developmental-delay-endocrinologist-2004/) - This review discusses the main concerns related to the management of menstruation in adolescent females with developmental delay. Results from a questionnaire evaluating the current practice of menstrual control in developmentally delayed females by pediatric endocrinologists are also summarized. Guidelines for clinical care are provided, taking into account the specific health issues of this particular - [Consensus Statement on Management of Intersex Disorders](https://pedsendo.org/clinical-resource/consensus-statement-on-management-of-intersex-disorders/) - The birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical techniques, understanding psychosocial issues, and recognizing and accepting the place of patient advocacy. The Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology considered it timely - [Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin](https://pedsendo.org/clinical-resource/reduction-in-the-incidence-of-type-2-diabetes-with-lifestyle-intervention-or-metformin/) - Prospective study conducted by the Diabetes Prevention Program Research Group, looking at reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. - [TODAY: A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes](https://pedsendo.org/clinical-resource/today-a-clinical-trial-to-maintain-glycemic-control-in-youth-with-type-2-diabetes/) - A comparison of the efficacy of three treatment regimens to achieve durable glycemic control in children and adolescents with recent-onset type 2 diabetes. - [Hgb A1c Measurement for the Diagnosis of Type 2 Diabetes in Children (Int. J of Ped. Endocrinology 2012)](https://pedsendo.org/clinical-resource/hgb-a1c-measurement-for-the-diagnosis-of-type-2-diabetes-in-children-int-j-of-ped-endocrinology-2012/) - Laboratory measurements of hemoglobin A1c above 6.5% were approved as an additional diagnostic criteria for diabetes mellitus by the American Diabetes Association in 2010. Several pediatric studies have cast HbA1c measurement in children in an unfavorable light in the pediatric population, by comparing HbA1c measurements to results on oral glucose tolerance test (OGTT) or fasting - [The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus (DCCT)](https://pedsendo.org/clinical-resource/the-effect-of-intensive-treatment-of-diabetes-on-the-development-and-progression-of-long-term-complications-in-insulin-dependent-diabetes-mellitus-dcct/) - DCCT research group results on effect of intensive treatment on complications. - [Historic Value: Pancreatic Extracts in the Treatment of Diabetes Mellitus](https://pedsendo.org/clinical-resource/historic-value-pancreatic-extracts-in-the-treatment-of-diabetes-mellitus/) - Iconic paper by Banting and Best describing use of insulin in diabetes for the first time. - [Risk Factors for Cerebral Edema in Children With Diabetic Ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics (NEJM 2001)](https://pedsendo.org/clinical-resource/risk-factors-for-cerebral-edema-in-children-with-diabetic-ketoacidosis-the-pediatric-emergency-medicine-collaborative-research-committee-of-the-american-academy-of-pediatrics-nejm-2001/) - A Multi-Center Study in 61 Children to Identify Risk Factors for Cerebral Edema in Diabetic Ketoacidosis, presented by the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics - [ESPE/PES Consensus Statement on DKA in Children and Adolescents (Pediatrics 2004)](https://pedsendo.org/clinical-resource/espe-pes-consensus-statement-on-dka-in-children-and-adolescents-pediatrics-2004/) - There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA to be managed. There is an agreement that prevention of DKA and reduction of its incidence should be a goal in managing children with diabetes. To explore these issues, - [Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes. PES D&T Committee Position statement. (Pediatrics 2006)](https://pedsendo.org/clinical-resource/continuous-subcutaneous-insulin-infusion-in-very-young-children-with-type-1-diabetes-pes-dt-committee-position-statement-pediatrics-2006/) - This review summarizes efficacy and safety of continuous subcutaneous insulin infusion in children ≤6 years of age, present potential pros and cons of using insulin pumps in this population, and propose clinical management guidelines that could be useful for both practitioners and third-party payers alike. Keeping in mind the recent significant increase in number of - [Hyperglycemic Hyperosmolar Syndrome in Children: Pathophysiological Considerations and Suggested Guidelines for Treatment (J of Pediatrics 2011)](https://pedsendo.org/clinical-resource/hyperglycemic-hyperosmolar-syndrome-in-children-pathophysiological-considerations-and-suggested-guidelines-for-treatment-j-of-pediatrics-2011-2/) - HHS pathophysiology, treatment and complications in children. - [Cystic Fibrosis-Related Diabetes (CFRD) ISPAD Clinical Practice Consensus Guidelines](https://pedsendo.org/clinical-resource/cystic-fibrosis-related-diabetes-cfrd-ispad-clinical-practice-consensus-guidelines/) - Updated ISPAD guidelines on pathophysiology, diagnosis, clinical course and management of Cystic-fibrosis Related Diabetes. These talk about the role of glucose tolerance tests, hemoglobin A1c, continuous glucose monitoring and other clinical tools to help manage this unique condition. - [ADA Standards of Medical Care in Diabetes - 2020](https://pedsendo.org/clinical-resource/ada-standards-of-medical-care-in-diabetes-2020/) - Annually revised Standards of Diabetes Care published by ADA in Diabetes Care. - [Hypophosphatasia and Asfotase Alfa - ALEXION Website](https://pedsendo.org/clinical-resource/hypophosphatasia-and-asfotase-alfa-alexion-website/) - [Monitoring Guidance for Patients with Hypophosphatasia Treated with Asfotase Alfa (Mol Genet Metab. 2017)](https://pedsendo.org/clinical-resource/monitoring-guidance-for-patients-with-hypophosphatasia-treated-with-asfotase-alfa-mol-genet-metab-2017/) - [A Diagnostic Algorithm for Children with Low Alkaline Phosphatase (JPeds 2016)](https://pedsendo.org/clinical-resource/a-diagnostic-algorithm-for-children-with-low-alkaline-phosphatase-jpeds-2016/) - Congenital and acquired conditions leading to low Alkaline Phosphatase. - [Global Consensus Recommendations on Prevention and Management of Nutritional Rickets](https://pedsendo.org/clinical-resource/global-consensus-recommendations-on-prevention-and-management-of-nutritional-rickets/) - This consensus document defines nutritional rickets and its diagnostic criteria and describes the clinical management of rickets and osteomalacia. Risk factors, particularly in mothers and infants, are ranked, and specific prevention recommendations including food fortification and supplementation are offered for both the clinical and public health contexts. - [Approach to the Child with Fractures](https://pedsendo.org/clinical-resource/approach-to-the-child-with-fractures/) - Differential diagnosis Evaluation Treatment Side Effects and monitoring of Bisphosphonates. - [Informing Evidence-Based Clinical Practice Guidelines for Children with Cerebral Palsy at Risk of Osteoporosis: An Update (Dev Med Child Neurol 2016)](https://pedsendo.org/clinical-resource/informing-evidence-based-clinical-practice-guidelines-for-children-with-cerebral-palsy-at-risk-of-osteoporosis-an-update-dev-med-child-neurol-2016/) - New evidence for weight-bearing, bisphosphonates, and vitamin D and calcium interventions, updating the systematic review and clinical practice guidelines for osteoporosis in children with cerebral palsy (CP) published in 2011. - [Treatment of Cushing's Syndrome: ENDO Society Practice Guideline (JCEM 2015)](https://pedsendo.org/clinical-resource/treatment-of-cushings-syndrome-endo-society-practice-guideline-jcem-2015/) - Optimal adjunctive management First-line treatment options Remission and recurrence Glucocorticoid replacement and discontinuation, and resolution of other hormonal deficiencies Second-line therapeutic options Surgery Long-term follow up. - [Diagnosis of Cushing's Syndrome: ENDO Society Practice Guideline (JCEM 2008)](https://pedsendo.org/clinical-resource/diagnosis-of-cushings-syndrome-endo-society-practice-guideline-jcem-2008/) - Who should be tested Initial screening Subsequent evaluations - [Diagnosis and Treatment of Primary Adrenal Insufficiency (JCEM 2016)](https://pedsendo.org/clinical-resource/diagnosis-and-treatment-of-primary-adrenal-insufficiency-jcem-2016/) - Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline Testing Treatment Monitoring Adrenal crisis prevention - [Rare Defects in Adrenal Steroidogenesis (Eur J Endo 2018)](https://pedsendo.org/clinical-resource/rare-defects-in-adrenal-steroidogenesis-eur-j-endo-2018/) - [Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn Screen (JCEM 2018)](https://pedsendo.org/clinical-resource/adrenoleukodystrophy-guidance-for-adrenal-surveillance-in-males-identified-by-newborn-screen-jcem-2018/) - [Historic Value: Treatment of Congenital Adrenal Hyperplasia with Cortisone](https://pedsendo.org/clinical-resource/historic-value-treatment-of-congenital-adrenal-hyperplasia-with-cortisone/) - [Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline (JCEM 2018)](https://pedsendo.org/clinical-resource/congenital-adrenal-hyperplasia-due-to-steroid-21-hydroxylase-deficiency-an-endocrine-society-clinical-practice-guideline-jcem-2018/) - CAH due to 21-OHase deficiency ENDO Clinical Practice Guideline 2018 - [COVID-19 Resources Related to Endocrinology and Diabetes](https://pedsendo.org/clinical-resource/covid-19-resources-related-to-endocrinology-and-diabetes/) - [Emergency Management of Adrenal Insufficiency (PES Drugs and Therapeutics Committee 2019)](https://pedsendo.org/clinical-resource/emergency-management-of-adrenal-insufficiency-pes-drugs-and-therapeutics-committee-2019/) ## Patient Resources - [Nutritional Tool Kit for Dyslipidemia Management](https://pedsendo.org/patient-resource/nutritional-tool-kit-for-dyslipidemia-management/) - [Ketotic Hypoglycemia](https://pedsendo.org/patient-resource/what-is-ketotic-hypoglycemia/) - What is Ketotic Hypoglycemia? Hypoglycemia is a condition where your blood sugar is under normal ranges. While this is a common problem in patients with diabetes, it can happen in people without diabetes. People with low blood sugars can have symptoms such as sluggishness, tiredness, irritability, shakiness, unconsciousness, or seizures. While some children may start - [Turner Syndrome](https://pedsendo.org/patient-resource/turner-syndrome/) - Turner Syndrome: A Guide for Families What is Turner Syndrome? Turner syndrome happens when a girl is born missing part or all of one X chromosome. This is a change in the genes that happens by chance. It happens in about 1 out of every 2,000 to 2,500 baby girls born. It is not passed - [Noonan Syndrome: A Guide for Parents](https://pedsendo.org/patient-resource/noonan-syndrome-a-guide-for-parents/) - Noonan syndrome is a genetic condition diagnosed in 1 in 1000-2500 live births. It can cause a variety of issues that can affect the heart, growth and learning. Noonan syndrome can be inherited from a parent, or it can be a random genetic difference that the baby is born with. Children with Noonan syndrome often - [Prenatal Diagnosis of Differences of Sex Development (DSD)](https://pedsendo.org/patient-resource/prenatal-diagnosis-of-differences-of-sex-development-dsd/) - What is a DSD? The term “differences in sex development” or DSD refers to the situation in which the baby’s external genitalia appear atypical. In other words, the external genitalia do not look typical for a boy or a girl. Approximately 1 in 4000 infants have a DSD. Atypical external genitalia are usually noted at - [Primary Ovarian Insufficiency](https://pedsendo.org/patient-resource/primary-ovarian-insufficiency/) - What is primary ovarian insufficiency? Primary ovarian insufficiency (POI) is the medical condition in which the ovaries stop working normally in girls and women before age 40 years. In the past, this condition has also been called premature ovarian failure. In these patients, the ovaries stop producing eggs every month and do not produce normal - [Osteogenesis Imperfecta](https://pedsendo.org/patient-resource/osteogenesis-imperfecta/) - Osteogenesis Imperfecta What is osteogenesis imperfecta? Osteogenesis imperfecta (OI) is a genetic bone disorder in which bones are fragile and break more easily. It has also been called “brittle bone disease”. It is a rare condition that affects 1 in 20,000 births. There are 16 different types that vary from mild to severe. What causes - [McCune-Albright Syndrome](https://pedsendo.org/patient-resource/19969/) - What is McCune-Albright Syndrome? McCune-Albright Syndrome encompasses three main components but can have several more features. The three main components are early onset of puberty, abnormal skin pigmentation called café-au-lait spots, and a bone disorder called fibrous dysplasia of the bone. Other features include other endocrine hormone abnormalities like increased secretion of thyroid hormones, growth - [Hypoglycemia](https://pedsendo.org/patient-resource/hypoglycemia/) - Hypoglycemia, or low blood sugar, is any blood sugar below 70 mg/dL. Our goal is for you to have less than 2 low blood sugars in a week during the daytime, never have a low blood sugar while you are asleep and to avoid severe hypoglycemia needing assistance from others at all times. Check blood - [Neonatal Hypoglycemia](https://pedsendo.org/patient-resource/neonatal-hypoglycemia/) - As a baby transitions from life inside their mother into the outside world, several different processing within the baby’s body are changing quickly. One important process is the baby’s body learns to keep its blood sugar stable. Sugar (sometimes called glucose) is used to provide energy for the baby, especially for the baby’s brain. It - [Glycogen Storage Disease: A Guide for Families](https://pedsendo.org/patient-resource/glycogen-storage-disease-a-guide-for-families/) - What are glycogen storage diseases? Glycogen storage diseases (or GSDs), as the name suggests, are a group of conditions caused by an inability to store or release glycogen in the liver or muscle. Glycogen is made from joining multiple glucose (or sugar) molecules together. In order to save extra glucose eaten during a meal, liver - [Differences of Sex Development (DSD)](https://pedsendo.org/patient-resource/differences-of-sex-development-dsd/) - Differences of Sex Development (DSD) What to Expect After the Birth of a Baby with Atypical Genitalia Congratulations on the birth of your baby! This handout will help you understand the first steps of caring for a baby with atypical external genital development. Such conditions affect the development of the external genitalia and are called - [Hyperprolactinemia](https://pedsendo.org/patient-resource/hyperprolactinemia/) - Hyperprolactinemia What is Hyperprolactinemia? Hyperprolactinemia is a condition where your child’s body produces higher-than-normal levels of prolactin, a hormone made in the pituitary gland in the brain. Prolactin naturally increases after giving birth in females and plays a role in stimulating breast milk production. However, it can also be high due to the following reasons: - [Transgender Care](https://pedsendo.org/patient-resource/transgender-care/) - Introduction to Health for Transgender Youth: What is Gender Identity? Gender identity is a person’s intrinsic sense of being male, female, a combination of male and female, or neither male or female. Gender identity can be the same as one’s assigned sex at birth (“cis-gender”), or may vary. Transgender is umbrella term for people whose - [Prediabetes in Children and Adolescents: A Guide for Families](https://pedsendo.org/patient-resource/type-2-prediabetes-in-children-and-adolescents-a-guide-for-families/) - Prediabetes in Children and Adolescents: A Guide for Families What is Prediabetes? Prediabetes refers to high blood glucose levels but not yet high enough to be diagnosed with Type 2 diabetes. Patients with prediabetes should be monitored closely because it may develop into Type 2 diabetes over time. Glucose (sugar) is the primary fuel of your - [Mini Dose Glucagon](https://pedsendo.org/patient-resource/mini-dose-glucagon/) - PATIENT INSTRUCTIONS FOR MINI DOSE GLUCAGON: Why do I need to use it? · During illness, sick children may be unable to keep down food. · In patients on insulin therapy, the lack of food intake and the insulin “onboard” can make blood sugars drop quickly. · Low doses - [Goiter](https://pedsendo.org/patient-resource/goiter/) - Goiter What is goiter? “Goiter” is the name used for an enlarged thyroid gland. The thyroid gland is a butterfly-shaped endocrine organ located in your neck. The thyroid gland makes thyroid hormones which then move through the blood stream to other tissues in the body. Thyroid hormones help with overall body health. Specifically, thyroid hormones - [Metformin: What I Need to Know](https://pedsendo.org/patient-resource/metformin-what-i-need-to-know/) - What is metformin used for? • Prediabetes, Type 2 Diabetes How does it work? • Metformin helps keep blood sugars in a normal range by helping our body use our own insulin better. It also causes the liver to make less sugar. What forms does metformin come in? • Metformin immediate release o 500 mg - [Long Term Complications of Diabetes](https://pedsendo.org/patient-resource/long-term-complications-of-diabetes/) - • Hemoglobin A1c (glycosylated hemoglobin) reflects your average blood glucose over the last approximately 90 days. It measures how much sugar is attached to your red blood cells. o Diabetes range greater than >6.5% o Target for diabetes varies based on your type of diabetes and your age so check with your healthcare provider for - [Liraglutide: What I Need to Know](https://pedsendo.org/patient-resource/liraglutide-what-i-need-to-know/) - How is it given? • Given as an injection once a day How do I give the injection? • Liraglutide comes in a “pen” form. Add a needle to the pen to give the injection. • Given under the skin (subcutaneously) similar to insulin How is it usually dosed? • Typical doses are 0.6 mg - [Intranasal(in) Glucagon](https://pedsendo.org/patient-resource/intranasalin-glucagon/) - PATIENT INSTRUCTIONS FOR INTRANASAL(IN) GLUCAGON: Why do I need to use it? · Glucagon should be used to raise glucose levels that are dangerously low. · Glucagon raises the glucose by stimulating the release of glycogen from the liver and muscles. When do I need to use it? · In the event that - [Insulin Pump Failure: A Guide for Families](https://pedsendo.org/patient-resource/insulin-pump-failure-a-guide-for-families/) - Pump Site Failure This is the most common cause for insulin pump failure. The site may have disconnected or kinked stopping the flow of insulin. When to suspect pump failure: • Consider pump failure when blood sugars continue to be high even though you are giving correction boluses through the pump • Consider pump failure - [Exenatide: What I Need to Know](https://pedsendo.org/patient-resource/exenatide-what-i-need-to-know/) - How is it given? • Given as an injection once a week How do I give the injection? • Exenatide comes in a “pen” form. Add a needle to the pen to give the injection. • Given under the skin (subcutaneously) similar to insulin How is it usually dosed? • 2 mg injection once a - [Obesity](https://pedsendo.org/patient-resource/obesity/) - Obesity What is obesity? Obesity is an increasingly common situation that affects approximately one in five children globally. Obesity in childhood predicts future weight status and is associated with an increased risk for health problems. How is obesity defined? Body mass index (BMI) is a calculation based on a child’s height and weight. BMI is - [Driving and Diabetes](https://pedsendo.org/patient-resource/driving-and-diabetes/) - Having diabetes does not mean you cannot drive a car, but some extra steps are needed to make sure you are driving safely! How can diabetes affect my driving? • Treatment with insulin and some oral anti-diabetes medications may cause low blood sugars leading to sleepiness, dizziness, confusion, blurry vision, loss of consciousness, or seizures. - [Diabetes Insipidus](https://pedsendo.org/patient-resource/diabetes-insipidus/) - What is diabetes insipidus (DI)? Diabetes insipidus is a rare disorder in which a person urinates an excessive amount, is more thirsty than usual, and drinks an excessive amount of fluid. This can be caused by a hormone deficiency (anti-diuretic hormone or ADH) or a decreased ability of the kidney to respond to this hormone. - [Diabetes and Pregnancy](https://pedsendo.org/patient-resource/diabetes-and-pregnancy/) - If you are planning pregnancy, think you are pregnant or are confirmed to be pregnant, let your diabetes team know right away so they can help you with proper management. Preconception Counseling: • Pregnancy and healthy pregnancy is possible with diabetes and is possible any time • Achieving glucose levels as near normal as safely - [Reactive Hypoglycemia](https://pedsendo.org/patient-resource/reactive-hypoglycemia/) - Reactive Hypoglycemia Definition Reactive hypoglycemia (also called functional hypoglycemia) is a condition in which a patient feels low blood sugar symptoms but has a blood sugar reading within the normal range. The symptoms then resolve with eating or drinking. Symptoms of hypoglycemia Symptoms of low blood sugar include hunger, irritability, sweating, nausea, shaking, heart racing, - [Hypothalamic Obesity](https://pedsendo.org/patient-resource/hypothalamic-obesity/) - What is Hypothalamic Obesity? Hypothalamic obesity (HO) is a rare health problem that happens when part of the brain called the hypothalamus gets injured or does not work the right way. The hypothalamus helps control hunger/satiety (feeling full) and how your body uses energy. If it is damaged: • You may feel hungry all the - [The Biological Reality of Sex and Intersex: A Response to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government”](https://pedsendo.org/patient-resource/the-biological-reality-of-sex-and-intersex/) - The Biological Reality of Sex and Intersex: A Response to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government” What is the reason for this Statement? This Statement responds to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government,” - [Burosumab (CRYSVITA®)](https://pedsendo.org/patient-resource/burosumab-crysvita/) - Burosumab (CRYSVITA®) What are bones made of? Bones are made up of many minerals including calcium and phosphorus. Low phosphorus levels in the body can lead to poor bone health and symptoms may include bone pain, bowed legs, and softer, weaker bones. What is X-linked hypophosphatemia? X-linked hypophosphatemia (XLH) is a genetic disease caused by - [Bone Health](https://pedsendo.org/patient-resource/bone-health/) - Bone Health Your bones are an important part of your body and store very important minerals. Did you know that your bones gain strength until you are 20-30 years of age and then at an older age you start losing bone strength? The amount of bone you gain during childhood can protect you from weak - [Bone Density Testing](https://pedsendo.org/patient-resource/bone-density-testing/) - Bone density test in children Your child’s doctor has ordered a bone density test for your child. This may be because your child has a history of multiple fractures, or is suspected to have a specific bone health concern such as brittle bone disease or low bone density due to chronic medical conditions. The purpose - [MODY: Monogenic diabetes, or Maturity-Onset Diabetes of the Young](https://pedsendo.org/patient-resource/mody-monogenic-diabetes-or-maturity-onset-diabetes-of-the-young-2/) - MODY: Monogenic diabetes, or Maturity-Onset Diabetes of the Young What is monogenic diabetes? Monogenic diabetes, or Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes. It is different from Type 1 Diabetes and Type 2 Diabetes. MODY is caused by a mutation in a single gene, and therefore can be passed from parents to - [Acquired Hypothyroidism](https://pedsendo.org/patient-resource/acquired-hypothyroidism/) - Acquired Hypothyroidism in Children: A Guide for Families What is the thyroid? The thyroid gland is a butterfly-shaped organ usually located in the lower front of the neck. The thyroid gland makes the thyroid hormones which are released into the bloodstream to be carried to other tissues in the body. The thyroid hormones are thyroxine - [Bisphosphonate Therapy](https://pedsendo.org/patient-resource/pamidronate-and-zoledronic-acid-infusions/) - Pamidronate and Zoledronic Acid Infusions What are Pamidronate and Zoledronic Acid? Pamidronate and zoledronic acid are medications that belong to a class of drugs known as “bisphosphonates”. Why are these medications prescribed? These medications are prescribed for children who have fragile bones and multiple bone fractures. At the level of bone cells, new bone is - [Fertility Preservation](https://pedsendo.org/patient-resource/fertility-preservation/) - Fertility Preservation What is fertility preservation? Fertility is the ability to conceive or have a biological child (a child that is related by blood to the parent). This requires an oocyte (an immature egg) and a sperm cell. Oocytes are made by girls/ women in the ovaries and sperm cells are made by boys/men in - [Craniopharyngioma](https://pedsendo.org/patient-resource/craniopharyngioma/) - What is Craniopharyngioma? Craniopharyngioma is a brain tumor in the midline of the brain. This is located near the hypothalamus and pituitary gland, and where the two optic nerves cross each other (chiasm). The hypothalamus and pituitary gland play an important role in making and adjusting the levels of the body’s hormones. The optic nerves - [Cancer Survivorship](https://pedsendo.org/patient-resource/cancer-survivorship/) - Endocrinology Late Effects in Cancer Survivors: A Guide for Families Advances over the years have allowed more children to “beat cancer” and survive into adulthood. Unfortunately, cancer treatments can cause health complications long after the cancer has been cured, called “late effects.” Not all cancer survivors are at risk for the same late effects. The - [Hypoparathyroidism](https://pedsendo.org/patient-resource/hypoparathyroidism/) - Hypoparathyroidism: A Guide for Families What is hypoparathyroidism? Calcium is essential for the functioning of your body’s nerves, muscles, bones, and cells. Therefore, the body monitors and tries to keep levels of calcium, and the related mineral phosphorus, normal at all times. An important hormone to regulate these levels is parathyroid hormone (PTH). Hypoparathyroidism is - [DiGeorge Syndrome](https://pedsendo.org/patient-resource/digeorge-syndrome/) - What is DiGeorge Syndrome? DiGeorge syndrome is a genetic condition where a small part of chromosome 22 is missing. A patient with DiGeorge syndrome is missing a segment in one copy of chromosome 22 at a location called q11.2 (22q11.2 deletion syndrome). The deletion can involve many genes that are close together. The signs and - [Optic Nerve Hypoplasia](https://pedsendo.org/patient-resource/optic-nerve-hypoplasia/) - Optic Nerve Hypoplasia / Hypopituitarism (previously known as Septo-optic Dysplasia) What is Optic Nerve Hypoplasia / Hypopituitarism? This rare condition is associated with small or underdeveloped optic nerves, abnormal formation of structures along the midline or middle of the brain, and hypoplasia or underdevelopment of the pituitary gland. It is diagnosed in 1 out of - [Premature Adrenarche](https://pedsendo.org/patient-resource/premature-adrenarche/) - Premature Adrenarche: A Guide for Families What is Premature Adrenarche? Pubic hair typically appears after age 8 years in girls and after age 9 years in boys. Changes in the hormones made by the adrenal gland lead to the development of pubic hair, axillary hair, acne, and adult-type body odor at the time of puberty. - [Polycystic Ovary Syndrome](https://pedsendo.org/patient-resource/polycystic-ovary-syndrome/) - Polycystic Ovary Syndrome: A Guide for Families What is Polycystic Ovary Syndrome (PCOS)? Polycystic ovary syndrome (PCOS) is common disorder in girls associated with symptoms of excess body hair (hirsutism), severe acne, and menstrual cycle problems. The excess body hair can be on the face, chin, neck, back, chest, breasts, or abdomen. The menstrual cycle - [Hyperthyroidism](https://pedsendo.org/patient-resource/hyperthyroidism/) - Hyperthyroidism: A Guide for Families What is Hyperthyroidism? Hyperthyroidism refers to too much thyroid hormone in the blood coming from the thyroid gland. The signs and symptoms are listed below. It can occur at any age but more often above age 10 and more often in girls than in boys. Children and adolescents may have - [Hypercholesterolemia](https://pedsendo.org/patient-resource/hypercholesterolemia/) - Hypercholesterolemia: A Guide for Families What is Hypercholesterolemia? Hypercholesterolemia in a child means elevated blood cholesterol levels. Hyperlipidemia is a more general term that refers to elevation of cholesterol or triglyceride level. Total cholesterol is made up of non–high-density lipoprotein (HDL) cholesterol (non–HDL-C) and HDL cholesterol (HDL-C). Non–HDL-C is made up of low-density lipoprotein (LDL) - [Growth Hormone Deficiency](https://pedsendo.org/patient-resource/growth-hormone-deficiency/) - Growth Hormone Deficiency: A Guide for Families What is Growth Hormone Deficiency? Growth hormone deficiency is a rare cause of growth failure in which the child does not make enough growth hormone to grow normally. Growth hormone is one of several hormones made by the pituitary gland, which is located at the base of the - [Delayed Puberty - Girls](https://pedsendo.org/patient-resource/delayed-puberty-girls/) - Delayed Puberty in Girls: A Guide for Families How is Delayed Puberty in Girls Defined? Puberty starts when the pituitary gland begins to produce two hormones, luteinizing hormone (called LH) and follicle-stimulating hormone (called FSH), which cause the ovaries to enlarge and begin producing estrogens. The growth spurt starts shortly after breasts begin to develop, - [Delayed Puberty - Boys](https://pedsendo.org/patient-resource/delayed-puberty-boys/) - Delayed Puberty in Boys: A Guide for Families How is Delayed Puberty in Boys Defined? Boys can start puberty at a wide range of ages, with 95% starting between the ages of 9 and 14, so we consider puberty delayed when it has not started by age 14. The earliest sign of puberty in boys - [Constitutional Growth Delay](https://pedsendo.org/patient-resource/constitutional-growth-delay/) - Constitutional Growth Delay and Familial Short Stature: A Guide for Families What is Short Stature? Doctors usually define short stature based on standard growth charts, rather than how a child compares in height with his or her classmates. Growth charts show that for each age, there is a range of heights that are normal for - [Congenital Hypothyroidism](https://pedsendo.org/patient-resource/congenital-hypothyroidism/) - Congenital Hypothyroidism: A Guide for Families What is Congenital Hypothyroidism? Hypothyroidism refers to an underactive thyroid gland. Congenital hypothyroidism occurs when a baby is born without the ability to make normal amounts of thyroid hormone. Congenital hypothyroidism occurs in about 1 in 3,000 to 4,000 newborns. It is often permanent with lifelong treatment. Thyroid hormone - [Congenital Adrenal Hyperplasia](https://pedsendo.org/patient-resource/congenital-adrenal-hyperplasia/) - Congenital Adrenal Hyperplasia: A Guide for Families What is Congenital Adrenal Hyperplasia (CAH)? The adrenal glands are located on top of the kidneys and produce several different hormones. Congenital adrenal hyperplasia (CAH) is a common inherited disorder in which the adrenal gland cannot make enough of a hormone, called cortisol, or a salt-preserving hormone, called - [Type 2 Diabetes](https://pedsendo.org/patient-resource/type-2-diabetes/) - Type 2 Diabetes: A Guide for Families What is Type 2 Diabetes? Diabetes is diagnosed when a high level of sugar is detected in the blood. Although there are other types of diabetes, including type 1 diabetes and gestational diabetes, type 2 diabetes is the most common form overall. It is less common in children, - [Type 1 Diabetes](https://pedsendo.org/patient-resource/type-1-diabetes/) - Type 1 Diabetes: A Guide for Families What is Type 1 Diabetes? Type 1 diabetes is a disease characterized by a high level of sugar in the blood caused by a lack of insulin. Insulin is a hormone (a special messenger compound) made in cells (called beta cells) in an organ located behind the stomach - [Thyroid Hormone Administration](https://pedsendo.org/patient-resource/thyroid-hormone-administration/) - Thyroid Hormone Administration: A Guide for Families What is Thyroid Hormone? Thyroid hormone is the medication prescribed by your child’s doctor to treat hypothyroidism, also known as an underactive thyroid gland. The body makes 2 forms of thyroid hormone, levothyroxine (T4) and triiodothyronine (T3). Generally, prescribed thyroid hormone comes in the form of T4, which - [Short Stature](https://pedsendo.org/patient-resource/short-stature/) - Short Stature: A Guide for Families What is Short Stature? Short stature refers to any child who has a height well below what is typical for that child’s age and sex. The term is most commonly applied to children whose height, when plotted on a growth curve in the pediatrician’s office, is below the line - [Pubertal Gynecomastia](https://pedsendo.org/patient-resource/pubertal-gynecomastia/) - Pubertal Gynecomastia: A Guide for Families What is Gynecomastia? Gynecomastia is the medical term for the presence of breast tissue in boys and men. Many boys have the appearance of a small amount of breast tissue in early puberty. Occasionally, the amount of tissue can appear excessive and may cause some pain or tenderness. What - [Premature Thelarche](https://pedsendo.org/patient-resource/premature-thelarche/) - Premature Thelarche: A Guide for Families What is Premature Thelarche? Thelarche is a medical term referring to the appearance of breast development in girls, which usually occurs after age 8 years and is accompanied by other signs of puberty, including a growth spurt. Premature thelarche describes girls who develop a small amount of breast tissue - [Precocious Puberty](https://pedsendo.org/patient-resource/precocious-puberty/) - Precocious Puberty: A Guide for Families What is Precocious Puberty? Puberty is defined as the presence of secondary sexual characteristics: breast development in girls, pubic hair, and testicular and penile enlargement in boys. Precocious puberty is usually defined as onset of puberty before age 8 in girls and before age 9 in boys. It has - [Klinefelter Syndrome](https://pedsendo.org/patient-resource/klinefelter-syndrome/) - Klinefelter Syndrome: A Guide for Families What is Klinefelter Syndrome? It is a condition in boys caused by the presence of an extra X chromosome. Boys normally have one X and one Y chromosome, but most boys with Klinefelter syndrome have two X and one Y chromosome. It is relatively common, occurring in about 1 - [Hypertriglyceridemia](https://pedsendo.org/patient-resource/hypertriglyceridemia/) - Hypertriglyceridemia: A Guide for Families What is Hypertriglyceridemia? Triglycerides are a type of fat circulating in the blood. They are an important source of stored energy. Hypertriglyceridemia means an elevated blood level of fasting triglycerides. It is important to fast for 8 to 12 hours before checking triglyceride levels. Patients with high triglyceride levels also - [Growth in Babies Born Small for Gestational Age](https://pedsendo.org/patient-resource/growth-in-babies-born-small-for-gestational-age/) - Growth in Babies Born Small for Gestational Age: A Guide for Families What Does Small for Gestational Age (SGA) Mean? Small for gestational age (SGA) refers to a baby who is born with a weight below the 10th percentile on the growth chart for gestational age and sex. Having a weight below the 10th percentile - [Adrenal Insufficiency](https://pedsendo.org/patient-resource/adrenal-insufficiency/) - Adrenal Insufficiency: A Guide for Families What is Adrenal Insufficiency? The adrenal gland is located on top of the kidney and makes 3 types of hormones: corticosteroids or glucocorticoids (the main hormone is cortisol, which is also known as hydrocortisone); mineralocorticoids (the main hormone is aldosterone); and weak male-type sex steroid hormones known as the - [Genetic Testing](https://pedsendo.org/patient-resource/genetic-testing/) - Genetic Testing: A Guide for Families What is Genetic Testing? Genetic testing looks for changes in the structure of an individual’s genes. Genes are the DNA instructions that are inherited, or “passed down,” from parents. Each person has one copy of genes inherited from his or her mother and another copy inherited from his or - [Growth Hormone Injections](https://pedsendo.org/patient-resource/growth-hormone-injections/) - Growth Hormone Injections: Useful Tips for Parents What is Growth Hormone Treatment? Growth hormone is a protein hormone that is usually made by the pituitary gland to help your child grow. If you are reading this, your doctor has discussed the possibility of treating your child’s condition with growth hormone. After training, you will be ## Special Interest Groups - [Turner Syndrome](https://pedsendo.org/sig/turner-syndrome/) - Mission Statement To enhance the clinical care of individuals with Turner syndrome, the PES TS SIG aims to improve dissemination of knowledge, increase awareness, establish mechanisms for research and clinical collaborations, and organize advocacy efforts. Goals and Objectives Advocacy Subcommittee: Liaisons : Doris Fadoju, Nandini Vijayakanthi Support formation of Turner syndrome multidisciplinary clinics in more - [Advanced Practice Providers (APP)](https://pedsendo.org/sig/advanced-practice-providers-app/) - Mission Statement Advanced practice providers (APPs) include nurse practitioners (NPs) and physician assistants (PAs), functioning in various specialized healthcare roles. Pediatric endocrine APPs are trained to care for all endocrine diagnoses. The Pediatric Endocrine Society APP Special Interest Group (PES APP SIG) provides a community for pediatric endocrine APPs—promoting professional growth, strengthening the presence of - [Tumor Related Endocrine and Neuroendocrine Disorders](https://pedsendo.org/sig/tumor-related-endocrine-and-neuroendocrine-disorders/) - Mission Statement Cancer affects approximately 1 in 285 children before the age of 20, and advances in oncology have created a growing population of patients whose care increasingly depends on expertise at the intersection of endocrinology and cancer. From endocrine and neuroendocrine tumors and hereditary cancer predisposition syndromes to the endocrine consequences of cancer therapies - [Ethics](https://pedsendo.org/sig/ethics/) - Mission Statement Ethical dilemmas frequently arise in the care of pediatric patients. Our mission is to identify and address ethical considerations in pediatric endocrinology. Our goals are to ensure that ethical principles are 1) considered in the development of new practice guidelines, and 2) integrated both into fellow training and into ongoing medical education after - [Bone and Mineral](https://pedsendo.org/sig/bone-and-mineral/) - Mission Statement Pediatric bone and mineral disorders include a vast number of acquired and genetic conditions encompassing numerous medical/surgical disciplines and requiring multidisciplinary care. Pediatric endocrinologists play an important role in providing care for these patients. The Bone and Mineral Special Interest Group aims to increase awareness, share knowledge, promote collaborations, and provide education to - [Differences of Sex Development](https://pedsendo.org/sig/differences-of-sex-development/) - Mission Statement The PES DSD SIG is a professional network of PES members with an interest in endocrine conditions that cause atypical genital development. The mission of the DSD SIG is to improve care for patients with these conditions by reviewing and disseminating best practices for management, promoting education of fellows and other trainees, identifying - [PMOS](https://pedsendo.org/sig/pmos/) - New Resources! PMOS Toolkit. Click here to download. MISSION STATEMENT: Polyendocrine Metabolic Ovarian Syndrome (PMOS) (formerly known as Polycystic ovary syndrome (PCOS)) is a common endocrinopathy that presents in adolescence. The diagnosis of PMOS can be challenging and is associated with conditions also treated by endocrinologists including obesity, dyslipidemia, dysglycemia. As pediatric endocrinologists, we are - [Adrenal SIG](https://pedsendo.org/sig/pes-adrenal-sig/) - Mission Statement Pediatric adrenal gland disorders include a wide variety of acquired and genetic conditions that require interdisciplinary care. The PES Adrenal SIG is a professional network of PES members with an interest in adrenal gland disorders in children. • Congenital adrenal hyperplasia (CAH) • Adrenocortical tumors • Pheochromocytoma • Primary hyperaldosteronism • Cushing’s disease - [Prader-Willi Syndrome](https://pedsendo.org/sig/prader-willi-syndrome/) - The PES PWS SIG will help all PES members to improve their clinical care of patients with PWS through increased education, collaboration and resource development. This will include efforts focused on clinical research, optimization of standards of care, and education for patients, families, and providers. The PES PWS SIG aims promote partnerships and collaboration between multidisciplinary clinical teams, individual experts, and - [Diabetes](https://pedsendo.org/sig/diabetes/) - Mission Statement Pediatric diabetes is the preeminent and ever growing challenge to the field of Pediatric Endocrinology. The Diabetes Special Interest Group aims to bring pediatric diabetes to the forefront of the PES in order to enhance care, improve outcomes and train the future generations of pediatric endocrinologists. We intend to provide support and guidance - [Lipid](https://pedsendo.org/sig/lipid/) - Mission Statement Cardiovascular disease is the leading cause of morbidity and mortality in the United States. In addition to highly prevalent genetic dyslipidemias, many endocrinology related conditions such as diabetes, metabolic syndrome, Cushing’s syndrome, growth hormone deficiency, congenital adrenal hyperplasia, polycystic ovary syndrome, hypopituitarism (to name a few) are associated with dyslipidemia. As pediatric endocrinologists, - [Hypoglycemia](https://pedsendo.org/sig/hypoglycemia/) - Mission Statement Hypoglycemia disorders are rare, but their consequences in children can be severe and have a lasting impact. The PES Hypoglycemia Disorders Special Interest Group (SIG) aims to improve the diagnosis and management of infants and children with hypoglycemia disorders through education, clinical care standardization, research and advocacy. Goals and Objectives Education Develop and - [Diabetes Type II](https://pedsendo.org/sig/diabetes-type-ii/) - Mission: The PES Type 2 Diabetes SIG aims to improve the treatment of clinical care of those with youth-onset diabetes by addressing the unique features of this disease, which differs both from youth-onset type 1 diabetes and adult-onset type 2 diabetes, through education, clinical care standardization, research and advocacy. Goals: 1. To develop and maintain - [Obesity](https://pedsendo.org/sig/obesity/) - Mission Statement To promote prevention and support excellence in the treatment of pediatric obesity and its comorbidities. Goals and Objectives The Pediatric Obesity SIG will: Provide up-to-date recommendations and research findings in the diagnosis and management of obesity and related comorbidities Educate subspecialists, primary care physicians, patients and the public regarding recommendations for the prevention - [Transgender Health](https://pedsendo.org/sig/transgender-health/) - Bills that threaten the health of transgender and gender diverse (TGD) youth have been introduced in multiple state legislatures across the United States. These bills undermine medical recommendations and seek to criminalize health care professionals who provide gender-affirming care such as puberty suppressing medications and gender-affirming hormone therapy. Read full position statement here. Mission Statement The - [Thyroid Disease SIG](https://pedsendo.org/sig/thyroid-disease-sig/) - Mission: The incidence of the pediatric thyroid disease is increasing including mild and borderline forms of congenital hypothyroidism, autoimmune thyroid disease, thyroid nodules, and pediatric thyroid cancer. A significant number of children have abnormal thyroid function as a response to obesity. There is growing interest in setting specialized thyroid clinics and using point of care ultrasound. The Thyroid Special Interest Group aims to support pediatric endocrinologists providing special thyroid care to improve ## Committees - [Drugs & Therapeutics Committee](https://pedsendo.org/committee/drugs-therapeutics-committee/) - Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES. - [Practice Management Committee](https://pedsendo.org/committee/practice-management-committee/) - Charged with providing members of PES with tools and information to facilitate the practice of pediatric endocrinology. The focus is to promote multidisciplinary practice models, develop educational materials for Endocrinology providers, develop CME curricula, and develop position statements on key issues in pediatric endocrinology. If you have ideas for future topics you’d like to see - [Training Committee](https://pedsendo.org/committee/training-committee/) - Charged with providing information on regulatory issues that impact the training and certification of fellows. This council will work with other committees to develop a research advisor program, develop milestones, increase fellow participation in PES, organize educational activities, and improve communication. - [Research Affairs Committee](https://pedsendo.org/committee/research-affairs-committee/) - Charged with facilitating the research endeavors of PES members and prioritizing the research goals of PES. This council will formulate policies for research grant support, develop national/regional research advisor programs, and establish collaborative relationships with international pediatric research groups. Subcommittees: Mentoring Grants The various Grants awarded by the Society are adjudicated by the Research Affairs - [Program Committee](https://pedsendo.org/committee/program-committee/) - Charged with organizing the scientific program of the now freestanding annual meeting of PES. Additional tasks include participation in abstract review, organization of Scientific Symposia, Meet-the-Professor sessions, Plenaries, Clinical Practice Sessions, the Year-in-Review program, and Satellite Symposia, along with selecting the Leona Cutler and Human Growth Foundation Best Poster Awards. - [Nominating Committee](https://pedsendo.org/committee/nominating-committee/) - Charged with coordinating, reviewing, and arranging ballots for election of new members to the PES Board of Directors. - [Membership Committee](https://pedsendo.org/committee/membership-committee/) - Charged with accepting and reviewing all applications for membership to the Society. A recent strategic objective of this committee is to encourage and increase fellow involvement in the Society. - [Awards Committee](https://pedsendo.org/committee/awards-honors-committee/) - This committee will adjudicate the PES Laureate Awards (Clinician Award, Educator Award, Judson J Van Wyk Prize, New Investigator Award, Outstanding PES Mentor Award and the Senior Investigator Award). - [Professional Development Committee](https://pedsendo.org/committee/professional-development-committee/) - The Professional Development Committee is responsible for advancing professional growth, career development, and training of pediatric endocrinologists and trainees across the educational spectrum. - [Education Resources Committee](https://pedsendo.org/committee/education-committee/) - The Education Resources Committee is responsible for developing, organizing, and implementing educational resources for the Pediatric Endocrine Society. The Committee oversees the creation, curation, and dissemination of high-quality, accessible educational materials for patients, families, healthcare practitioners, pediatric fellows, residents, and medical students. - [Health Systems Disparity Committee](https://pedsendo.org/committee/edi-committee/) - Mission Statement: Our mission is to affirm the ideology of the PES as a scientific community that fosters inclusion, acceptance, and support for every person independent of race, ethnicity, gender, sexual orientation, or religion. Towards this end, our focus is to: Recognize implicit and explicit bias in healthcare in Pediatric Endocrinology, and address related healthcare - [History Committee](https://pedsendo.org/committee/history-committee/) - To collect, validate, collate and archive information, documents, photographic and graphic materials relevant to the history of PES and to make such materials available to the members and to generate periodically publications relevant to the history of PES and its members. - [International Relations Committee](https://pedsendo.org/committee/international-relations-committee/) - Charged with the development of international collaboration and interaction of PES with other societies/organizations to globally benefit children with endocrine conditions—with special focus on collaborations that may help to improve care in resource-constrained environments. - [Public Policy Committee](https://pedsendo.org/committee/public-policy-committee/) - Charged with identification of political and policy issues that impact the care of children with pediatric endocrine conditions and the licensure of competent pediatric endocrinologists. To develop a rapid response team to deal with critical political and policy issues that affect children with pediatric endocrine and metabolic conditions. Also assist other councils and committees with - [Website & Social Media Committee](https://pedsendo.org/committee/website-social-media-committee/) - The Website Committee is charged to review website function and utilization, to coordinate with SIGs and other committees regarding sharing of content and updates to appear on the website, and to optimize use of multiple social media platforms for societal communication. ## Categories - [Uncategorized](https://pedsendo.org/category/uncategorized/) - [Historical Tidbits](https://pedsendo.org/category/historical-tidbits/) - [Public Policy](https://pedsendo.org/category/public-policy/) - [Oral History](https://pedsendo.org/category/oral-history/) - [News & Announcements](https://pedsendo.org/category/news-announcements/) - [President's Message](https://pedsendo.org/category/presidents-message/) - [New Meds and Tech](https://pedsendo.org/category/new-meds-and-tech/) - [Member Spotlight](https://pedsendo.org/category/member-spotlight/) - [Fellow Spotlight](https://pedsendo.org/category/member-spotlight/fellow-spotlight/) - [Student Spotlight](https://pedsendo.org/category/member-spotlight/student-spotlight/) - [Drug Alerts/Recalls](https://pedsendo.org/category/drug-alerts/) - [Drug Shortages](https://pedsendo.org/category/drug-shortages/) - [In Memoriam](https://pedsendo.org/category/in-memoriam/) - [Practice Management Pearls](https://pedsendo.org/category/practice-managemet-pearls/) - [PES Leadership Advantage](https://pedsendo.org/category/pes-leadership-advantage/) - [Fellowship Posting](https://pedsendo.org/category/fellowship-posting/) - [APP Spotlight](https://pedsendo.org/category/member-spotlight/app-spotlight/) - [Regional Society](https://pedsendo.org/category/regional-society/) ## Event Categories - [SIG Webinar](https://pedsendo.org/events/category/sig-webinar/) - [PES Leadership Advantage](https://pedsendo.org/events/category/pes-leadership-advantage/) ## Roles - [Staff](https://pedsendo.org/person-role/staff/) - [Board of Directors](https://pedsendo.org/person-role/board-of-directors/) ## Group Types - [SIG](https://pedsendo.org/group-type/sig/) ## Award Types - [Awards & Lectureships](https://pedsendo.org/award-type/awards-lectureships/) - [Fellows & Junior Faculty Awards](https://pedsendo.org/award-type/fellows-junior-faculty-awards/) - [Junior Faculty Grants (JFG)](https://pedsendo.org/award-type/junior-faculty-grants-jfg-2/) - [Research Fellowship Grants (RFG)](https://pedsendo.org/award-type/research-fellowship-grants-rfg/) - [Other Grants](https://pedsendo.org/award-type/other-grants/) - [EDI Grant](https://pedsendo.org/award-type/edi-grant/) - [Abstract Award](https://pedsendo.org/award-type/abstract-award/) ## Age Ranges - [3-11 years](https://pedsendo.org/age-range/3-11-years/) - [4-10 years](https://pedsendo.org/age-range/4-10-years/) ## Resource Types - [Care Guideline](https://pedsendo.org/resource-type/care-guideline/) - [Consensus Statement](https://pedsendo.org/resource-type/consensus-statement/) - [Review](https://pedsendo.org/resource-type/review/) - [Article](https://pedsendo.org/resource-type/article/) - [Paper](https://pedsendo.org/resource-type/paper/) - [Paper Review](https://pedsendo.org/resource-type/paper-review/) - [Referral Guidelines](https://pedsendo.org/resource-type/referral-guidelines/) - [Referral Guideline](https://pedsendo.org/resource-type/referral-guideline/) ## Audiences - [Clinicians](https://pedsendo.org/audience/clinicians/) - [Fellows](https://pedsendo.org/audience/fellows/) - [Residents](https://pedsendo.org/audience/residents/) - [Students](https://pedsendo.org/audience/students/) - [Researchers](https://pedsendo.org/audience/researchers/) - [Patients](https://pedsendo.org/audience/patients/) ## Society Topics - [Education](https://pedsendo.org/society-topic/education/) - [Care Guidelines](https://pedsendo.org/society-topic/care-guidelines/) - [Advocacy](https://pedsendo.org/society-topic/advocacy/) - [Clinical Care](https://pedsendo.org/society-topic/clinical-care/) - [Ethics](https://pedsendo.org/society-topic/ethics/) - [Policy](https://pedsendo.org/society-topic/policy/) - [Referral Guidelines](https://pedsendo.org/society-topic/referral-guidelines/) ## Clinical Topics - [Hypoglycemia](https://pedsendo.org/clinical-topic/hypoglycemia/) - [Lipid Disorders](https://pedsendo.org/clinical-topic/lipid-disorders/) - [Thyroid Disorders](https://pedsendo.org/clinical-topic/thyroid-disorders/) - [Adrenal](https://pedsendo.org/clinical-topic/adrenal/) - [Differences of Sex Development](https://pedsendo.org/clinical-topic/disorders-of-sexual-differentiation/) - [Adrenal Insufficiency](https://pedsendo.org/clinical-topic/adrenal/adrenal-insufficiency/) - [CAH](https://pedsendo.org/clinical-topic/adrenal/cah/) - [Bone and Mineral Metabolism](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/) - [Calcium](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/calcium/) - [Phosphate](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/phosphate/) - [Alkaline Phosphatase](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/alkaline-phosphatase/) - [Vitamin D](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/vitamin-d/) - [Osteoporosis](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/osteoporosis/) - [Rickets](https://pedsendo.org/clinical-topic/bone-and-mineral-metabolism/rickets/) - [Endocrine Care in Childhood Cancer Survivors](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/) - [Endocrine Care for Children with Intellectual Disabilities](https://pedsendo.org/clinical-topic/endocrine-care-for-children-with-intellectual-disabilities/) - [Genetic Disorders](https://pedsendo.org/clinical-topic/genetic-disorders/) - [Klinefelter Syndrome](https://pedsendo.org/clinical-topic/genetic-disorders/klinefelter-syndrome/) - [Prader Willi Syndrome](https://pedsendo.org/clinical-topic/genetic-disorders/prader-willi-syndrome/) - [Silver-Russell Syndrome](https://pedsendo.org/clinical-topic/genetic-disorders/silver-russell-syndrome/) - [Turner Syndrome](https://pedsendo.org/clinical-topic/genetic-disorders/turner-syndrome/) - [Growth](https://pedsendo.org/clinical-topic/growth/) - [Delayed Growth](https://pedsendo.org/clinical-topic/growth/delayed-growth/) - [Multiple Endocrine Neoplasia Syndromes](https://pedsendo.org/clinical-topic/multiple-endocrine-neoplasia-syndromes/) - [MEN1](https://pedsendo.org/clinical-topic/multiple-endocrine-neoplasia-syndromes/men1/) - [MEN2](https://pedsendo.org/clinical-topic/multiple-endocrine-neoplasia-syndromes/men2/) - [Obesity/Metabolic Syndrome](https://pedsendo.org/clinical-topic/obesity-metabolic-syndrome/) - [Endocrine Consequences of Obesity](https://pedsendo.org/clinical-topic/obesity-metabolic-syndrome/endocrine-consequences-of-obesity/) - [PCOS](https://pedsendo.org/clinical-topic/obesity-metabolic-syndrome/pcos/) - [Puberty Disorders](https://pedsendo.org/clinical-topic/puberty-disorders/) - [Female](https://pedsendo.org/clinical-topic/puberty-disorders/female/) - [Male](https://pedsendo.org/clinical-topic/puberty-disorders/male/) - [Research](https://pedsendo.org/clinical-topic/research/) - [Hyperthyroidism](https://pedsendo.org/clinical-topic/thyroid-disorders/hyperthyroidism/) - [Hypothyroidism](https://pedsendo.org/clinical-topic/thyroid-disorders/hypothyroidism/) - [Thyroid and Prematurity](https://pedsendo.org/clinical-topic/thyroid-disorders/thyroid-and-prematurity/) - [Transgender Care](https://pedsendo.org/clinical-topic/transgender-care/) - [Clinical Care Guidelines](https://pedsendo.org/clinical-topic/transgender-care/clinical-care-guidelines/) - [Advocacy](https://pedsendo.org/clinical-topic/transgender-care/advocacy/) - [Impaired Growth](https://pedsendo.org/clinical-topic/growth/impaired-growth/) - [Delayed Puberty](https://pedsendo.org/clinical-topic/puberty-disorders/delayed-puberty/) - [Congenital Adrenal Hyperplasia](https://pedsendo.org/clinical-topic/adrenal/congenital-adrenal-hyperplasia/) - [Cushing's](https://pedsendo.org/clinical-topic/adrenal/cushings/) - [Diabetes](https://pedsendo.org/clinical-topic/diabetes/) - [Type 2](https://pedsendo.org/clinical-topic/diabetes/type-2-diabetes/) - [Obesity](https://pedsendo.org/clinical-topic/diabetes/obesity/) - [CFRD](https://pedsendo.org/clinical-topic/diabetes/cfrd-diabetes/) - [Type 1](https://pedsendo.org/clinical-topic/diabetes/type-1-diabetes/) - [Pituitary Consequences](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/pituitary-consequences/) - [General Reviews](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/general-reviews/) - [Transplant](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/transplant/) - [Non-brain Solid Tumors](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/non-brain-solid-tumors/) - [Brain Solid Tumors](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/brain-solid-tumors/) - [Thyroid Consequences](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/thyroid-consequences/) - [Gonads](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/gonads/) - [Bone Consequences and Metabolic Syndrome](https://pedsendo.org/clinical-topic/endocrine-care-in-childhood-cancer-survivors/bone-consequences-and-metabolic-syndrome/) - [Puberty](https://pedsendo.org/clinical-topic/puberty/) - [Precocious Puberty](https://pedsendo.org/clinical-topic/puberty/precocious-puberty/) - [Thyroid](https://pedsendo.org/clinical-topic/thyroid/) - [Thyroid Nodules](https://pedsendo.org/clinical-topic/thyroid/thyroid-nodules-thyroid/) - [Hypothyroidism](https://pedsendo.org/clinical-topic/thyroid/hypothyroidism-thyroid/) - [Tumor Related and Neuroendocrine](https://pedsendo.org/clinical-topic/tumor-related-and-neuroendocrine/) ## Sexes - [Studies with Male Participants](https://pedsendo.org/sex/studies-with-male-participants/)